<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>Lab 06 - Regular Expressions and Web Scraping</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>
<style type="text/css">@font-face {
font-family: "et-book";
src: url(data:font/ttf;base64,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) format("truetype");
font-weight: normal;
font-style: normal
}
@font-face {
font-family: "et-book";
src: url(data:font/ttf;base64,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) format("truetype");
font-weight: normal;
font-style: italic
}
@font-face {
font-family: "et-book";
src: url(data:font/ttf;base64,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) format("truetype");
font-weight: bold;
font-style: normal
}
@font-face {
font-family: "et-book-roman-old-style";
src: url(data:font/ttf;base64,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) format("truetype");
font-weight: normal;
font-style: normal;
}
body { font-family: et-book, Palatino, "Palatino Linotype", "Palatino LT STD", "Book Antiqua", Georgia, serif; }
.numeral, .sidenote-number { font-family: et-book-roman-old-style; }
</style>
<style type="text/css">body {
background-color: #fffff8;
}
</style>
<style type="text/css">h1, h2, h3.subtitle { font-style: italic; }
</style>
<style type="text/css">
@charset "UTF-8";

html { font-size: 15px; }
body { width: 87.5%;
margin-left: auto;
margin-right: auto;
padding-left: 12.5%;
color: #111;
max-width: 1400px;
counter-reset: sidenote-counter; }
h1.title { font-weight: 400;
font-style: normal;
margin-top: 4rem;
margin-bottom: 1.5rem;
font-size: 3.2rem;
line-height: 1; }
h1 {
font-weight: 400;
margin-top: 2.1rem;
margin-bottom: 0;
font-size: 2.2rem;
line-height: 1; }
h2 {
font-weight: 400;
font-size: 1.7rem;
margin-top: 2rem;
margin-bottom: 0;
line-height: 1; }
h3.subtitle {
font-weight: 400;
margin-top: 1rem;
margin-bottom: 1rem;
font-size: 1.8rem;
display: block;
line-height: 1; }
h4.author, h4.date {
font-size: 1.4rem;
font-weight: 400;
margin: 1rem auto;
line-height: 1;
}
.danger { color: red; }
article { position: relative;
padding: 5rem 0rem; }
section { padding-top: 1rem;
padding-bottom: 1rem; }
p, ol, ul { font-size: 1.4rem; }
p { line-height: 2rem;
margin-top: 1.4rem;
margin-bottom: 1.4rem;
padding-right: 0;
vertical-align: baseline; }
blockquote { font-size: 1.4rem; }
blockquote p { width: 50%; }
blockquote footer { width: 50%;
font-size: 1.1rem;
text-align: right; }
ol, ul { width: 45%;
-webkit-padding-start: 5%;
-webkit-padding-end: 5%; }
li { padding: 0.5rem 0; }
table {
border-top: 2px solid #111;
border-bottom: 2px solid #111;
font-size: 1.1rem;
}
th {
border-bottom: 1px solid #111;
}
div.figure {
padding: 0;
border: 0;
font-size: 100%;
font: inherit;
vertical-align: baseline;
max-width: 55%;
-webkit-margin-start: 0;
-webkit-margin-end: 0;
margin: 0 0 3em 0;
}

a:link, a:visited { color: inherit; }
a:link { text-decoration: none;
background: -webkit-linear-gradient(#fffff8, #fffff8), -webkit-linear-gradient(#fffff8, #fffff8), -webkit-linear-gradient(#333, #333);
background: linear-gradient(#fffff8, #fffff8), linear-gradient(#fffff8, #fffff8), linear-gradient(#333, #333);
-webkit-background-size: 0.05em 1px, 0.05em 1px, 1px 1px;
-moz-background-size: 0.05em 1px, 0.05em 1px, 1px 1px;
background-size: 0.05em 1px, 0.05em 1px, 1px 1px;
background-repeat: no-repeat, no-repeat, repeat-x;
text-shadow: 0.03em 0 #fffff8, -0.03em 0 #fffff8, 0 0.03em #fffff8, 0 -0.03em #fffff8, 0.06em 0 #fffff8, -0.06em 0 #fffff8, 0.09em 0 #fffff8, -0.09em 0 #fffff8, 0.12em 0 #fffff8, -0.12em 0 #fffff8, 0.15em 0 #fffff8, -0.15em 0 #fffff8;
background-position: 0% 93%, 100% 93%, 0% 93%; }
@media screen and (-webkit-min-device-pixel-ratio: 0) { a:link { background-position-y: 87%, 87%, 87%; } }
a:link::selection { text-shadow: 0.03em 0 #b4d5fe, -0.03em 0 #b4d5fe, 0 0.03em #b4d5fe, 0 -0.03em #b4d5fe, 0.06em 0 #b4d5fe, -0.06em 0 #b4d5fe, 0.09em 0 #b4d5fe, -0.09em 0 #b4d5fe, 0.12em 0 #b4d5fe, -0.12em 0 #b4d5fe, 0.15em 0 #b4d5fe, -0.15em 0 #b4d5fe;
background: #b4d5fe; }
a:link::-moz-selection { text-shadow: 0.03em 0 #b4d5fe, -0.03em 0 #b4d5fe, 0 0.03em #b4d5fe, 0 -0.03em #b4d5fe, 0.06em 0 #b4d5fe, -0.06em 0 #b4d5fe, 0.09em 0 #b4d5fe, -0.09em 0 #b4d5fe, 0.12em 0 #b4d5fe, -0.12em 0 #b4d5fe, 0.15em 0 #b4d5fe, -0.15em 0 #b4d5fe;
background: #b4d5fe; }

img {max-width: 100%;}
.marginnote img { display: block; }
.sidenote, .marginnote { float: right;
clear: right;
margin-right: -60%;
width: 50%;
margin-top: 0;
margin-bottom: 1rem;
font-size: 1.1rem;
line-height: 1.3;
vertical-align: baseline;
position: relative; }
.sidenote-number {
position: relative;
vertical-align: baseline; }
.sidenote-number { font-size: 1rem;
top: -0.5rem;
left: 0.1rem; }
p, footer, table, hr { width: 55%; }
hr { margin-left: 0; }
table table, li p, li pre { width: auto; }
li p, li pre {margin-top: auto; }
div.fullwidth, table.fullwidth { max-width: 90%; }
div.fullwidth > * { width: auto; }
#TOC, h1.title { max-width: 90%; }
#TOC ol, #TOC ul { width: auto; }
div.fullwidth p.caption {
margin-right: 0;
max-width: 33%;
}
p.caption { text-align: left; }
@media screen and (max-width: 760px) { p, footer, ol, ul, table, hr { width: 90%; }
pre { width: 87.5%; }
ul { width: 85%; }
figure { max-width: 90%; }
div.fullwidth p.caption { max-width: none; }
blockquote p, blockquote footer { width: 90%; }}
.sans { font-family: "Gill Sans", "Gill Sans MT", Calibri, sans-serif;
letter-spacing: .03em; }
code { font-family: Consolas, "Liberation Mono", Menlo, Courier, monospace;
font-size: 1.125rem;
line-height: 1.6; }
pre code { font-size: 1rem; }
p code { white-space: inherit; }
h1 code, h2 code, h3 code { font-size: 0.80em; }
.marginnote code, .sidenote code { font-size: 1rem; }
pre { width: 52.5%;
overflow-x: auto; }
.fullwidth { max-width: 90%;
clear:both; }
span.newthought { font-variant: small-caps;
font-size: 1.2em; }
input.margin-toggle { display: none; }
label.sidenote-number { display: inline; }
label.margin-toggle:not(.sidenote-number) { display: none; }
@media (max-width: 760px) { label.margin-toggle:not(.sidenote-number) { display: inline; }
.sidenote, .marginnote { display: none; }
.shownote,
.margin-toggle:checked + .sidenote,
.margin-toggle:checked + .marginnote {
display: block;
float: left;
left: 1rem;
clear: both;
width: 95%;
margin: 1rem 2.5%;
vertical-align: baseline;
position: relative;
}
label { cursor: pointer; }
div.figure { max-width: 90%; }
pre { width: 90%;
padding: 0; }
}
</style>
<style type="text/css">.hljs-literal {
color: #990073;
}
.hljs-number {
color: #099;
}
.hljs-comment {
color: #998;
font-style: italic;
}
.hljs-keyword {
color: #900;
font-weight: bold;
}
.hljs-string {
color: #d14;
}
</style>
<script src="data:application/javascript;base64,/*! highlight.js v9.12.0 | BSD3 License | git.io/hljslicense */
!function(e){var n="object"==typeof window&&window||"object"==typeof self&&self;"undefined"!=typeof exports?e(exports):n&&(n.hljs=e({}),"function"==typeof define&&define.amd&&define([],function(){return n.hljs}))}(function(e){function n(e){return e.replace(/&/g,"&amp;").replace(/</g,"&lt;").replace(/>/g,"&gt;")}function t(e){return e.nodeName.toLowerCase()}function r(e,n){var t=e&&e.exec(n);return t&&0===t.index}function a(e){return k.test(e)}function i(e){var n,t,r,i,o=e.className+" ";if(o+=e.parentNode?e.parentNode.className:"",t=B.exec(o))return w(t[1])?t[1]:"no-highlight";for(o=o.split(/\s+/),n=0,r=o.length;r>n;n++)if(i=o[n],a(i)||w(i))return i}function o(e){var n,t={},r=Array.prototype.slice.call(arguments,1);for(n in e)t[n]=e[n];return r.forEach(function(e){for(n in e)t[n]=e[n]}),t}function u(e){var n=[];return function r(e,a){for(var i=e.firstChild;i;i=i.nextSibling)3===i.nodeType?a+=i.nodeValue.length:1===i.nodeType&&(n.push({event:"start",offset:a,node:i}),a=r(i,a),t(i).match(/br|hr|img|input/)||n.push({event:"stop",offset:a,node:i}));return a}(e,0),n}function c(e,r,a){function i(){return e.length&&r.length?e[0].offset!==r[0].offset?e[0].offset<r[0].offset?e:r:"start"===r[0].event?e:r:e.length?e:r}function o(e){function r(e){return" "+e.nodeName+'="'+n(e.value).replace('"',"&quot;")+'"'}s+="<"+t(e)+E.map.call(e.attributes,r).join("")+">"}function u(e){s+="</"+t(e)+">"}function c(e){("start"===e.event?o:u)(e.node)}for(var l=0,s="",f=[];e.length||r.length;){var g=i();if(s+=n(a.substring(l,g[0].offset)),l=g[0].offset,g===e){f.reverse().forEach(u);do c(g.splice(0,1)[0]),g=i();while(g===e&&g.length&&g[0].offset===l);f.reverse().forEach(o)}else"start"===g[0].event?f.push(g[0].node):f.pop(),c(g.splice(0,1)[0])}return s+n(a.substr(l))}function l(e){return e.v&&!e.cached_variants&&(e.cached_variants=e.v.map(function(n){return o(e,{v:null},n)})),e.cached_variants||e.eW&&[o(e)]||[e]}function s(e){function n(e){return e&&e.source||e}function t(t,r){return new RegExp(n(t),"m"+(e.cI?"i":"")+(r?"g":""))}function r(a,i){if(!a.compiled){if(a.compiled=!0,a.k=a.k||a.bK,a.k){var o={},u=function(n,t){e.cI&&(t=t.toLowerCase()),t.split(" ").forEach(function(e){var t=e.split("|");o[t[0]]=[n,t[1]?Number(t[1]):1]})};"string"==typeof a.k?u("keyword",a.k):x(a.k).forEach(function(e){u(e,a.k[e])}),a.k=o}a.lR=t(a.l||/\w+/,!0),i&&(a.bK&&(a.b="\\b("+a.bK.split(" ").join("|")+")\\b"),a.b||(a.b=/\B|\b/),a.bR=t(a.b),a.e||a.eW||(a.e=/\B|\b/),a.e&&(a.eR=t(a.e)),a.tE=n(a.e)||"",a.eW&&i.tE&&(a.tE+=(a.e?"|":"")+i.tE)),a.i&&(a.iR=t(a.i)),null==a.r&&(a.r=1),a.c||(a.c=[]),a.c=Array.prototype.concat.apply([],a.c.map(function(e){return l("self"===e?a:e)})),a.c.forEach(function(e){r(e,a)}),a.starts&&r(a.starts,i);var c=a.c.map(function(e){return e.bK?"\\.?("+e.b+")\\.?":e.b}).concat([a.tE,a.i]).map(n).filter(Boolean);a.t=c.length?t(c.join("|"),!0):{exec:function(){return null}}}}r(e)}function f(e,t,a,i){function o(e,n){var t,a;for(t=0,a=n.c.length;a>t;t++)if(r(n.c[t].bR,e))return n.c[t]}function u(e,n){if(r(e.eR,n)){for(;e.endsParent&&e.parent;)e=e.parent;return e}return e.eW?u(e.parent,n):void 0}function c(e,n){return!a&&r(n.iR,e)}function l(e,n){var t=N.cI?n[0].toLowerCase():n[0];return e.k.hasOwnProperty(t)&&e.k[t]}function p(e,n,t,r){var a=r?"":I.classPrefix,i='<span class="'+a,o=t?"":C;return i+=e+'">',i+n+o}function h(){var e,t,r,a;if(!E.k)return n(k);for(a="",t=0,E.lR.lastIndex=0,r=E.lR.exec(k);r;)a+=n(k.substring(t,r.index)),e=l(E,r),e?(B+=e[1],a+=p(e[0],n(r[0]))):a+=n(r[0]),t=E.lR.lastIndex,r=E.lR.exec(k);return a+n(k.substr(t))}function d(){var e="string"==typeof E.sL;if(e&&!y[E.sL])return n(k);var t=e?f(E.sL,k,!0,x[E.sL]):g(k,E.sL.length?E.sL:void 0);return E.r>0&&(B+=t.r),e&&(x[E.sL]=t.top),p(t.language,t.value,!1,!0)}function b(){L+=null!=E.sL?d():h(),k=""}function v(e){L+=e.cN?p(e.cN,"",!0):"",E=Object.create(e,{parent:{value:E}})}function m(e,n){if(k+=e,null==n)return b(),0;var t=o(n,E);if(t)return t.skip?k+=n:(t.eB&&(k+=n),b(),t.rB||t.eB||(k=n)),v(t,n),t.rB?0:n.length;var r=u(E,n);if(r){var a=E;a.skip?k+=n:(a.rE||a.eE||(k+=n),b(),a.eE&&(k=n));do E.cN&&(L+=C),E.skip||(B+=E.r),E=E.parent;while(E!==r.parent);return r.starts&&v(r.starts,""),a.rE?0:n.length}if(c(n,E))throw new Error('Illegal lexeme "'+n+'" for mode "'+(E.cN||"<unnamed>")+'"');return k+=n,n.length||1}var N=w(e);if(!N)throw new Error('Unknown language: "'+e+'"');s(N);var R,E=i||N,x={},L="";for(R=E;R!==N;R=R.parent)R.cN&&(L=p(R.cN,"",!0)+L);var k="",B=0;try{for(var M,j,O=0;;){if(E.t.lastIndex=O,M=E.t.exec(t),!M)break;j=m(t.substring(O,M.index),M[0]),O=M.index+j}for(m(t.substr(O)),R=E;R.parent;R=R.parent)R.cN&&(L+=C);return{r:B,value:L,language:e,top:E}}catch(T){if(T.message&&-1!==T.message.indexOf("Illegal"))return{r:0,value:n(t)};throw T}}function g(e,t){t=t||I.languages||x(y);var r={r:0,value:n(e)},a=r;return t.filter(w).forEach(function(n){var t=f(n,e,!1);t.language=n,t.r>a.r&&(a=t),t.r>r.r&&(a=r,r=t)}),a.language&&(r.second_best=a),r}function p(e){return I.tabReplace||I.useBR?e.replace(M,function(e,n){return I.useBR&&"\n"===e?"<br>":I.tabReplace?n.replace(/\t/g,I.tabReplace):""}):e}function h(e,n,t){var r=n?L[n]:t,a=[e.trim()];return e.match(/\bhljs\b/)||a.push("hljs"),-1===e.indexOf(r)&&a.push(r),a.join(" ").trim()}function d(e){var n,t,r,o,l,s=i(e);a(s)||(I.useBR?(n=document.createElementNS("http://www.w3.org/1999/xhtml","div"),n.innerHTML=e.innerHTML.replace(/\n/g,"").replace(/<br[ \/]*>/g,"\n")):n=e,l=n.textContent,r=s?f(s,l,!0):g(l),t=u(n),t.length&&(o=document.createElementNS("http://www.w3.org/1999/xhtml","div"),o.innerHTML=r.value,r.value=c(t,u(o),l)),r.value=p(r.value),e.innerHTML=r.value,e.className=h(e.className,s,r.language),e.result={language:r.language,re:r.r},r.second_best&&(e.second_best={language:r.second_best.language,re:r.second_best.r}))}function b(e){I=o(I,e)}function v(){if(!v.called){v.called=!0;var e=document.querySelectorAll("pre code");E.forEach.call(e,d)}}function m(){addEventListener("DOMContentLoaded",v,!1),addEventListener("load",v,!1)}function N(n,t){var r=y[n]=t(e);r.aliases&&r.aliases.forEach(function(e){L[e]=n})}function R(){return x(y)}function w(e){return e=(e||"").toLowerCase(),y[e]||y[L[e]]}var E=[],x=Object.keys,y={},L={},k=/^(no-?highlight|plain|text)$/i,B=/\blang(?:uage)?-([\w-]+)\b/i,M=/((^(<[^>]+>|\t|)+|(?:\n)))/gm,C="</span>",I={classPrefix:"hljs-",tabReplace:null,useBR:!1,languages:void 0};return e.highlight=f,e.highlightAuto=g,e.fixMarkup=p,e.highlightBlock=d,e.configure=b,e.initHighlighting=v,e.initHighlightingOnLoad=m,e.registerLanguage=N,e.listLanguages=R,e.getLanguage=w,e.inherit=o,e.IR="[a-zA-Z]\\w*",e.UIR="[a-zA-Z_]\\w*",e.NR="\\b\\d+(\\.\\d+)?",e.CNR="(-?)(\\b0[xX][a-fA-F0-9]+|(\\b\\d+(\\.\\d*)?|\\.\\d+)([eE][-+]?\\d+)?)",e.BNR="\\b(0b[01]+)",e.RSR="!|!=|!==|%|%=|&|&&|&=|\\*|\\*=|\\+|\\+=|,|-|-=|/=|/|:|;|<<|<<=|<=|<|===|==|=|>>>=|>>=|>=|>>>|>>|>|\\?|\\[|\\{|\\(|\\^|\\^=|\\||\\|=|\\|\\||~",e.BE={b:"\\\\[\\s\\S]",r:0},e.ASM={cN:"string",b:"'",e:"'",i:"\\n",c:[e.BE]},e.QSM={cN:"string",b:'"',e:'"',i:"\\n",c:[e.BE]},e.PWM={b:/\b(a|an|the|are|I'm|isn't|don't|doesn't|won't|but|just|should|pretty|simply|enough|gonna|going|wtf|so|such|will|you|your|they|like|more)\b/},e.C=function(n,t,r){var a=e.inherit({cN:"comment",b:n,e:t,c:[]},r||{});return a.c.push(e.PWM),a.c.push({cN:"doctag",b:"(?:TODO|FIXME|NOTE|BUG|XXX):",r:0}),a},e.CLCM=e.C("//","$"),e.CBCM=e.C("/\\*","\\*/"),e.HCM=e.C("#","$"),e.NM={cN:"number",b:e.NR,r:0},e.CNM={cN:"number",b:e.CNR,r:0},e.BNM={cN:"number",b:e.BNR,r:0},e.CSSNM={cN:"number",b:e.NR+"(%|em|ex|ch|rem|vw|vh|vmin|vmax|cm|mm|in|pt|pc|px|deg|grad|rad|turn|s|ms|Hz|kHz|dpi|dpcm|dppx)?",r:0},e.RM={cN:"regexp",b:/\//,e:/\/[gimuy]*/,i:/\n/,c:[e.BE,{b:/\[/,e:/\]/,r:0,c:[e.BE]}]},e.TM={cN:"title",b:e.IR,r:0},e.UTM={cN:"title",b:e.UIR,r:0},e.METHOD_GUARD={b:"\\.\\s*"+e.UIR,r:0},e});hljs.registerLanguage("sql",function(e){var t=e.C("--","$");return{cI:!0,i:/[<>{}*#]/,c:[{bK:"begin end start commit rollback savepoint lock alter create drop rename call delete do handler insert load replace select truncate update set show pragma grant merge describe use explain help declare prepare execute deallocate release unlock purge reset change stop analyze cache flush optimize repair kill install uninstall checksum restore check backup revoke comment",e:/;/,eW:!0,l:/[\w\.]+/,k:{keyword:"abort abs absolute acc acce accep accept access accessed accessible account acos action activate add addtime admin administer advanced advise aes_decrypt aes_encrypt after agent aggregate ali alia alias allocate allow alter always analyze ancillary and any anydata anydataset anyschema anytype apply archive archived archivelog are as asc ascii asin assembly assertion associate asynchronous at atan atn2 attr attri attrib attribu attribut attribute attributes audit authenticated authentication authid authors auto autoallocate autodblink autoextend automatic availability avg backup badfile basicfile before begin beginning benchmark between bfile bfile_base big bigfile bin binary_double binary_float binlog bit_and bit_count bit_length bit_or bit_xor bitmap blob_base block blocksize body both bound buffer_cache buffer_pool build bulk by byte byteordermark bytes cache caching call calling cancel capacity cascade cascaded case cast catalog category ceil ceiling chain change changed char_base char_length character_length characters characterset charindex charset charsetform charsetid check checksum checksum_agg child choose chr chunk class cleanup clear client clob clob_base clone close cluster_id cluster_probability cluster_set clustering coalesce coercibility col collate collation collect colu colum column column_value columns columns_updated comment commit compact compatibility compiled complete composite_limit compound compress compute concat concat_ws concurrent confirm conn connec connect connect_by_iscycle connect_by_isleaf connect_by_root connect_time connection consider consistent constant constraint constraints constructor container content contents context contributors controlfile conv convert convert_tz corr corr_k corr_s corresponding corruption cos cost count count_big counted covar_pop covar_samp cpu_per_call cpu_per_session crc32 create creation critical cross cube cume_dist curdate current current_date current_time current_timestamp current_user cursor curtime customdatum cycle data database databases datafile datafiles datalength date_add date_cache date_format date_sub dateadd datediff datefromparts datename datepart datetime2fromparts day day_to_second dayname dayofmonth dayofweek dayofyear days db_role_change dbtimezone ddl deallocate declare decode decompose decrement decrypt deduplicate def defa defau defaul default defaults deferred defi defin define degrees delayed delegate delete delete_all delimited demand dense_rank depth dequeue des_decrypt des_encrypt des_key_file desc descr descri describ describe descriptor deterministic diagnostics difference dimension direct_load directory disable disable_all disallow disassociate discardfile disconnect diskgroup distinct distinctrow distribute distributed div do document domain dotnet double downgrade drop dumpfile duplicate duration each edition editionable editions element ellipsis else elsif elt empty enable enable_all enclosed encode encoding encrypt end end-exec endian enforced engine engines enqueue enterprise entityescaping eomonth error errors escaped evalname evaluate event eventdata events except exception exceptions exchange exclude excluding execu execut execute exempt exists exit exp expire explain export export_set extended extent external external_1 external_2 externally extract failed failed_login_attempts failover failure far fast feature_set feature_value fetch field fields file file_name_convert filesystem_like_logging final finish first first_value fixed flash_cache flashback floor flush following follows for forall force form forma format found found_rows freelist freelists freepools fresh from from_base64 from_days ftp full function general generated get get_format get_lock getdate getutcdate global global_name globally go goto grant grants greatest group group_concat group_id grouping grouping_id groups gtid_subtract guarantee guard handler hash hashkeys having hea head headi headin heading heap help hex hierarchy high high_priority hosts hour http id ident_current ident_incr ident_seed identified identity idle_time if ifnull ignore iif ilike ilm immediate import in include including increment index indexes indexing indextype indicator indices inet6_aton inet6_ntoa inet_aton inet_ntoa infile initial initialized initially initrans inmemory inner innodb input insert install instance instantiable instr interface interleaved intersect into invalidate invisible is is_free_lock is_ipv4 is_ipv4_compat is_not is_not_null is_used_lock isdate isnull isolation iterate java join json json_exists keep keep_duplicates key keys kill language large last last_day last_insert_id last_value lax lcase lead leading least leaves left len lenght length less level levels library like like2 like4 likec limit lines link list listagg little ln load load_file lob lobs local localtime localtimestamp locate locator lock locked log log10 log2 logfile logfiles logging logical logical_reads_per_call logoff logon logs long loop low low_priority lower lpad lrtrim ltrim main make_set makedate maketime managed management manual map mapping mask master master_pos_wait match matched materialized max maxextents maximize maxinstances maxlen maxlogfiles maxloghistory maxlogmembers maxsize maxtrans md5 measures median medium member memcompress memory merge microsecond mid migration min minextents minimum mining minus minute minvalue missing mod mode model modification modify module monitoring month months mount move movement multiset mutex name name_const names nan national native natural nav nchar nclob nested never new newline next nextval no no_write_to_binlog noarchivelog noaudit nobadfile nocheck nocompress nocopy nocycle nodelay nodiscardfile noentityescaping noguarantee nokeep nologfile nomapping nomaxvalue nominimize nominvalue nomonitoring none noneditionable nonschema noorder nopr nopro noprom nopromp noprompt norely noresetlogs noreverse normal norowdependencies noschemacheck noswitch not nothing notice notrim novalidate now nowait nth_value nullif nulls num numb numbe nvarchar nvarchar2 object ocicoll ocidate ocidatetime ociduration ociinterval ociloblocator ocinumber ociref ocirefcursor ocirowid ocistring ocitype oct octet_length of off offline offset oid oidindex old on online only opaque open operations operator optimal optimize option optionally or oracle oracle_date oradata ord ordaudio orddicom orddoc order ordimage ordinality ordvideo organization orlany orlvary out outer outfile outline output over overflow overriding package pad parallel parallel_enable parameters parent parse partial partition partitions pascal passing password password_grace_time password_lock_time password_reuse_max password_reuse_time password_verify_function patch path patindex pctincrease pctthreshold pctused pctversion percent percent_rank percentile_cont percentile_disc performance period period_add period_diff permanent physical pi pipe pipelined pivot pluggable plugin policy position post_transaction pow power pragma prebuilt precedes preceding precision prediction prediction_cost prediction_details prediction_probability prediction_set prepare present preserve prior priority private private_sga privileges procedural procedure procedure_analyze processlist profiles project prompt protection public publishingservername purge quarter query quick quiesce quota quotename radians raise rand range rank raw read reads readsize rebuild record records recover recovery recursive recycle redo reduced ref reference referenced references referencing refresh regexp_like register regr_avgx regr_avgy regr_count regr_intercept regr_r2 regr_slope regr_sxx regr_sxy reject rekey relational relative relaylog release release_lock relies_on relocate rely rem remainder rename repair repeat replace replicate replication required reset resetlogs resize resource respect restore restricted result result_cache resumable resume retention return returning returns reuse reverse revoke right rlike role roles rollback rolling rollup round row row_count rowdependencies rowid rownum rows rtrim rules safe salt sample save savepoint sb1 sb2 sb4 scan schema schemacheck scn scope scroll sdo_georaster sdo_topo_geometry search sec_to_time second section securefile security seed segment select self sequence sequential serializable server servererror session session_user sessions_per_user set sets settings sha sha1 sha2 share shared shared_pool short show shrink shutdown si_averagecolor si_colorhistogram si_featurelist si_positionalcolor si_stillimage si_texture siblings sid sign sin size size_t sizes skip slave sleep smalldatetimefromparts smallfile snapshot some soname sort soundex source space sparse spfile split sql sql_big_result sql_buffer_result sql_cache sql_calc_found_rows sql_small_result sql_variant_property sqlcode sqldata sqlerror sqlname sqlstate sqrt square standalone standby start starting startup statement static statistics stats_binomial_test stats_crosstab stats_ks_test stats_mode stats_mw_test stats_one_way_anova stats_t_test_ stats_t_test_indep stats_t_test_one stats_t_test_paired stats_wsr_test status std stddev stddev_pop stddev_samp stdev stop storage store stored str str_to_date straight_join strcmp strict string struct stuff style subdate subpartition subpartitions substitutable substr substring subtime subtring_index subtype success sum suspend switch switchoffset switchover sync synchronous synonym sys sys_xmlagg sysasm sysaux sysdate sysdatetimeoffset sysdba sysoper system system_user sysutcdatetime table tables tablespace tan tdo template temporary terminated tertiary_weights test than then thread through tier ties time time_format time_zone timediff timefromparts timeout timestamp timestampadd timestampdiff timezone_abbr timezone_minute timezone_region to to_base64 to_date to_days to_seconds todatetimeoffset trace tracking transaction transactional translate translation treat trigger trigger_nestlevel triggers trim truncate try_cast try_convert try_parse type ub1 ub2 ub4 ucase unarchived unbounded uncompress under undo unhex unicode uniform uninstall union unique unix_timestamp unknown unlimited unlock unpivot unrecoverable unsafe unsigned until untrusted unusable unused update updated upgrade upped upper upsert url urowid usable usage use use_stored_outlines user user_data user_resources users using utc_date utc_timestamp uuid uuid_short validate validate_password_strength validation valist value values var var_samp varcharc vari varia variab variabl variable variables variance varp varraw varrawc varray verify version versions view virtual visible void wait wallet warning warnings week weekday weekofyear wellformed when whene whenev wheneve whenever where while whitespace with within without work wrapped xdb xml xmlagg xmlattributes xmlcast xmlcolattval xmlelement xmlexists xmlforest xmlindex xmlnamespaces xmlpi xmlquery xmlroot xmlschema xmlserialize xmltable xmltype xor year year_to_month years yearweek",literal:"true false null",built_in:"array bigint binary bit blob boolean char character date dec decimal float int int8 integer interval number numeric real record serial serial8 smallint text varchar varying void"},c:[{cN:"string",b:"'",e:"'",c:[e.BE,{b:"''"}]},{cN:"string",b:'"',e:'"',c:[e.BE,{b:'""'}]},{cN:"string",b:"`",e:"`",c:[e.BE]},e.CNM,e.CBCM,t]},e.CBCM,t]}});hljs.registerLanguage("r",function(e){var r="([a-zA-Z]|\\.[a-zA-Z.])[a-zA-Z0-9._]*";return{c:[e.HCM,{b:r,l:r,k:{keyword:"function if in break next repeat else for return switch while try tryCatch stop warning require library attach detach source setMethod setGeneric setGroupGeneric setClass ...",literal:"NULL NA TRUE FALSE T F Inf NaN NA_integer_|10 NA_real_|10 NA_character_|10 NA_complex_|10"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{b:"`",e:"`",r:0},{cN:"string",c:[e.BE],v:[{b:'"',e:'"'},{b:"'",e:"'"}]}]}});hljs.registerLanguage("perl",function(e){var t="getpwent getservent quotemeta msgrcv scalar kill dbmclose undef lc ma syswrite tr send umask sysopen shmwrite vec qx utime local oct semctl localtime readpipe do return format read sprintf dbmopen pop getpgrp not getpwnam rewinddir qqfileno qw endprotoent wait sethostent bless s|0 opendir continue each sleep endgrent shutdown dump chomp connect getsockname die socketpair close flock exists index shmgetsub for endpwent redo lstat msgctl setpgrp abs exit select print ref gethostbyaddr unshift fcntl syscall goto getnetbyaddr join gmtime symlink semget splice x|0 getpeername recv log setsockopt cos last reverse gethostbyname getgrnam study formline endhostent times chop length gethostent getnetent pack getprotoent getservbyname rand mkdir pos chmod y|0 substr endnetent printf next open msgsnd readdir use unlink getsockopt getpriority rindex wantarray hex system getservbyport endservent int chr untie rmdir prototype tell listen fork shmread ucfirst setprotoent else sysseek link getgrgid shmctl waitpid unpack getnetbyname reset chdir grep split require caller lcfirst until warn while values shift telldir getpwuid my getprotobynumber delete and sort uc defined srand accept package seekdir getprotobyname semop our rename seek if q|0 chroot sysread setpwent no crypt getc chown sqrt write setnetent setpriority foreach tie sin msgget map stat getlogin unless elsif truncate exec keys glob tied closedirioctl socket readlink eval xor readline binmode setservent eof ord bind alarm pipe atan2 getgrent exp time push setgrent gt lt or ne m|0 break given say state when",r={cN:"subst",b:"[$@]\\{",e:"\\}",k:t},s={b:"->{",e:"}"},n={v:[{b:/\$\d/},{b:/[\$%@](\^\w\b|#\w+(::\w+)*|{\w+}|\w+(::\w*)*)/},{b:/[\$%@][^\s\w{]/,r:0}]},i=[e.BE,r,n],o=[n,e.HCM,e.C("^\\=\\w","\\=cut",{eW:!0}),s,{cN:"string",c:i,v:[{b:"q[qwxr]?\\s*\\(",e:"\\)",r:5},{b:"q[qwxr]?\\s*\\[",e:"\\]",r:5},{b:"q[qwxr]?\\s*\\{",e:"\\}",r:5},{b:"q[qwxr]?\\s*\\|",e:"\\|",r:5},{b:"q[qwxr]?\\s*\\<",e:"\\>",r:5},{b:"qw\\s+q",e:"q",r:5},{b:"'",e:"'",c:[e.BE]},{b:'"',e:'"'},{b:"`",e:"`",c:[e.BE]},{b:"{\\w+}",c:[],r:0},{b:"-?\\w+\\s*\\=\\>",c:[],r:0}]},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\/\\/|"+e.RSR+"|\\b(split|return|print|reverse|grep)\\b)\\s*",k:"split return print reverse grep",r:0,c:[e.HCM,{cN:"regexp",b:"(s|tr|y)/(\\\\.|[^/])*/(\\\\.|[^/])*/[a-z]*",r:10},{cN:"regexp",b:"(m|qr)?/",e:"/[a-z]*",c:[e.BE],r:0}]},{cN:"function",bK:"sub",e:"(\\s*\\(.*?\\))?[;{]",eE:!0,r:5,c:[e.TM]},{b:"-\\w\\b",r:0},{b:"^__DATA__$",e:"^__END__$",sL:"mojolicious",c:[{b:"^@@.*",e:"$",cN:"comment"}]}];return r.c=o,s.c=o,{aliases:["pl","pm"],l:/[\w\.]+/,k:t,c:o}});hljs.registerLanguage("ini",function(e){var b={cN:"string",c:[e.BE],v:[{b:"'''",e:"'''",r:10},{b:'"""',e:'"""',r:10},{b:'"',e:'"'},{b:"'",e:"'"}]};return{aliases:["toml"],cI:!0,i:/\S/,c:[e.C(";","$"),e.HCM,{cN:"section",b:/^\s*\[+/,e:/\]+/},{b:/^[a-z0-9\[\]_-]+\s*=\s*/,e:"$",rB:!0,c:[{cN:"attr",b:/[a-z0-9\[\]_-]+/},{b:/=/,eW:!0,r:0,c:[{cN:"literal",b:/\bon|off|true|false|yes|no\b/},{cN:"variable",v:[{b:/\$[\w\d"][\w\d_]*/},{b:/\$\{(.*?)}/}]},b,{cN:"number",b:/([\+\-]+)?[\d]+_[\d_]+/},e.NM]}]}]}});hljs.registerLanguage("diff",function(e){return{aliases:["patch"],c:[{cN:"meta",r:10,v:[{b:/^@@ +\-\d+,\d+ +\+\d+,\d+ +@@$/},{b:/^\*\*\* +\d+,\d+ +\*\*\*\*$/},{b:/^\-\-\- +\d+,\d+ +\-\-\-\-$/}]},{cN:"comment",v:[{b:/Index: /,e:/$/},{b:/={3,}/,e:/$/},{b:/^\-{3}/,e:/$/},{b:/^\*{3} /,e:/$/},{b:/^\+{3}/,e:/$/},{b:/\*{5}/,e:/\*{5}$/}]},{cN:"addition",b:"^\\+",e:"$"},{cN:"deletion",b:"^\\-",e:"$"},{cN:"addition",b:"^\\!",e:"$"}]}});hljs.registerLanguage("go",function(e){var t={keyword:"break default func interface select case map struct chan else goto package switch const fallthrough if range type continue for import return var go defer bool byte complex64 complex128 float32 float64 int8 int16 int32 int64 string uint8 uint16 uint32 uint64 int uint uintptr rune",literal:"true false iota nil",built_in:"append cap close complex copy imag len make new panic print println real recover delete"};return{aliases:["golang"],k:t,i:"</",c:[e.CLCM,e.CBCM,{cN:"string",v:[e.QSM,{b:"'",e:"[^\\\\]'"},{b:"`",e:"`"}]},{cN:"number",v:[{b:e.CNR+"[dflsi]",r:1},e.CNM]},{b:/:=/},{cN:"function",bK:"func",e:/\s*\{/,eE:!0,c:[e.TM,{cN:"params",b:/\(/,e:/\)/,k:t,i:/["']/}]}]}});hljs.registerLanguage("bash",function(e){var t={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},s={cN:"string",b:/"/,e:/"/,c:[e.BE,t,{cN:"variable",b:/\$\(/,e:/\)/,c:[e.BE]}]},a={cN:"string",b:/'/,e:/'/};return{aliases:["sh","zsh"],l:/\b-?[a-z\._]+\b/,k:{keyword:"if then else elif fi for while in do done case esac function",literal:"true false",built_in:"break cd continue eval exec exit export getopts hash pwd readonly return shift test times trap umask unset alias bind builtin caller command declare echo enable help let local logout mapfile printf read readarray source type typeset ulimit unalias set shopt autoload bg bindkey bye cap chdir clone comparguments compcall compctl compdescribe compfiles compgroups compquote comptags comptry compvalues dirs disable disown echotc echoti emulate fc fg float functions getcap getln history integer jobs kill limit log noglob popd print pushd pushln rehash sched setcap setopt stat suspend ttyctl unfunction unhash unlimit unsetopt vared wait whence where which zcompile zformat zftp zle zmodload zparseopts zprof zpty zregexparse zsocket zstyle ztcp",_:"-ne -eq -lt -gt -f -d -e -s -l -a"},c:[{cN:"meta",b:/^#![^\n]+sh\s*$/,r:10},{cN:"function",b:/\w[\w\d_]*\s*\(\s*\)\s*\{/,rB:!0,c:[e.inherit(e.TM,{b:/\w[\w\d_]*/})],r:0},e.HCM,s,a,t]}});hljs.registerLanguage("python",function(e){var r={keyword:"and elif is global as in if from raise for except finally print import pass return exec else break not with class assert yield try while continue del or def lambda async await nonlocal|10 None True False",built_in:"Ellipsis NotImplemented"},b={cN:"meta",b:/^(>>>|\.\.\.) /},c={cN:"subst",b:/\{/,e:/\}/,k:r,i:/#/},a={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,c:[b],r:10},{b:/(u|b)?r?"""/,e:/"""/,c:[b],r:10},{b:/(fr|rf|f)'''/,e:/'''/,c:[b,c]},{b:/(fr|rf|f)"""/,e:/"""/,c:[b,c]},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},{b:/(fr|rf|f)'/,e:/'/,c:[c]},{b:/(fr|rf|f)"/,e:/"/,c:[c]},e.ASM,e.QSM]},s={cN:"number",r:0,v:[{b:e.BNR+"[lLjJ]?"},{b:"\\b(0o[0-7]+)[lLjJ]?"},{b:e.CNR+"[lLjJ]?"}]},i={cN:"params",b:/\(/,e:/\)/,c:["self",b,s,a]};return c.c=[a,s,b],{aliases:["py","gyp"],k:r,i:/(<\/|->|\?)|=>/,c:[b,s,a,e.HCM,{v:[{cN:"function",bK:"def"},{cN:"class",bK:"class"}],e:/:/,i:/[${=;\n,]/,c:[e.UTM,i,{b:/->/,eW:!0,k:"None"}]},{cN:"meta",b:/^[\t ]*@/,e:/$/},{b:/\b(print|exec)\(/}]}});hljs.registerLanguage("julia",function(e){var r={keyword:"in isa where baremodule begin break catch ccall const continue do else elseif end export false finally for function global if import importall let local macro module quote return true try using while type immutable abstract bitstype typealias ",literal:"true false ARGS C_NULL DevNull ENDIAN_BOM ENV I Inf Inf16 Inf32 Inf64 InsertionSort JULIA_HOME LOAD_PATH MergeSort NaN NaN16 NaN32 NaN64 PROGRAM_FILE QuickSort RoundDown RoundFromZero RoundNearest RoundNearestTiesAway RoundNearestTiesUp RoundToZero RoundUp STDERR STDIN STDOUT VERSION catalan e|0 eu|0 eulergamma golden im nothing pi γ π φ ",built_in:"ANY AbstractArray AbstractChannel AbstractFloat AbstractMatrix AbstractRNG AbstractSerializer AbstractSet AbstractSparseArray AbstractSparseMatrix AbstractSparseVector AbstractString AbstractUnitRange AbstractVecOrMat AbstractVector Any ArgumentError Array AssertionError Associative Base64DecodePipe Base64EncodePipe Bidiagonal BigFloat BigInt BitArray BitMatrix BitVector Bool BoundsError BufferStream CachingPool CapturedException CartesianIndex CartesianRange Cchar Cdouble Cfloat Channel Char Cint Cintmax_t Clong Clonglong ClusterManager Cmd CodeInfo Colon Complex Complex128 Complex32 Complex64 CompositeException Condition ConjArray ConjMatrix ConjVector Cptrdiff_t Cshort Csize_t Cssize_t Cstring Cuchar Cuint Cuintmax_t Culong Culonglong Cushort Cwchar_t Cwstring DataType Date DateFormat DateTime DenseArray DenseMatrix DenseVecOrMat DenseVector Diagonal Dict DimensionMismatch Dims DirectIndexString Display DivideError DomainError EOFError EachLine Enum Enumerate ErrorException Exception ExponentialBackOff Expr Factorization FileMonitor Float16 Float32 Float64 Function Future GlobalRef GotoNode HTML Hermitian IO IOBuffer IOContext IOStream IPAddr IPv4 IPv6 IndexCartesian IndexLinear IndexStyle InexactError InitError Int Int128 Int16 Int32 Int64 Int8 IntSet Integer InterruptException InvalidStateException Irrational KeyError LabelNode LinSpace LineNumberNode LoadError LowerTriangular MIME Matrix MersenneTwister Method MethodError MethodTable Module NTuple NewvarNode NullException Nullable Number ObjectIdDict OrdinalRange OutOfMemoryError OverflowError Pair ParseError PartialQuickSort PermutedDimsArray Pipe PollingFileWatcher ProcessExitedException Ptr QuoteNode RandomDevice Range RangeIndex Rational RawFD ReadOnlyMemoryError Real ReentrantLock Ref Regex RegexMatch RemoteChannel RemoteException RevString RoundingMode RowVector SSAValue SegmentationFault SerializationState Set SharedArray SharedMatrix SharedVector Signed SimpleVector Slot SlotNumber SparseMatrixCSC SparseVector StackFrame StackOverflowError StackTrace StepRange StepRangeLen StridedArray StridedMatrix StridedVecOrMat StridedVector String SubArray SubString SymTridiagonal Symbol Symmetric SystemError TCPSocket Task Text TextDisplay Timer Tridiagonal Tuple Type TypeError TypeMapEntry TypeMapLevel TypeName TypeVar TypedSlot UDPSocket UInt UInt128 UInt16 UInt32 UInt64 UInt8 UndefRefError UndefVarError UnicodeError UniformScaling Union UnionAll UnitRange Unsigned UpperTriangular Val Vararg VecElement VecOrMat Vector VersionNumber Void WeakKeyDict WeakRef WorkerConfig WorkerPool "},t="[A-Za-z_\\u00A1-\\uFFFF][A-Za-z_0-9\\u00A1-\\uFFFF]*",a={l:t,k:r,i:/<\//},n={cN:"number",b:/(\b0x[\d_]*(\.[\d_]*)?|0x\.\d[\d_]*)p[-+]?\d+|\b0[box][a-fA-F0-9][a-fA-F0-9_]*|(\b\d[\d_]*(\.[\d_]*)?|\.\d[\d_]*)([eEfF][-+]?\d+)?/,r:0},o={cN:"string",b:/'(.|\\[xXuU][a-zA-Z0-9]+)'/},i={cN:"subst",b:/\$\(/,e:/\)/,k:r},l={cN:"variable",b:"\\$"+t},c={cN:"string",c:[e.BE,i,l],v:[{b:/\w*"""/,e:/"""\w*/,r:10},{b:/\w*"/,e:/"\w*/}]},s={cN:"string",c:[e.BE,i,l],b:"`",e:"`"},d={cN:"meta",b:"@"+t},u={cN:"comment",v:[{b:"#=",e:"=#",r:10},{b:"#",e:"$"}]};return a.c=[n,o,c,s,d,u,e.HCM,{cN:"keyword",b:"\\b(((abstract|primitive)\\s+)type|(mutable\\s+)?struct)\\b"},{b:/<:/}],i.c=a.c,a});hljs.registerLanguage("coffeescript",function(e){var c={keyword:"in if for while finally new do return else break catch instanceof throw try this switch continue typeof delete debugger super yield import export from as default await then unless until loop of by when and or is isnt not",literal:"true false null undefined yes no on off",built_in:"npm require console print module global window document"},n="[A-Za-z$_][0-9A-Za-z$_]*",r={cN:"subst",b:/#\{/,e:/}/,k:c},i=[e.BNM,e.inherit(e.CNM,{starts:{e:"(\\s*/)?",r:0}}),{cN:"string",v:[{b:/'''/,e:/'''/,c:[e.BE]},{b:/'/,e:/'/,c:[e.BE]},{b:/"""/,e:/"""/,c:[e.BE,r]},{b:/"/,e:/"/,c:[e.BE,r]}]},{cN:"regexp",v:[{b:"///",e:"///",c:[r,e.HCM]},{b:"//[gim]*",r:0},{b:/\/(?![ *])(\\\/|.)*?\/[gim]*(?=\W|$)/}]},{b:"@"+n},{sL:"javascript",eB:!0,eE:!0,v:[{b:"```",e:"```"},{b:"`",e:"`"}]}];r.c=i;var s=e.inherit(e.TM,{b:n}),t="(\\(.*\\))?\\s*\\B[-=]>",o={cN:"params",b:"\\([^\\(]",rB:!0,c:[{b:/\(/,e:/\)/,k:c,c:["self"].concat(i)}]};return{aliases:["coffee","cson","iced"],k:c,i:/\/\*/,c:i.concat([e.C("###","###"),e.HCM,{cN:"function",b:"^\\s*"+n+"\\s*=\\s*"+t,e:"[-=]>",rB:!0,c:[s,o]},{b:/[:\(,=]\s*/,r:0,c:[{cN:"function",b:t,e:"[-=]>",rB:!0,c:[o]}]},{cN:"class",bK:"class",e:"$",i:/[:="\[\]]/,c:[{bK:"extends",eW:!0,i:/[:="\[\]]/,c:[s]},s]},{b:n+":",e:":",rB:!0,rE:!0,r:0}])}});hljs.registerLanguage("cpp",function(t){var e={cN:"keyword",b:"\\b[a-z\\d_]*_t\\b"},r={cN:"string",v:[{b:'(u8?|U)?L?"',e:'"',i:"\\n",c:[t.BE]},{b:'(u8?|U)?R"',e:'"',c:[t.BE]},{b:"'\\\\?.",e:"'",i:"."}]},s={cN:"number",v:[{b:"\\b(0b[01']+)"},{b:"(-?)\\b([\\d']+(\\.[\\d']*)?|\\.[\\d']+)(u|U|l|L|ul|UL|f|F|b|B)"},{b:"(-?)(\\b0[xX][a-fA-F0-9']+|(\\b[\\d']+(\\.[\\d']*)?|\\.[\\d']+)([eE][-+]?[\\d']+)?)"}],r:0},i={cN:"meta",b:/#\s*[a-z]+\b/,e:/$/,k:{"meta-keyword":"if else elif endif define undef warning error line pragma ifdef ifndef include"},c:[{b:/\\\n/,r:0},t.inherit(r,{cN:"meta-string"}),{cN:"meta-string",b:/<[^\n>]*>/,e:/$/,i:"\\n"},t.CLCM,t.CBCM]},a=t.IR+"\\s*\\(",c={keyword:"int float while private char catch import module export virtual operator sizeof dynamic_cast|10 typedef const_cast|10 const for static_cast|10 union namespace unsigned long volatile static protected bool template mutable if public friend do goto auto void enum else break extern using asm case typeid short reinterpret_cast|10 default double register explicit signed typename try this switch continue inline delete alignof constexpr decltype noexcept static_assert thread_local restrict _Bool complex _Complex _Imaginary atomic_bool atomic_char atomic_schar atomic_uchar atomic_short atomic_ushort atomic_int atomic_uint atomic_long atomic_ulong atomic_llong atomic_ullong new throw return and or not",built_in:"std string cin cout cerr clog stdin stdout stderr stringstream istringstream ostringstream auto_ptr deque list queue stack vector map set bitset multiset multimap unordered_set unordered_map unordered_multiset unordered_multimap array shared_ptr abort abs acos asin atan2 atan calloc ceil cosh cos exit exp fabs floor fmod fprintf fputs free frexp fscanf isalnum isalpha iscntrl isdigit isgraph islower isprint ispunct isspace isupper isxdigit tolower toupper labs ldexp log10 log malloc realloc memchr memcmp memcpy memset modf pow printf putchar puts scanf sinh sin snprintf sprintf sqrt sscanf strcat strchr strcmp strcpy strcspn strlen strncat strncmp strncpy strpbrk strrchr strspn strstr tanh tan vfprintf vprintf vsprintf endl initializer_list unique_ptr",literal:"true false nullptr NULL"},n=[e,t.CLCM,t.CBCM,s,r];return{aliases:["c","cc","h","c++","h++","hpp"],k:c,i:"</",c:n.concat([i,{b:"\\b(deque|list|queue|stack|vector|map|set|bitset|multiset|multimap|unordered_map|unordered_set|unordered_multiset|unordered_multimap|array)\\s*<",e:">",k:c,c:["self",e]},{b:t.IR+"::",k:c},{v:[{b:/=/,e:/;/},{b:/\(/,e:/\)/},{bK:"new throw return else",e:/;/}],k:c,c:n.concat([{b:/\(/,e:/\)/,k:c,c:n.concat(["self"]),r:0}]),r:0},{cN:"function",b:"("+t.IR+"[\\*&\\s]+)+"+a,rB:!0,e:/[{;=]/,eE:!0,k:c,i:/[^\w\s\*&]/,c:[{b:a,rB:!0,c:[t.TM],r:0},{cN:"params",b:/\(/,e:/\)/,k:c,r:0,c:[t.CLCM,t.CBCM,r,s,e]},t.CLCM,t.CBCM,i]},{cN:"class",bK:"class struct",e:/[{;:]/,c:[{b:/</,e:/>/,c:["self"]},t.TM]}]),exports:{preprocessor:i,strings:r,k:c}}});hljs.registerLanguage("ruby",function(e){var b="[a-zA-Z_]\\w*[!?=]?|[-+~]\\@|<<|>>|=~|===?|<=>|[<>]=?|\\*\\*|[-/+%^&*~`|]|\\[\\]=?",r={keyword:"and then defined module in return redo if BEGIN retry end for self when next until do begin unless END rescue else break undef not super class case require yield alias while ensure elsif or include attr_reader attr_writer attr_accessor",literal:"true false nil"},c={cN:"doctag",b:"@[A-Za-z]+"},a={b:"#<",e:">"},s=[e.C("#","$",{c:[c]}),e.C("^\\=begin","^\\=end",{c:[c],r:10}),e.C("^__END__","\\n$")],n={cN:"subst",b:"#\\{",e:"}",k:r},t={cN:"string",c:[e.BE,n],v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/`/,e:/`/},{b:"%[qQwWx]?\\(",e:"\\)"},{b:"%[qQwWx]?\\[",e:"\\]"},{b:"%[qQwWx]?{",e:"}"},{b:"%[qQwWx]?<",e:">"},{b:"%[qQwWx]?/",e:"/"},{b:"%[qQwWx]?%",e:"%"},{b:"%[qQwWx]?-",e:"-"},{b:"%[qQwWx]?\\|",e:"\\|"},{b:/\B\?(\\\d{1,3}|\\x[A-Fa-f0-9]{1,2}|\\u[A-Fa-f0-9]{4}|\\?\S)\b/},{b:/<<(-?)\w+$/,e:/^\s*\w+$/}]},i={cN:"params",b:"\\(",e:"\\)",endsParent:!0,k:r},d=[t,a,{cN:"class",bK:"class module",e:"$|;",i:/=/,c:[e.inherit(e.TM,{b:"[A-Za-z_]\\w*(::\\w+)*(\\?|\\!)?"}),{b:"<\\s*",c:[{b:"("+e.IR+"::)?"+e.IR}]}].concat(s)},{cN:"function",bK:"def",e:"$|;",c:[e.inherit(e.TM,{b:b}),i].concat(s)},{b:e.IR+"::"},{cN:"symbol",b:e.UIR+"(\\!|\\?)?:",r:0},{cN:"symbol",b:":(?!\\s)",c:[t,{b:b}],r:0},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\$\\W)|((\\$|\\@\\@?)(\\w+))"},{cN:"params",b:/\|/,e:/\|/,k:r},{b:"("+e.RSR+"|unless)\\s*",k:"unless",c:[a,{cN:"regexp",c:[e.BE,n],i:/\n/,v:[{b:"/",e:"/[a-z]*"},{b:"%r{",e:"}[a-z]*"},{b:"%r\\(",e:"\\)[a-z]*"},{b:"%r!",e:"![a-z]*"},{b:"%r\\[",e:"\\][a-z]*"}]}].concat(s),r:0}].concat(s);n.c=d,i.c=d;var l="[>?]>",o="[\\w#]+\\(\\w+\\):\\d+:\\d+>",u="(\\w+-)?\\d+\\.\\d+\\.\\d(p\\d+)?[^>]+>",w=[{b:/^\s*=>/,starts:{e:"$",c:d}},{cN:"meta",b:"^("+l+"|"+o+"|"+u+")",starts:{e:"$",c:d}}];return{aliases:["rb","gemspec","podspec","thor","irb"],k:r,i:/\/\*/,c:s.concat(w).concat(d)}});hljs.registerLanguage("yaml",function(e){var b="true false yes no null",a="^[ \\-]*",r="[a-zA-Z_][\\w\\-]*",t={cN:"attr",v:[{b:a+r+":"},{b:a+'"'+r+'":'},{b:a+"'"+r+"':"}]},c={cN:"template-variable",v:[{b:"{{",e:"}}"},{b:"%{",e:"}"}]},l={cN:"string",r:0,v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/\S+/}],c:[e.BE,c]};return{cI:!0,aliases:["yml","YAML","yaml"],c:[t,{cN:"meta",b:"^---s*$",r:10},{cN:"string",b:"[\\|>] *$",rE:!0,c:l.c,e:t.v[0].b},{b:"<%[%=-]?",e:"[%-]?%>",sL:"ruby",eB:!0,eE:!0,r:0},{cN:"type",b:"!!"+e.UIR},{cN:"meta",b:"&"+e.UIR+"$"},{cN:"meta",b:"\\*"+e.UIR+"$"},{cN:"bullet",b:"^ *-",r:0},e.HCM,{bK:b,k:{literal:b}},e.CNM,l]}});hljs.registerLanguage("css",function(e){var c="[a-zA-Z-][a-zA-Z0-9_-]*",t={b:/[A-Z\_\.\-]+\s*:/,rB:!0,e:";",eW:!0,c:[{cN:"attribute",b:/\S/,e:":",eE:!0,starts:{eW:!0,eE:!0,c:[{b:/[\w-]+\(/,rB:!0,c:[{cN:"built_in",b:/[\w-]+/},{b:/\(/,e:/\)/,c:[e.ASM,e.QSM]}]},e.CSSNM,e.QSM,e.ASM,e.CBCM,{cN:"number",b:"#[0-9A-Fa-f]+"},{cN:"meta",b:"!important"}]}}]};return{cI:!0,i:/[=\/|'\$]/,c:[e.CBCM,{cN:"selector-id",b:/#[A-Za-z0-9_-]+/},{cN:"selector-class",b:/\.[A-Za-z0-9_-]+/},{cN:"selector-attr",b:/\[/,e:/\]/,i:"$"},{cN:"selector-pseudo",b:/:(:)?[a-zA-Z0-9\_\-\+\(\)"'.]+/},{b:"@(font-face|page)",l:"[a-z-]+",k:"font-face page"},{b:"@",e:"[{;]",i:/:/,c:[{cN:"keyword",b:/\w+/},{b:/\s/,eW:!0,eE:!0,r:0,c:[e.ASM,e.QSM,e.CSSNM]}]},{cN:"selector-tag",b:c,r:0},{b:"{",e:"}",i:/\S/,c:[e.CBCM,t]}]}});hljs.registerLanguage("fortran",function(e){var t={cN:"params",b:"\\(",e:"\\)"},n={literal:".False. .True.",keyword:"kind do while private call intrinsic where elsewhere type endtype endmodule endselect endinterface end enddo endif if forall endforall only contains default return stop then public subroutine|10 function program .and. .or. .not. .le. .eq. .ge. .gt. .lt. goto save else use module select case access blank direct exist file fmt form formatted iostat name named nextrec number opened rec recl sequential status unformatted unit continue format pause cycle exit c_null_char c_alert c_backspace c_form_feed flush wait decimal round iomsg synchronous nopass non_overridable pass protected volatile abstract extends import non_intrinsic value deferred generic final enumerator class associate bind enum c_int c_short c_long c_long_long c_signed_char c_size_t c_int8_t c_int16_t c_int32_t c_int64_t c_int_least8_t c_int_least16_t c_int_least32_t c_int_least64_t c_int_fast8_t c_int_fast16_t c_int_fast32_t c_int_fast64_t c_intmax_t C_intptr_t c_float c_double c_long_double c_float_complex c_double_complex c_long_double_complex c_bool c_char c_null_ptr c_null_funptr c_new_line c_carriage_return c_horizontal_tab c_vertical_tab iso_c_binding c_loc c_funloc c_associated  c_f_pointer c_ptr c_funptr iso_fortran_env character_storage_size error_unit file_storage_size input_unit iostat_end iostat_eor numeric_storage_size output_unit c_f_procpointer ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode newunit contiguous recursive pad position action delim readwrite eor advance nml interface procedure namelist include sequence elemental pure integer real character complex logical dimension allocatable|10 parameter external implicit|10 none double precision assign intent optional pointer target in out common equivalence data",built_in:"alog alog10 amax0 amax1 amin0 amin1 amod cabs ccos cexp clog csin csqrt dabs dacos dasin datan datan2 dcos dcosh ddim dexp dint dlog dlog10 dmax1 dmin1 dmod dnint dsign dsin dsinh dsqrt dtan dtanh float iabs idim idint idnint ifix isign max0 max1 min0 min1 sngl algama cdabs cdcos cdexp cdlog cdsin cdsqrt cqabs cqcos cqexp cqlog cqsin cqsqrt dcmplx dconjg derf derfc dfloat dgamma dimag dlgama iqint qabs qacos qasin qatan qatan2 qcmplx qconjg qcos qcosh qdim qerf qerfc qexp qgamma qimag qlgama qlog qlog10 qmax1 qmin1 qmod qnint qsign qsin qsinh qsqrt qtan qtanh abs acos aimag aint anint asin atan atan2 char cmplx conjg cos cosh exp ichar index int log log10 max min nint sign sin sinh sqrt tan tanh print write dim lge lgt lle llt mod nullify allocate deallocate adjustl adjustr all allocated any associated bit_size btest ceiling count cshift date_and_time digits dot_product eoshift epsilon exponent floor fraction huge iand ibclr ibits ibset ieor ior ishft ishftc lbound len_trim matmul maxexponent maxloc maxval merge minexponent minloc minval modulo mvbits nearest pack present product radix random_number random_seed range repeat reshape rrspacing scale scan selected_int_kind selected_real_kind set_exponent shape size spacing spread sum system_clock tiny transpose trim ubound unpack verify achar iachar transfer dble entry dprod cpu_time command_argument_count get_command get_command_argument get_environment_variable is_iostat_end ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode is_iostat_eor move_alloc new_line selected_char_kind same_type_as extends_type_ofacosh asinh atanh bessel_j0 bessel_j1 bessel_jn bessel_y0 bessel_y1 bessel_yn erf erfc erfc_scaled gamma log_gamma hypot norm2 atomic_define atomic_ref execute_command_line leadz trailz storage_size merge_bits bge bgt ble blt dshiftl dshiftr findloc iall iany iparity image_index lcobound ucobound maskl maskr num_images parity popcnt poppar shifta shiftl shiftr this_image"};return{cI:!0,aliases:["f90","f95"],k:n,i:/\/\*/,c:[e.inherit(e.ASM,{cN:"string",r:0}),e.inherit(e.QSM,{cN:"string",r:0}),{cN:"function",bK:"subroutine function program",i:"[${=\\n]",c:[e.UTM,t]},e.C("!","$",{r:0}),{cN:"number",b:"(?=\\b|\\+|\\-|\\.)(?=\\.\\d|\\d)(?:\\d+)?(?:\\.?\\d*)(?:[de][+-]?\\d+)?\\b\\.?",r:0}]}});hljs.registerLanguage("awk",function(e){var r={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},b="BEGIN END if else while do for in break continue delete next nextfile function func exit|10",n={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,r:10},{b:/(u|b)?r?"""/,e:/"""/,r:10},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},e.ASM,e.QSM]};return{k:{keyword:b},c:[r,n,e.RM,e.HCM,e.NM]}});hljs.registerLanguage("makefile",function(e){var i={cN:"variable",v:[{b:"\\$\\("+e.UIR+"\\)",c:[e.BE]},{b:/\$[@%<?\^\+\*]/}]},r={cN:"string",b:/"/,e:/"/,c:[e.BE,i]},a={cN:"variable",b:/\$\([\w-]+\s/,e:/\)/,k:{built_in:"subst patsubst strip findstring filter filter-out sort word wordlist firstword lastword dir notdir suffix basename addsuffix addprefix join wildcard realpath abspath error warning shell origin flavor foreach if or and call eval file value"},c:[i]},n={b:"^"+e.UIR+"\\s*[:+?]?=",i:"\\n",rB:!0,c:[{b:"^"+e.UIR,e:"[:+?]?=",eE:!0}]},t={cN:"meta",b:/^\.PHONY:/,e:/$/,k:{"meta-keyword":".PHONY"},l:/[\.\w]+/},l={cN:"section",b:/^[^\s]+:/,e:/$/,c:[i]};return{aliases:["mk","mak"],k:"define endef undefine ifdef ifndef ifeq ifneq else endif include -include sinclude override export unexport private vpath",l:/[\w-]+/,c:[e.HCM,i,r,a,n,t,l]}});hljs.registerLanguage("java",function(e){var a="[À-ʸa-zA-Z_$][À-ʸa-zA-Z_$0-9]*",t=a+"(<"+a+"(\\s*,\\s*"+a+")*>)?",r="false synchronized int abstract float private char boolean static null if const for true while long strictfp finally protected import native final void enum else break transient catch instanceof byte super volatile case assert short package default double public try this switch continue throws protected public private module requires exports do",s="\\b(0[bB]([01]+[01_]+[01]+|[01]+)|0[xX]([a-fA-F0-9]+[a-fA-F0-9_]+[a-fA-F0-9]+|[a-fA-F0-9]+)|(([\\d]+[\\d_]+[\\d]+|[\\d]+)(\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))?|\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))([eE][-+]?\\d+)?)[lLfF]?",c={cN:"number",b:s,r:0};return{aliases:["jsp"],k:r,i:/<\/|#/,c:[e.C("/\\*\\*","\\*/",{r:0,c:[{b:/\w+@/,r:0},{cN:"doctag",b:"@[A-Za-z]+"}]}),e.CLCM,e.CBCM,e.ASM,e.QSM,{cN:"class",bK:"class interface",e:/[{;=]/,eE:!0,k:"class interface",i:/[:"\[\]]/,c:[{bK:"extends implements"},e.UTM]},{bK:"new throw return else",r:0},{cN:"function",b:"("+t+"\\s+)+"+e.UIR+"\\s*\\(",rB:!0,e:/[{;=]/,eE:!0,k:r,c:[{b:e.UIR+"\\s*\\(",rB:!0,r:0,c:[e.UTM]},{cN:"params",b:/\(/,e:/\)/,k:r,r:0,c:[e.ASM,e.QSM,e.CNM,e.CBCM]},e.CLCM,e.CBCM]},c,{cN:"meta",b:"@[A-Za-z]+"}]}});hljs.registerLanguage("stan",function(e){return{c:[e.HCM,e.CLCM,e.CBCM,{b:e.UIR,l:e.UIR,k:{name:"for in while repeat until if then else",symbol:"bernoulli bernoulli_logit binomial binomial_logit beta_binomial hypergeometric categorical categorical_logit ordered_logistic neg_binomial neg_binomial_2 neg_binomial_2_log poisson poisson_log multinomial normal exp_mod_normal skew_normal student_t cauchy double_exponential logistic gumbel lognormal chi_square inv_chi_square scaled_inv_chi_square exponential inv_gamma weibull frechet rayleigh wiener pareto pareto_type_2 von_mises uniform multi_normal multi_normal_prec multi_normal_cholesky multi_gp multi_gp_cholesky multi_student_t gaussian_dlm_obs dirichlet lkj_corr lkj_corr_cholesky wishart inv_wishart","selector-tag":"int real vector simplex unit_vector ordered positive_ordered row_vector matrix cholesky_factor_corr cholesky_factor_cov corr_matrix cov_matrix",title:"functions model data parameters quantities transformed generated",literal:"true false"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0}]}});hljs.registerLanguage("javascript",function(e){var r="[A-Za-z$_][0-9A-Za-z$_]*",t={keyword:"in of if for while finally var new function do return void else break catch instanceof with throw case default try this switch continue typeof delete let yield const export super debugger as async await static import from as",literal:"true false null undefined NaN Infinity",built_in:"eval isFinite isNaN parseFloat parseInt decodeURI decodeURIComponent encodeURI encodeURIComponent escape unescape Object Function Boolean Error EvalError InternalError RangeError ReferenceError StopIteration SyntaxError TypeError URIError Number Math Date String RegExp Array Float32Array Float64Array Int16Array Int32Array Int8Array Uint16Array Uint32Array Uint8Array Uint8ClampedArray ArrayBuffer DataView JSON Intl arguments require module console window document Symbol Set Map WeakSet WeakMap Proxy Reflect Promise"},a={cN:"number",v:[{b:"\\b(0[bB][01]+)"},{b:"\\b(0[oO][0-7]+)"},{b:e.CNR}],r:0},n={cN:"subst",b:"\\$\\{",e:"\\}",k:t,c:[]},c={cN:"string",b:"`",e:"`",c:[e.BE,n]};n.c=[e.ASM,e.QSM,c,a,e.RM];var s=n.c.concat([e.CBCM,e.CLCM]);return{aliases:["js","jsx"],k:t,c:[{cN:"meta",r:10,b:/^\s*['"]use (strict|asm)['"]/},{cN:"meta",b:/^#!/,e:/$/},e.ASM,e.QSM,c,e.CLCM,e.CBCM,a,{b:/[{,]\s*/,r:0,c:[{b:r+"\\s*:",rB:!0,r:0,c:[{cN:"attr",b:r,r:0}]}]},{b:"("+e.RSR+"|\\b(case|return|throw)\\b)\\s*",k:"return throw case",c:[e.CLCM,e.CBCM,e.RM,{cN:"function",b:"(\\(.*?\\)|"+r+")\\s*=>",rB:!0,e:"\\s*=>",c:[{cN:"params",v:[{b:r},{b:/\(\s*\)/},{b:/\(/,e:/\)/,eB:!0,eE:!0,k:t,c:s}]}]},{b:/</,e:/(\/\w+|\w+\/)>/,sL:"xml",c:[{b:/<\w+\s*\/>/,skip:!0},{b:/<\w+/,e:/(\/\w+|\w+\/)>/,skip:!0,c:[{b:/<\w+\s*\/>/,skip:!0},"self"]}]}],r:0},{cN:"function",bK:"function",e:/\{/,eE:!0,c:[e.inherit(e.TM,{b:r}),{cN:"params",b:/\(/,e:/\)/,eB:!0,eE:!0,c:s}],i:/\[|%/},{b:/\$[(.]/},e.METHOD_GUARD,{cN:"class",bK:"class",e:/[{;=]/,eE:!0,i:/[:"\[\]]/,c:[{bK:"extends"},e.UTM]},{bK:"constructor",e:/\{/,eE:!0}],i:/#(?!!)/}});hljs.registerLanguage("tex",function(c){var e={cN:"tag",b:/\\/,r:0,c:[{cN:"name",v:[{b:/[a-zA-Zа-яА-я]+[*]?/},{b:/[^a-zA-Zа-яА-я0-9]/}],starts:{eW:!0,r:0,c:[{cN:"string",v:[{b:/\[/,e:/\]/},{b:/\{/,e:/\}/}]},{b:/\s*=\s*/,eW:!0,r:0,c:[{cN:"number",b:/-?\d*\.?\d+(pt|pc|mm|cm|in|dd|cc|ex|em)?/}]}]}}]};return{c:[e,{cN:"formula",c:[e],r:0,v:[{b:/\$\$/,e:/\$\$/},{b:/\$/,e:/\$/}]},c.C("%","$",{r:0})]}});hljs.registerLanguage("xml",function(s){var e="[A-Za-z0-9\\._:-]+",t={eW:!0,i:/</,r:0,c:[{cN:"attr",b:e,r:0},{b:/=\s*/,r:0,c:[{cN:"string",endsParent:!0,v:[{b:/"/,e:/"/},{b:/'/,e:/'/},{b:/[^\s"'=<>`]+/}]}]}]};return{aliases:["html","xhtml","rss","atom","xjb","xsd","xsl","plist"],cI:!0,c:[{cN:"meta",b:"<!DOCTYPE",e:">",r:10,c:[{b:"\\[",e:"\\]"}]},s.C("<!--","-->",{r:10}),{b:"<\\!\\[CDATA\\[",e:"\\]\\]>",r:10},{b:/<\?(php)?/,e:/\?>/,sL:"php",c:[{b:"/\\*",e:"\\*/",skip:!0}]},{cN:"tag",b:"<style(?=\\s|>|$)",e:">",k:{name:"style"},c:[t],starts:{e:"</style>",rE:!0,sL:["css","xml"]}},{cN:"tag",b:"<script(?=\\s|>|$)",e:">",k:{name:"script"},c:[t],starts:{e:"</script>",rE:!0,sL:["actionscript","javascript","handlebars","xml"]}},{cN:"meta",v:[{b:/<\?xml/,e:/\?>/,r:10},{b:/<\?\w+/,e:/\?>/}]},{cN:"tag",b:"</?",e:"/?>",c:[{cN:"name",b:/[^\/><\s]+/,r:0},t]}]}});hljs.registerLanguage("markdown",function(e){return{aliases:["md","mkdown","mkd"],c:[{cN:"section",v:[{b:"^#{1,6}",e:"$"},{b:"^.+?\\n[=-]{2,}$"}]},{b:"<",e:">",sL:"xml",r:0},{cN:"bullet",b:"^([*+-]|(\\d+\\.))\\s+"},{cN:"strong",b:"[*_]{2}.+?[*_]{2}"},{cN:"emphasis",v:[{b:"\\*.+?\\*"},{b:"_.+?_",r:0}]},{cN:"quote",b:"^>\\s+",e:"$"},{cN:"code",v:[{b:"^```w*s*$",e:"^```s*$"},{b:"`.+?`"},{b:"^( {4}|	)",e:"$",r:0}]},{b:"^[-\\*]{3,}",e:"$"},{b:"\\[.+?\\][\\(\\[].*?[\\)\\]]",rB:!0,c:[{cN:"string",b:"\\[",e:"\\]",eB:!0,rE:!0,r:0},{cN:"link",b:"\\]\\(",e:"\\)",eB:!0,eE:!0},{cN:"symbol",b:"\\]\\[",e:"\\]",eB:!0,eE:!0}],r:10},{b:/^\[[^\n]+\]:/,rB:!0,c:[{cN:"symbol",b:/\[/,e:/\]/,eB:!0,eE:!0},{cN:"link",b:/:\s*/,e:/$/,eB:!0}]}]}});hljs.registerLanguage("json",function(e){var i={literal:"true false null"},n=[e.QSM,e.CNM],r={e:",",eW:!0,eE:!0,c:n,k:i},t={b:"{",e:"}",c:[{cN:"attr",b:/"/,e:/"/,c:[e.BE],i:"\\n"},e.inherit(r,{b:/:/})],i:"\\S"},c={b:"\\[",e:"\\]",c:[e.inherit(r)],i:"\\S"};return n.splice(n.length,0,t,c),{c:n,k:i,i:"\\S"}});"></script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>






<link rel="stylesheet" href="style.css" type="text/css" />




</head>

<body>




<h1 class="title toc-ignore">Lab 06 - Regular Expressions and Web
Scraping</h1>



<div id="learning-goals" class="section level1">
<h1>Learning goals</h1>
<ul>
<li>Use a real world API to make queries and process the data.</li>
<li>Use regular expressions to parse the information.</li>
<li>Practice your GitHub skills.</li>
</ul>
</div>
<div id="lab-description" class="section level1">
<h1>Lab description</h1>
<p>In this lab, we will be working with the <a href="https://www.ncbi.nlm.nih.gov/home/develop/api/">NCBI API</a> to
make queries and extract information using XML and regular expressions.
For this lab, we will be using the <code>httr</code>, <code>xml2</code>,
and <code>stringr</code> R packages.</p>
<p>This markdown document should be rendered using
<code>github_document</code> document ONLY and pushed to your
<em>JSC370-labs</em> repository in <code>lab06/README.md</code>.</p>
<div id="question-1-how-many-sars-cov-2-papers" class="section level2">
<h2>Question 1: How many sars-cov-2 papers?</h2>
<p>Build an automatic counter of sars-cov-2 papers using PubMed. You
will need to apply XPath as we did during the lecture to extract the
number of results returned by PubMed in the following web address:</p>
<pre><code>https://pubmed.ncbi.nlm.nih.gov/?term=sars-cov-2</code></pre>
<p>Complete the lines of code:</p>
<pre class="r"><code>pubmedurl &lt;- &quot;https://pubmed.ncbi.nlm.nih.gov/?term=sars-cov-2&quot;
# Downloading the website
website &lt;- xml2::read_html(pubmedurl)

# Finding the counts
counts &lt;- xml2::xml_find_first(website, &quot;/html/body/main/div[9]/div[2]/div[2]/div[1]/div[1]/span&quot;)

# Turning it into text
counts &lt;- as.character(counts)

# Extracting the data using regex
stringr::str_extract(counts, &quot;[0-9,]+&quot;)</code></pre>
<pre><code>## [1] &quot;192,687&quot;</code></pre>
<pre class="r"><code>stringr::str_extract(counts, &quot;[\\d,]+&quot;)</code></pre>
<pre><code>## [1] &quot;192,687&quot;</code></pre>
<ul>
<li>How many sars-cov-2 papers are there?</li>
</ul>
<p>There are 192,687 sars-cov-2 papers.</p>
<p>Dont forget to commit your work!</p>
</div>
<div id="question-2-academic-publications-on-covid19-and-hawaii" class="section level2">
<h2>Question 2: Academic publications on COVID19 and Hawaii</h2>
<p>Use the function <code>httr::GET()</code> to make the following
query:</p>
<ol style="list-style-type: decimal">
<li><p>Baseline URL: <a href="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi" class="uri">https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi</a></p></li>
<li><p>Query parameters:</p>
<ul>
<li>db: pubmed</li>
<li>term: covid19 hawaii</li>
<li>retmax: 1000</li>
</ul></li>
</ol>
<p>The parameters passed to the query are documented <a href="https://www.ncbi.nlm.nih.gov/books/NBK25499/">here</a>.</p>
<pre class="r"><code>ncbiurl &lt;- &quot;https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi&quot;

library(httr)
query_ids &lt;- GET(
  url   = ncbiurl,
  query = list(
    db = &quot;pubmed&quot;,
    term = &quot;covid19 hawaii&quot;,
    retmax = 1000
  )
)
# Extracting the content of the response of GET
ids &lt;- httr::content(query_ids)</code></pre>
<p>The query will return an XML object, we can turn it into a character
list to analyze the text directly with <code>as.character()</code>.
Another way of processing the data could be using lists with the
function <code>xml2::as_list()</code>. We will skip the latter for
now.</p>
<p>Take a look at the data, and continue with the next question (dont
forget to commit and push your results to your GitHub repo!).</p>
<pre class="r"><code>ids</code></pre>
<pre><code>## {xml_document}
## &lt;eSearchResult&gt;
## [1] &lt;Count&gt;338&lt;/Count&gt;
## [2] &lt;RetMax&gt;338&lt;/RetMax&gt;
## [3] &lt;RetStart&gt;0&lt;/RetStart&gt;
## [4] &lt;IdList&gt;\n  &lt;Id&gt;36757946&lt;/Id&gt;\n  &lt;Id&gt;36743999&lt;/Id&gt;\n  &lt;Id&gt;36721521&lt;/Id&gt;\n ...
## [5] &lt;TranslationSet&gt;\n  &lt;Translation&gt;\n    &lt;From&gt;covid19&lt;/From&gt;\n    &lt;To&gt;&quot;cov ...
## [6] &lt;QueryTranslation&gt;(&quot;covid 19&quot;[MeSH Terms] OR &quot;covid 19&quot;[All Fields] OR &quot;c ...</code></pre>
</div>
<div id="question-3-get-details-about-the-articles" class="section level2">
<h2>Question 3: Get details about the articles</h2>
<p>The Ids are wrapped around text in the following way:
<code>&lt;Id&gt;... id number ...&lt;/Id&gt;</code>. we can use a
regular expression that extract that information. Fill out the following
lines of code:</p>
<pre class="r"><code># Turn the result into a character vector
ids &lt;- as.character(ids)

# Find all the ids (find &quot;&lt;Id&gt;.,..,.&lt;/Id&gt;&quot;)
ids &lt;- stringr::str_extract_all(ids, &quot;&lt;Id&gt;\\d+&lt;/Id&gt;&quot;)[[1]]

# Remove all the leading and trailing &lt;Id&gt; &lt;/Id&gt;. Make use of &quot;|&quot;
ids &lt;- stringr::str_remove_all(ids, &quot;&lt;Id&gt;|&lt;/Id&gt;&quot;)</code></pre>
<p>With the ids in hand, we can now try to get the abstracts of the
papers. As before, we will need to coerce the contents (results) to a
list using:</p>
<ol style="list-style-type: decimal">
<li><p>Baseline url: <a href="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi" class="uri">https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi</a></p></li>
<li><p>Query parameters:</p>
<ul>
<li>db: pubmed</li>
<li>id: A character with all the ids separated by comma, e.g.,
1232131,546464,13131</li>
<li>retmax: 1000</li>
<li>rettype: abstract</li>
</ul></li>
</ol>
<p><strong>Pro-tip</strong>: If you want <code>GET()</code> to take some
element literal, wrap it around <code>I()</code> (as you would do in a
formula in R). For example, the text <code>&quot;123,456&quot;</code> is replaced
with <code>&quot;123%2C456&quot;</code>. If you dont want that behavior, you
would need to do the following <code>I(&quot;123,456&quot;)</code>.</p>
<pre class="r"><code>ncbiurl2 &lt;-&quot;https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi&quot;
publications &lt;- GET(
  url   = ncbiurl2,
  query = list(
    db = &quot;pubmed&quot;,
    retmax = 1000,
    rettype = &quot;abstract&quot;,
    id = I(paste(ids, collapse = &quot;,&quot;))
    )
)

# Turning the output into character vector
publications &lt;- httr::content(publications)
publications_txt &lt;- as.character(publications)</code></pre>
<p>With this in hand, we can now analyze the data. This is also a good
time for committing and pushing your work!</p>
</div>
<div id="question-4-distribution-of-universities-schools-and-departments" class="section level2">
<h2>Question 4: Distribution of universities, schools, and
departments</h2>
<p>Using the function <code>stringr::str_extract_all()</code> applied on
<code>publications_txt</code>, capture all the terms of the form:</p>
<ol style="list-style-type: decimal">
<li>University of </li>
<li> Institute of </li>
</ol>
<p>Write a regular expression that captures all such instances</p>
<pre class="r"><code>library(stringr)
institution &lt;- str_extract_all(
  publications_txt,
  &quot;University\\s+of\\s+[[:alpha:]\\s]+|[A-Za-z\\s]+\\s+Institute\\s+of\\s+[[:alpha:]\\s]+&quot;
  ) 


institution &lt;- unlist(institution)
as.data.frame(table(institution))</code></pre>
<pre><code>##                                                                                                                             institution
## 1                                                                                      Beijing Institute of Pharmacology and Toxicology
## 2                                                                                                            Berlin Institute of Health
## 3                                                                        Breadfruit Institute of the National Tropical Botanical Garden
## 4    Dr Ganesan reported receiving grants from the Defense Health Program and the National Institute of Allergy and Infectious Disease 
## 5                                                                                           Medanta Institute of Education and Research
## 6                                                                                               Mediterranean Institute of Oceanography
## 7                                                                                                      MGM Institute of Health Sciences
## 8                                                                                Monterrey Institute of Technology and Higher Education
## 9                                                                                 National Institute of Allergy and Infectious Diseases
## 10                                                                                   National Institute of Biostructures and Biosystems
## 11                                                                                    National Institute of Infectious Diseases website
## 12                                                                                                  National Institute of Public Health
## 13                                                                       National Research Institute of Tuberculosis and Lung Diseases 
## 14                                                           Organizational health literacy is defined by the Institute of Medicine as 
## 15                                                   School of Electronic Engineering Kumoh National Institute of Technology Gumi Korea
## 16                                                          School of Physical Therapy and Graduate Institute of Rehabilitation Science
## 17                                                                                     Task Force IT Service Higher Institute of Health
## 18                                                                     the Institute of Biomedical Sciences and School of Life Sciences
## 19                                                                                           UMR Plant Health Institute of Montpellier 
## 20                                                                                        University of Ontario Institute of Technology
## 21                                                                                 Australian Institute of Tropical Health and Medicine
## 22                                                                                                   Broad Institute of Harvard and MIT
## 23                                                                                                        Genome Institute of Singapore
## 24                                                                                                Heidelberg Institute of Global Health
## 25                                                                                                        i Institute of Marine Biology
## 26                                                                                             Indian Institute of Tropical Meteorology
## 27                                                                            Leeds Institute of Rheumatic and Musculoskeletal Medicine
## 28                                                                                          Leonard Davis Institute of Health Economics
## 29                                                 Massachusetts Institute of Technology Koch Institute for Integrative Cancer Research
## 30                                                                                                         Mayo Institute of Technology
## 31                                                                                            Medical Research Institute of New Zealand
## 32                                                                                              Mediterranean Institute of Oceanography
## 33                                                                                National Institute of Allergy and Infectious Diseases
## 34                                                                          National Institute of Biomedical Imaging and Bioengineering
## 35                                                                                  National Institute of Environmental Health Sciences
## 36                                                                                      National Institute of General Medical Sciences 
## 37                                                                             National Institute of Neurological Disorders and Stroke 
## 38                                                                           Nordic Institute of Chiropractic and Clinical Biomechanics
## 39                                                                                             Prophylactic Institute of Southern Italy
## 40                                                                                               Rutgers Cancer Institute of New Jersey
## 41                                                          School of Physical Therapy and Graduate Institute of Rehabilitation Science
## 42                                                                                                    Swiss Institute of Bioinformatics
## 43                                                                                                                University of Alabama
## 44                                                                                                                University of Alberta
## 45                                                                                                       University of Applied Sciences
## 46                                                                                         University of Applied Sciences Mainz Germany
## 47                                                                                     University of Applied Sciences Rosenheim Germany
## 48                                                                                                                University of Arizona
## 49                                                                                                          University of Arizona Press
## 50                                                                                                               University of Arkansas
## 51                                                                                          University of Arkansas for Medical Sciences
## 52                                                                                University of Arkansas for Medical Sciences Northwest
## 53                                                                                                                  University of Basel
## 54                                                                                               University of Benin Benin City Nigeria
## 55                                                                                                               University of Botswana
## 56                                                                                                               University of Bradford
## 57                                                                                                                University of Bristol
## 58                                                                                                       University of British Columbia
## 59                                                                                    University of British Columbia School of Medicine
## 60                                                                                                                University of Calgary
## 61                                                                                                             University of California
## 62                                                                                University of California Cancer Consortium experience
## 63                                                                                                       University of California Davis
## 64                                                                           University of California Davis Comprehensive Cancer Center
## 65                                                                                        University of California Davis Medical Center
## 66                                                                                                University of California Los Angeles 
## 67                                                                       University of California Los Angeles Geffen School of Medicine
## 68                                                                                                       University of California Press
## 69                                                                                                   University of California Riverside
## 70                                                                                                   University of California San Diego
## 71                                                                                University of California San Diego School of Medicine
## 72                                                                                               University of California San Francisco
## 73                                                                            University of California San Francisco School of Medicine
## 74                                                                                                              University of Cambridge
## 75                                                                                          University of Campinas Piracicaba SP Brazil
## 76                                                                                                                University of Chicago
## 77                                                                                                 University of Chicago Medical Center
## 78                                                                                                       University of Chicago Medicine
## 79                                                                                                          University of Chicago Press
## 80                                                                                    University of Chicago Pritzker School of Medicine
## 81                                                                                            University of Chinese Academy of Sciences
## 82                                                                                                             University of Cincinnati
## 83                                                                                               University of Cincinnati Cancer Center
## 84                                                                                                               University of Colorado
## 85                                                                                                        University of Colorado Denver
## 86                                                                                            University of Colorado School of Medicine
## 87                                                                                                            University of Connecticut
## 88                                                                                                             University of Copenhagen
## 89                                                                                                                University of Crdoba
## 90                                                                                                 University of Dayton Dayton Ohio USA
## 91                                                                                                     University of Education Freiburg
## 92                                                                                                                 University of Exeter
## 93                                                                                                               University of Florence
## 94                                                                                                                University of Florida
## 95                                                                                                                University of Georgia
## 96                                                                                                                  University of Ghana
## 97                                                                                                                University of Granada
## 98                                                                                                                 University of Guilan
## 99                                                                                                                  University of Haifa
## 100                                                                                                                 University of Hawai
## 101                                                                                                      University of Hawai i at Mnoa
## 102                                                                      University of Hawaii Cancer Center and Hawaii Tumor Registry
## 103                                                                                                                University of Hawaii
## 104                                                                                                               University of Hawaii 
## 105                                                                                       University of Hawaii Actions to Address COVID
## 106                                                                                               University of Hawaii and Z Consulting
## 107                                                                                                        University of Hawaii at Hilo
## 108                                                                                                       University of Hawaii at Manoa
## 109                                                                                                       University of Hawaii At Manoa
## 110                                                                                                       University of Hawaii at Mnoa
## 111                                                                                                       University of Hawai at Mnoa
## 112                                                                                                      University of Hawaii at Mnoa 
## 113                                                                                       University of Hawaii at Manoa Honolulu HI USA
## 114                                                                                                University of Hawaii at Manoa John A
## 115                                                                       University of Hawaii at Manoa John A Burns School of Medicine
## 116                                                                       University of Hawaii at Manoa Office of Public Health Studies
## 117                                                                                                       University of Hawaii at Manon
## 118                                                                                                  University of Hawaii Cancer Center
## 119                                                                         University of Hawaii Cancer Center \nThe multiethnic cohort
## 120                                                                      University of Hawaii Cancer Center and Department of Pathology
## 121                                                                                 University of Hawaii Economic Research Organization
## 122                                                                                University of Hawaii Economic Research Organization 
## 123                                                                                                     University of Hawai i at Mnoa
## 124                                                                                                         University of Hawaii John A
## 125                                                                                                     University of Hawaii Law Review
## 126                                                                                      University of Hawaii Manoa Honolulu Hawaii USA
## 127                                                                                                          University of Hawaii News 
## 128                                                                                                          University of Hawaii Press
## 129                                                                                             University of Hawaii School of Medicine
## 130                                                                                                         University of Hawaii System
## 131                                                                        University of Health and Welfare Graduate School Tokyo Japan
## 132                                                                     University of Health and Welfare School of Medicine  Guidebook 
## 133                                                                                                       University of Health Sciences
## 134                                                                                           University of Health Sciences in Bethesda
## 135                                                                                                             University of Hong Kong
## 136                                                                                                              University of Honolulu
## 137                                                                                                     University of Honolulu at Manoa
## 138                                                                                                                University of Ibadan
## 139                                                                                                              University of Illinois
## 140                                                                                                      University of Illinois Chicago
## 141                                                                                                        University of Illinois Press
## 142                                                                                                       University of Illinois Urbana
## 143                                                                                    University of Information Science and Technology
## 144                                                                                                                  University of Iowa
## 145                                                                                                          University of Juiz de Fora
## 146                                                                                                                University of Kansas
## 147                                                                                                      University of Kansas Alzheimer
## 148                                                                                                 University of Kansas Medical Center
## 149                                                                                                              University of Kentucky
## 150                                                                                                   University of Kentucky UKnowledge
## 151                                                                                                                University of Korea 
## 152                                                                                                               University of KwaZulu
## 153                                                                                                              University of Lausanne
## 154                                                                                                                 University of Leeds
## 155                                                                                                                University of Leuven
## 156                                                                                                            University of Louisville
## 157                                                                                                                 University of Maine
## 158                                                                                                                University of Malaya
## 159                                                                                                              University of Maryland
## 160                                                                                                             University of Maryland 
## 161                                                                                                        University of Maryland COVID
## 162                                                                                           University of Maryland School of Medicine
## 163                                                                                                  University of Massachusetts Boston
## 164                                                                                     University of Massachusetts Chan Medical School
## 165                                                                                          University of Massachusetts Medical School
## 166                                                                                                      University of Medical Sciences
## 167                                                                                                              University of Medicine
## 168                                                                                          University of Medicine and Health Sciences
## 169                                                                                                             University of Melbourne
## 170                                                                                                                 University of Miami
## 171                                                                                                   University of Miami Health System
## 172                                                                                                              University of Michigan
## 173                                                                                          University of Michigan Rogel Cancer Center
## 174                                                                                                         University of Minas Gerais 
## 175                                                                                                             University of Minnesota
## 176                                                           University of Minnesota Center for Infectious Disease Research and Policy
## 177                                                                                                       University of Minnesota Press
## 178                                                                                University of Minnesota Rural Health Research Center
## 179                                                                                                              University of Missouri
## 180                                                                                                               University of Montana
## 181                                                                                                           University of Mount Union
## 182                                                                                                                University of Murcia
## 183                                                                                               University of Nebraska Medical Center
## 184                                                                                              University of Nebraska Medical Center 
## 185                                                                                                                University of Nevada
## 186                                                                                                           University of New England
## 187                                                                                                         University of New Hampshire
## 188                                                                                                            University of New Mexico
## 189                                                                                                       University of New South Wales
## 190                                                                                                University of New South Wales Sydney
## 191                                                                                                              University of New York
## 192                                                                                                             University of New York 
## 193                                                                University of New York College of Environmental Science and Forestry
## 194                                                                                        University of New York New York New York USA
## 195                                                                                                        University of North Carolina
## 196                                                                                          University of North Carolina at Greensboro
## 197                                                                                            University of North Carolina Chapel Hill
## 198                                                                                     University of North Carolina School of Medicine
## 199                                                                                                          University of North Dakota
## 200                                                                                                           University of North Texas
## 201                                                                                             University of Ohio Global Field Program
## 202                                                                                                                  University of Oslo
## 203                                                                                                                University of Oxford
## 204                                                                                                               University of Palermo
## 205                                                                                                                 University of Paris
## 206                                                                                                          University of Pennsylvania
## 207                                                                                            University of Pennsylvania Health System
## 208                                                                              University of Pennsylvania Perelman School of Medicine
## 209                                                                                                    University of Pennsylvania Press
## 210                                                                                       University of Pennsylvania School of Medicine
## 211                                                                                                            University of Pittsburgh
## 212                                                                                             University of Pittsburgh Medical Center
## 213                                                                                            University of Pittsburgh Medical Center 
## 214                                                                                             University of Pittsburgh Medical Centre
## 215                                                                                         University of Pittsburgh School of Medicine
## 216                                                                                                                 University of Porto
## 217                                                                                               University of Puerto Rico at Mayagez
## 218                                                                               University of Puerto Rico Comprehensive Cancer Center
## 219                                                                                                            University of Queensland
## 220                                                                                       University of Queensland Mayne Medical School
## 221                                                                                                          University of Rhode Island
## 222                                                                                                              University of Richmond
## 223                                                                                                     University of Rio Grande do Sul
## 224                                                                                              University of Rochester Medical Center
## 225                                                                                                                University of Rwanda
## 226                                                                                                             University of Sao Paulo
## 227                                                                                                            University of So Paulo 
## 228                                                                                                University of Science and Technology
## 229                                                                                             University of Sergipe Aracaju SE Brazil
## 230                                                                                                             University of Singapore
## 231                                                                                                        University of South Carolina
## 232                                                                                                         University of South Florida
## 233                                                                                                   University of Southern California
## 234                                                                        University of Southern California Los Angeles California USA
## 235                                                                                                      University of Southern Denmark
## 236                                                                                                                University of Sydney
## 237                                                                                                               University of Syndney
## 238                                                                                                            University of Technology
## 239                                                                                      University of Technology Owerri Owerri Nigeria
## 240                                                                                                                 University of Texas
## 241                                                                                                  University of Texas at San Antonio
## 242                                                                                          University of Texas Health Sciences Center
## 243                                                                              University of Texas Health Sciences Center at Houston 
## 244                                                                                       University of Texas MD Anderson Cancer Center
## 245                                                                                                    University of Texas Southwestern
## 246                                                                                     University of Texas Southwestern Medical Center
## 247                                                                                                   University of the Health Sciences
## 248                                                    University of the Health Sciences Infectious Diseases Clinical Research Program 
## 249                                                                                                       University of the Philippines
## 250                                                                                             University of the Philippines Los Baos
## 251                                                                                                         University of Thessalonica 
## 252                                                                                                               University of Toronto
## 253                                                                                                                University of Toulon
## 254                                                                                                              University of Tbingen
## 255                                                                                                                  University of Utah
## 256                                                                                               University of Utah School of Medicine
## 257                                                                                                                   University of Uyo
## 258                                                                                                            University of Washington
## 259                                                                                         University of Washington School of Medicine
## 260                                                                                     University of Washington Seattle Washington USA
## 261                                                                                                          University of West Georgia
## 262                                                                                                     University of Western Australia
## 263                                                                                                             University of Wisconsin
## 264                                                                                                     University of Wisconsin Madison
## 265                                                                                                       University of Wisconsin Press
## 266                                                                                                      University of Wisconsin System
## 267                                                                                                               University of Wyoming
## 268                                                                                                                  University of York
## 269                                                                                              Walter Reed Army Institute of Research
## 270                                                                                        Winship Cancer Institute of Emory University
##     Freq
## 1      2
## 2      4
## 3      1
## 4      1
## 5      1
## 6      1
## 7      1
## 8      1
## 9      1
## 10     1
## 11     1
## 12     1
## 13     2
## 14     1
## 15     1
## 16     1
## 17     1
## 18     1
## 19     1
## 20     1
## 21    15
## 22     2
## 23     1
## 24     1
## 25     2
## 26     5
## 27     2
## 28     8
## 29     1
## 30     1
## 31     4
## 32     1
## 33     2
## 34     1
## 35     3
## 36     1
## 37     1
## 38     1
## 39     2
## 40     1
## 41     2
## 42     1
## 43     3
## 44     2
## 45     2
## 46     1
## 47     1
## 48     5
## 49     2
## 50     2
## 51     4
## 52    20
## 53     8
## 54     1
## 55     1
## 56     1
## 57     5
## 58     2
## 59     2
## 60    23
## 61    69
## 62     1
## 63     1
## 64     1
## 65     1
## 66     1
## 67     1
## 68     4
## 69     1
## 70     4
## 71     4
## 72     7
## 73     2
## 74     1
## 75     3
## 76    11
## 77     1
## 78     1
## 79     2
## 80     1
## 81     1
## 82    12
## 83     4
## 84     1
## 85     1
## 86     3
## 87     3
## 88     8
## 89     1
## 90     1
## 91     1
## 92     1
## 93     1
## 94     9
## 95     2
## 96     1
## 97     2
## 98     1
## 99     1
## 100  359
## 101    8
## 102    1
## 103  111
## 104    4
## 105    1
## 106    1
## 107    5
## 108  212
## 109    1
## 110    9
## 111    1
## 112    2
## 113    1
## 114    1
## 115    1
## 116    1
## 117    1
## 118   26
## 119    1
## 120    1
## 121    3
## 122    2
## 123    2
## 124   11
## 125    1
## 126    1
## 127    1
## 128    4
## 129    3
## 130    1
## 131    2
## 132    1
## 133    6
## 134    3
## 135    4
## 136    3
## 137    3
## 138    1
## 139    1
## 140    1
## 141    1
## 142    4
## 143    2
## 144    4
## 145    4
## 146    2
## 147    1
## 148    1
## 149    1
## 150    1
## 151    1
## 152    3
## 153    1
## 154    2
## 155    1
## 156    1
## 157    2
## 158    3
## 159   10
## 160    6
## 161    2
## 162    5
## 163    1
## 164   21
## 165    2
## 166    3
## 167    4
## 168    2
## 169    2
## 170    2
## 171    1
## 172    8
## 173    2
## 174    1
## 175    3
## 176    1
## 177    1
## 178    1
## 179    2
## 180    3
## 181    1
## 182    1
## 183    4
## 184    1
## 185    3
## 186    1
## 187    1
## 188    6
## 189    3
## 190    1
## 191    2
## 192    2
## 193    3
## 194    1
## 195    2
## 196    2
## 197    1
## 198    1
## 199    1
## 200    2
## 201    1
## 202    6
## 203   11
## 204    1
## 205    1
## 206   92
## 207    6
## 208   13
## 209    1
## 210    7
## 211    8
## 212    1
## 213    1
## 214    2
## 215    3
## 216    3
## 217    1
## 218    2
## 219    2
## 220    1
## 221    3
## 222    1
## 223    1
## 224    4
## 225    1
## 226    2
## 227    4
## 228   34
## 229    1
## 230    1
## 231    3
## 232    1
## 233   24
## 234    2
## 235    1
## 236    2
## 237    1
## 238    2
## 239    3
## 240    1
## 241    1
## 242    1
## 243    2
## 244    4
## 245    1
## 246    2
## 247  241
## 248    1
## 249    1
## 250    1
## 251    1
## 252   15
## 253    1
## 254    7
## 255    5
## 256    3
## 257    1
## 258    8
## 259    3
## 260    1
## 261    1
## 262    1
## 263    9
## 264    2
## 265    1
## 266    1
## 267    1
## 268    1
## 269    1
## 270    2</code></pre>
<p>Repeat the exercise and this time focus on schools and departments in
the form of</p>
<ol style="list-style-type: decimal">
<li>School of </li>
<li>Department of </li>
</ol>
<p>And tabulate the results</p>
<pre class="r"><code>schools_and_deps &lt;- str_extract_all(
  publications_txt,
  &quot;School\\s+of\\s+[[:alpha:]\\s]+|Department\\s+of\\s+[[:alpha:]\\s]+&quot;
  )
as.data.frame(table(schools_and_deps))</code></pre>
<pre><code>##                                                                                                                                                                                     schools_and_deps
## 1                                                                                                                                                                           Department of\nEducation
## 2                                                                                                                                                                          Department of\nEducation 
## 3                                                                                                                                                                             Department of\nHealth 
## 4                                                                                                                                                                    Department of Ageing and Health
## 5                                                                                                                                                  Department of Agricultural and Resource Economics
## 6                                                                                                                                                                          Department of Agriculture
## 7                                                                                                                                                    Department of Agriculture and Consumer Services
## 8                                                                                                                                                         Department of Agriculture Research Service
## 9                                                                                                                                                                              Department of Anatomy
## 10                                                                                                                                                       Department of Anesthesia and Intensive Care
## 11                                                                                                                                                        Department of Anesthesia and Pain Medicine
## 12                                                                                                                                       Department of Anesthesilogy Critical Care and Pain Medicine
## 13                                                                                                                                                                      Department of Anesthesiology
## 14                                                                                                                                                  Department of Anesthesiology and Pain Management
## 15                                                                                                                                                                        Department of Anthropology
## 16                                                         Department of Applied Business Studies in the Robbins College of Business and Entrepreneurship Fort Hays State University Hays Kansas USA
## 17                                                                                                                                                              Department of Applied Health Science
## 18                                                                                                                                                      Department of Atmospheric and Space Sciences
## 19                                                                                                                                                                Department of Atmospheric Sciences
## 20                                                                                                                                                                   Department of Behavioral Health
## 21                                                                                                                                                                        Department of Biochemistry
## 22                                                                                                                                                                          Department of Bioethics 
## 23                                                                                                                                                                 Department of Biological Sciences
## 24                                                                                                               Department of Biological Sciences and the Advanced Environmental Research Institute
## 25                                                                                                                                                                             Department of Biology
## 26                                                                                                                                                    Department of Biology Brigham Young University
## 27                                                                                                                                                              Department of Biomedical Engineering
## 28                                                                                                                                                              Department of Biomedical Informatics
## 29                                                                                                                                                                          Department of Biophysics
## 30                                                                                                                                                                         Department of Biosciences
## 31                                                                                                    Department of Biosciences Piracicaba Dental School University of Campinas Piracicaba SP Brazil
## 32                                                                                                                                                                       Department of Biostatistics
## 33                                                                                                                                                    Department of Biostatistics and Bioinformatics
## 34                                                                                                                                               Department of Biostatistics and Medical Informatics
## 35                                                                                                                                                          Department of Botany and Plant Pathology
## 36                                                                                                                                                                            Department of Business
## 37                                                                                                                                               Department of Business Economic Development Tourism
## 38                                                                                                                                                                          Department of Cardiology
## 39                                                                                                                                                              Department of Cardiovascular Surgery
## 40                                                                                                                                                          Department of Cell and Molecular Biology
## 41                                                                                                                                                                           Department of Chemistry
## 42                                                                                                                                                            Department of Chemistry and Bioscience
## 43                                                                                                                                                 Department of Civil and Environmental Engineering
## 44                                                                                                             Department of Civil and Environmental Engineering and Water Resources Research Center
## 45                                                                                                                                                                  Department of Clinical Education
## 46                                                                                                                                                              Department of Clinical Investigation
## 47                                                                                                                                                               Department of Clinical Pharmacology
## 48                                                                                                                                                                   Department of Clinical Research
## 49                                                                                                                                                                            Department of Commerce
## 50                                                                                                                                                                          Department of Commerce  
## 51                                                                                                                                                                       Department of Communication
## 52                                                                                                                                                Department of Communication Sciences and Disorders
## 53                                                                                                                                                                       Department of Communicology
## 54                                                                                                                                                       Department of Community and Health Services
## 55                                                                                                                                                                    Department of Community Health
## 56                                                                                                                                                                    Department of Community Safety
## 57                                                                                                                                             Department of Computational and Quantitative Medicine
## 58                                                                                                                                                                    Department of Computer Science
## 59                                                                                                                                                                       Department of Critical Care
## 60                                                                                                                                                              Department of Critical Care Medicine
## 61                                                                                                                                                             Department of Critical Care Medicine 
## 62                                                                                                                                                                 Department of Cyberinfrastructure
## 63                                                                                                                                                                             Department of Defense
## 64                                                                                                                                                                            Department of Defense 
## 65                                                                                                                        Department of Defense for clinical trials of convalescent plasma for COVID
## 66                                                                                                                                                                 Department of Defense institution
## 67                                                                                                                                 Department of Defense Joint Program Executive Office for Chemical
## 68                                                                                                                                                Department of Defense Military Treatment Facility 
## 69                                                                                                                                             Department of Defense on Domestic Travel Restrictions
## 70                                                                                                                                                       Department of Defense Suicide Event Report 
## 71                                                                                                                                                                     Department of Defense website
## 72                                                                                                                           Department of Dentistry Federal University of Sergipe Aracaju SE Brazil
## 73                                                                                                                                                                         Department of Dermatology
## 74                                                                                                                                                                             Department of Ecology
## 75                                                                                                                                                    Department of Ecology and Evolutionary Biology
## 76                                                                                                                                                         Department of Economic and Social Affairs
## 77                                                                                                                                                                           Department of Economics
## 78                                                                                                                                                                 Department of Economics and UHERO
## 79                                                                                                                                                                           Department of Education
## 80                                                                                                                                                                          Department of Education 
## 81                                                                                                                                                                 Department of Education data book
## 82                                                                                                                                                                   Department of Education website
## 83                                                                                                                                                                  Department of Emergency Medicine
## 84                                                                                                                      Department of English Studies Universitat Jaume I Castello de la Plana Spain
## 85                                                                                                                                                     Department of Environmental and Global Health
## 86                                                                                                                                                                Department of Environmental Health
## 87                                                                                                                                                       Department of Environmental Health Sciences
## 88                                                                                                                                                              Department of Environmental Medicine
## 89                                                                                                                                                               Department of Environmental Science
## 90                                                                                                Department of Environmental Science and Management Humboldt State University Arcata California USA
## 91                                                                                                                                                  Department of Environmental Studies and Sciences
## 92                                                                                                                                                                        Department of Epidemiology
## 93                                                                                                                                                      Department of Epidemiology and Biostatistics
## 94                                                                                                                       Department of Epidemiology and Biostatistics at the School of Public Health
## 95                                                                                                                                                  Department of Epidemiology and Population Health
## 96                                                                                                                                                           Department of Experimental Therapeutics
## 97                                                                                                                                                                             Department of Family 
## 98                                                                                                                                                                     Department of Family Medicine
## 99                                                                                                                                                Department of Family Medicine and Community Health
## 100                                                                                                                                             Department of Family Medicine and Community Medicine
## 101                                                                                                                                                  Department of Family Medicine and Public Health
## 102                                                                                                                                         Department of Family Medicine and Public Health Medicine
## 103                                                 Department of Family Medicine clinic called patients instructed by our physicians to quarantine for exposure risk or symptoms of potential COVID
## 104                                                                                                                                                                      Department of Fish and Game
## 105                                                                                                                                                                          Department of Fisheries
## 106                                                                                                                                            Department of Forestry and Environmental Conservation
## 107                                                                                                                                               Department of Forestry and Environmental Resources
## 108                                                                                                                                                     Department of Forestry and Natural Resources
## 109                                                                                                                                                                   Department of General Medicine
## 110                                                                                                                                                 Department of Genetic and Molecular Epidemiology
## 111                                                                                                                                                                          Department of Geography
## 112                                                                                                                                                Department of Geography and Environmental Science
## 113                                                                                                                                       Department of Geography and Geographic Information Science
## 114                                                                                                                                        Department of Geosciences and Natural Resource Management
## 115                                                                                                                                                  Department of Geosciences and Natural Resources
## 116                                                                                                                                                                 Department of Geriatric Medicine
## 117                                                                                                                                                                             Department of Health
## 118                                                                                                                                                                           Department of Health\n
## 119                                                                                                                                                                            Department of Health 
## 120                                                                                                                                                                           Department of Health  
## 121                                                                                                                                           Department of Health  Alcohol and Drug Abuse Division 
## 122                                                                                                                   Department of Health  Child and Adolescent Mental Health Performance Standards
## 123                                                                                                                                                Department of Health  Current Situation in Hawaii
## 124                                                                                                                                                            Department of Health  Dikos Ntsaag
## 125                                                                                                                                                               Department of Health  Hawaii Covid
## 126                                                                                                                                                               Department of Health  Hawaii COVID
## 127                                                                                                                                Department of Health  Secondary Hawaii State Department of Health
## 128                                                                                                                              Department of Health  What the Hawaii Department of Health is Doing
## 129                                                                                                                                                       Department of Health  What You Should Know
## 130                                                                                                                                                              Department of Health Accessed March
## 131                                                                                                                                                             Department of Health Accessed March 
## 132                                                                                                                                                                     Department of Health Affairs
## 133                                                                                                                                                         Department of Health and\nHuman Services
## 134                                                                                                                                                        Department of Health and Exercise Science
## 135                                                                                                                                                         Department of Health and Human Resources
## 136                                                                                                                                                          Department of Health and Human Services
## 137                                                                                                                                                         Department of Health and Human Services 
## 138                                                                                                  Department of Health and Human Services  Supply and demand projections of the nursing workforce
## 139                                                                       Department of Health and Human Services  The feasibility of using electronic health data for research on small populations
## 140                                                                     Department of Health and Human Services Implements Electronic Death Registration System to Streamline Death Reporting in NC 
## 141                                                                                                                                                    Department of Health and Human Services Part 
## 142                                                                                                                                                             Department of Health and Kinesiology
## 143                                                                                                                                                            Department of Health and Social Care 
## 144                                                                                                                                                    Department of Health and the New South Wales 
## 145 Department of Health Behavioral Health Administration led and contracted a coalition of agencies to plan and implement an isolation and quarantine facility placement service that included food
## 146                                                                                                                               Department of Health Chronic Disease Management and Control Branch
## 147                                                                                                                                                        Department of Health Coronavirus Disease 
## 148                                                                                                                                                                      Department of Health D of H
## 149                                                                                                                                           Department of Health Disease Outbreak Control Division
## 150                                                                                                                                          Department of Health Disease Outbreak Control Division 
## 151                                                                                                                                             Department of Health Family Health Services Division
## 152                                                                                                                                                                       Department of Health Hawai
## 153                                                                                                                                                                       Department of Health https
## 154                                                                                                                                                          Department of Health Organization Chart
## 155                                                                                                                                          Department of Health partnered with University of Hawai
## 156                                                                                                                                                       Department of Health Policy and Management
## 157                                                                                                                                                                   Department of Health receives 
## 158                                                                                                                                         Department of Health serves a rural island community of 
## 159                                                                                                                                                                    Department of Health Services
## 160                                                                                                                                                Department of Health Services Research and Policy
## 161                                                                                                                                                             Department of Health Systems Science
## 162                                                                                                                                                             Department of Health to bring health
## 163                                                                                                                      Department of Health to support modelling contributions to Australian COVID
## 164                                                                                                                                                           Department of Health webpage for Hawai
## 165                                                                                                                                                                     Department of Health website
## 166                                                                                                                                                                     Department of Health Website
## 167                                                                                                                                                                         Department of Hematology
## 168                                                                                                                                                            Department of Hematology and Oncology
## 169                                                                                                                                                                       Department of Home Affairs
## 170                                                                                                           Department of Homeland Security  Threat and hazard identification and risk assessment 
## 171                                                                                                                                                                    Department of Human Nutrition
## 172                                                                                                                                                  Department of Immunology and Infectious Disease
## 173                                                                                                                                                                 Department of Infectious Control
## 174                                                                                                                                                                 Department of Infectious Disease
## 175                                                                                                                                                                Department of Infectious Diseases
## 176                                                                                                                                              Department of Infectious Diseases and Public Health
## 177                                                                                                                                         Department of Information Systems and Business Analytics
## 178                                                                                                                                           Department of Information Systems and Computer Science
## 179                                                                                                                                                                     Department of Intensive Care
## 180                                                                                                                                                            Department of Intensive Care Medicine
## 181                                                                                                                                                                   Department of Internal Affairs
## 182                                                                                                                                                                  Department of Internal Medicine
## 183                                                                                                                                                   Department of Internal Medicine and Pediatrics
## 184                                                                                                                                                               Department of International Health
## 185                                                                                                                                                   Department of Kinesiology and Exercise Science
## 186                                                                                                                                                                              Department of Labor
## 187                                                                                                                                                     Department of Labor and Industrial Relations
## 188                                                                                                                                                                Department of Laboratory Medicine
## 189                                                                                                                                                                        Department of Mathematics
## 190                                                                                                                 Department of Mathematics Federal University of Technology Owerri Owerri Nigeria
## 191                                                                                                                                 Department of Mathematics University of Benin Benin City Nigeria
## 192                                                                                                                         Department of Mathematics University of Hawaii Manoa Honolulu Hawaii USA
## 193                                                                                                                                                             Department of Mechanical Engineering
## 194                                                                                                                                                   Department of Medical Ethics and Health Policy
## 195                                                                                                                                                               Department of Medical Informatics 
## 196                                                                                                                                                                   Department of Medical Oncology
## 197                                                                                                                                                                   Department of Medical Research
## 198                                                                                                                                                                   Department of Medical Sciences
## 199                                                                                                                                                                           Department of Medicine
## 200                                                                                                                                                                          Department of Medicine 
## 201                                                                                                                                                       Department of Metabolism and Endocrinology
## 202                                                                                                                                                                       Department of Microbiology
## 203                                                                                                                                                        Department of Microbiology and Immunology
## 204                                                                                                                                                    Department of Molecular and Cellular Sciences
## 205                                                                                                                                           Department of Molecular Biosciences and Bioengineering
## 206                                                                                                                                                            Department of Molecular Biotechnology
## 207                                                                                                                                                             Department of Native Hawaiian Health
## 208                                                                                                                                                                  Department of Natural Resources
## 209                                                                                                                                     Department of Natural Resources and Environmental Management
## 210                                                                                                                                       Department of Natural Resources and Environmental Sciences
## 211                                                                                                                                                          Department of Natural Resources Science
## 212                                                                                                                                                        Department of Nephrology and Rheumatology
## 213                                                                                                                                                               Department of Neurological Surgery
## 214                                                                                                                                                                          Department of Neurology
## 215                                                                                                                                                                       Department of Neurosurgery
## 216                                                                                                                                                                            Department of Nursing
## 217                                                                                                                                                                          Department of Nutrition
## 218                                                                                                                                                         Department of Nutrition and Food Studies
## 219                                                                                                                                                                                 Department of OB
## 220                                                                                                                                                                         Department of Obstetrics
## 221                                                                                                                                                                        Department of Obstetrics 
## 222                                                                                                                                                               Department of Occupational Therapy
## 223                                                                                                                                                                      Department of Ophthalmology
## 224                                                                                                                                                                Department of Orthopaedic Surgery
## 225                                                                                                                                                                 Department of Orthopedic Surgery
## 226                                                                                                                                                                     Department of Otolaryngology
## 227                                                                                                                                                            Department of Paediatric Rheumatology
## 228                                                                                                                                                             Department of Parliamentary Services
## 229                                                                                                                                                                          Department of Pathology
## 230                                                                                                                                                  Department of Pathology and Laboratory Medicine
## 231                                                                                                                                                              Department of Pediatric Dermatology
## 232                                                                                                                                                                Department of Pediatric Neurology
## 233                                                                                                                                                                         Department of Pediatrics
## 234                                                                                                                                                        Department of Pediatrics and Child Health
## 235                                                                                                                                                         Department of Pharmaceutical Biomedicine
## 236                                                                                                                                                                       Department of Pharmacology
## 237                                                                                                                                                                           Department of Pharmacy
## 238                                                                                                                                                        Department of Pharmacy and Biotechnology 
## 239                                                                                                                                                        Department of Physical Activity and Sport
## 240                                                                                                                                                                 Department of Physical Medicine 
## 241                                                                                                                                               Department of Physical Medicine and Rehabilitation
## 242                                                                                                                                                                         Department of Physiology
## 243                                                                                                                                                                        Department of Physiology 
## 244                                                                                                                                                          Department of Physiology and Biophysics
## 245                                                                                                                                                                      Department of Physiotherapy
## 246                                                                                                                                        Department of Plant and Environmental Protection Sciences
## 247                                                                                                                                                                        Department of Population 
## 248                                                                                                                                        Department of Population and Quantitative Health Sciences
## 249                                                                                                                                                                  Department of Population Health
## 250                                                                                                                                                         Department of Population Health Sciences
## 251                                                                                                                                                    Department of Prevention and Community Health
## 252                                                                                                                                                                Department of Preventive Medicine
## 253                                                                                                                                                               Department of Preventive Medicine 
## 254                                                                                                                                              Department of Preventive Medicine and Biostatistics
## 255                                                                                                                                                                         Department of Psychiatry
## 256                                                                                                                                                 Department of Psychiatry and Behavioral Sciences
## 257                                                                                                                                              Department of Psychiatry and Department of Medicine
## 258                                                                                                                                                      Department of Psychiatry and Human Behavior
## 259                                                                                                                                     Department of Psychiatry Emory University School of Medicine
## 260                                                                                                                                                                         Department of Psychology
## 261                                                                                                                                 Department of Psychology Brigham Young University Provo Utah USA
## 262                                                                                                                                                                      Department of Public Health
## 263                                                                                                                                                                     Department of Public Health 
## 264                                                                                                                                              Department of Public Health and Infectious Diseases
## 265                                                                                                                                                     Department of Public Health and Primary Care
## 266                                                                                                                                                  Department of Public Health and Social Services
## 267                                                                                                                                                             Department of Public Health Sciences
## 268                                                                                                                                                        Department of Pulmonary and Critical Care
## 269                                                                                                                                                                 Department of Pulmonary Diseases
## 270                                                                                                                                                        Department of Quantitative Health Science
## 271                                                                                                                                                       Department of Quantitative Health Sciences
## 272                                                                                                                                                Department of Radiotherapy and Radiation Oncology
## 273                                                                                                                                                            Department of Rehabilitation Medicine
## 274                                                                                                                                                            Department of Rehabilitation Sciences
## 275                                                                                                                                                                           Department of Research
## 276                                                                                                                                                                          Department of Research 
## 277                                                                                                                                                Department of Research and Clinical Investigation
## 278                                                                                                                                                            Department of Research and Evaluation
## 279                                                                                                                                                                       Department of Rheumatology
## 280                                                                                                                                               Department of Rheumatology and Clinical Immunology
## 281                                                                                                                                                        Department of Rheumatology and Immunology
## 282                           Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia
## 283                                                                                                                                                                   Department of Smoking and COPD
## 284                                                                                                  Department of Social and Behavioral Sciences and Lee Kum Sheung Center for Health and Happiness
## 285                                                                                                                                                                    Department of Social Medicine
## 286                                                                                                                                                                        Department of Social Work
## 287                                                                                                      Department of Social Work and H Kpuna National Resource Center for Native Hawaiian Elders
## 288                                                                                                                                                                          Department of Sociology
## 289                                                                                                                                           Department of Sports Science and Clinical Biomechanics
## 290                                                                                                                                                                              Department of State
## 291                                                                                                                                                                           Department of State  U
## 292                                                                                                                                                                         Department of Statistics
## 293                                                                                                                                                                Department of Statistics Malaysia
## 294                                                                                                                                                                            Department of Surgery
## 295                                                                                                                                                                           Department of Surgery 
## 296                                                                                                                                                                 Department of Surgery and Cancer
## 297                                                                                                                                                                           Department of Taxation
## 298                                                                                                                                                                       Department of the Interior
## 299                                                                                                                                                               Department of Traffic Engineering 
## 300                                                                                                                                                     Department of Translational Medical Sciences
## 301                                                                                                                                                                     Department of Transportation
## 302                                                                                                                                                                  Department of Tropical Medicine
## 303                                                                                                                        Department of Tropical Medicine and Medical Microbiology and Pharmacology
## 304                                                                                                                                                   Department of Tropical Plant and Soil Sciences
## 305                                                                                                                                                                     Department of Twin Research 
## 306                                                                                                                                             Department of Twin Research and Genetic Epidemiology
## 307                                                                                                                                                                            Department of Urology
## 308                                                                                                                                                                   Department of Veterans Affairs
## 309                                                                                                                                                     Department of Veterans Affairs  COVID Coach 
## 310                                                                                                                                                  Department of Veterans Affairs during the COVID
## 311                                                                                                                                        Department of Veterans Affairs hospitals during the COVID
## 312                                                                                                                                                 Department of Veterinary Integrative Biosciences
## 313                                                                                                                                                                Department of Veterinary Medicine
## 314                                                                                                                                                                  Department of Veterinary School
## 315                                                                                                                                      Department of Virus and Microbiological Special Diagnostics
## 316                                                                                                                                                                           Department of Wildlife
## 317                                                                                                                                                  Department of Wildlife Ecology and Conservation
## 318                                                                                                                                                             Department of Zoology and Physiology
## 319                                                                                                                                                                     School of Aerospace Medicine
## 320                                                                                                                                                            School of Agriculture and Environment
## 321                                                                                                                         School of Applied Economics and Management Cornell University Ithaca USA
## 322                                                                                                            School of Aquatic and Fishery Science University of Washington Seattle Washington USA
## 323                                                                                                                                                                             School of Biological
## 324                                                                                                                                                                    School of Biological Sciences
## 325                                                                                                                                                                School of Biomedical Engineering 
## 326                                                                                                                                                                       School of Brown University
## 327                                                                                                                                                                               School of Business
## 328                                                                                                                            School of Business Mainz University of Applied Sciences Mainz Germany
## 329                                                                                                          School of Business Rosenheim Technical University of Applied Sciences Rosenheim Germany
## 330                                                                                                                  School of Business University of Southern California Los Angeles California USA
## 331                                                                                                                                                                   School of Chemical Engineering
## 332                                                                                                                                                                      School of Clinical Medicine
## 333                                                                                                                                                          School of Communication and Information
## 334                                                                                                                                                       School of Economics and Political Science 
## 335                                                                                                                                                        School of Education and Human Development
## 336                                                                                                                                                                      School of Education Science
## 337                                                                                                               School of Electronic Engineering Kumoh National Institute of Technology Gumi Korea
## 338                                                                                                                                                                 School of Energy and Environment
## 339                                                                                                                                                                            School of Engineering
## 340                                                                                                  School of Environmental and Biological Sciences Rutgers University New Brunswick New Jersey USA
## 341                                                                                                                                                   School of Epidemiology and Preventive Medicine
## 342                                                                                                                                                                                 School of Forest
## 343                                                                                                                                                         School of Forestry and Natural Resources
## 344                                                                                                                                                         School of Forestry and Wildlife Sciences
## 345                                                                                                                                                               School of Government Working Paper
## 346                                                                                                                                                                               School of Hawaiian
## 347                                                                                                                                             School of Hawaiian Knowledge and University of Hawai
## 348                                                                                                                                                                                 School of Health
## 349                                                                                                                                                                 School of Health Administration 
## 350                                                                                                                                                     School of Health and Rehabilitation Sciences
## 351                                                                                                                                                                               School of Hygiene 
## 352                                                                                                                                                          School of Hygiene and Tropical Medicine
## 353                                                                                                                                                      School of Immunology and Microbial Sciences
## 354                                                                                                                                                                                    School of Law
## 355                                                                                                                                                                          School of Life Sciences
## 356                                                                                                                                                                               School of Medicine
## 357                                                                                                                                                                   School of Medicine  Guidebook 
## 358                                                                                                                                              School of Medicine  Office of International Affairs
## 359                                                                                                                                                           School of Medicine and Health Sciences
## 360                                                                                                                                                          School of Medicine and Medical Sciences
## 361                                                                                                                           School of Medicine and New York University Langone Orthopedic Hospital
## 362                                                                                                                                                             School of Medicine and Public Health
## 363                                                                                                                                        School of Medicine and University of Hawaii Cancer Center
## 364                                                                                                                                                                  School of Medicine at Dartmouth
## 365                                                                                                                                                                School of Medicine at Mount Sinai
## 366                                                                                                                                                                       School of Medicine at UCLA
## 367                                                                                                                                                       School of Medicine Biocontainment Facility
## 368                                                                                                                                                School of Medicine Dept of Native Hawaiian Health
## 369                                                                                                                            School of Medicine have helped elucidate the connections between diet
## 370                                                                                                                                                                         School of Medicine in St
## 371                                                                                                                                                                   School of Medicine in St Louis
## 372                                                                                                                                                                     School of Medicine in the US
## 373                                                                                                                                                   School of Medicine of the University of Hawaii
## 374                                                                                                                                          School of Medicine of University of Southern California
## 375                                                                                                                                                                        School of Medicine of USC
## 376                                                                                                                                                School of Medicine Univ of Hawaii Honolulu HI USA
## 377                                                                                                                                                      School of Medicine University of California
## 378                                                                                                                                                      School of Natural Resources and Environment
## 379                                                                                                                                                       School of Natural Sciences and Mathematics
## 380                                                                                                                                                                                School of Nursing
## 381                                                                                                                                                                               School of Nursing 
## 382                                                                                                                                                             School of Nursing and Dental Hygiene
## 383                                                                                                                                      School of Nursing and Dental Hygiene at University of Hawai
## 384                                                                                                                  School of Nursing at The University of Texas Health Sciences Center at Houston 
## 385                                                                                                                                                 School of Ocean and Earth Science and Technology
## 386                                                                                                                                                              School of Pacific and Asian Studies
## 387                                                                                                                                                                               School of Pharmacy
## 388                                                                                                                                                          School of Pharmacy and Medical Sciences
## 389                                                                                                                                                                     School of Physical Education
## 390                                                                                                                                                           School of Physical Education and Sport
## 391                                                                                                                      School of Physical Therapy and Graduate Institute of Rehabilitation Science
## 392                                                                                                                                                                          School of Physiotherapy
## 393                                                                                                                                               School of Population Health and Community Medicine
## 394                                                                                                                                                       School of Public and Environmental Affairs
## 395                                                                                                        School of Public and Environmental Affairs and associate vice provost for health sciences
## 396                                                                                                                                                                          School of Public Health
## 397                                                                                                                                                  School of Public Health and Preventive Medicine
## 398                                                                                                                                                                          School of Public Policy
## 399                                                                                                                                                                         School of Public Service
## 400                                                                                                                                                                               School of Sciences
## 401                                                                                                                                                                        School of Social Sciences
## 402                                                                                                                                                                            School of Social Work
## 403                                                                                                                                                                           School of Social Work 
## 404                                                                                                                                                          School of Social Work and Public Health
## 405                                                                                                                                                         School of the University of Pennsylvania
## 406                                                                                                                                                                         School of Transportation
## 407                                                                                                                                                School of Veterinary Medicine at Tufts University
##     Freq
## 1      1
## 2      1
## 3      1
## 4      1
## 5      1
## 6      6
## 7      1
## 8      1
## 9     30
## 10     2
## 11     1
## 12     1
## 13    14
## 14     1
## 15     3
## 16     1
## 17     3
## 18     2
## 19     1
## 20     3
## 21     2
## 22     1
## 23    10
## 24     2
## 25    30
## 26     2
## 27     1
## 28     3
## 29     1
## 30     1
## 31     3
## 32    16
## 33     5
## 34     1
## 35     1
## 36    33
## 37     1
## 38     1
## 39     1
## 40     4
## 41     2
## 42     1
## 43    12
## 44     1
## 45     1
## 46     3
## 47     1
## 48     6
## 49     4
## 50     1
## 51     2
## 52     1
## 53     2
## 54     2
## 55     2
## 56     1
## 57     1
## 58     1
## 59     2
## 60     2
## 61    11
## 62     1
## 63     8
## 64     3
## 65     1
## 66     2
## 67     2
## 68     1
## 69     1
## 70     1
## 71     1
## 72     1
## 73    27
## 74     2
## 75     2
## 76     5
## 77     8
## 78    10
## 79     5
## 80     2
## 81     1
## 82     1
## 83    18
## 84     2
## 85     2
## 86     1
## 87     1
## 88     1
## 89     1
## 90     2
## 91     2
## 92    15
## 93     6
## 94     1
## 95     4
## 96     1
## 97     1
## 98     2
## 99    10
## 100    1
## 101    1
## 102    1
## 103    1
## 104    1
## 105    1
## 106    2
## 107    2
## 108    2
## 109    7
## 110    1
## 111    4
## 112    2
## 113    4
## 114    3
## 115    1
## 116    1
## 117  133
## 118    2
## 119   11
## 120    2
## 121    1
## 122    1
## 123    2
## 124    1
## 125    1
## 126    3
## 127    1
## 128    1
## 129    1
## 130    1
## 131    1
## 132    1
## 133    1
## 134    1
## 135    1
## 136   29
## 137    3
## 138    1
## 139    1
## 140    1
## 141    1
## 142    3
## 143    1
## 144    1
## 145    1
## 146    1
## 147    2
## 148    1
## 149    2
## 150    7
## 151    1
## 152    3
## 153    1
## 154    1
## 155    1
## 156    1
## 157    1
## 158    1
## 159    2
## 160    1
## 161    5
## 162    1
## 163    1
## 164    1
## 165    3
## 166    1
## 167    2
## 168    1
## 169    1
## 170    1
## 171    1
## 172    1
## 173    3
## 174    5
## 175   20
## 176    1
## 177    1
## 178    1
## 179    2
## 180    1
## 181   22
## 182   61
## 183    2
## 184    3
## 185    2
## 186    1
## 187    2
## 188    3
## 189   14
## 190    3
## 191    1
## 192    1
## 193    8
## 194    9
## 195    1
## 196    5
## 197    1
## 198    1
## 199  202
## 200    4
## 201    1
## 202    3
## 203   12
## 204    1
## 205    8
## 206    1
## 207    5
## 208    5
## 209    1
## 210    4
## 211    3
## 212    5
## 213   12
## 214    4
## 215    1
## 216    1
## 217    5
## 218    2
## 219    8
## 220   18
## 221    2
## 222    2
## 223    1
## 224    4
## 225    5
## 226    4
## 227    1
## 228    1
## 229   10
## 230    8
## 231    2
## 232    2
## 233   44
## 234    1
## 235    1
## 236    2
## 237    1
## 238    1
## 239    1
## 240    1
## 241    3
## 242    4
## 243    3
## 244    9
## 245    1
## 246    1
## 247    2
## 248    5
## 249    6
## 250    4
## 251    1
## 252   15
## 253    5
## 254  159
## 255   26
## 256    6
## 257    1
## 258    2
## 259    1
## 260    8
## 261    2
## 262   10
## 263    2
## 264    1
## 265    2
## 266    1
## 267    2
## 268    1
## 269    1
## 270    1
## 271   33
## 272    1
## 273    1
## 274    6
## 275    1
## 276   21
## 277    1
## 278    8
## 279    3
## 280    2
## 281    2
## 282    1
## 283    8
## 284    1
## 285    3
## 286    3
## 287    1
## 288    9
## 289    1
## 290    2
## 291    1
## 292    5
## 293    1
## 294   17
## 295   22
## 296    2
## 297    2
## 298    1
## 299    1
## 300    1
## 301    1
## 302   62
## 303    4
## 304    1
## 305    2
## 306    2
## 307    1
## 308   14
## 309    2
## 310    1
## 311    1
## 312    2
## 313    4
## 314    1
## 315    1
## 316    2
## 317    3
## 318    1
## 319    7
## 320    1
## 321    1
## 322    1
## 323    1
## 324    3
## 325    3
## 326    2
## 327    1
## 328    1
## 329    1
## 330    2
## 331    1
## 332    1
## 333    2
## 334    1
## 335    1
## 336    2
## 337    1
## 338    2
## 339    1
## 340    2
## 341    6
## 342    1
## 343    2
## 344    2
## 345    1
## 346    1
## 347    1
## 348    2
## 349   11
## 350    1
## 351    1
## 352    1
## 353    1
## 354    1
## 355    3
## 356  639
## 357    1
## 358    1
## 359    1
## 360    2
## 361    2
## 362    1
## 363    1
## 364    2
## 365    9
## 366    4
## 367    2
## 368    1
## 369    1
## 370    1
## 371    1
## 372    1
## 373    1
## 374    6
## 375    2
## 376    2
## 377    6
## 378    1
## 379    3
## 380   22
## 381   14
## 382   32
## 383    2
## 384    2
## 385    1
## 386    1
## 387    1
## 388    1
## 389    1
## 390    2
## 391    3
## 392    1
## 393    2
## 394    1
## 395    1
## 396   74
## 397   18
## 398    8
## 399    1
## 400    4
## 401    3
## 402   11
## 403   33
## 404   22
## 405    1
## 406    1
## 407    1</code></pre>
</div>
<div id="question-5-form-a-database" class="section level2">
<h2>Question 5: Form a database</h2>
<p>We want to build a dataset which includes the title and the abstract
of the paper. The title of all records is enclosed by the HTML tag
<code>ArticleTitle</code>, and the abstract by
<code>Abstract</code>.</p>
<p>Before applying the functions to extract text directly, it will help
to process the XML a bit. We will use the
<code>xml2::xml_children()</code> function to keep one element per id.
This way, if a paper is missing the abstract, or something else, we will
be able to properly match PUBMED IDS with their corresponding
records.</p>
<pre class="r"><code>pub_char_list &lt;- xml2::xml_children(publications)
pub_char_list &lt;- sapply(pub_char_list, as.character)</code></pre>
<p>Now, extract the abstract and article title for each one of the
elements of <code>pub_char_list</code>. You can either use
<code>sapply()</code> as we just did, or simply take advantage of
vectorization of <code>stringr::str_extract</code></p>
<pre class="r"><code>abstracts &lt;- str_extract(pub_char_list, &quot;&lt;Abstract&gt;(\\n|.)+&lt;/Abstract&gt;&quot;)
# abstracts &lt;- str_remove_all(abstracts, &quot;&lt;Abstract&gt;|&lt;/Abstract&gt;&quot;)
abstracts &lt;- str_remove_all(abstracts, &quot;&lt;/?[[:alnum:]]+&gt;&quot;)
abstracts &lt;- str_replace_all(abstracts, &quot;\\s+&quot;, &quot; &quot;)
table(is.na(abstracts))</code></pre>
<pre><code>## 
## FALSE  TRUE 
##   285    53</code></pre>
<ul>
<li>How many of these dont have an abstract?</li>
</ul>
<p><em>Answer here.</em></p>
<p>Among all the article, there are 53 article that do not have
abstract.</p>
<p>Now, the title</p>
<pre class="r"><code>titles &lt;- str_extract(pub_char_list, &quot;&lt;ArticleTitle&gt;(\\n|.)+&lt;/ArticleTitle&gt;&quot;)
titles &lt;- str_remove_all(titles, &quot;&lt;/?[[:alnum:]]+&gt;&quot;)
table(is.na(titles))</code></pre>
<pre><code>## 
## FALSE 
##   338</code></pre>
<ul>
<li>How many of these dont have a title ?</li>
</ul>
<p><em>Answer here.</em></p>
<p>Among all the article, there is 0 article that have no title.</p>
<p>Finally, put everything together into a single
<code>data.frame</code> and use <code>knitr::kable</code> to print the
results</p>
<pre class="r"><code>database &lt;- data.frame(
  title = titles,
  abstract = abstracts
)
knitr::kable(database)</code></pre>
<table>
<colgroup>
<col width="5%" />
<col width="94%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">title</th>
<th align="left">abstract</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">A machine learning approach identifies distinct
early-symptom cluster phenotypes which correlate with hospitalization,
failure to return to activities, and prolonged COVID-19 symptoms.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Accurate
COVID-19 prognosis is a critical aspect of acute and long-term clinical
management. We identified discrete clusters of early stage-symptoms
which may delineate groups with distinct disease severity phenotypes,
including risk of developing long-term symptoms and associated
inflammatory profiles.
<AbstractText Label="METHODS" NlmCategory="METHODS">1,273 SARS-CoV-2
positive U.S. Military Health System beneficiaries with quantitative
symptom scores (FLU-PRO Plus) were included in this analysis. We
employed machine-learning approaches to identify symptom clusters and
compared risk of hospitalization, long-term symptoms, as well as peak
CRP and IL-6 concentrations.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified three
distinct clusters of participants based on their FLU-PRO Plus symptoms:
cluster 1 (Nasal cluster) is highly correlated with reporting
runny/stuffy nose and sneezing, cluster 2 (Sensory cluster) is highly
correlated with loss of smell or taste, and cluster 3
(Respiratory/Systemic cluster) is highly correlated with the
respiratory (cough, trouble breathing, among others) and systemic (body
aches, chills, among others) domain symptoms. Participants in the
Respiratory/Systemic cluster were twice as likely as those in the Nasal
cluster to have been hospitalized, and 1.5 times as likely to report
that they had not returned-to-activities, which remained significant
after controlling for confounding covariates (P &lt; 0.01).
Respiratory/Systemic and Sensory clusters were more likely to have
symptoms at six-months post-symptom-onset (P = 0.03). We observed higher
peak CRP and IL-6 in the Respiratory/Systemic cluster (P &lt; 0.01).
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We
identified early symptom profiles potentially associated with
hospitalization, return-to-activities, long-term symptoms, and
inflammatory profiles. These findings may assist in patient prognosis,
including prediction of long COVID risk. Copyright: This is an open
access article, free of all copyright, and may be freely reproduced,
distributed, transmitted, modified, built upon, or otherwise used by
anyone for any lawful purpose. The work is made available under the
Creative Commons CC0 public domain dedication.</td>
</tr>
<tr class="even">
<td align="left">Barriers and Challenges for Career Milestones Among
Faculty Mentees.</td>
<td align="left">Critical career milestones for faculty (e.g., tenure,
securing grant funding) relate to career advancement, job satisfaction,
service/leadership, scholarship/research, clinical or teaching
activities, professionalism, compensation, and work-life balance.
However, barriers and challenges to these milestones encountered by
junior faculty have been inadequately studied, particularly those
affecting underrepresented minorities in science (URM-S). Additionally,
little is known about how barriers and challenges to career milestones
have changed during the COVID-19 pandemic for URM-S and non-URM faculty
mentees in science. In this study, we conducted semi-structured
interviews with 31 faculty mentees from four academic institutions
(located in New Mexico, Arizona, Idaho, and Hawaii), including 22 URM-S
(women or racial/ethnic). Respondents were given examples of critical
career milestones and were asked to identify and discuss barriers and
challenges that they have encountered or expect to encounter while
working toward achieving these milestones. We performed thematic
descriptive analysis using NVivo software in an iterative, team-based
process. Our preliminary analysis identified five key themes that
illustrate barriers and challenges encountered: Job and career
development, Discrimination and a lack of workplace diversity; Lack of
interpersonal relationships and inadequate social support at the
workplace; Personal and family matters; and Unique COVID-19-related
issues. COVID-19 barriers and challenges were related to online
curriculum creation and administration, interpersonal relationship
development, inadequate training/service/conference opportunities, and
disruptions in childcare and schooling. Although COVID-19 helped create
new barriers and challenges for junior faculty mentees, traditional
barriers and challenges for critical career milestones continue to be
reported among our respondents. URM-S respondents also identified
discrimination and diversity-related barriers and challenges. Subsequent
interviews will focus on 12-month and 24-month follow-ups and provide
additional insight into the unique challenges and barriers to critical
career milestones that URM and non-URM faculty in science have
encountered during the unique historical context of the COVID-19
pandemic.</td>
</tr>
<tr class="odd">
<td align="left">COVID-19 Information on YouTube: Analysis of Quality
and Reliability of Videos in Eleven Widely Spoken Languages across
Africa.</td>
<td align="left"><AbstractText Label="INTRODUCTION">Whilst the
coronavirus disease 2019 (COVID-19) vaccination rollout is well
underway, there is a concern in Africa where less than 2% of global
vaccinations have occurred. In the absence of herd immunity, health
promotion remains essential. YouTube has been widely utilised as a
source of medical information in previous outbreaks and pandemics. There
are limited data on COVID-19 information on YouTube videos, especially
in languages widely spoken in Africa. This study investigated the
quality and reliability of such videos.
<AbstractText Label="METHODS">Medical information related to COVID-19
was analysed in 11 languages (English, isiZulu, isiXhosa, Afrikaans,
Nigerian Pidgin, Hausa, Twi, Arabic, Amharic, French, and Swahili).
Cohens Kappa was used to measure inter-rater reliability. A total of
562 videos were analysed. Viewer interaction metrics and video
characteristics, source, and content type were collected. Quality was
evaluated using the Medical Information Content Index (MICI) scale and
reliability was evaluated by the modified DISCERN tool.
<AbstractText Label="RESULTS">Kappa coefficient of agreement for all
languages was p &lt; 0.01. Informative videos (471/562, 83.8%) accounted
for the majority, whilst misleading videos (12/562, 2.13%) were minimal.
Independent users (246/562, 43.8%) were the predominant source type.
Transmission of information (477/562 videos, 84.9%) was most prevalent,
whilst content covering screening or testing was reported in less than a
third of all videos. The mean total MICI score was 5.75/5 (SD 4.25) and
the mean total DISCERN score was 3.01/5 (SD 1.11).
<AbstractText Label="CONCLUSION">YouTube is an invaluable, easily
accessible resource for information dissemination during health
emergencies. Misleading videos are often a concern; however, our study
found a negligible proportion. Whilst most videos were fairly reliable,
the quality of videos was poor, especially noting a dearth of
information covering screening or testing. Governments, academic
institutions, and healthcare workers must harness the capability of
digital platforms, such as YouTube to contain the spread of
misinformation. Copyright  2023 Kapil Narain et al.</td>
</tr>
<tr class="even">
<td align="left">BNT162b2 against COVID-19-associated Emergency
Department and Urgent Care Visits among Children 5-11 Years of Age: a
Test Negative Design.</td>
<td align="left">In a 1:1 matched test-negative design among
5-11-year-olds in the Kaiser Permanente Southern California health
system (n=3984), BNT162b2 effectiveness against omicron-related
emergency department or urgent care encounters was 60% [95%CI: 47-69]
&lt;3 months post-dose-two and 28% [8-43] after 3 months. A booster
improved protection to 77% [53-88].  The Author(s) 2023. Published by
Oxford University Press on behalf of The Journal of the Pediatric
Infectious Diseases Society.</td>
</tr>
<tr class="odd">
<td align="left">COVID-19 Information Seeking Behaviors of University of
Hawaii at Mnoa Undergraduates: Information Channels, Sources, and
Consumption.</td>
<td align="left">This study explored how undergraduate students at the
University of Hawaii at Manoa sought and consumed information about the
virus that causes COVID-19. This study also examined student perceptions
of the severity of and their susceptibility to the virus and their main
concerns about it. Four hundred fifty-six students completed online
surveys between October and early December of 2020 and 2021. Students
reported low to moderate levels of information seeking across four
domains: (1) knowledge about COVID-19 and its symptoms; (2) preventing
the spread of the virus; (3) the current state of the pandemic in
Hawaii; and (4) the likely future of the pandemic in Hawaii. Overall,
websites, television, and Instagram were the top 3 channels used by
students to seek information for these domains. Students reported
primarily paying attention to information from government and news
organizations as sources. However, students preferred channels and
sources varied with the type of information they sought. Students also
reported believing that COVID-19 is severe and that they are susceptible
to being infected with it. The more time students reported seeking
information, the greater their perceptions of COVID-19s severity across
all domains. Students primary concerns about COVID-19 centered on state
regulations/policies, vaccines, tourism/travel, the economy, and
pandemic/post-pandemic life. These findings can help public health
practitioners in Hawaii determine how best to reach an undergraduate
student population with information related to COVID-19. Copyright 2023
by University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Analysis of mRNA COVID-19 Vaccine Uptake Among
Immunocompromised Individuals in a Large US Health System.</td>
<td align="left"><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Immunocompromised
individuals are at increased risk for severe outcomes due to SARS-CoV-2
infection. Given the varying and complex nature of COVID-19 vaccination
recommendations, it is important to understand COVID-19 vaccine uptake
in this vulnerable population.
<AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To assess mRNA
COVID-19 vaccine uptake and factors associated with uptake among
immunocompromised individuals from December 14, 2020, through August 6,
2022.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="UNASSIGNED">This
cohort study was conducted with patients of Kaiser Permanente Southern
California (KPSC), an integrated health care system in the US. The study
included patients aged 18 years or older who were immunocompromised
(individuals with an immunocompromising condition or patients who
received immunosuppressive medications in the year prior to December 14,
2020) and still met criteria for being immunocompromised 1 year later.
<AbstractText Label="EXPOSURES" NlmCategory="UNASSIGNED">Age, sex,
self-identified race and ethnicity, prior positive COVID-19 test result,
immunocompromising condition, immunomodulating medication,
comorbidities, health care utilization, and neighborhood median income.
<AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">Outcomes
were the number of doses of mRNA COVID-19 vaccine received and the
factors associated with receipt of at least 4 doses, estimated by hazard
ratios (HRs) and 95% Wald CIs via Cox proportional hazards regression.
Statistical analyses were conducted between August 9 and 23, 2022.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Overall, 42 697
immunocompromised individuals met the study eligibility criteria. Among
these, 18 789 (44.0%) were aged 65 years or older; 20 061 (47.0%) were
women and 22 635 (53.0%) were men. With regard to race and ethnicity,
4295 participants (10.1%) identified as Asian or Pacific Islander, 5174
(12.1%) as Black, 14 289 (33.5%) as Hispanic, and 17 902 (41.9%) as
White. As of the end of the study period and after accounting for
participant censoring due to death or disenrollment from the KPSC health
plan, 78.0% of immunocompromised individuals had received a third dose
of mRNA COVID-19 vaccine. Only 41.0% had received a fourth dose, which
corresponds to a primary series and a monovalent booster dose for
immunocompromised individuals. Uptake of a fifth dose was only 0.9%
following the US Centers for Disease Control and Prevention (CDC)
recommendation to receive a second monovalent booster (ie, fifth dose).
Adults aged 65 years or older (HR, 3.95 [95% CI, 3.70-4.22]) were more
likely to receive at least 4 doses compared with those aged 18 to 44
years or 45 to 64 years (2.52 [2.36-2.69]). Hispanic and non-Hispanic
Black adults (HR, 0.77 [95% CI, 0.74-0.80] and 0.82 [0.78-0.87],
respectively, compared with non-Hispanic White adults), individuals with
prior documented SARS-CoV-2 infection (0.71 [0.62-0.81] compared with
those without), and individuals receiving high-dose corticosteroids
(0.88 [0.81-0.95] compared with those who were not) were less likely to
receive at least 4 doses.
<AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">These
findings suggest that adherence to CDC mRNA monovalent COVID-19 booster
dose recommendations among immunocompromised individuals was low. Given
the increased risk for severe COVID-19 in this vulnerable population and
the well-established additional protection afforded by booster doses,
targeted and tailored efforts to ensure that immunocompromised
individuals remain up to date with COVID-19 booster dose recommendations
are warranted.</td>
</tr>
<tr class="odd">
<td align="left">Persistent COVID-19 Symptoms at 6 Months After Onset
and the Role of Vaccination Before or After SARS-CoV-2 Infection.</td>
<td align="left"><AbstractText Label="IMPORTANCE">Understanding the
factors associated with post-COVID conditions is important for
prevention. <AbstractText Label="OBJECTIVE">To identify characteristics
associated with persistent post-COVID-19 symptoms and to describe
post-COVID-19 medical encounters.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cohort
study used data from the Epidemiology, Immunology, and Clinical
Characteristics of Emerging Infectious Diseases With Pandemic Potential
(EPICC) study implemented in the US military health system (MHS); MHS
beneficiaries aged 18 years or older who tested positive for SARS-CoV-2
from February 28, 2020, through December 31, 2021, were analyzed, with
1-year follow-up. <AbstractText Label="EXPOSURES">SARS-CoV-2 infection.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">The outcomes analyzed
included survey-reported symptoms through 6 months after SARS-CoV-2
infection and International Statistical Classification of Diseases and
Related Health Problems, Tenth Revision diagnosis categories reported in
medical records 6 months following SARS-CoV-2 infection vs 3 months
before infection. <AbstractText Label="RESULTS">More than half of the
1832 participants in these analyses were aged 18 to 44 years (1226
[66.9%]; mean [SD] age, 40.5 [13.7] years), were male (1118 [61.0%]),
were unvaccinated at the time of their infection (1413 [77.1%]), and had
no comorbidities (1290 [70.4%]). A total of 728 participants (39.7%) had
illness that lasted 28 days or longer (28-89 days: 364 [19.9%]; 90
days: 364 [19.9%]). Participants who were unvaccinated prior to
infection (risk ratio [RR], 1.39; 95% CI, 1.04-1.85), reported moderate
(RR, 1.80; 95% CI, 1.47-2.22) or severe (RR, 2.25; 95% CI, 1.80-2.81)
initial illnesses, had more hospitalized days (RR per each day of
hospitalization, 1.02; 95% CI, 1.00-1.03), and had a Charlson
Comorbidity Index score of 5 or greater (RR, 1.55; 95% CI, 1.01-2.37)
were more likely to report 28 or more days of symptoms. Among
unvaccinated participants, postinfection vaccination was associated with
a 41% lower risk of reporting symptoms at 6 months (RR, 0.59; 95% CI,
0.40-0.89). Participants had higher risk of pulmonary (RR, 2.00; 95% CI,
1.40-2.84), diabetes (RR, 1.46; 95% CI, 1.00-2.13), neurological (RR,
1.29; 95% CI, 1.02-1.64), and mental health-related medical encounters
(RR, 1.28; 95% CI, 1.01-1.62) at 6 months after symptom onset than at
baseline (before SARS-CoV-2 infection).
<AbstractText Label="CONCLUSIONS AND RELEVANCE">In this cohort study,
more severe acute illness, a higher Charlson Comorbidity Index score,
and being unvaccinated were associated with a higher risk of reporting
COVID-19 symptoms lasting 28 days or more. Participants with COVID-19
were more likely to seek medical care for diabetes, pulmonary,
neurological, and mental health-related illness for at least 6 months
after onset compared with their pre-COVID baseline health care use
patterns. These findings may inform the risk-benefit ratio of COVID-19
vaccination policy.</td>
</tr>
<tr class="even">
<td align="left">Gut microbial indicators of metabolic health underlie
age-related differences in obesity and diabetes risk among Native
Hawaiians and Pacific Islanders.</td>
<td align="left">Native Hawaiians and Pacific Islanders (NHPIs) suffer
from higher prevalence of and mortality to type 2 diabetes mellitus
(T2DM) than any other major race/ethnic group in Hawaii. Health
inequities in this indigenous population was further exacerbated by the
SARS-CoV-2 pandemic. T2DM progression and medical complications
exacerbated by COVID-19 are partially regulated by the gut microbiome.
However, there is limited understanding of the role of gut bacteria in
the context of inflammation-related diseases of health disparities
including T2DM and obesity. To address these gaps, we used a
community-based research approach from a cohort enriched with NHPI
residents on the island of Oahu, Hawaii (N=138). Gut microbiome
profiling was achieved via 16s rDNA metagenomic sequencing analysis from
stool DNA. Gut bacterial capacity for butyrate-kinase (BUK)-mediated
fiber metabolism was assessed using quantitative PCR to measure the
abundance of BUK DNA and RNA relative to total bacterial load per stool
sample. In our cohort, age positively correlated with hemoglobin A1c (%;
R=0.39; P&lt;0.001) and body mass index (BMI; R=0.28; P&lt;0.001). The
relative abundance of major gut bacterial phyla significantly varied
across age groups, including Bacteroidetes (P&lt;0.001), Actinobacteria
(P=0.007), and Proteobacteria (P=0.008). A1c was negatively correlated
with the relative levels of BUK DNA copy number (R=-0.17; P=0.071) and
gene expression (R=-0.33; P=0.003). Interestingly, we identified
specific genera of gut bacteria potentially mediating the effects of
diet on metabolic health in this cohort. Additionally, -diversity among
gut bacterial genera significantly varied across T2DM and BMI
categories. Together, these results provide insight into age-related
differences in gut bacteria that may influence T2DM and obesity in
NHPIs. Furthermore, we observed overlapping patterns between gut
bacteria and T2DM risk factors, indicating more nuanced, interdependent
interactions among these factors as partial determinants of health
outcomes. This study adds to the paucity of NHPI-specific data to
further elucidate the biological characteristics associated with
pre-existing health inequities in this racial/ethnic group that is
significantly underrepresented in biomedical research. Copyright  2022
Wells, Kunihiro, Phankitnirundorn, Peres, McCracken, Umeda, Lee, Kim,
Juarez and Maunakea.</td>
</tr>
<tr class="odd">
<td align="left">2021 Annual Report of the National Poison Data System
(NPDS) from Americas Poison Centers: 39th Annual Report.</td>
<td align="left"><AbstractText Label="ABSTRACTINTRODUCTION" NlmCategory="UNASSIGNED">This
is the 39th Annual Report of Americas Poison Centers National Poison
Data System (NPDS). As of 1 January, 2021, all 55 of the nations poison
centers (PCs) uploaded case data automatically to NPDS. The upload
interval was 4.87 [4.38, 8.62] (median [25%, 75%]) minutes, effectuating
a near real-time national exposure and information database and
surveillance system.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We analyzed the
case data tabulating specific indices from NPDS. The methodology was
similar to that of previous years. Where changes were introduced, the
differences are identified. Cases with medical outcomes of death were
evaluated by a team of medical and clinical toxicologist reviewers using
an ordinal scale of 1-6 to assess the Relative Contribution to Fatality
(RCF) of the exposure.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In 2021,
2,851,166 closed encounters were logged by NPDS: 2,080,917 human
exposures, 62,189 animal exposures, 703,086 information requests, 4,920
human confirmed nonexposures, and 54 animal confirmed nonexposures.
Total encounters showed a 14.0% decrease from 2020, and human exposure
cases decreased by 2.22%, while health care facility (HCF) human
exposure cases increased by 7.20%. All information requests decreased by
37.0%, medication identification (Drug ID) requests decreased by 20.8%,
and medical information requests showed a 61.1% decrease, although these
remain about 13-fold higher than before the COVID-19 pandemic. Drug
Information requests showed a 146% increase, reflecting COVID-19 vaccine
calls to PCs. Human exposures with less serious outcomes have decreased
1.80% per year since 2008, while those with more serious outcomes
(moderate, major or death) have increased 4.56% per year since
2000.Consistent with the previous year, the top 5 substance classes most
frequently involved in all human exposures were analgesics (11.2%),
household cleaning substances (7.49%), cosmetics/personal care products
(5.88%), antidepressants (5.61%), and sedatives/hypnotics/antipsychotics
(4.73%). As a class, antidepressant exposures increased most rapidly, by
1,663 cases/year (5.30%/year) over the past 10 years for cases with more
serious outcomes.The top 5 most common exposures in children age 5 years
or less were cosmetics/personal care products (10.8%), household
cleaning substances (10.7%), analgesics (8.16%), dietary
supplements/herbals/homeopathic (7.00%), and foreign
bodies/toys/miscellaneous (6.51%). Drug identification requests
comprised 3.64% of all information contacts. NPDS documented 4,497 human
exposures resulting in death; 3,809 (84.7%) of these were judged as
related (RCF of 1-Undoubtedly responsible, 2-Probably responsible, or
3-Contributory).
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">These data
support the continued value of PC expertise and the need for specialized
medical toxicology information to manage more serious exposures.
Unintentional and intentional exposures continue to be a significant
cause of morbidity and mortality in the US. The near real-time status of
NPDS represents a national public health resource to collect and monitor
US exposure cases and information contacts. The continuing mission of
NPDS is to provide a nationwide infrastructure for surveillance for all
types of exposures (e.g., foreign body, infectious, venomous, chemical
agent, or commercial product), and the identification and tracking of
significant public health events. NPDS is a model system for the near
real-time surveillance of national and global public health.</td>
</tr>
<tr class="even">
<td align="left">Phenotypic alteration of low-density granulocytes in
people with pulmonary post-acute sequalae of SARS-CoV-2 infection.</td>
<td align="left"><AbstractText Label="BACKGROUND">Low-density
granulocytes (LDGs) are a distinct subset of neutrophils whose increased
abundance is associated with the severity of COVID-19. However, the
long-term effects of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection on LDG levels and phenotypic alteration remain
unexplored. <AbstractText Label="METHODS">Using participants nave to
SARS-CoV-2 (NP), infected with SARS-CoV-2 with no residual symptoms
(NRS), and infected with SARS-CoV-2 with chronic pulmonary symptoms
(PPASC), we compared LDG levels and their phenotype by measuring the
expression of markers for activation, maturation, and neutrophil
extracellular trap (NET) formation using flow cytometry.
<AbstractText Label="RESULTS">The number of LDGs was elevated in PPASC
compared to NP. Individuals infected with SARS-CoV-2 (NRS and PPASC)
demonstrated increased CD10+ and CD16hi subset counts of LDGs compared
to NP group. Further characterization of LDGs demonstrated that LDGs
from COVID-19 convalescents (PPASC and NRS) displayed increased markers
of NET forming ability and aggregation with platelets compared to LDGs
from NP, but no differences were observed between PPASC and NRS.
<AbstractText Label="CONCLUSIONS">Our data from a small cohort study
demonstrates that mature neutrophils with a heightened activation
phenotype remain in circulation long after initial SARS-CoV-2 infection.
Persistent elevation of markers for neutrophil activation and NET
formation on LDGs, as well as an enhanced proclivity for
platelet-neutrophil aggregation (PNA) formation in COVID-19 convalescent
individuals may be associated with PPASC prognosis and development.
Copyright  2022 Dean, Devendra, Jiyarom, Subia, Tallquist, Nerurkar,
Chang, Chow, Shikuma and Park.</td>
</tr>
<tr class="odd">
<td align="left">More Than a Health Fair: Preventive Health Care During
COVID-19 Vaccine Events.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">During
the initial phase of the COVID-19 pandemic, facilities transformed some
medical care to virtual appointments. There was a subsequent decline in
chronic disease screening and management, as well as cancer screening
rates.
<AbstractText Label="OBSERVATIONS" NlmCategory="UNASSIGNED">COVID-19
vaccine events offered an opportunity to provide face-to-face preventive
care to veterans, and mobile vaccine events enabled us to reach rural
veterans. In this quality improvement project, we partnered with state
and community organizations to reach veterans at large vaccine events,
as well as in rural sites and homeless housing. The program resulted in
the successful provision of preventive care to 115 veterans at these
events, with high follow-up for recommended medical care. In all, 404
clinical reminders were completed and 10 new veterans were enrolled for
health care. Important clinical findings included an invasive colorectal
cancer, positive HIV point-of-care test, diabetic retinal disease,
uncontrolled hypertension, and depression.
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Vaccine
events offer a venue for chronic disease screening, referral, and cancer
screening. Copyright  2022 Frontline Medical Communications Inc.,
Parsippany, NJ, USA.</td>
</tr>
<tr class="even">
<td align="left">Identifying Risk Factors for Complication and
Readmission with Same-Day Discharge Arthroplasty.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The
COVID-19 pandemic caused a surge of same-day discharge (SDD) for total
joint arthroplasty. However, SDD may not be beneficial for all patients.
Therefore, continued investigation into the safety of SDD is necessary
as well as risk stratification for improved patient outcomes.
<AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective
cohort study examined 31,851 elective SDD hip and knee arthroplasties
from 2016 to 2020 in a large national database. Logistic regression
models were used to identify patient variables and preoperative
comorbidities that contribute to postoperative complication or
readmission with SDD. Adjusted odds ratios (AOR) and 95% confidence
intervals (CI) were calculated.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">SDD increased from
1.4% in 2016 to 14.6% in 2020. SDD is associated with lower odds of
readmission (AOR: 0.994, CI: 0.992-0.996) and postoperative
complications (AOR: 0.998, CI: 0.997-1.000). Patients who have
preoperative dyspnea (AOR: 1.03, CI: 1.02-1.04, P &lt; .001), chronic
obstructive pulmonary disease (AOR: 1.02, CI: 1.01-1.03, P = .002), and
hypoalbuminemia (AOR: 1.02, CI: 1.00-1.03, P &lt; .001), had higher odds
of postoperative complications. Patients who had preoperative dyspnea
(AOR: 1.02, CI: 1.01-1.03), hypertension (AOR: 1.01, CI: 1.01-1.03, P =
.003), chronic corticosteroid use (AOR: 1.02, CI: 1.01-1.03, P &lt;
.001), bleeding disorder (AOR: 1.02; CI: 1.01-1.03, P &lt; .001), and
hypoalbuminemia (AOR: 1.01, CI: 1.00-1.02, P = .038), had higher odds of
readmission.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">SDD is safe
with certain comorbidities. Preoperative screening for cardiopulmonary
comorbidities (eg, dyspnea, hypertension, and chronic obstructive
pulmonary disease), chronic corticosteroid use, bleeding disorder, and
hypoalbuminemia may improve SDD outcomes. Copyright  2022 Elsevier
Inc.All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Uncoupling Inequality: Reflections on the Ethics of
Benchmarks for Digital Media.</td>
<td align="left">Our collaboration seeks to demonstrate shared
interrogation by exploring the ethics of machine learning benchmarks
from a socio-technical management perspective with insight from public
health and ethnic studies. Benchmarks, such as ImageNet, are annotated
open data sets for training algorithms. The COVID-19 pandemic reinforced
the practical need for ethical information infrastructures to analyze
digital and social media, especially related to medicine and race.
Social media analysis that obscures Black teen mental health and ignores
anti-Asian hate fails as information infrastructure. Despite
inadequately handling non-dominant voices, machine learning benchmarks
are the basis for analysis in operational systems. Turning to the
management literature, we interrogate cross-cutting problems of
benchmarks through the lens of coupling, or mutual interdependence
between people, technologies, and environments. Uncoupling inequality
from machine learning benchmarks may require conceptualizing the social
dependencies that build structural barriers to inclusion.</td>
</tr>
<tr class="even">
<td align="left">Integrated Analysis of Bulk RNA-Seq and Single-Cell
RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer
Patients.</td>
<td align="left">Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is a highly contagious and pathogenic coronavirus that
emerged in late 2019 and caused a pandemic of respiratory illness termed
as coronavirus disease 2019 (COVID-19). Cancer patients are more
susceptible to SARS-CoV-2 infection. The treatment of cancer patients
infected with SARS-CoV-2 is more complicated, and the patients are at
risk of poor prognosis compared to other populations. Patients infected
with SARS-CoV-2 are prone to rapid development of acute respiratory
distress syndrome (ARDS) of which pulmonary fibrosis (PF) is considered
a sequelae. Both ARDS and PF are factors that contribute to poor
prognosis in COVID-19 patients. However, the molecular mechanisms among
COVID-19, ARDS and PF in COVID-19 patients with cancer are not
well-understood. In this study, the common differentially expressed
genes (DEGs) between COVID-19 patients with and without cancer were
identified. Based on the common DEGs, a series of analyses were
performed, including Gene Ontology (GO) and pathway analysis,
protein-protein interaction (PPI) network construction and hub gene
extraction, transcription factor (TF)-DEG regulatory network
construction, TF-DEG-miRNA coregulatory network construction and drug
molecule identification. The candidate drug molecules (e.g.,
Tamibarotene CTD 00002527) obtained by this study might be helpful for
effective therapeutic targets in COVID-19 patients with cancer. In
addition, the common DEGs among ARDS, PF and COVID-19 patients with and
without cancer are TNFSF10 and IFITM2. These two genes may serve as
potential therapeutic targets in the treatment of COVID-19 patients with
cancer. Changes in the expression levels of TNFSF10 and IFITM2 in
CD14+/CD16+ monocytes may affect the immune response of COVID-19
patients. Specifically, changes in the expression level of TNFSF10 in
monocytes can be considered as an immune signature in COVID-19 patients
with hematologic cancer. Targeting N6-methyladenosine (m6A) pathways
(e.g., METTL3/SERPINA1 axis) to restrict SARS-CoV-2 reproduction has
therapeutic potential for COVID-19 patients.</td>
</tr>
<tr class="odd">
<td align="left">Social Networks, Health Information Sharing, and
Pandemic Perceptions among Young Adults in Hawaii during the COVID-19
Pandemic.</td>
<td align="left">Limited information exists about social network
variation and health information sharing during COVID-19, especially for
Native Hawaiians (NH), Other Pacific Islanders (OPI), and Filipinos, who
experienced COVID-19 inequities. Hawaii residents aged 18-35 completed
an online survey regarding social media sources of COVID-19 information
and social network health information measured by how many people
participants: (1) talked to and (2) listened to about health. Regression
models were fit with age, gender, race/ethnicity, chronic disease
status, pandemic perceptions, and health literacy as predictors of
information sources (logistic) and social network size (Poisson).
Respondents were 68% female; 41% NH, OPI, or Filipino; and 73% conducted
a recent COVID-19 digital search for themselves or others. Respondents
listened to others or discussed their own health with ~2-3 people.
Respondents who talked with more people about their health were more
likely to have larger networks for listening to others. In regression
models, those who perceived greater risk of acquiring COVID-19 discussed
their health with more people; in discussing others health, women and
those with chronic diseases listened to a greater number. Understanding
young adults social networks and information sources is important for
health literacy and designing effective health communications,
especially to reach populations experiencing health inequities.</td>
</tr>
<tr class="even">
<td align="left">Impact of healthcare capacity disparities on the
COVID-19 vaccination coverage in the United States: A cross-sectional
study.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The
impact of the COVID-19 vaccination campaign in the US has been hampered
by a substantial geographical heterogeneity of the vaccination coverage.
Several studies have proposed vaccination hesitancy as a key driver of
the vaccination uptake disparities. However, the impact of other
important structural determinants such as local disparities in
healthcare capacity is virtually unknown.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this
cross-sectional study, we conducted causal inference and geospatial
analyses to assess the impact of healthcare capacity on the vaccination
coverage disparity in the US. We evaluated the causal relationship
between the healthcare system capacity of 2417 US counties and their
COVID-19 vaccination rate. We also conducted geospatial analyses using
spatial scan statistics to identify areas with low vaccination rates.
<AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">We found a
causal effect of the constraints in the healthcare capacity of a county
and its low-vaccination uptake. Counties with higher constraints in
their healthcare capacity were more probable to have COVID-19
vaccination rates 50, with 35% higher constraints in low-vaccinated
areas (vaccination rates  50) compared to high-vaccinated areas
(vaccination rates &gt; 50). We also found that COVID-19 vaccination in
the US exhibits a distinct spatial structure with defined vaccination
coldspots.
<AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">We found
that the healthcare capacity of a county is an important determinant of
low vaccine uptake. Our study highlights that even in high-income
nations, internal disparities in healthcare capacity play an important
role in the health outcomes of the nation. Therefore, strengthening the
funding and infrastructure of the healthcare system, particularly in
rural underserved areas, should be intensified to help vulnerable
communities.
<AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">None.  2022 The
Authors.</td>
</tr>
<tr class="odd">
<td align="left">Racial Disparities in Patient-Provider Communication
During Telehealth Visits Versus Face-to-face Visits Among Asian and
Native Hawaiian and Other Pacific Islander Patients With Cancer:
Cross-sectional Analysis.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Telehealth
visits increase patients access to care and are often rated as just as
good as face-to-face visits by oncology patients. Telehealth visits
have become increasingly more common in the care of patients with cancer
since the advent of the COVID-19 pandemic. Asians and Pacific Islanders
are two of the fastest growing racial groups in the United States, but
there are few studies assessing patient satisfaction with telemedicine
among these two racial groups.
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our objective
was to compare satisfaction with communication during telehealth visits
versus face-to-face visits among oncology patients, with a specific
focus on Asian patients and Native Hawaiian and other Pacific Islander
(NHOPI) patients. <AbstractText Label="METHODS" NlmCategory="METHODS">We
surveyed a racially diverse group of patients who were treated at
community cancer centers in Hawaii and had recently experienced a
face-to-face visit or telehealth visit. Questions for assessing
satisfaction with patient-physician communication were adapted from a
previously published study of cancer survivors. Variables that impact
communication, including age, sex, household income, education level,
and cancer type and stage, were captured. Multivariable logistic models
for patient satisfaction were created, with adjustments for
sociodemographic factors.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants who
attended a face-to-face visit reported higher levels of satisfaction in
all communication measures than those reported by participants who
underwent a telehealth encounter. The univariate analysis revealed lower
levels of satisfaction during telehealth visits among Asian participants
and NHOPI participants compared to those among White participants for
all measures of communication (eg, when asked to what degree [y]our
physician listened carefully to you). Asian patients and NHOPI patients
were significantly less likely than White patients to strongly agree
with the statement (P&lt;.004 and P&lt;.007, respectively). Racial
differences in satisfaction with communication persisted in the
multivariate analysis even after adjusting for sociodemographic factors.
There were no significant racial differences in communication during
face-to-face visits.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Asian
patients and NHOPI patients were significantly less content with
patient-physician communication during telehealth visits when compared
to White patients. This difference among racial groups was not seen in
face-to-face visits. The observation that telehealth increases racial
disparities in health care satisfaction should prompt further
exploration. Jared D Acoba, Chelsea Yin, Michael Meno, Justin Abe, Ian
Pagano, Sharon Tamashiro, Kristy Fujinaga, Christa Braun-Inglis, Jami
Fukui. Originally published in JMIR Cancer (<a href="https://cancer.jmir.org" class="uri">https://cancer.jmir.org</a>),
09.12.2022.</td>
</tr>
<tr class="even">
<td align="left">SARS-CoV-2 Non-structural protein 1(NSP1) mutation
virulence and natural selection: Evolutionary trends in the six
continents.</td>
<td align="left"><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Rapid
transmission and reproduction of RNA viruses prepare conducive
conditions to have a high rate of mutations in their genetic sequence.
The viral mutations make adapt the severe acute respiratory syndrome
coronavirus 2 in the host environment and help the evolution of the
virus then also caused a high mortality rate by the virus that threatens
worldwide health. Mutations and adaptation help the virus to escape
confrontations that are done against it.
<AbstractText Label="METHODS" NlmCategory="METHODS">In the present
study, we analyzed 6,510,947 sequences of non-structural protein 1 as
one of the conserved regions of the virus to find out frequent mutations
and substitute amino acids in comparison with the wild type. NSP1
mutations rate divided into continents were different.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Based on this
continental categorization, E87D in global vision and also in Europe
notably increased. The E87D mutation has signed up to January 2022 as
the first frequent mutation observed. The remarkable mutations, H110Y
and R24C have the second and third frequencies, respectively.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">According to
the important role of non-structural protein 1 on the host mRNA
translation, developing drug design against the protein could be so
hopeful to find more effective ways the control and then treatment of
the global pandemic coronavirus disease 2019. Published by Elsevier
B.V.</td>
</tr>
<tr class="odd">
<td align="left">Genomic analysis of SARS-CoV-2 variants of concern
circulating in Hawaii to facilitate public-health policies.</td>
<td align="left">Using genomics, bioinformatics and statistics, herein
we demonstrate the effect of statewide and nationwide quarantine on the
introduction of SARS-CoV-2 variants of concern (VOC) in Hawaii. To
define the origins of introduced VOC, we analyzed 260 VOC sequences from
Hawaii, and 301,646 VOC sequences worldwide, deposited in the GenBank
and global initiative on sharing all influenza data (GISAID), and
constructed phylogenetic trees. The trees define the most recent common
ancestor as the origin. Further, the multiple sequence alignment used to
generate the phylogenetic trees identified the consensus single
nucleotide polymorphisms in the VOC genomes. These consensus sequences
allow for VOC comparison and identification of mutations of interest in
relation to viral immune evasion and host immune activation. Of note is
the P71L substitution within the E protein, the protein sensed by TLR2
to produce cytokines, found in the B.1.351 VOC may diminish the efficacy
of some vaccines. Based on the phylogenetic trees, the B.1.1.7, B.1.351,
B.1.427, and B.1.429 VOC have been introduced in Hawaii multiple times
since December 2020 from several definable geographic regions. From the
first worldwide report of VOC in GenBank and GISAID, to the first
arrival of VOC in Hawaii, averages 320 days with quarantine, and 132
days without quarantine. As such, the effect of quarantine is shown to
significantly affect the time to arrival of VOC in Hawaii. Further, the
collective 2020 quarantine of 43-states in the United States
demonstrates a profound impact in delaying the arrival of VOC in states
that did not practice quarantine, such as Utah. Our data demonstrates
that at least 76% of all definable SARS-CoV-2 VOC have entered Hawaii
from California, with the B.1.351 variant in Hawaii originating
exclusively from the United Kingdom. These data provide a foundation for
policy-makers and public-health officials to apply precision public
health genomics to real-world policies such as mandatory screening and
quarantine. Copyright:  2022 Maison et al.This is an open access
article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction
in any medium, provided the original author and source are
credited.</td>
</tr>
<tr class="even">
<td align="left">Effective Pandemic Response: Lessons from Kauai.</td>
<td align="left">Local health jurisdictions have struggled to protect
their communities during the pandemic, and successes are few. The Kauai
District Health Office (KDHO) of the Hawaii Department of Health serves
a rural island community of 73,000 residents. As a state agency, KDHO
works closely with the county mayor and administration. Kauai has
experienced comparatively low COVID-19 case and case-fatality rates
while maintaining strong community and leadership cohesion. Kauais
response was highly rated by residents in a recent Community Assessment
for Public Health Emergency Response survey. In this article, we
describe examples of local response efforts in the areas of (1) policy
and regulations, (2) health-directed isolation and quarantine, (3) case
investigation and contact tracing, (4) testing availability, (5) vaccine
rollout and availability, and (6) public information, as well as the
factors that have contributed to Kauais successes. KDHO regularly
prioritizes agencywide initiatives that cross program silos; staff have
experience using the incident command system in real-world situations;
the community health worker team is multicultural, multilingual, and
well established; and staff are integral members of the community they
serve. Preexisting partnerships were strong, including those with county
agencies, healthcare partners, and nongovernmental organizations, which
facilitated early and effective collaboration. Response successes
include implementation of unified command, coordinated public messaging,
early protective measures, effective disease control and outbreak
response, attention to secondary impacts of the pandemic, free community
testing, mass vaccination, and mobile vaccinations and testing. The
value of local health departments engaging regularly and authentically
with partners and communities cannot be overstated. It has saved lives
on Kauai. Local health jurisdictions should focus on all-hazards and
all-staff endeavors to enhance their disaster response
effectiveness.</td>
</tr>
<tr class="odd">
<td align="left">The association between social determinants of health
and psychological distress during the COVID-19 pandemic: a secondary
analysis among four racial/ethnic groups.</td>
<td align="left"><AbstractText Label="BACKGROUND">Racial disparities in
psychological distress associated with COVID-19 remain unclear in the
U.S. This study aims to investigate the associations between social
determinants of health and COVID-19-related psychological distress
across different racial/ethnic groups in the US (i.e., non-Hispanic
Whites, Hispanic, non-Hispanic Asians, and non-Hispanic African
Americans). <AbstractText Label="METHODS">This study used
cross-sectional data from the 2020 California Health Interview Survey
Adult Data Files (N = 21,280). Adjusting for covariates-including age,
gender, COVID-19 pandemic challenges, and risk of severe illness from
COVID-19-four sets of weighted binary logistic regressions were
conducted. <AbstractText Label="RESULTS">The rates of moderate/severe
psychological distress significantly varied across four racial/ethnic
groups (p &lt; 0.001), with the highest rate found in the Hispanic
group. Across the five domains of social determinants of health, we
found that unemployment, food insecurity, housing instability, high
educational attainment, usual source of health care, delayed medical
care, and low neighborhood social cohesion and safety were associated
with high levels of psychological distress in at least one racial/ethnic
group (p &lt; 0.05). <AbstractText Label="CONCLUSION">Our study suggests
that Hispanic adults face more adverse social determinants of health and
are disproportionately impacted by the pandemic. Public health practice
and policy should highlight social determinants of heath that are
associated with different racial/ethnic groups and develop tailored
programs to reduce psychological distress.  2022. The Author(s).</td>
</tr>
<tr class="even">
<td align="left">Disparities in the unmet mental health needs between
LGBTQ+ and non-LGBTQ+ populations during COVID-19 in the United States
from 21 July 2021 to 9 May 2022.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Evidence
highlighted the likelihood of unmet mental health needs (UMHNs) among
LGBTQ+ than non-LGBTQ+ populations during COVID-19. However, there lacks
evidence to accurately answer to what extent the gap was in UMHN between
LGBTQ+ and non-LGBTQ+ populations. We aim to evaluate the difference in
UMHN between LGBTQ+ and non-LGBTQ+ during COVID-19.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Cross-sectional
data from Household Pulse Survey between 21 July 2021 and 9 May 2022
were analyzed. LGBTQ+ was defined based on self-reported sex at birth,
gender, and sexual orientation identity. UMHN was assessed by a
self-reported question. Multivariable logistic regressions generated
adjusted odds ratios (AODs) of UMHN, both on overall and subgroups,
controlling for a variety of socio-demographic and
economic-affordability confounders.
<AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">81267 LGBTQ+ and
722638 non-LGBTQ+ were studied. The difference in UMHN between LGBTQ+
and non-LGBTQ+ (as reference) varied from 4.9% (95% CI 1.2-8.7%) in
Hawaii to 16.0% (95% CI 12.2-19.7%) in Utah. In multivariable models,
compared with non-LGBTQ+ populations, LGBTQ+ had a higher likelihood to
report UMHN (AOR = 2.27, 95% CI 2.18-2.39), with the highest likelihood
identified in transgender (AOR = 3.63, 95% CI 2.97-4.39); compared with
LGBTQ+ aged 65+, LGBTQ+ aged 18-25 had a higher likelihood to report
UMHN (AOR = 1.34, 95% CI 1.03-1.75); compared with White LGBTQ+
populations, Black and Hispanic LGBTQ+ had a lower likelihood to report
UMHN (AOR = 0.72, 95% CI 0.63-0.82; AOR = 0.85, 95% CI 0.75-0.97,
respectively).
<AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">During the
COVID-19, LGBTQ+ had a substantial additional risk of UMHN than
non-LGBTQ+. Disparities among age groups, subtypes of LGBTQ+, and
geographic variance were also identified. Copyright  2022 Chen, Wang,
She, Qin and Ming.</td>
</tr>
<tr class="odd">
<td align="left">Comparison of resident COVID-19 mortality between
unionized and nonunionized private nursing homes.</td>
<td align="left">Using bargaining agreement data from the Federal
Mediation Conciliation Services, we found that the median national
resident COVID-19 mortality percentage (as of April 24, 2022) of
unionized nursing homes and that of nonunionized ones were not
statically different (10.2% vs.10.7%; P = 0.32). The median nursing
home resident COVID-19 mortality percentage varied from 0% in Hawaii to
above 16% in Rhode Island (16.6%). Unionized nursing homes had a
statistically significant lower median mortality percentage than
nonunionized nursing homes (P &lt; 0.1) in Missouri, and had a higher
median mortality percentage than nonunionized nursing homes (P &lt;
0.05) in Alabama and Tennessee. Higher average resident age, lower
percentage of Medicare residents, small size, for-profit ownership, and
chain organization affiliation were associated with higher resident
COVID-19 mortality percentage. Overall, no evidence was found that
nursing home resident COVID-19 mortality percentage differed between
unionized nursing homes and nonunionized nursing homes in the U.S.
Copyright:  2022 Olson et al.This is an open access article
distributed under the terms of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited.</td>
</tr>
<tr class="even">
<td align="left">COVID-19 and Excess All-Cause Mortality in the US and
20 Comparison Countries, June 2021-March 2022.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Differences in COVID-19 Hospitalizations by
Self-Reported Race and Ethnicity in a Hospital in Honolulu, Hawaii.</td>
<td align="left"><AbstractText Label="INTRODUCTION">The true extent of
racial and ethnic disparities in COVID-19 hospitalizations may be hidden
by misclassification of race and ethnicity. This study aimed to quantify
this inaccuracy in a hospitals electronic medical record (EMR) against
the gold standard of self-identification and then project data onto
state-level COVID-19 hospitalizations by self-identified race and
ethnicity. <AbstractText Label="METHODS">To identify misclassification
of race and ethnicity in the EMRs of a hospital in Honolulu, Hawaii,
research and quality improvement staff members surveyed all available
patients (N = 847) in 5 cohorts in 2007, 2008, 2010, 2013, and 2020 at
randomly selected hospital and ambulatory units. The survey asked
patients to self-identify up to 12 races and ethnicities. We compared
these data with data from EMRs. We then estimated the number of COVID-19
hospitalizations by projecting racial misclassifications onto publicly
available data. We determined significant differences via
simulation-constructed medians and 95% CIs.
<AbstractText Label="RESULTS">EMR-based and self-identified race and
ethnicity were the same in 86.5% of the sample. Native Hawaiians (79.2%)
were significantly less likely than non-Native Hawaiians (89.4%) to be
correctly classified on initial analysis; this difference was driven by
Native Hawaiians being more likely than non-Native Hawaiians to be
multiracial (93.4% vs 30.3%). When restricted to multiracial patients
only, we found no significant difference in accuracy (P = .32). The
number of COVID-19-related hospitalizations was 8.7% higher among Native
Hawaiians and 3.9% higher among Pacific Islanders when we projected
self-identified race and ethnicity rather than using EMR data.
<AbstractText Label="CONCLUSION">Using self-identified rather than
hospital EMR data on race and ethnicity may uncover further disparities
in COVID-19 hospitalizations.</td>
</tr>
<tr class="even">
<td align="left">COVID-19 excess deaths in Eastern European countries
associated with weaker regulation implementation and lower vaccination
coverage.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Since
winter 2020, excess deaths due to COVID-19 have been higher in Eastern
Europe than most of Western Europe, partly because regulatory
enforcement was poor.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This paper
analysed data from 50 countries in the WHO European Region, in addition
to data from USA and Canada. Excess mMortality and vaccination data were
retrieved from Our World In Data and regulation implementation was
assessed using standard methods. Multiple linear regression was used to
assess the association between mortality and each covariate.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Excess mortality
increased by 4.1 per 100 000 (P = 0.038) for every percentage decrease
in vaccination rate and with 6/100 000 (p=0.011) for every decreased
unit in the regulatory implementation score a country achieved in the
Rule of Law Index.
<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Degree of
regulation enforcement, likely including public health measure
enforcement, may be an important factor in controlling COVID-19s
deleterious health impacts. Copyright  Authors 2022; licensee World
Health Organization. EMHJ is an open access journal. This paper is
available under the Creative Commons Attribution Non-Commercial
ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; <a href="https://creativecommons.org/licenses/by-nc-sa/3.0/igo" class="uri">https://creativecommons.org/licenses/by-nc-sa/3.0/igo</a>).</td>
</tr>
<tr class="odd">
<td align="left">Medical School Faculty and Staff Well-being in Fall
2020 during the COVID-19 Pandemic.</td>
<td align="left">The COVID-19 pandemic increased stress and worry among
faculty and staff members at universities across the US. To assess the
well-being of university faculty and staff, a survey was administered at
a medical school in the state of Hawaii during early fall 2020. The
purpose of the exploratory study was to assess and gauge faculty and
staff members well-being regarding the schools response to COVID-19.
Participants in this study represented a convenience sample of
compensated teaching, research, and administrative faculty and staff
members. A total of 80 faculty and 73 staff members participated.
Overall, faculty and staff reported relatively low levels of worries and
stress. Staff members reported greater levels of worry and stress than
faculty members in 8 of the 11 questions. Statistical differences were
detected in 3 questions, with staff reporting higher levels of worry and
stress in their health and well-being of themselves (P &lt; .001),
paying bills (P &lt; .001), and losing their jobs (P &lt; .001). Both
faculty and staff reported good overall satisfaction on the timeliness
and clarity of messages that they received, support from leadership and
the school, and support to adjust to changes in response to COVID-19.
For both faculty and staff, the greatest worry or concern for the
open-ended question on worry and stress was related to financial and
economic issues. Data from this survey and can contribute to an
understanding of medical school employee well-being during a major
operational disruption and may help develop policies and programs to
assist employees in different employment categories during future
disruptions. Copyright 2022 by University Health Partners of Hawaii
(UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">A review of state regulations for child care:
Preventing, recognizing and reporting child maltreatment.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Prior
to the COVID-19 pandemic, nearly 60% of children under 5 years of age
were cared for in out-of-home child care arrangements in the United
States. Thus, child care provides an opportunity to identify and address
potential child maltreatment. However, during the pandemic, rates of
reporting child maltreatment decreased-likely because children spent
less time in the presence of mandated reporters. As children return to
child care, states must have regulations in place to help child care
providers prevent, recognize and report child maltreatment. However,
little is known about the extent to which state regulations address
child maltreatment. Therefore, the purpose of this cross-sectional study
was to assess state regulations related to child maltreatment and
compare them to national standards.
<AbstractText Label="METHOD" NlmCategory="METHODS">We reviewed state
regulations for all 50 states and the District of Columbia for child
care centres (centres) and family child care homes (homes) through
31 July 2021 and compared these regulations to eight national health and
safety standards on child maltreatment. We coded regulations as either
not meeting, partially meeting or fully meeting each standard.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Three states
(Colorado, Utah and Washington) had regulations for centres, and one
state (Washington) had regulations for homes that at least partially met
all eight national standards. Nearly all states had regulations
consistent with the standards requiring that caregivers and teachers are
mandated reporters of child maltreatment and requiring that they be
trained in preventing, recognizing and reporting child maltreatment. One
state (Hawaii) did not have regulations consistent with any of the
national standards for either centres or homes.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Generally,
states lacked regulations related to the prevention, recognition and
reporting of child maltreatment for both centres and homes. Encouraging
states to adopt regulations that meet national standards and further
exploring their impact on child welfare are important next steps.  2022
John Wiley &amp; Sons Ltd.</td>
</tr>
<tr class="odd">
<td align="left">Demographic disparities in COVID-19 vaccine hesitancy
among U.S. adults: Analysis of household pulse survey data from Jul 21
to Oct 11 in 2021.</td>
<td align="left">Monitoring COVID-19 vaccine hesitancy helps design and
implement strategies to increase vaccine uptake. Utilizing the large
scale cross-sectional Household Pulse Survey data collected between July
21 and October 11 in 2021, this study aims to construct measures of
COVID-19 vaccine hesitancy and identify demographic disparities among
U.S. adults (18y+). Factor analysis identified three factors of vaccine
hesitancy: safety concerns (prevalence: 70.1 %). trust issues (53.5 %),
and not seen as necessary (33.8 %). Among those who did not show
willingness to receive COVID-19 vaccine, females were more likely to
have safety concerns (73.7 %) compared to males (66.7 %), but less
likely to have trust issues (female: 49.7 %; male: 57.1 %) or not seen
as necessary (female: 23.8 %; male 43.4 %). Higher education was
associated with higher prevalence of not seen as necessary. Younger
adults and Whites had higher prevalence of having trust issues and not
seen as necessary compared to their counter parts. Copyright  2022
Elsevier Ltd.All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">Maternal telehealth: innovations and Hawaii
perspectives.</td>
<td align="left">Access to maternal-fetal medicine (MFM) subspecialty
services is a critical part of a healthcare system that optimizes
pregnancy outcomes for women with complex medical and obstetrical
disorders. Healthcare services in the State of Hawaii consist of a
complicated patchwork of independently run community health clinics and
hospital systems which are difficult for many pregnant patients to
navigate. Maternal telehealth services have been identified as a
solution to increase access to subspecialty prenatal services for women
in rural communities or neighboring islands, especially during the
COVID-19 pandemic. Telehealth innovations have been rapidly developing
in the areas of remote ultrasound, hypertension management, diabetes
management, and fetal monitoring. This report describes how telehealth
innovations are being introduced by MFM specialists to optimize care for
a unique population of high-risk patients in a remote area of the world
such as Hawaii, as well as review currently available telemedicine
technologies and future innovations.  2022 Walter de Gruyter GmbH,
Berlin/Boston.</td>
</tr>
<tr class="odd">
<td align="left">Developmental toxicity of remdesivir, an anti-COVID-19
drug, is implicated by in vitro assays using morphogenetic embryoid
bodies of mouse and human pluripotent stem cells.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Remdesivir
is an antiviral drug approved for the treatment of COVID-19, whose
developmental toxicity remains unclear. More information about the
safety of remdesivir is urgently needed for people of childbearing
potential, who are affected by the ongoing pandemic. Morphogenetic
embryoid bodies (MEBs) are three-dimensional (3D) aggregates of
pluripotent stem cells that recapitulate embryonic body patterning in
vitro, and have been used as effective embryo models to detect the
developmental toxicity of chemical exposures specifically and
sensitively. <AbstractText Label="METHODS" NlmCategory="METHODS">MEBs
were generated from mouse P19C5 and human H9 pluripotent stem cells, and
used to examine the effects of remdesivir. The morphological effects
were assessed by analyzing the morphometric parameters of MEBs after
exposure to varying concentrations of remdesivir. The molecular impact
of remdesivir was evaluated by measuring the transcript levels of
developmental regulator genes.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mouse MEB
morphogenesis was impaired by remdesivir at 1-8 M. Remdesivir affected
MEBs in a manner dependent on metabolic conversion, and its potency was
higher than GS-441524 and GS-621763, presumptive anti-COVID-19 drugs
that act similarly to remdesivir. The expressions of developmental
regulator genes, particularly those involved in axial and somite
patterning, were dysregulated by remdesivir. The early stage of MEB
development was more vulnerable to remdesivir exposure than the later
stage. The morphogenesis and gene expression profiles of human MEBs were
also impaired by remdesivir at 1-8 M.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Remdesivir
impaired mouse and human MEBs at concentrations that are comparable to
the therapeutic plasma levels in humans, urging further investigation
into the potential impact of remdesivir on developing embryos.  2022
The Authors. Birth Defects Research published by Wiley Periodicals
LLC.</td>
</tr>
<tr class="even">
<td align="left">COVID-19 Restrictions and Adolescent Cigarette and
E-cigarette Use in California.</td>
<td align="left"><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Shelter-in-place
orders altered facilitators and barriers to tobacco use (e.g., outlet
closures, restricted social gatherings). This study examined whether the
duration of time in shelter in place and compliance with different
shelter-in-place orders influenced adolescent cigarette and E-cigarette
use and how the use may differ by demographic characteristics.
<AbstractText Label="METHODS" NlmCategory="METHODS">Shelter-in-place
policy data obtained from government websites were merged with
cross-sectional 2020 survey data on adolescents in California. Treatment
variables included the proportion of time in shelter in place and
self-reported compliance with shelter-in-place orders (for essential
businesses and retail spaces and social and outdoor contexts).
Multilevel logit models for dichotomous past 6-month cigarette and
E-cigarette use and multilevel negative binomial regression models for
past 6-month frequency of use were used. Moderation analyses were
conducted on demographic measures. The sample included 1,196 adolescents
(mean age=15.8 years, age range=13-19 years, 49.2% female, 50.0% White).
Analyses were conducted in 2022.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">No associations were
found between the proportion of time in shelter in place and outcomes.
Shelter-in-place compliance with essential business and retail space
orders was associated with lower odds of using cigarettes and
E-cigarettes in the past 6 months. Compliance with social and outdoor
context-related orders were associated with lower odds of using
E-cigarettes and fewer days using cigarettes and E-cigarettes. Being
aged 18 years moderated the associations between essential
business/retail space and social/outdoor context-related
shelter-in-place compliance orders and past 6-month frequency of
cigarette smoking.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Findings
support tailored interventions for less compliant and older adolescents
for future pandemic mitigation measures. Copyright  2022 American
Journal of Preventive Medicine. Published by Elsevier Inc.All rights
reserved.</td>
</tr>
<tr class="odd">
<td align="left">Extended reality veterinary medicine case studies for
diagnostic veterinary imaging instruction: Assessing student perceptions
and examination performance.</td>
<td align="left">Educational technologies in veterinary medicine aim to
train veterinarians faster and improve clinical outcomes. COVID-19
pandemic, shifted face-to-face teaching to online, thus, the need to
provide effective education remotely was exacerbated. Among recent
technology advances for veterinary medical education, extended reality
(XR) is a promising teaching tool. This study aimed to develop a case
resolution approach for radiographic anatomy studies using XR technology
and assess students achievement of differential diagnostic skills.
Learning objectives based on Blooms taxonomy keywords were used to
develop four clinical cases (3 dogs/1 cat) of spinal injuries utilizing
CT scans and XR models and presented to 22 third-year veterinary
medicine students. Quantitative assessment (ASMT) of 7 questions probing
memorization, understanding and application, analysis and
evaluation was given before and after contact with XR technology as
well as qualitative feedback via a survey. Mean ASMT scores increased
during case resolution (pre 51.6% (37%)/post 60.1% ( 34%); p &lt;
0.01), but without significant difference between cases (Kruskal-Wallis
H = 2.18, NS). Learning objectives were examined for six questions
(Q1-Q6) across cases (C1-4): Memorization improved sequentially (Q1, 2
8/8), while Understanding and Application (Q3,4) showed the greatest
improvement (26.7%-76.9%). Evaluation and Analysis (Q5,6) was somewhat
mixed, improving (5/8), no change (3/8) and declining (1/8).Positive
student perceptions suggest that case studies online delivery was well
received stimulating learning in diagnostic imaging and anatomy while
developing visual-spatial skills that aid understanding cross-sectional
images. Therefore, XR technology could be a useful approach to
complement radiological instruction in veterinary medicine.  2022
Wiley-VCH GmbH.</td>
</tr>
<tr class="even">
<td align="left">BNT162b2 vaccine effectiveness against SARS-CoV-2
omicron BA.4 and BA.5.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">A history of the MetaSUB consortium: Tracking urban
microbes around the globe.</td>
<td align="left">The MetaSUB Consortium, founded in 2015, is a global
consortium with an interdisciplinary team of clinicians, scientists,
bioinformaticians, engineers, and designers, with members from more than
100 countries across the globe. This network has continually collected
samples from urban and rural sites including subways and transit
systems, sewage systems, hospitals, and other environmental sampling.
These collections have been ongoing since 2015 and have continued when
possible, even throughout the COVID-19 pandemic. The consortium has
optimized their workflow for the collection, isolation, and sequencing
of DNA and RNA collected from these various sites and processing them
for metagenomics analysis, including the identification of SARS-CoV-2
and its variants. Here, the Consortium describes its foundations, and
its ongoing work to expand on this network and to focus its scope on the
mapping, annotation, and prediction of emerging pathogens, mapping
microbial evolution and antibiotic resistance, and the discovery of
novel organisms and biosynthetic gene clusters.  2022 The Authors.</td>
</tr>
<tr class="even">
<td align="left">SUMMIT: An integrative approach for better
transcriptomic data imputation improves causal gene identification.</td>
<td align="left">Genes with moderate to low expression heritability may
explain a large proportion of complex trait etiology, but such genes
cannot be sufficiently captured in conventional transcriptome-wide
association studies (TWASs), partly due to the relatively small
available reference datasets for developing expression genetic
prediction models to capture the moderate to low genetically regulated
components of gene expression. Here, we introduce a method, the
Summary-level Unified Method for Modeling Integrated Transcriptome
(SUMMIT), to improve the expression prediction model accuracy and the
power of TWAS by using a large expression quantitative trait loci (eQTL)
summary-level dataset. We apply SUMMIT to the eQTL summary-level data
provided by the eQTLGen consortium. Through simulation studies and
analyses of genome-wide association study summary statistics for 24
complex traits, we show that SUMMIT improves the accuracy of expression
prediction in blood, successfully builds expression prediction models
for genes with low expression heritability, and achieves higher
statistical power than several benchmark methods. Finally, we conduct a
case study of COVID-19 severity with SUMMIT and identify 11 likely
causal genes associated with COVID-19 severity.  2022. The
Author(s).</td>
</tr>
<tr class="odd">
<td align="left">Pregnant Through the COVID-19 Chaos: Insights on How
Women Use Information in the Perinatal Period During a Pandemic.</td>
<td align="left"><AbstractText Label="PURPOSE/AIMS" NlmCategory="OBJECTIVE">To
gain insights in how women use technology to address health information
needs during the prenatal and postpartum time frame.
<AbstractText Label="DESIGN" NlmCategory="METHODS">An exploratory
qualitative study recruited pregnant and recent postpartum women to
share their perspectives on information they needed and how they
obtained it. <AbstractText Label="METHODS" NlmCategory="METHODS">Women
who were pregnant or &lt;90 days postpartum (n = 26) were recruited via
social media and invited to share their experiences. Design thinking
methodology was used to develop questions to understand information
needs in the perinatal period as well as in context of the COVID-19
pandemic. Verbatim transcripts were coded by the research team according
to Braun and Clarkes reflexive thematic analysis.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Five themes explain
the experience of seeking information to support the perinatal period.
Women explained the need for the following: (1) information and
relationships are inseparable, (2) current practices leave needs unmet,
(3) the pandemic exposes vulnerability in prenatal care, (4) left to
figure it out alone, and (5) bridging the gap through technology.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Aggregated
findings suggest how usual care can be modified to improve support for
women through personalized care, improved information support, and use
of technology. The study findings inform innovative strategies using
current technologies to improve health promotion in a dynamic health
environment. Copyright  2022 Wolters Kluwer Health, Inc.All rights
reserved.</td>
</tr>
<tr class="even">
<td align="left">Substance Use From Social Distancing and Isolation By
US Nativity During the Time of Covid-19: Cross-Sectional Study.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The
Covid-19 pandemic had many unprecedented secondary outcomes resulting in
various mental health issues leading to substance use coping behaviors.
The extent of substance use changes in a US sample by nativity have not
been previously described.
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our aim was to
design an online survey to assess the social distancing and isolation
issues exacerbated by the Covid-19 pandemic to describe substance use as
coping behaviors by comparing substance use changes prior to and during
the pandemic. <AbstractText Label="METHODS" NlmCategory="METHODS">A
comprehensive 116-item survey to understand the impact of Covid-19 and
social distancing on physical and psychosocial mental health and chronic
diseases was designed. Approximately 10,000 online surveys were
distributed by Qualtrics LLC between 13 May 2021 and 09 January 2022
across the US (i.e., continental US, Hawaii, Alaska, and territories) to
adults 18 and older. We oversampled low income and rural adults among
non-Hispanic White, non-Hispanic Black, Hispanic/Latino adults, and
foreign-born participants. Of the 5,938 surveys returned, 5,413 surveys
were used after Qualtrics proprietary expert review fraud detection, and
detailed assessments of completion rate and timing to complete the
survey. Participant demographics, substance use coping behaviors, and
substance use prior to and during the pandemic are described by the
overall US resident sample, followed by US born and foreign-born
self-report. Substance use included tobacco use, e-cigarettes/vaping,
alcohol use, marijuana use, and other illicit substance use. Marginal
homogeneity based on Stuart-Maxwell test was used to assess changes in
self-reported substance use prior to and during the pandemic.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The sample was
mostly White (2182/5413, 40.3%), women (3369/5406, 62.3%) that
identified as straight/heterosexual (4805/5406, 89.3%), reported making
$75,000 (1405/5355, 26.2%) and had vocational/technical training
(1746/5404, 32.3%). Significant changes were found in alcohol use
self-reports the overall sample. Significant changes were also observed
among US born and foreign-born samples. Similarities were observed
between US born and foreign-born participants on increased alcohol use
from: (1) no alcohol use prior to the pandemic to using alcohol once to
several times a month; and (2) once to several times per week to
everyday to several times per day. While significant changes were
observed from no prior alcohol use to some level of increased use, the
inverse was observed as well and more pronounced among foreign-born
participants. That is, there was a 5.1% overall change in some level of
alcohol use prior to the pandemic to no alcohol use during the pandemic
among foreign born, compared to the 4.3% change among US born.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To better
prepare for the inadvertent effects of public health policies meant to
protect individuals, we must understand the mental health burdens that
can precipitate into substance use coping mechanisms that not only have
a deleterious effect on physical and mental health but exacerbate
morbidity and mortality to disease like Covid-19.</td>
</tr>
<tr class="odd">
<td align="left">COVID-19 Restriction Movement Control Order (MCO)
Impacted Emissions of Peninsular Malaysia Using Sentinel-2a and
Sentinel-5p Satellite.</td>
<td align="left">The unprecedented outbreak of Coronavirus Disease 2019
(COVID-19) has impacted the whole world in every aspect including
health, social life, economic activity, education, and the environment.
The pandemic has led to an improvement in air quality all around the
world, including in Malaysia. Lockdowns have resulted in industry
shutting down and road travel decreasing which can reduce the emission
of Greenhouse Gases (GHG) and air pollution. This research assesses the
impact of the COVID-19 lockdown on emissions using the Air Pollution
Index (API), aerosols, and GHG which is Nitrogen Dioxide (NO2) in
Malaysia. The data used is from Sentinel-5p and Sentinel-2A which
monitor the air quality based on Ozone (O3) and NO2 concentration. Using
an interpolated API Index Map comparing 2019, before the implementation
of a Movement Control Order (MCO), and 2020, after the MCO period we
examine the impact on pollution during and after the COVID-19 lockdown.
Data used Sentinel-5p, Sentinel-2A, and Air Pollution Index of Malaysia
(APIMS) to monitor the air quality that contains NO2 concentration. The
result has shown the recovery in air quality during the MCO
implementation which indirectly shows anthropogenic activities towards
the environmental condition. The study will help to enhance and support
the policy and scope for air pollution management strategies as well as
raise public awareness of the main causes that contribute to air
pollution.  King Abdulaziz University and Springer Nature Switzerland
AG 2022, Springer Nature or its licensor holds exclusive rights to this
article under a publishing agreement with the author(s) or other
rightsholder(s); author self-archiving of the accepted manuscript
version of this article is solely governed by the terms of such
publishing agreement and applicable law.</td>
</tr>
<tr class="even">
<td align="left">Forgone Health Care for Non-COVID-19-Related Needs
Among Medicare Beneficiaries During the COVID-19 Pandemic, Summer
2020-Winter 2021.</td>
<td align="left"><AbstractText Label="INTRODUCTION">Forgone health care,
defined as not using health care despite perceiving a need for it, is
associated with poor health outcomes, especially among people with
chronic conditions. The objective of our study was to examine how the
pandemic affected forgone health care during 3 stages of the pandemic.
<AbstractText Label="METHODS">We used the Medicare Current Beneficiary
Survey COVID-19 Rapid Response Questionnaire administered in summer
2020, fall 2020, and winter 2021 to examine sociodemographic
characteristics, chronic diseases, COVID-19 vaccination status, and
telehealth availability in relation to beneficiary reports of forgone
health care. <AbstractText Label="RESULTS">Of the 3 periods studied, the
overall rate of forgone health care was highest in summer 2020 (20.8%),
followed by fall 2020 (7.8%) and winter 2021 (6.5%). COVID-19
vaccination status, age, sex, race and ethnicity, US region,
availability of primary care telehealth appointments, and chronic
conditions (heart disease, arthritis, depression, osteoporosis or a
broken hip, and diabetes or high blood glucose) were significantly
related to forgone care. <AbstractText Label="CONCLUSION">High rates of
forgone care among Medicare participants varied over time and were
significantly related to beneficiary characteristics. Our findings
highlight the need for health care reform and changes in policy to
address the issue of access to care for people with chronic conditions
during a pandemic or other public health emergency.</td>
</tr>
<tr class="odd">
<td align="left">Dynamic SARS-CoV-2 emergence algorithm for
rationally-designed logical next-generation vaccines.</td>
<td align="left">SARS-CoV-2 worldwide spread and evolution has resulted
in variants containing mutations resulting in immune evasive epitopes
that decrease vaccine efficacy. We acquired SARS-CoV-2 positive clinical
samples and compared the worldwide emerged spike mutations from Variants
of Concern/Interest, and developed an algorithm for monitoring the
evolution of SARS-CoV-2 in the context of vaccines and monoclonal
antibodies. The algorithm partitions logarithmic-transformed prevalence
data monthly and Pearsons correlation determines exponential emergence
of amino acid substitutions (AAS) and lineages. The SARS-CoV-2 genome
evaluation indicated 49 mutations, with 44 resulting in AAS. Nine of the
ten most worldwide prevalent (&gt;70%) spike protein changes have
Pearsons coefficient r &gt; 0.9. The tenth, D614G, has a prevalence
&gt;99% and r-value of 0.67. The resulting algorithm is based on the
patterns these ten substitutions elucidated. The strong positive
correlation of the emerged spike protein changes and algorithmic
predictive value can be harnessed in designing vaccines with relevant
immunogenic epitopes. Monitoring, next-generation vaccine design, and
mAb clinical efficacy must keep up with SARS-CoV-2 evolution, as the
virus is predicted to remain endemic.  2022. The Author(s).</td>
</tr>
<tr class="even">
<td align="left">Effectiveness and durability of BNT162b2 vaccine
against hospital and emergency department admissions due to SARS-CoV-2
omicron sub-lineages BA.1 and BA.2 in a large health system in the USA:
a test-negative, case-control study.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The
SARS-CoV-2 omicron (B.1.1.529 BA.1) lineage was first detected in
November, 2021, and is associated with reduced vaccine effectiveness. By
March, 2022, BA.1 had been replaced by sub-lineage BA.2 in the USA. As
new variants evolve, vaccine performance must be continually assessed.
We aimed to evaluate the effectiveness and durability of BNT162b2
(Pfizer-BioNTech) against hospital and emergency department admissions
for BA.1 and BA.2.
<AbstractText Label="METHODS" NlmCategory="METHODS">In this
test-negative, case-control study, we sourced data from the electronic
health records of adult (aged 18 years) members of Kaiser Permanente
Southern California (KPSC), which is a health-care system in the USA,
who were admitted to one of 15 KPSC hospitals or emergency departments
(without subsequent hospitalisation) between Dec 27, 2021, and June 4,
2022, with an acute respiratory infection and were tested for SARS-CoV-2
by RT-PCR. Omicron sub-lineage was determined by use of sequencing,
spike gene target failure, and the predominance of variants in certain
time periods. Our main outcome was the effectiveness of two or three
doses of BNT162b2 in preventing emergency department or hospital
admission. Variant-specific vaccine effectiveness was evaluated by
comparing the odds ratios from logistic regression models of vaccination
between test-positive cases and test-negative controls, adjusting for
the month of admission, age, sex, race and ethnicity, body-mass index,
Charlson Comorbidity Index, previous influenza or pneumococcal vaccines,
and previous SARS-CoV-2 infection. We also assessed effectiveness by the
time since vaccination. This study is registered at ClinicalTrials.gov,
NCT04848584, and is ongoing.
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Of 65 813 total
admissions during the study period, we included 16 994 in our analyses,
of which 7435 were due to BA.1, 1056 were due to BA.2, and 8503 were not
due to SARS-CoV-2. In adjusted analyses, two-dose vaccine effectiveness
was 40% (95% CI 27 to 50) for hospitalisation and 29% (18 to 38) for
emergency department admission against BA.1 and 56% (31 to 72) for
hospitalisation and 16% (-5 to 33) for emergency department admission
against BA.2. Three-dose vaccine effectiveness was 79% (74 to 83) for
hospitalisation and 72% (67 to 77) for emergency department admission
against BA.1 and 71% (55 to 81) for hospitalisation and 21% (1 to 37)
for emergency department admission against BA.2. Less than 3 months
after the third dose, vaccine effectiveness was 80% (74 to 84) for
hospitalisation and 74% (69 to 78) for emergency department admission
against BA.1. Vaccine effectiveness 3 months or more after the third
dose was 76% (69 to 82) against BA.1-related hospitalisation and 65% (56
to 73) against BA.1-related emergency department admission. Against
BA.2, vaccine effectiveness was 74% (47 to 87) for hospitalisation and
59% (40 to 72) for emergency department admission at less than 3 months
after the third dose and 70% (53 to 81) for hospitalisation and 5% (-21
to 25) for emergency department admission at 3 months or more after the
third dose.
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Two doses
of BNT162b2 provided only partial protection against BA.1-related and
BA.2-related hospital and emergency department admission, which
underscores the need for booster doses against omicron. Although three
doses offered high levels of protection (70%) against hospitalisation,
variant-adapted vaccines are probably needed to improve protection
against less severe endpoints, like emergency department admission,
especially for BA.2.
<AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Pfizer. Copyright
 2023 Elsevier Ltd.All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Trends of International Electives in Medical Education
Undergraduates in Japan.</td>
<td align="left">Increasing numbers of medical students participate in
international electives. However, this recent trend has yet to be
examined in non-Western high-income countries such as Japan. The aim of
this study is to assess recent trends in Japan, and to suggest ways in
which those trends might be influenced. A retrospective cross-sectional
analysis of responses to an 8-item questionnaire sent in August 2019 to
82 medical schools in Japan is reported. The responses were received in
September 2019. Narrative responses were obtained regarding rationales
for exchange programs, participant feedback, and challenges encountered.
Responses were translated into English and categorized into themes. Of
82 Japanese medical schools, 56 (68%) responded to the questionnaire.
Both the number of incoming and outgoing exchange students had increased
steadily over the preceding 3-year period. The leading destinations for
Japanese students were the United States (30%), other Asian (36%), and
European countries (24%). Narrative responses reveal different
rationales from those reported by medical schools in Western high-income
countries. Only a few Japanese students chose low or middle-income
countries as their destinations, as opposed to the trend seen in Western
high-income countries. The reported challenges encountered by the
exchange programs may provide insights for improvement. Exchanges have
been greatly affected by the coronavirus disease 2019 pandemic. The
results can serve as pre-pandemic baseline data and should promote
further international collaboration for medical education under current
circumstances. Copyright 2022 by University Health Partners of Hawaii
(UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Fenfluramine provides clinically meaningful reduction
in frequency of drop seizures in patients with Lennox-Gastaut syndrome:
Interim analysis of an open-label extension study.</td>
<td align="left"><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This
study was undertaken to evaluate the long-term safety and effectiveness
of fenfluramine in patients with Lennox-Gastaut syndrome (LGS).
<AbstractText Label="METHODS" NlmCategory="METHODS">Eligible patients
with LGS who completed a 14-week phase 3 randomized clinical trial
enrolled in an open-label extension (OLE; NCT03355209). All patients
were initially started on .2 mg/kg/day fenfluramine and after 1 month
were titrated by effectiveness and tolerability, which were assessed at
3-month intervals. The protocol-specified treatment duration was 12
months, but COVID-19-related delays resulted in 142 patients completing
their final visit after 12 months.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">As of October 19,
2020, 247 patients were enrolled in the OLE. Mean age was 14.3  7.6
years (79 [32%] adults) and median fenfluramine treatment duration was
364 days; 88.3% of patients received 2-4 concomitant antiseizure
medications. Median percentage change in monthly drop seizure frequency
was -28.6% over the entire OLE (n = 241) and -50.5% at Month 15 (n =
142, p &lt; .0001); 75 of 241 patients (31.1%) experienced 50%
reduction in drop seizure frequency. Median percentage change in nondrop
seizure frequency was -45.9% (n = 192, p = .0038). Generalized
tonic-clonic seizures (GTCS) and tonic seizures were most responsive to
treatment, with median reductions over the entire OLE of 48.8% (p &lt;
.0001, n = 106) and 35.8% (p &lt; .0001, n = 186), respectively. A total
of 37.6% (95% confidence interval [CI] = 31.4%-44.1%, n = 237) of
investigators and 35.2% of caregivers (95% CI = 29.1%-41.8%, n = 230)
rated patients as Much Improved/Very Much Improved on the Clinical
Global Impression of Improvement scale. The most frequent
treatment-emergent adverse events were decreased appetite (16.2%) and
fatigue (13.4%). No cases of valvular heart disease (VHD) or pulmonary
arterial hypertension (PAH) were observed.
<AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">Patients
with LGS experienced sustained reductions in drop seizure frequency on
fenfluramine treatment, with a particularly robust reduction in
frequency of GTCS, the key risk factor for sudden unexpected death in
epilepsy. Fenfluramine was generally well tolerated; VHD or PAH was not
observed long-term. Fenfluramine may provide an important long-term
treatment option for LGS.  2022 UCB and The Authors. Epilepsia
published by Wiley Periodicals LLC on behalf of International League
Against Epilepsy.</td>
</tr>
<tr class="odd">
<td align="left">Racial/Ethnic Disparities in Getting COVID-19 Vaccine:
Do Age, Gender, and Education Matter?</td>
<td align="left"><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">COVID-19
disproportionately affects racial/ethnic minorities and vaccine can help
mitigate infection and transition, decrease rate of hospitalization,
lower mortality rate, and control the pandemic. This study aims to
examine disparities in COVID-19 vaccination rate by age among Whites,
Hispanics, Blacks, and Asian Americans, and the modification effects by
gender and education.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We used seven
waves of biweekly surveys from the Household Pulse Survey collected
between July 21, 2021, and October 11, 2021.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Asians reported
the highest, Blacks reported the lowest vaccination rate, and gender
differences were minimal. Increasing age was associated with higher
vaccination rate except for the oldest age group. The decline was from
84.4% (70-79 years) to 41.1% (80-88 years: 41.1%) among Hispanics and
92.8% to 69.6% among Asians. Educational effect was the most salient
among younger adults with the largest gaps observed in Blacks. Among
18-29-year Black participants, the vaccination rates were 31.1%
(confidence interval [95% CI]: 25.7-37.1) for high school or lower,
58.9% (95% CI: 54.2-63.5) for some college or associate degree, and
74.2% (95% CI: 69.4-78.5) for bachelor or higher degrees, leaving a
43.1% gap between the lowest and the highest education levels. The gaps
in this age group were 33.7% among Whites, 32.1% among Hispanics, and
20.5% among Asian Americans.
<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our study
advances the existing literature on COVID-19 vaccination by providing
empirical evidence on the dynamic race/ethnic-age-education differences
across racial/ethnic groups. The findings from our study provide
scientific foundation for the development of more strategies to improve
vaccination rate for the minority populations.  Wei Zhang et al., 2022;
Published by Mary Ann Liebert, Inc.</td>
</tr>
<tr class="even">
<td align="left">Trends in Enrollment in Employer-Sponsored Health
Insurance in the US Before and During the COVID-19 Pandemic, January
2019 to June 2021.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Hydroxychloroquine/chloroquine for the treatment of
hospitalized patients with COVID-19: An individual participant data
meta-analysis.</td>
<td align="left"><AbstractText Label="BACKGROUND">Results from
observational studies and randomized clinical trials (RCTs) have led to
the consensus that hydroxychloroquine (HCQ) and chloroquine (CQ) are not
effective for COVID-19 prevention or treatment. Pooling individual
participant data, including unanalyzed data from trials terminated
early, enables more detailed investigation of the efficacy and safety of
HCQ/CQ among subgroups of hospitalized patients.
<AbstractText Label="METHODS">We searched ClinicalTrials.gov in May and
June 2020 for US-based RCTs evaluating HCQ/CQ in hospitalized COVID-19
patients in which the outcomes defined in this study were recorded or
could be extrapolated. The primary outcome was a 7-point ordinal scale
measured between day 28 and 35 post enrollment; comparisons used
proportional odds ratios. Harmonized de-identified data were collected
via a common template spreadsheet sent to each principal investigator.
The data were analyzed by fitting a prespecified Bayesian ordinal
regression model and standardizing the resulting predictions.
<AbstractText Label="RESULTS">Eight of 19 trials met eligibility
criteria and agreed to participate. Patient-level data were available
from 770 participants (412 HCQ/CQ vs 358 control). Baseline
characteristics were similar between groups. We did not find evidence of
a difference in COVID-19 ordinal scores between days 28 and 35
post-enrollment in the pooled patient population (odds ratio, 0.97; 95%
credible interval, 0.76-1.24; higher favors HCQ/CQ), and found no
convincing evidence of meaningful treatment effect heterogeneity among
prespecified subgroups. Adverse event and serious adverse event rates
were numerically higher with HCQ/CQ vs control (0.39 vs 0.29 and 0.13 vs
0.09 per patient, respectively). <AbstractText Label="CONCLUSIONS">The
findings of this individual participant data meta-analysis reinforce
those of individual RCTs that HCQ/CQ is not efficacious for treatment of
COVID-19 in hospitalized patients.</td>
</tr>
<tr class="even">
<td align="left">Development and validation of novel sepsis
subphenotypes using trajectories of vital signs.</td>
<td align="left"><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Sepsis
is a heterogeneous syndrome and identification of sub-phenotypes is
essential. This study used trajectories of vital signs to develop and
validate sub-phenotypes and investigated the interaction of
sub-phenotypes with treatment using randomized controlled trial data.
<AbstractText Label="METHODS" NlmCategory="METHODS">All patients with
suspected infection admitted to four academic hospitals in Emory
Healthcare between 2014-2017 (training cohort) and 2018-2019 (validation
cohort) were included. Group-based trajectory modeling was applied to
vital signs from the first 8 h of hospitalization to develop and
validate vitals trajectory sub-phenotypes. The associations between
sub-phenotypes and outcomes were evaluated in patients with sepsis. The
interaction between sub-phenotype and treatment with balanced
crystalloids versus saline was tested in a secondary analysis of SMART
(Isotonic Solutions and Major Adverse Renal Events Trial).
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 12,473
patients with suspected infection in training and 8256 patients in
validation cohorts, and 4 vitals trajectory sub-phenotypes were found.
Group A (N = 3483, 28%) were hyperthermic, tachycardic, tachypneic, and
hypotensive. Group B (N = 1578, 13%) were hyperthermic, tachycardic,
tachypneic (not as pronounced as Group A) and hypertensive. Groups C (N
= 4044, 32%) and D (N = 3368, 27%) had lower temperatures, heart rates,
and respiratory rates, with Group C normotensive and Group D
hypotensive. In the 6,919 patients with sepsis, Groups A and B were
younger while Groups C and D were older. Group A had the lowest
prevalence of congestive heart failure, hypertension, diabetes mellitus,
and chronic kidney disease, while Group B had the highest prevalence.
Groups A and D had the highest vasopressor use (p &lt; 0.001 for all
analyses above). In logistic regression, 30-day mortality was
significantly higher in Groups A and D (p &lt; 0.001 and p = 0.03,
respectively). In the SMART trial, sub-phenotype significantly modified
treatment effect (p = 0.03). Group D had significantly lower odds of
mortality with balanced crystalloids compared to saline (odds ratio (OR)
0.39, 95% confidence interval (CI) 0.23-0.67, p &lt; 0.001).
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Sepsis
sub-phenotypes based on vital sign trajectory were consistent across
cohorts, had distinct outcomes, and different responses to treatment
with balanced crystalloids versus saline.  2022. Springer-Verlag GmbH
Germany, part of Springer Nature.</td>
</tr>
<tr class="odd">
<td align="left">Dynamics of Trust and Consumption of COVID-19
Information Implicate a Mechanism for COVID-19 Vaccine and Booster
Uptake.</td>
<td align="left">Vaccine hesitancy remains a significant barrier to
achieving herd immunity and preventing the further spread of COVID-19.
Understanding contributors to vaccine hesitancy and how they change over
time may improve COVID-19 mitigation strategies and public health
policies. To date, no mechanism explains how trust in and consumption of
different sources of information affect vaccine uptake. A total of 1594
adults enrolled in our COVID-19 testing program completed standardized
surveys on demographics, vaccination status, use, reliance, and trust in
sources of COVID-19 information, from September to October 2021, during
the COVID-19 Delta wave. Of those, 802 individuals (50.3%) completed a
follow-up survey, from January to February 2022, during the
Omicron-wave. Regression analyses were performed to understand
contributors to vaccine and booster uptake over time. Individuals
vaccinated within two months of eligibility (early vaccinees) tended to
have more years of schooling, with greater trust in and consumption of
official sources of COVID-19 information, compared to those who waited
3-6 months (late vaccinees), or those who remained unvaccinated at 6
months post-eligibility (non-vaccinees). Most (70.1%) early vaccinees
took the booster shot, compared to only 30.5% of late vaccinees, with
the latter group gaining trust and consumption of official information
after four months. These data provide the foundation for a mechanism
based on the level of trust in and consumption of official information
sources, where those who increased their level of trust in and
consumption of official information sources were more likely to receive
a booster. This study shows that social factors, including education and
individual-level degree of trust in (and consumption of) sources of
COVID-19 information, interact and change over time to be associated
with vaccine and booster uptakes. These results are critical for the
development of effective public health policies and offer insights into
hesitancy over the course of the COVID-19 vaccine and booster
rollout.</td>
</tr>
<tr class="even">
<td align="left">Effects of the COVID 19 Pandemic on School Nurses
Resiliency and Ability to Cope: A Mixed Methods Study in the State of
Hawaii.</td>
<td align="left">This mixed-method study examined school nurses
experiences during the Coronavirus Disease 2019 pandemic related to role
change, psychological feelings, and coping/resiliency in the State of
Hawaii. A total of 30 school nurses completed a Brief Resilience Coping
Scale plus a series of open-ended questions in January 2022. On the
coping scale, over 40% of participants scored high, 52% scored medium,
and 7% scored a low resilient/coping level. We did not identify any
association between coping level and participant characteristics. Three
qualitative themes emerged: 1) school nurses experience chronic negative
emotions related to the pandemic, 2) school nurses demonstrate
attributes of resilience, and 3) school nurses utilize positive coping
techniques. The pandemic created significant stresses and negative
emotions among school nurses. Yet, school nurses reported effective
coping strategies and demonstrated strength/resilience. Support and open
communication between school nurses, their employers, and other
school-based stakeholders is needed to provide continued support for
school nurses.</td>
</tr>
<tr class="odd">
<td align="left">Veterans Use of Telehealth for Veterans Health
Administration Community Care Urgent Care During the Early COVID-19
Pandemic.</td>
<td align="left"><AbstractText Label="BACKGROUND">Since the onset of the
COVID-19 pandemic, telehealth has been an option for Veterans receiving
urgent care through Veterans Health Administration Community Care (CC).
<AbstractText Label="OBJECTIVE">We assessed use, arrangements, Veteran
decision-making, and experiences with CC urgent care delivered via
telehealth. <AbstractText Label="DESIGN">Convergent parallel mixed
methods, combining multivariable regression analyses of claims data with
semistructured Veteran interviews.
<AbstractText Label="SUBJECTS">Veterans residing in the Western United
States and Hawaii, with CC urgent care claims March 1 to September 30,
2020. <AbstractText Label="KEY RESULTS">In comparison to having
in-person only visits, having a telehealth-only visit was more likely
for Veterans who were non-Hispanic Black, were urban-dwelling, lived
further from the clinic used, had a COVID-related visit, and did not
require an in-person procedure. Predictors of having both telehealth and
in-person (compared with in-person only) visits were other (non-White,
non-Black) non-Hispanic race/ethnicity, urban-dwelling status, living
further from the clinic used, and having had a COVID-related visit. Care
arrangements varied widely; telephone-only care was common. Veteran
decisions about using telehealth were driven by limitations in in-person
care availability and COVID-related concerns. Veterans receiving care
via telehealth generally reported high satisfaction.
<AbstractText Label="CONCLUSIONS">CC urgent care via telehealth played
an important role in providing Veterans with care access early in the
COVID-19 pandemic. Use of telehealth differed by Veteran
characteristics; lack of in-person care availability was a driver.
Future work should assess for changes in telehealth use with pandemic
progression, geographic differences, and impact on care quality, care
coordination, outcomes, and costs to ensure Veterans optimal and
equitable access to care.</td>
</tr>
<tr class="even">
<td align="left">Assessing the Impact of COVID-19 on the Health of
Native Hawaiian/Pacific Islander People in the United States, 2021.</td>
<td align="left"><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Minimal
research has assessed COVID-19s unique impact on the Native
Hawaiian/Pacific Islander (NH/PI) population-an Indigenous-colonized
racial group with social and health disparities that increase their risk
for COVID-19 morbidity and mortality. To address this gap, we explored
the scope of COVID-19 outcomes, vaccination status, and health in
diverse NH/PI communities.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">NH/PI staff at
partner organizations collected survey data from April through November
2021 from 319 community-dwelling NH/PI adults in 5 states with large
NH/PI populations: Arkansas, California, Oregon, Utah, and Washington.
Data were analyzed with descriptive statistics, Pearson 2 tests,
independent and paired t tests, and linear and logistic regression
analyses. <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">During
the COVID-19 pandemic, 30% of survey participants had contracted
COVID-19, 16% had a close family member who died of the disease, and 64%
reported COVID-19 vaccine uptake. Thirty percent reported fair/poor
health, 21% currently smoked cigarettes, and 58% reported obesity.
Survey participants reported heightened COVID-19-related psychosocial
distress (mean score = 4.9 on 10-point scale), which was more likely
when health outcomes (general health, sleep, obesity) were poor or a
family member had died of COVID-19. Logistic regression indicated that
age, experiencing COVID-19 distress, and past-year use of influenza
vaccines were associated with higher odds of COVID-19 vaccine uptake
(1.06, 1.18, and 7.58 times, respectively).
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our empirical
findings highlight the acute and understudied negative impact of
COVID-19 on NH/PI communities in the United States and suggest new
avenues for improving NH/PI community health, vaccination, and recovery
from COVID-19.</td>
</tr>
<tr class="odd">
<td align="left">Vaccine-Associated Shifts in SARS-CoV-2 Infectivity
Among the Native Hawaiian and Other Pacific Islander Population in
Hawaii.</td>
<td align="left">Native Hawaiians and other Pacific Islanders (NHPIs)
across the country have experienced significant disparities because of
the COVID-19 pandemic. The Pacific Alliance Against COVID-19 used a
community-based participatory approach involving academic and community
partners to expand sustainable COVID-19 testing capacity and mitigate
the severe consequences among NHPI communities in Hawaii. We describe
the approach of this one-year study, some of the results, and how the
data are being used to inform next steps for the communities. Clinical
Trials.gov identifier: NCT04766333. (Am J Public Health.
2022;112(S9):S896-S899. <a href="https://doi.org/10.2105/AJPH.2022.306973" class="uri">https://doi.org/10.2105/AJPH.2022.306973</a>).</td>
</tr>
<tr class="even">
<td align="left">Resilience of breadfruit agro-ecosystems in Hawaii
during the COVID-19 pandemic.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The
COVID-19 pandemic is interrupting domestic and global food supply chains
resulting in reduced access to healthy diverse diets. Hawaii has been
described as a model social-ecological system and it has been suggested
that indigenous agro-ecosystems have the potential to be highly
productive and resilient under changing land-use and climate change
disturbance. However, little research has yet been conducted exploring
the disruption and resilience of agro-ecosystems in Hawaii caused by
the COVID-19 pandemic. The breadfruit tree (Artocarpus altilis;
Moraceae) is a signature, multi-purpose-tree of the complex perennial
agro-ecosystems systems in Oceania.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This case study
explores the ways in which the breadfruit agro-ecosystems of Hawaii
have shown resilience during the COVID-19 pandemic.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our study
suggests that breadfruit has increased its value as a subsistence crop
during the COVID-19 pandemic, even in a developed economy like Hawaii,
and that resilience of Hawaiian breadfruit agroe-cosystems during a
crisis can be supported through cooperatives and food-hubs.
<AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="UNASSIGNED">The
online version contains supplementary material available at
10.1186/s43170-022-00125-3.  The Author(s) 2022.</td>
</tr>
<tr class="odd">
<td align="left">Effect of a Condensed NBA Season on Injury Risk: An
Analysis of the 2020 Season and Player Safety.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Health
and safety concerns surrounding the coronavirus 2019 (COVID-19) pandemic
led the National Basketball Association (NBA) to condense and accelerate
the 2020 season. Although prior literature has suggested that inadequate
rest may lead to an increased injury risk, the unique circumstances
surrounding this season offer a unique opportunity to evaluate player
safety in the setting of reduced interval rest.
<AbstractText Label="HYPOTHESIS" NlmCategory="UNASSIGNED">We
hypothesized that the condensed 2020 NBA season resulted in an increased
overall injury risk as compared with the 2015 to 2018 seasons.
<AbstractText Label="STUDY DESIGN" NlmCategory="UNASSIGNED">Descriptive
epidemiology study.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A publicly
available database, Pro Sports Transactions, was queried for injuries
that forced players to miss 1 game between the 2015 and 2020 seasons.
Data from the 2019 season were omitted given the abrupt suspension of
the league year. All injury incidences were calculated per 1000
game-exposures (GEs). The primary outcome was the overall injury
proportion ratio (IPR) between the 2020 season and previous seasons.
Secondary measures included injury incidences stratified by type,
severity, age, position, and minutes per game.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 4346
injuries occurred over a 5-season span among 2572 unique player-seasons.
The overall incidence of injury during the 2020 season was 48.20 per
1000 GEs but decreased to 39.97 per 1000 GEs when excluding COVID-19.
Despite this exclusion, the overall injury rate in 2020 remained
significantly greater (IPR, 1.42 [95% CI, 1.32-1.52]) than that of the
2015 to 2018 seasons (28.20 per 1000 GEs). On closer evaluation, the
most notable increases seen in the 2020 season occurred within minor
injuries requiring only a 1-game absence (IPR, 1.53 [95% CI, 1.37-1.70])
and in players who were aged 25 to 29 years (IPR, 1.57 [95% CI,
1.40-2.63]), averaging 30.0 minutes per game (IPR, 1.67 [95% CI,
1.47-1.90]), and playing the point guard position (IPR, 1.67 [95%
1.44-1.95]).
<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Players in the
condensed 2020 NBA season had a significantly higher incidence of
injuries when compared with the prior 4 seasons, even when excluding
COVID-19-related absences. This rise is consistent with the other
congested NBA seasons of 1998 and 2011. These findings suggest that
condensing the NBA schedule is associated with an increased risk to
player health and safety.  The Author(s) 2022.</td>
</tr>
<tr class="even">
<td align="left">The mental health impact of COVID-19-related stressors
among treatment-seeking trauma-exposed veterans.</td>
<td align="left">Trauma-exposed veterans receiving mental health care
may have an elevated risk of experiencing COVID-19-related difficulties.
Using data from several ongoing clinical trials (N = 458), this study
examined exposure to COVID-19-related stressors and their associations
with key sociodemographic factors and mental health outcomes. The
results showed that exposure to COVID-19-related stressors was common,
higher among veterans who were racial/ethnic minorities d = 0.32, and
associated with elevated posttraumatic stress disorder (PTSD), r = .288,
and depressive symptom severity, r = .246. Women veterans experienced
more difficulty accessing social support, d = 0.31, and higher levels of
COVID-19-related distress, d = 0.31, than men. Qualitative data were
consistent with survey findings and highlighted the broader societal
context in veterans experience of COVID-19-related distress. These
findings may inform future research on the impact of the pandemic on
veterans, particularly those who are women and members of minoritized
racial/ethnic groups, as well as mental health treatment planning for
this population.  2022 International Society for Traumatic Stress
Studies.</td>
</tr>
<tr class="odd">
<td align="left">Defining and Addressing Anesthesiology Needs in
Simulation-based Medical Education.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">This
studys primary aim was to determine how training programs use
simulation-based medical education (SBME), because SBME is linked to
superior clinical performance.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">An anonymous
10-question survey was distributed to anesthesiology residency program
directors across the United States. The survey aimed to assess where and
how SBME takes place, which resources are available, frequency of and
barriers to its use, and perceived utility of a dedicated departmental
education laboratory.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The survey
response rate was 30.4% (45/148). SBME typically occurred at shared
on-campus laboratories, with residents typically participating in SBME 1
to 4 times per year. Frequently practiced skills included airway
management, trauma scenarios, nontechnical skills, and ultrasound
techniques (all  77.8%). Frequently cited logistical barriers to
simulation laboratory use included COVID-19 precautions (75.6%),
scheduling (57.8%), and lack of trainers (48.9%). Several respondents
also acknowledged financial barriers. Most respondents believed a
dedicated departmental education laboratory would be a useful or very
useful resource (77.8%).
<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">SBME is a
widely incorporated activity but may be impeded by barriers that our
survey helped identify. Barriers can be addressed by departmental
education laboratories. We discuss how such laboratories increase
capabilities to support structured SBME events and how costs can be
offset. Other academic departments may also benefit from establishing
such laboratories.</td>
</tr>
<tr class="even">
<td align="left">S2 Subunit of SARS-CoV-2 Spike Protein Induces Domain
Fusion in Natural Pulmonary Surfactant Monolayers.</td>
<td align="left">Pulmonary surfactant has been attempted as a supportive
therapy to treat COVID-19. Although it is mechanistically accepted that
the fusion peptide in the S2 subunit of the S protein plays a
predominant role in mediating viral fusion with the host cell membrane,
it is still unknown how the S2 subunit interacts with the natural
surfactant film. Using combined bio-physicochemical assays and atomic
force microscopy imaging, it was found that the S2 subunit inhibited the
biophysical properties of the surfactant and induced microdomain fusion
in the surfactant monolayer. The surfactant inhibition has been
attributed to membrane fluidization caused by insertion of the S2
subunit mediated by its fusion peptide. These findings may provide novel
insight into the understanding of bio-physicochemical mechanisms
responsible for surfactant interactions with SARS-CoV-2 and may have
translational implications in the further development of surfactant
replacement therapy for COVID-19 patients.</td>
</tr>
<tr class="odd">
<td align="left">Use of a Digital Assistant to Report COVID-19 Rapid
Antigen Self-test Results to Health Departments in 6 US
Communities.</td>
<td align="left"><AbstractText Label="IMPORTANCE">Widespread
distribution of rapid antigen tests is integral to the US strategy to
address COVID-19; however, it is estimated that few rapid antigen test
results are reported to local departments of health.
<AbstractText Label="OBJECTIVE">To characterize how often individuals in
6 communities throughout the United States used a digital assistant to
log rapid antigen test results and report them to their local
departments of health.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This prospective
cohort study is based on anonymously collected data from the
beneficiaries of the Say Yes! Covid Test program, which distributed more
than 3 000 000 rapid antigen tests at no cost to residents of 6
communities (Louisville, Kentucky; Indianapolis, Indiana; Fulton County,
Georgia; Oahu, Hawaii; Ann Arbor and Ypsilanti, Michigan; and
Chattanooga, Tennessee) between April and October 2021. A descriptive
evaluation of beneficiary use of a digital assistant for logging and
reporting their rapid antigen test results was performed.
<AbstractText Label="INTERVENTIONS">Widespread community distribution of
rapid antigen tests.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">Number and proportion
of tests logged and reported to the local department of health through
the digital assistant. <AbstractText Label="RESULTS">A total of 313 000
test kits were distributed, including 178 785 test kits that were
ordered using the digital assistant. Among all distributed kits, 14 398
households (4.6%) used the digital assistant, but beneficiaries reported
three-quarters of their rapid antigen test results to their state public
health departments (30 965 tests reported of 41 465 total test results
[75.0%]). The reporting behavior varied by community and was
significantly higher among communities that were incentivized for
reporting test results vs those that were not incentivized or partially
incentivized (90.5% [95% CI, 89.9%-91.2%] vs 70.5%; [95% CI,
70.0%-71.0%]). In all communities, positive tests were less frequently
reported than negative tests (60.4% [95% CI, 58.1%-62.8%] vs 75.5% [95%
CI, 75.1%-76.0%]). <AbstractText Label="CONCLUSIONS AND RELEVANCE">These
results suggest that application-based reporting with incentives may be
associated with increased reporting of rapid tests for COVID-19.
However, increasing the adoption of the digital assistant may be a
critical first step.</td>
</tr>
<tr class="even">
<td align="left">Evaluation of Spending Differences Between
Beneficiaries in Medicare Advantage and the Medicare Shared Savings
Program.</td>
<td align="left"><AbstractText Label="IMPORTANCE">The 2 primary efforts
of Medicare to advance value-based care are Medicare Advantage (MA) and
the fee-for-service-based Medicare Shared Savings Program (MSSP). It is
unknown how spending differs between the 2 programs after accounting for
differences in patient clinical risk. <AbstractText Label="OBJECTIVE">To
examine how spending and utilization differ between MA and MSSP
beneficiaries after accounting for differences in clinical risk using
data from administrative claims and electronic health records.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This
retrospective economic evaluation used data from 15 763 propensity
score-matched beneficiaries who were continuously enrolled in MA or MSSP
from January 1, 2014, to December 31, 2018, with diabetes, congestive
heart failure (CHF), chronic kidney disease (CKD), or hypertension.
Participants received care at a large nonprofit academic health system
in the southern United States that bears risk for Medicare beneficiaries
through both the MA and MSSP programs. Differences in beneficiary risk
were mitigated by propensity score matching using validated clinical
criteria based on data from administrative claims and electronic health
records. Data were analyzed from January 2019 to May 2022.
<AbstractText Label="EXPOSURES">Enrollment in MA or attribution to an
accountable care organization in the MSSP program.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">Per-beneficiary annual
total spending and subcomponents, including inpatient hospital,
outpatient hospital, skilled nursing facility, emergency department,
primary care, and specialist spending. <AbstractText Label="RESULTS">The
sample of 15 763 participants included 12 720 (81%) MA and 3043 (19%)
MSSP beneficiaries. MA beneficiaries, compared with MSSP beneficiaries,
were more likely to be older (median [IQR] age, 75.0 [69.9-81.8] years
vs 73.1 [68.3-79.8] years), male (5515 [43%] vs 1119 [37%]), and White
(9644 [76%] vs 2046 [69%]) and less likely to live in low-income zip
codes (2338 [19%] vs 750 [25%]). The mean unadjusted per-member per-year
spending difference between MSSP and MA disease-specific subcohorts was
$2159 in diabetes, $4074 in CHF, $2560 in CKD, and $2330 in
hypertension. After matching on clinical risk and demographic factors,
MSSP spending was higher for patients with diabetes (mean per-member
per-year spending difference in 2015: $2454; 95% CI, $1431-$3574), CHF
($3699; 95% CI, $1235-$6523), CKD ($2478; 95% CI, $1172-$3920), and
hypertension ($2258; 95% CI, $1616-2,939). Higher MSSP spending among
matched beneficiaries was consistent over time. In the matched cohort in
2018, MSSP total spending ranged from 23% (CHF) to 30% (CKD) higher than
MA. Adjusting for differential trends in coding intensity did not affect
these results. Higher outpatient hospital spending among MSSP
beneficiaries contributed most to spending differences between MSSP and
MA, representing 49% to 62% of spending differences across disease
cohorts. <AbstractText Label="CONCLUSIONS AND RELEVANCE">In this study,
utilization and spending were consistently higher for MSSP than MA
beneficiaries within the same health system even after adjusting for
granular metrics of clinical risk. Nonclinical factors likely contribute
to the large differences in MA vs MSSP spending, which may create
challenges for health systems participating in MSSP relative to their
participation in MA.</td>
</tr>
<tr class="odd">
<td align="left">What Getting COVID-19 Finally at This Stage in the
Pandemic Taught Me About Compassion to Others and Myself.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Planning and Implementation of COVID-19 Isolation and
Quarantine Facilities in Hawaii: A Public Health Case Report.</td>
<td align="left">In response to the second surge of COVID-19 cases in
Hawaii in the fall of 2020, the Hawaii State Department of Health
Behavioral Health Administration led and contracted a coalition of
agencies to plan and implement an isolation and quarantine facility
placement service that included food, testing, and transportation
assistance for a state capitol and major urban center. The goal of the
program was to provide safe isolation and quarantine options for
individual residents at risk of not being able to comply with isolation
and quarantine mandates. Drawing upon historical lived experiences in
planning and implementing the system for isolation and quarantine
facilities, this qualitative public health case study report applies the
plan-do-study-act (PDSA) improvement model and framework to review and
summarize the implementation of this system. This case study also offers
lessons for a unique opportunity for collaboration led by a public
behavioral health leadership that expands upon traditionally narrow
infectious disease control, by developing a continuum of care that not
only addresses immediate COVID-19 concerns but also longer-term supports
and services including housing, access to mental health services, and
other social services. This case study highlights the role of a state
agency in building a coalition of agencies, including a public
university, to respond to the pandemic. The case study also discusses
how continuous learning was executed to improve delivery of care.</td>
</tr>
<tr class="odd">
<td align="left">Native Hawaiian/Pacific Islander alcohol, tobacco and
other drug use, mental health and treatment need in the United States
during COVID-19.</td>
<td align="left"><AbstractText Label="INTRODUCTION">Before COVID-19,
Native Hawaiians/Pacific Islanders (NH/PI) endured a heavy burden of
alcohol, tobacco and other drug (ATOD) use in prior US data. Responding
to reports that many NH/PI communities experienced severe COVID-19
disparities that could exacerbate their ATOD burden, we partnered with
NH/PI communities to assess the substance use patterns and treatment
needs of diverse NH/PIs during COVID-19.
<AbstractText Label="METHODS">Collaborating with NH/PI community
organisations across five states with large NH/PI populations, we
conducted a large-scale investigation of NH/PI ATOD use, mental health
and treatment need during COVID-19. Between April and November 2021,
NH/PI-heritage research staff from our community partners collected data
involving 306 NH/PI adults using several community-based recruitment
methods (e-mail, telephone, in-person) and two survey approaches: online
and paper-and-pencil. Multivariate regressions were conducted to examine
potential predictors of NH/PI alcohol use disorder and need for
behavioural health treatment. <AbstractText Label="RESULTS">During
COVID-19, 47% and 22% of NH/PI adults reported current alcohol and
cigarette use, while 35% reported lifetime illicit substance use (e.g.,
cannabis, opioid). Depression and anxiety were high, and alcohol use
disorder, major depression and generalised anxiety disorder prevalence
were 27%, 27% and 19%, respectively. One-third of participants reported
past-year treatment need with lifetime illicit substance use, COVID-19
distress and major depression respectively associating with 3.0, 1.2,
and 5.3 times greater adjusted odds for needing treatment.
<AbstractText Label="CONCLUSIONS">NH/PI adults reported heavy ATOD use,
depression, anxiety and treatment need during COVID-19. Targeted
research and treatment services may be warranted to mitigate COVID-19s
negative behavioural health impact on NH/PI communities.  2022 The
Authors. Drug and Alcohol Review published by John Wiley &amp; Sons
Australia, Ltd on behalf of Australasian Professional Society on Alcohol
and other Drugs.</td>
</tr>
<tr class="even">
<td align="left">National Guard Response to COVID-19: A Snapshot in Time
during the Pandemic.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Since
March of 2020, thousands of National Guard service members have played a
key role in the domestic response to COVID-19, ranging from medical
support, health screening, decontamination, personal protective
equipment (PPE) training, and more. As a result of these missions, there
was a hypothesized potential increase in COVID-19 exposure risk.
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Assess COVID-19
transmission rates and mortality rates in the US population compared to
the National Guard.
<AbstractText Label="METHODS" NlmCategory="METHODS">Six months of
retrospective data were assessed with analysis of a snapshot in time for
pandemic data on 29 July 2020. Potential relationships between National
Guard COVID-19 response personnel, cumulative US COVID-19 cases,
National Guard COVID-19 cases, and National Guard COVID-19 fatalities
were assessed. <AbstractText Label="RESULTS" NlmCategory="RESULTS">No
evidence of correlations exist between the number of National Guard
personnel supporting the COVID-19 response and the number of deaths in
the National Guard due to COVID-19 (p=0.547), and the number of National
Guard COVID-19 cases and the number of deaths in the National Guard due
to COVID-19 (p=0.214). The number of COVID-19 cases in the US was
positively correlated to the number of deaths in the US due to COVID-19
(rs=0.947, p is less than.001).
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Though much
of the data could not be reported due to operational security (OPSEC)
and capabilities, activities, limitations, and intentions (CALI)
concerns, the data herein demonstrate National Guard service members are
significantly less likely to suffer COVID-19 related mortality compared
to US civilians. Since the National Guard adheres the same medical and
physical fitness standards as set by their parent service (Army and Air
Force), it follows overall levels of medical readiness and fitness
should start with a higher baseline. Age, medical screening, PPE, and
physical fitness requirements have likely contributed to this
phenomenon. These results should empower National Guard service members
to feel more confident in their roles as they continue to support the
COVID-19 response efforts.</td>
</tr>
<tr class="odd">
<td align="left">Assessing the use of a micro-sampling device for
measuring blood protein levels in healthy subjects and COVID-19
patients.</td>
<td align="left"><AbstractText Label="BACKGROUND">Venous phlebotomy
performed by trained personnel is critical for patient diagnosis and
monitoring of chronic disease, but has limitations in
resource-constrained settings, and represents an infection control
challenge during outbreaks. Self-collection devices have the potential
to shift phlebotomy closer to the point of care, supporting telemedicine
strategies and virtual clinical trials. Here we assess a capillary blood
micro-sampling device, the Tasso Serum Separator Tube (SST), for
measuring blood protein levels in healthy subjects and non-hospitalized
COVID-19 patients. <AbstractText Label="METHODS">57 healthy controls and
56 participants with mild/moderate COVID-19 were recruited at two U.S.
military healthcare facilities. Healthy controls donated Tasso SST
capillary serum, venous plasma and venous serum samples at multiple time
points, while COVID-19 patients donated a single Tasso SST serum sample
at enrolment. Concentrations of 17 protein inflammatory biomarkers were
measured in all biospecimens by Ella multi-analyte immune-assay.
<AbstractText Label="RESULTS">Tasso SST serum protein measurements in
healthy control subjects were highly reproducible, but their agreements
with matched venous samples varied. Most of the selected proteins,
including CRP, Ferritin, IL-6 and PCT, were well-correlated between
Tasso SST and venous serum with little sample type bias, but
concentrations of D-dimer, IL-1B and IL-1Ra were not. Self-collection at
home with delayed sample processing was associated with significant
concentrations differences for several analytes compared to supervised,
in-clinic collection with rapid processing. Finally, Tasso SST serum
protein concentrations were significantly elevated in in
non-hospitalized COVID-19 patients compared with healthy controls.
<AbstractText Label="CONCLUSIONS">Self-collection of capillary blood
with micro-sampling devices provides an attractive alternative to
routine phlebotomy. However, concentrations of certain analytes may
differ significantly from those in venous samples, and factors including
user proficiency, temperature control and time lags between specimen
collection and processing need to be considered for their effect on
sample quality and reproducibility.</td>
</tr>
<tr class="even">
<td align="left">Review of adaptations of U.S. Commercial Fisheries in
response to the COVID-19 pandemic using the Resist-Accept-Direct (RAD)
framework.</td>
<td align="left">The COVID-19 pandemic transformed social and economic
systems globally, including fisheries systems. Decreases in seafood
demand, supply chain disruptions, and public safety regulations required
numerous adaptations to maintain the livelihoods and social resilience
of fishing communities. Surveys, interviews, and focus groups were
undertaken to assess impacts from and adaptive responses to the pandemic
in commercial fisheries in five U.S. regions: the Northeast, California,
Alaska, the U.S. Caribbean, and the Pacific Islands. Fishery adaptation
strategies were categorized using the Resist-Accept-Direct (RAD)
framework, a novel application to understand social transformation in a
social-ecological system in response to a disturbance. A number of
innovations emerged, or were facilitated, that could improve the
fisheries resilience to future disruptions. Fishers with diversified
options and strategic flexibility generally fared better, i.e., had
fewer disruptions to their livelihoods. Using the RAD framework to
identify adaptation strategies from fishery system actors highlights
opportunities for improving resilience of fisheries social-ecological
systems to future stressors.  2022 The Authors. Fisheries Management
and Ecology published by John Wiley &amp; Sons Ltd.</td>
</tr>
<tr class="odd">
<td align="left">Older Adults, Protective Factors, and Opportunities to
Promote Health during the COVID-19 Pandemic.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Factors associated with colorectal cancer screening
adherence and the impact of COVID-19 on screening patterns in
Connecticut, USA.</td>
<td align="left">Colorectal cancer (CRC) is one of the leading causes of
cancer death worldwide. Many communities remain under the 80% CRC
screening goal. We aimed to identify factors associated with
non-adherence to CRC screening and to describe the effect of the
COVID-19 pandemic in CRC screening patterns. A retrospective review of
patients aged 50-75 years seen at the Griffin Faculty Physicians primary
care offices between January 2019 and December 2020 was performed.
Logistic regression models were used to identify factors associated with
CRC screening non-adherence. Of 12,189 patients, 66.2% had an updated
CRC screen. On univariable logistic regression, factors associated with
CRC screening non-adherence included age  55 years [odds ratio (OR)
2.267, p &lt; 0.001], White/Caucasian race (OR 0.858, p = 0.030),
Medicaid insurance (OR 2.097, p &lt; 0.001), morbid obesity (OR 1.436, p
&lt; 0.001), current cigarette smoking (OR 1.849, p &lt; 0.001), and
elevated HbA1c (OR 1.178, p = 0.004). Age, Medicaid insurance, morbid
obesity, current smoking, and HbA1c  6.5% remained significant in the
final multivariable model. Compared to 2019, there was an 18.2% decrease
in the total number of CRC screening tests in 2020. The proportion of
colonoscopy procedures was lower in 2020 compared to the proportion of
colonoscopy procedures conducted in 2019 (65.9% vs 81.7%, p &lt; 0.001),
with a concurrent increase in stool-based tests. CRC screening rates in
our population are comparable to national statistics but below the 80%
goal. COVID-19 affected CRC screening. Our results underscore the need
to identify patient groups most vulnerable to missing CRC screening and
highlight the importance of stool-based testing to bridge screening
gaps.  2022. The Author(s), under exclusive licence to Societ Italiana
di Medicina Interna (SIMI).</td>
</tr>
<tr class="odd">
<td align="left">Effectiveness Associated With BNT162b2 Vaccine Against
Emergency Department and Urgent Care Encounters for Delta and Omicron
SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 Years.</td>
<td align="left"><AbstractText Label="IMPORTANCE">Data about the
duration of protection of 2 and 3 doses of BNT162b2 in children and
adolescents are needed to help inform recommendations for boosters in
this age group. <AbstractText Label="OBJECTIVE">To evaluate vaccine
effectiveness (VE) and durability associated with 2 doses of BNT162b2
against Delta- and Omicron-related emergency department (ED) and urgent
care (UC) encounters among adolescents aged 12 to 17 years and to
estimate VE associated with 3 doses against these same outcomes.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This
test-negative case-control study was conducted at Kaiser Permanente
Southern California, an integrated health care system using electronic
health records in the US. Participants included Kaiser Permanente
Southern California members ages 12 to 17 years with an ED or UC
encounter from November 1, 2021, through March 18, 2022, for acute
respiratory infection who were tested for SARS-CoV-2 via a reverse
transction-polymerase chain reaction test. Analyses were conducted from
March 21 to June 22, 2022. <AbstractText Label="EXPOSURES">BNT162b2
vaccination status ascertained from electronic health records and state
registry data. <AbstractText Label="MAIN OUTCOMES AND MEASURES">The main
outcome was VE associated with BNT162b2 against ED and UC encounters
related to Delta or Omicron variant SARS-CoV-2 infection.
<AbstractText Label="RESULTS">Analyses were conducted among 3168
adolescents, including 1004 with ED visits and 2164 with UC visits.
Median (IQR) age was 15 (13-16) years, and 1461 (46.1%) were boys. In
adjusted analyses, VE associated with 2 doses of BNT162b2 against ED or
UC encounters was highest within the first 2 months for both Delta (89%
[95% CI, 69% to 96%]) and Omicron (73% [95% CI, 54% to 84%]) variants
but waned to 49% (95% CI, 27% to 65%) for the Delta variant and 16% (95%
CI, -7% to 34%) for the Omicron variant at 6 months and beyond. A third
dose of BNT162b2 was associated with improved protection against the
Omicron variant (87% [95% CI, 72% to 94%]) after a median (IQR) of 19
(9-32) days after dose 3.
<AbstractText Label="CONCLUSIONS AND RELEVANCE">These findings suggest
that 2 doses of the BNT162b2 COVID-19 vaccine were associated with high
levels of protection against ED and UC encounters related to the Delta
and Omicron variants of SARS-CoV-2 in the first few months after
vaccination. However, effectiveness waned over time, especially against
Omicron. A third dose of BNT162b2 was associated with improved
protection against Omicron beyond that seen initially after 2 doses,
underscoring the importance of boosters for adolescents aged 12 to 17
years.</td>
</tr>
<tr class="even">
<td align="left">Evaluating and Improving Cancer Screening Process
Quality in a Multilevel Context: The PROSPR II Consortium Design and
Research Agenda.</td>
<td align="left"><AbstractText Label="BACKGROUND">Cancer screening is a
complex process involving multiple steps and levels of influence (e.g.,
patient, provider, facility, health care system, community, or
neighborhood). We describe the design, methods, and research agenda of
the Population-based Research to Optimize the Screening Process (PROSPR
II) consortium. PROSPR II Research Centers (PRC), and the Coordinating
Center aim to identify opportunities to improve screening processes and
reduce disparities through investigation of factors affecting cervical,
colorectal, and lung cancer screening in U.S. community health care
settings. <AbstractText Label="METHODS">We collected multilevel,
longitudinal cervical, colorectal, and lung cancer screening process
data from clinical and administrative sources on &amp;gt;9 million
racially and ethnically diverse individuals across 10 heterogeneous
health care systems with cohorts beginning January 1, 2010. To
facilitate comparisons across organ types and highlight data breadth, we
calculated frequencies of multilevel characteristics and volumes of
screening and diagnostic tests/procedures and abnormalities.
<AbstractText Label="RESULTS">Variations in patient, provider, and
facility characteristics reflected the PROSPR II health care systems and
differing target populations. PRCs identified incident diagnoses of
invasive cancers, in situ cancers, and precancers (invasive: 372
cervical, 24,131 colorectal, 11,205 lung; in situ: 911 colorectal, 32
lung; precancers: 13,838 cervical, 554,499 colorectal).
<AbstractText Label="CONCLUSIONS">PROSPR IIs research agenda aims to
advance: (i) conceptualization and measurement of the cancer screening
process, its multilevel factors, and quality; (ii) knowledge of cancer
disparities; and (iii) evaluation of the COVID-19 pandemics initial
impacts on cancer screening. We invite researchers to collaborate with
PROSPR II investigators. <AbstractText Label="IMPACT">PROSPR II is a
valuable data resource for cancer screening researchers. 2022 American
Association for Cancer Research.</td>
</tr>
<tr class="odd">
<td align="left">An Analysis of SARS-CoV-2 Vaccine Reactogenicity:
Variation by Type, Dose, and History, Severity, and Recency of Prior
SARS-CoV-2 Infection.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">There
is limited information on the functional consequences of coronavirus
disease 2019 (COVID-19) vaccine side effects. To support patient
counseling and public health messaging, we describe the risk and
correlates of COVID-19 vaccine side effects sufficient to prevent work
or usual activities and/or lead to medical care (severe side effects).
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The EPICC study
is a longitudinal cohort study of Military Healthcare System
beneficiaries including active duty service members, dependents, and
retirees. We studied 2789 adults who were vaccinated between December
2020 and December 2021.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Severe side
effects were most common with the Ad26.COV2.S (Janssen/Johnson and
Johnson) vaccine, followed by mRNA-1273 (Moderna) then BNT162b2
(Pfizer/BioNTech). Severe side effects were more common after the second
than first dose (11% vs 4%; P &lt; .001). First (but not second) dose
side effects were more common in those with vs without prior severe
acute respiratory syndrome coronavirus 2 infection (9% vs 2%; adjusted
odds ratio [aOR], 5.84; 95% CI, 3.8-9.1), particularly if the prior
illness was severe or critical (13% vs 2%; aOR, 10.57; 95% CI, 5.5-20.1)
or resulted in inpatient care (17% vs 2%; aOR, 19.3; 95% CI, 5.1-72.5).
Side effects were more common in women than men but not otherwise
related to demographic factors.
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Vaccine side
effects sufficient to prevent usual activities were more common after
the second than first dose and varied by vaccine type. First dose side
effects were more likely in those with a history of
COVID-19-particularly if that prior illness was severe or associated
with inpatient care. These findings may assist clinicians and patients
by providing a real-world evaluation of the likelihood of experiencing
impactful postvaccine symptoms. Published by Oxford University Press on
behalf of Infectious Diseases Society of America 2022.This work is
written by (a) US Government employee(s) and is in the public domain in
the US.</td>
</tr>
<tr class="even">
<td align="left">COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus
in a Cohort Study: Associations With Infecting Genotype, Vaccine
History, and Return to Health.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Patient-reported
outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection are an important measure of the full burden of coronavirus
disease (COVID). Here, we examine how (1) infecting genotype and
COVID-19 vaccination correlate with inFLUenza Patient-Reported Outcome
(FLU-PRO) Plus score, including by symptom domains, and (2) FLU-PRO Plus
scores predict return to usual activities and health.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The epidemiology,
immunology, and clinical characteristics of pandemic infectious diseases
(EPICC) study was implemented to describe the short- and long-term
consequences of SARS-CoV-2 infection in a longitudinal, observational
cohort. Multivariable linear regression models were run with FLU-PRO
Plus scores as the outcome variable, and multivariable Cox proportional
hazards models evaluated effects of FLU-PRO Plus scores on return to
usual health or activities.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among the 764
participants included in this analysis, 63% were 18-44 years old, 40%
were female, and 51% were White. Being fully vaccinated was associated
with lower total scores ( = -0.39; 95% CI, -0.57 to -0.21). The Delta
variant was associated with higher total scores ( = 0.25; 95% CI, 0.05
to 0.45). Participants with higher FLU-PRO Plus scores were less likely
to report returning to usual health and activities (health: hazard ratio
[HR], 0.46; 95% CI, 0.37 to 0.57; activities: HR, 0.56; 95% CI, 0.47 to
0.67). Fully vaccinated participants were more likely to report
returning to usual activities (HR, 1.24; 95% CI, 1.04 to 1.48).
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Full
SARS-CoV-2 vaccination is associated with decreased severity of
patient-reported symptoms across multiple domains, which in turn is
likely to be associated with earlier return to usual activities. In
addition, infection with the Delta variant was associated with higher
FLU-PRO Plus scores than previous variants, even after controlling for
vaccination status. Published by Oxford University Press on behalf of
the Infectious Diseases Society of America 2022.</td>
</tr>
<tr class="odd">
<td align="left">Neutrophilic Dermatosis and Management Strategies for
the Inpatient Dermatologist.</td>
<td align="left"><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="UNASSIGNED">Neutrophilic
dermatoses are a heterogeneous group of disorders with significant
overlap in associated conditions, clinical presentation, and
histopathologic features. This review provides a structural overview of
neutrophilic dermatoses that may present in the inpatient setting along
with diagnostic work-up and management strategies.
<AbstractText Label="RECENT FINDINGS" NlmCategory="UNASSIGNED">Sweets
syndrome has been found in patients with coronavirus disease 2019
(COVID-19). Pyoderma gangrenosum (PG) has been shown to be equally
associated with ulcerative colitis and Crohns disease. A clinical trial
shows that cyclosporine is equally effective as prednisone in treating
PG. Neutrophilic eccrine hidradenitis has been found in the setting of
newer antineoplastic medications, such as BRAF inhibitors, as well as in
the setting of malignancy without chemotherapy exposure.
<AbstractText Label="SUMMARY" NlmCategory="UNASSIGNED">Neutrophilic
dermatoses are a rare and complex group of dermatoses with varying and
overlapping clinical presentations. Physicians should be aware of the
growing list of associated diseases in order to build a better
differential diagnosis or to potentially investigate for co-existing
disease.  The Author(s), under exclusive licence to Springer
Science+Business Media, LLC, part of Springer Nature 2022.</td>
</tr>
<tr class="even">
<td align="left">Corrigendum to Prognostic Factors for COVID-19
Hospitalized Patients with Preexisting Type 2 Diabetes.</td>
<td align="left">[This corrects the article DOI: 10.1155/2022/9322332.].
Copyright  2022 Yuanyuan Fu et al.</td>
</tr>
<tr class="odd">
<td align="left">Next Gen Hawaii: Collaborative COVID-19 Social Media
Initiative to Engage Native Hawaiian, Other Pacific Islander, and
Filipino Youth.</td>
<td align="left">The Next Gen Hawaii social media project was initiated
in the fall of 2020 to address ongoing public health concerns and the
need for accessible and reliable information across Hawaiis diverse
communities by strategically amplifying the voices of Hawaiis youth in
their Native languages. The collaborative effort arose from
conversations within the Hawaiis Native Hawaiian &amp; Pacific
Islander COVID-19 Response, Recovery, and Resilience Team, composed of
diverse public and private organizations involved in statewide COVID-19
response efforts for Native Hawaiian and Pacific Islander communities.
Next Gen Hawaiis focus was on Native Hawaiian, Pacific Islander,
Filipino, and other populations disproportionately suffering from
COVID-19. Five social media platforms were developed to spread messaging
to youth and young adults about COVID-19. Public Health Ambassadors
(from high school to young adults) were recruited and engaged to create
culturally and linguistically rooted messaging to promote public health
and prevention-based social norms. This strength-based approach
recognized youth as important community leaders and ambassadors for
change and empowered them to create content for dissemination on
platforms with national and global reach. Messaging was designed to
build individual, community, and digital health literacy while
integrating core cultural values and strengths of Native Hawaiian,
Pacific Islander, and Filipino communities. Over 250 messages have been
delivered across Next Gen Hawaii social media channels on topics
including vaccine information, mask-wearing, staying together over
distances, mental health, and in-languages resources in Chuukese,
Chamorro, Marshallese, Samoan, Hawaiian, Ilocano, Tagalog, and other
Pacific-basin languages. Reach has included more than 75 000 views from
various social media channels, media features, successful webinars, and
relevant conference presentations. This Public Health Insights article
provides an overview of Next Gen Hawaiis activities and achievements
as well as lessons learned for other youth-focused public health social
media campaigns and organizations. Copyright 2022 by University Health
Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Detection of SARS-CoV-2 by Canine Olfaction: A Pilot
Study.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">As
the number of coronavirus disease 2019 (COVID-19) cases continue to
surge worldwide and new variants emerge, additional accurate, rapid, and
noninvasive screening methods to detect severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are needed. The number of COVID-19
cases reported globally is &gt;455 million, and deaths have surpassed 6
million. Current diagnostic methods are expensive, invasive, and produce
delayed results. While COVID-19 vaccinations are proven to help slow the
spread of infection and prevent serious illness, they are not equitably
available worldwide. Almost 40% of the worlds population remains
unvaccinated. Evidence suggests that SARS-CoV-2 virus-associated
volatile organic compounds found in the breath, urine, and sweat of
infected individuals can be detected by canine olfaction. Medical
detection dogs may be a feasible, accurate, and affordable SARS-CoV-2
screening method.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this
double-blinded, case-control, validation study, we obtained sweat
samples from inpatients and outpatients tested for SARS-CoV-2 by a
polymerase chain reaction test. Medical detection dogs were trained to
distinguish SARS-CoV-2-positive samples from SARS-CoV-2-negative samples
using reward-based reinforcement.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Samples were
obtained from 584 individuals (6-97 years of age; 24% positive
SARS-CoV-2 samples and 76% negative SARS-CoV-2 samples). In the testing
phase, all dogs performed with high accuracy in detecting SARS-CoV-2.
The overall diagnostic sensitivity was 98%, and specificity was 92%. In
a follow-up phase, 1 dog screened 153 patients for SARS-CoV-2 in a
hospital setting with 96% diagnostic sensitivity and 100% specificity.
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Canine
olfaction is an accurate and feasible method for diagnosis of
SARS-CoV-2, including asymptomatic and presymptomatic infected
individuals.  The Author(s) 2022. Published by Oxford University Press
on behalf of Infectious Diseases Society of America.</td>
</tr>
<tr class="odd">
<td align="left">Characteristics of hair loss after COVID-19: A
systematic scoping review.</td>
<td align="left"><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">While
there are literature reporting increased incidence of hair loss in
COVID-19 patients, insufficient evidence exists on the topic to date.
This review aims to identify the existing evidence and clinical
characteristics of hair loss with COVID-19 infection.
<AbstractText Label="METHODS" NlmCategory="METHODS">Following the PRISMA
Extension for Scoping Reviews, MEDLINE and EMBASE were searched for all
peer-reviewed articles with relevant keywords including Alopecia,
Telogen Effluvium (TE), and COVID-19 from their inception to
November 20, 2021. <AbstractText Label="RESULTS" NlmCategory="RESULTS">A
total of 26 articles, with 9 observational studies and 17 case reports
or series (a total of 58 cases), were included. Most studies dealt with
TE. There were no clear trends between COVID-19 severity and the extent
of hair loss. Analysis of the 58 cases also found similar results with
most of the cases being female (82.8%), the median onset of hair loss of
2.0 months, and the median time to recovery of hair loss of 5.0 months
with a resolution rate of 95%.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">While this
systematic review revealed uncertainty and a lack of strong evidence
regarding the association of COVID-19 and hair loss, hair loss in
COVID-19 may mainly include TE and be reversible in nature. Future
studies are warranted to determine the detailed pathophysiology and risk
factors of hair loss in COVID-19, including possible roles of estrogen,
progesterone, and pro-inflammatory cytokines.  2022 Wiley Periodicals
LLC.</td>
</tr>
<tr class="even">
<td align="left">Association Between Vaccination Coverage Disparity and
the Dynamics of the COVID-19 Delta and Omicron Waves in the US.</td>
<td align="left"><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The
US recently suffered the fourth and most severe wave of the COVID-19
pandemic. This wave was driven by the SARS-CoV-2 Omicron, a highly
transmissible variant that infected even vaccinated people. Vaccination
coverage disparities have played an important role in shaping the
epidemic dynamics. Analyzing the epidemiological impact of this uneven
vaccination coverage is essential to understand local differences in the
spread and outcomes of the Omicron wave. Therefore, the objective of
this study was to quantify the impact of vaccination coverage disparity
in the US in the dynamics of the COVID-19 pandemic during the third and
fourth waves of the pandemic driven by the Delta and Omicron variants.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This
cross-sectional study used COVID-19 cases, deaths, and vaccination
coverage from 2,417 counties. The main outcomes of the study were new
COVID-19 cases (incidence rate per 100,000 people) and new COVID-19
related deaths (mortality rate per 100,000 people) at county level and
the main exposure variable was COVID-19 vaccination rate at county
level. Geospatial and data visualization analyses were used to estimate
the association between vaccination rate and COVID-19 incidence and
mortality rates for the Delta and Omicron waves.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">During the
Omicron wave, areas with high vaccination rates (&gt;60%) experienced
1.4 (95% confidence interval [CI] 1.3-1.7) times higher COVID-19
incidence rate compared to areas with low vaccination rates (&lt;40%).
However, mortality rate was 1.6 (95% CI 1.5-1.7) higher in these
low-vaccinated areas compared to areas with vaccination rates higher
than 60%. As a result, areas with low vaccination rate had a 2.2 (95% CI
2.1-2.2) times higher case-fatality ratio. Geospatial clustering
analysis showed a more defined spatial structure during the Delta wave
with clusters with low vaccination rates and high incidence and
mortality located in southern states.
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Despite the
emergence of new virus variants with differential transmission
potential, the protective effect of vaccines keeps generating marked
differences in the distribution of critical health outcomes, with low
vaccinated areas having the largest COVID-19 related mortality during
the Delta and Omicron waves in the US. Vulnerable communities residing
in low vaccinated areas, which are mostly rural, are suffering the
highest burden of the COVID-19 pandemic during the vaccination era.
Copyright  2022 Cuadros, Moreno, Musuka, Miller, Coule and
MacKinnon.</td>
</tr>
<tr class="odd">
<td align="left">Opposing Role of Trust as a Modifier of COVID-19
Vaccine Uptake in an Indigenous Population.</td>
<td align="left">Native Hawaiians and other Pacific Islanders (NHPIs)
were disproportionately impacted by COVID-19 and remain significantly
under-vaccinated against SARS-CoV-2. To understand vaccine hesitancy, we
surveyed 1124 adults residing in a region with one of the lowest
vaccination rates in Hawaii during our COVID-19 testing program. Probit
regression analysis revealed that race/ethnicity was not directly
associated with the probability of vaccine uptake. Instead, a higher
degree of trust in official sources of COVID-19 information increased
the probability of vaccination by 20.68%, whereas a higher trust in
unofficial sources decreased the probability of vaccination by 12.49%
per unit of trust. These results revealed a dual and opposing role of
trust on vaccine uptake. Interestingly, NHPIs were the only
racial/ethnic group to exhibit a significant positive association
between trust in and consumption of unofficial sources of COVID-19
information, which explained the vaccine hesitancy observed in this
indigenous population. These results offer novel insight relevant to
COVID-19 mitigation efforts in minority populations.</td>
</tr>
<tr class="even">
<td align="left">RAGE against the Machine: Can Increasing Our
Understanding of RAGE Help Us to Battle SARS-CoV-2 Infection in
Pregnancy?</td>
<td align="left">The receptor of advanced glycation end products (RAGE)
is a receptor that is thought to be a key driver of inflammation in
pregnancy, SARS-CoV-2, and also in the comorbidities that are known to
aggravate these afflictions. In addition to this, vulnerable populations
are particularly susceptible to the negative health outcomes when these
afflictions are experienced in concert. RAGE binds a number of ligands
produced by tissue damage and cellular stress, and its activation
triggers the proinflammatory transcription factor Nuclear Factor Kappa B
(NF-B), with the subsequent generation of key proinflammatory
cytokines. While this is important for fetal membrane weakening, RAGE is
also activated at the end of pregnancy in the uterus, placenta, and
cervix. The comorbidities of hypertension, cardiovascular disease,
diabetes, and obesity are known to lead to poor pregnancy outcomes, and
particularly in populations such as Native Hawaiians and Pacific
Islanders. They have also been linked to RAGE activation when
individuals are infected with SARS-CoV-2. Therefore, we propose that
increasing our understanding of this receptor system will help us to
understand how these various afflictions converge, how forms of RAGE
could be used as a biomarker, and if its manipulation could be used to
develop future therapeutic targets to help those at risk.</td>
</tr>
<tr class="odd">
<td align="left">Methane sources from waste and natural gas sectors
detected in Pune, India, by concentration and isotopic analysis.</td>
<td align="left">Methane (CH4) is a potent greenhouse gas and also plays
a significant role in tropospheric chemistry. High-frequency
(sub-hourly) measurements of CH4 and carbon isotopic ratio (13CH4) have
been conducted at Pune (18.53N, 73.80E), an urban environment in
India, during 2018-2020. High CH4 concentrations were observed, with a
mean of 2100  196 ppb (1844-2749 ppb), relative to marine background
concentrations. The 13CH4 varied between -45.11 and -50.03  for the
entire study period with an average of -47.41  0.94 . The diurnal
variability of CH4 typically showed maximum values in the morning
(08:00-09:00 local time) and minimum in the afternoon (15:00 local
time). The deepest diurnal amplitude of ~500 ppb was observed during
winter (December-February), which was reduced to less than half, ~200
ppb, during the summer (March-May). CH4 concentration at Pune showed a
strong seasonality (470 ppb), much higher than that at Mauna Loa,
Hawaii. On the other hand, 13CH4 records did not show distinct
seasonality at Pune. The 13CH4 values revealed that the significant
sources of CH4 in Pune were from the waste sector (enhanced during the
monsoon season; signature of depleted 13CH4), followed by the natural
gas sector with a signature of enriched 13CH4. Our analysis of Covid-19
lockdown (April to May 2020) effect on the CH4 variability showed no
signal in the CH4 variability; however, the isotopic analysis indicated
a transient shift in the CH4 source to the waste sector (early summer of
2020). Copyright  2022 Elsevier B.V. All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">Anthropomorphic Character Animations Versus Digital
Chalk Talks in a Resident Diabetes Pharmacotherapy Curriculum: a
Randomized Controlled Trial.</td>
<td align="left"><AbstractText Label="BACKGROUND">Animation in medical
education has boomed over the past two decades, and demand for distance
learning technologies will likely continue in the context of the
COVID-19 pandemic. However, experimental data guiding best practices for
animation in medical education are scarce.
<AbstractText Label="OBJECTIVE">To compare the efficacy of two animated
video styles in a diabetes pharmacotherapy curriculum for internal
medicine residents. <AbstractText Label="DESIGN">Learners were
randomized to receive one of two versions of the same multimodal
didactic curriculum. They received identical lectures, group activities,
and quizzes, but were randomized to either digital chalk talk (DCT)
videos or Sugar-Coated Science (SCS). SCS is an animated series using
anthropomorphic characters, stories, and mnemonics to communicate
knowledge. <AbstractText Label="PARTICIPANTS">Ninety-two internal
medicine residents at a single academic medical center received the
curriculum within ambulatory medicine didactics.
<AbstractText Label="MAIN MEASURES">Knowledge was measured at multiple
time points, as was residents self-reported comfort using each
medication class covered. Surveys assessed video acceptability and
telepresence. Key themes were identified from open-ended feedback.
<AbstractText Label="KEY RESULTS">Baseline knowledge was low, consistent
with prior needs assessments. On immediate posttest, mean scores were
higher with SCS than DCT (74.8% versus 68.4%), but the difference was
not statistically significant, p = 0.10. Subgroup analyses revealed
increased knowledge in the SCS group for specific medication classes.
Delayed posttest showed significant knowledge gains averaging 17.6%
across all participants (p &lt; 0.05); these gains were similar between
animation types. SCS achieved significantly higher telepresence,
entertainment, and acceptability scores than DCT. Qualitative data
suggested that residents prioritize well-designed, multimodal curricula
over specific animation characteristics.
<AbstractText Label="CONCLUSION">SCS and DCTs both led to learning
within a multimodal curriculum, but SCS significantly enhanced learner
experience. Animation techniques exemplified by both SCS and DCTs have
roles in the medical educator toolkit. Selection between them should
incorporate context, learner factors, and production resources.  2022.
The Author(s), under exclusive licence to Society of General Internal
Medicine.</td>
</tr>
<tr class="odd">
<td align="left">Lived experiences of Asian Canadians encountering
discrimination during the COVID-19 pandemic: a qualitative interview
study.</td>
<td align="left"><AbstractText Label="BACKGROUND">Asian Canadians have
experienced increased cases of racialized discrimination after the first
emergence of SARS-CoV-2 in China. This study examined how the COVID-19
pandemic has affected Asian Canadians sense of safety and belonging in
their Canadian (i.e., geographical) communities.
<AbstractText Label="METHODS">We applied a qualitative description study
design in which semistructured interviews were conducted from Mar.23 to
May 27, 2021. Purposive and snowball sampling methods were used to
recruit Asian Canadians diverse in region, gender and age. Interviews
were conducted through Zoom videoconference or telephone, and
independent qualitative thematic analysis in duplicate was used to
derive primary themes and subthemes.
<AbstractText Label="RESULTS">Thirty-two Asian Canadians (median age 35
[interquartile range 24-46] yr, 56% female, 44% East Asian) participated
in the study. We identified 5 predominant themes associated with how the
COVID-19 pandemic affected the participants sense of security and
belonging to their communities: relation between socioeconomic status
(SES) and exposure to discrimination (i.e., how SES insulates or exposes
individuals to increased discrimination); politics, media and the
COVID-19 pandemic (i.e., the key role that politicians and media played
in enabling spread of discrimination against and fear of Asian people);
effect of discrimination on mental and social health (i.e., peoples
ability to interact and form meaningful relationships with others);
coping with the impact of discrimination (i.e., the way people appraise
and move forward in identity-threatening situations); and implications
for sense of safety and sense of belonging (i.e., people feeling unable
to safely use public spaces in person, including the need to remain
alert in anticipation of harm, leading to distress and exhaustion).
<AbstractText Label="INTERPRETATION">During the COVID-19 pandemic, Asian
Canadians in our study felt unsafe owing to the uncertain, unexpected
and unpredictable nature of discrimination, but also felt a strong sense
of belonging to Canadian society and felt well connected to their Asian
Canadian communities. Future work should seek to explore the influence
of social media on treatment of and attitudes toward Asian Canadians. 
2022 CMA Impact Inc.or its licensors.</td>
</tr>
<tr class="even">
<td align="left">Financial Implications of COVID-19 Polymerase Chain
Reaction Tests on Independent Laboratories.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pre-Surgical COVID-19 Incidence in Relation to Public
Health Initiatives and Community Perceptions.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">SNAPSHOT USA 2020: A second coordinated national camera
trap survey of the United States during the COVID-19 pandemic.</td>
<td align="left">Managing wildlife populations in the face of global
change requires regular data on the abundance and distribution of wild
animals, but acquiring these over appropriate spatial scales in a
sustainable way has proven challenging. Here we present the data from
Snapshot USA 2020, a second annual national mammal survey of the USA.
This project involved 152 scientists setting camera traps in a
standardized protocol at 1485 locations across 103 arrays in 43 states
for a total of 52,710 trap-nights of survey effort. Most (58) of these
arrays were also sampled during the same months (September and October)
in 2019, providing a direct comparison of animal populations in 2 years
that includes data from both during and before the COVID-19 pandemic.
All data were managed by the eMammal system, with all species
identifications checked by at least two reviewers. In total, we recorded
117,415 detections of 78 species of wild mammals, 9236 detections of at
least 43 species of birds, 15,851 detections of six domestic animals and
23,825 detections of humans or their vehicles. Spatial differences
across arrays explained more variation in the relative abundance than
temporal variation across years for all 38 species modeled, although
there are examples of significant site-level differences among years for
many species. Temporal results show how species allocate their time and
can be used to study species interactions, including between humans and
wildlife. These data provide a snapshot of the mammal community of the
USA for 2020 and will be useful for exploring the drivers of spatial and
temporal changes in relative abundance and distribution, and the impacts
of species interactions on daily activity patterns. There are no
copyright restrictions, and please cite this paper when using these
data, or a subset of these data, for publication.  2022 The Authors.
Ecology  2022 The Ecological Society of America.</td>
</tr>
<tr class="odd">
<td align="left">Awakening: The Unveiling of Historically Unaddressed
Social Inequities During the COVID-19 Pandemic in the United
States.</td>
<td align="left">The violence and victimization brought by colonization
and slavery and justified for over a century by race-based science have
resulted in enduring inequities for black, Indigenous and people of
color (BIPOC) across the United States. This is particularly true if
BIPOC individuals have other intersecting devalued identities. We
highlight how such longstanding inequities paved the way for the
disproportionate burdens of coronavirus disease 2019 (COVID-19) among
the BIPOC populations across the country and provide recommendations on
how to improve COVID-19 mitigation strategies with the goal of
eliminating disparities. Copyright  2022 Elsevier Inc.All rights
reserved.</td>
</tr>
<tr class="even">
<td align="left">The Effects of COVID-19 Vaccine Mandates in
Hawaii.</td>
<td align="left">Having been affected by the highest increase in
COVID-19 cases since the start of the pandemic, Honolulu and Maui
counties in Hawaii implemented vaccine passport mandates for select
industries in September 2021. However, the degree to which such mandates
impacted COVID-19 mitigation efforts and economics remains poorly
understood. Herein, we describe the effects of these mandates on changes
in three areas using difference-in-difference regression models: (1)
business foot traffic; (2) number of COVID-19 cases per 100,000
individuals, and (3) COVID-19 vaccination rates across counties affected
or unaffected by the mandates. We observed that although businesses
affected by mandates experienced a 6.7% decrease in foot traffic over
the 14 weeks after the mandates were implemented, the number of COVID-19
cases decreased by 19.0%. Notably, the vaccination rate increased by
1.41% in counties that implemented mandates. In addition, towards the
end of the studied period, the level of foot traffic at impacted
businesses converged towards the level of that of non-impacted
businesses. As such, the trade-off in temporary losses at businesses was
met with significant gains in public health and safety.</td>
</tr>
<tr class="odd">
<td align="left">Mitigation Planning and Policies Informed by COVID-19
Modeling: A Framework and Case Study of the State of Hawaii.</td>
<td align="left">In the face of great uncertainty and a global crisis
from COVID-19, mathematical and epidemiologic COVID-19 models
proliferated during the pandemic. Yet, many models were not created with
the explicit audience of policymakers, the intention of informing
specific scenarios, or explicit communication of assumptions,
limitations, and complexities. This study presents a case study of the
roles, uses, and approaches to COVID-19 modeling and forecasting in one
state jurisdiction in the United States. Based on an account of the
historical real-world events through lived experiences, we first examine
the specific modeling considerations used to inform policy decisions.
Then, we review the real-world policy use cases and key decisions that
were informed by modeling during the pandemic including the role of
modeling in informing planning for hospital capacity, isolation and
quarantine facilities, and broad public communication. Key lessons are
examined through the real-world application of modeling, noting the
importance of locally tailored models, the role of a scientific and
technical advisory group, and the challenges of communicating technical
considerations to a public audience.</td>
</tr>
<tr class="even">
<td align="left">Understanding Hybrid Immunity: Comparison and
Predictors of Humoral Immune Responses to Severe Acute Respiratory
Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease
2019 (COVID-19) Vaccines.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Comparison
of humoral responses in severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) vaccinees, those with SARS-CoV-2 infection, or combinations
of vaccine/ infection (hybrid immunity) may clarify predictors of
vaccine immunogenicity.
<AbstractText Label="METHODS" NlmCategory="METHODS">We studied 2660 US
Military Health System beneficiaries with a history of SARS-CoV-2
infection-alone (n = 705), vaccination-alone (n = 932),
vaccine-after-infection (n = 869), and vaccine-breakthrough-infection (n
= 154). Peak anti-spike-immunoglobulin G (IgG) responses through 183
days were compared, with adjustment for vaccine product, demography, and
comorbidities. We excluded those with evidence of clinical or
subclinical SARS-CoV-2 reinfection from all groups.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Multivariable
regression results indicated that vaccine-after-infection anti-spike-IgG
responses were higher than infection-alone (P &lt; .01), regardless of
prior infection severity. An increased time between infection and
vaccination was associated with greater post-vaccination IgG response (P
&lt; .01). Vaccination-alone elicited a greater IgG response but more
rapid waning of IgG (P &lt; .01) compared with infection-alone (P &lt;
.01). BNT162b2 and mRNA-1273 vaccine-receipt was associated with greater
IgG responses compared with JNJ-78436735 vaccine-receipt (P &lt; .01),
regardless of infection history. Those with vaccine-after-infection or
vaccine-breakthrough-infection had a more durable anti-spike-IgG
response compared to infection-alone (P &lt; .01).
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Vaccine-receipt
elicited higher anti-spike-IgG responses than infection-alone, although
IgG levels waned faster in those vaccinated (compared to
infection-alone). Vaccine-after-infection elicits a greater humoral
response compared with vaccine or infection alone; and the timing, but
not disease severity, of prior infection predicted these
post-vaccination IgG responses. While differences between groups were
small in magnitude, these results offer insights into vaccine
immunogenicity variations that may help inform vaccination timing
strategies.  The Author(s) 2022. Published by Oxford University Press
on behalf of the Infectious Diseases Society of America. All rights
reserved. For permissions, please e-mail: <a href="mailto:journals.permissions@oup.com" class="email">journals.permissions@oup.com</a>.</td>
</tr>
<tr class="odd">
<td align="left">Remdesivir impairs mouse preimplantation embryo
development at therapeutic concentrations.</td>
<td align="left">Remdesivir (RDV) is the first antiviral drug to be
approved by the US Food and Drug Administration for the treatment of
COVID-19. While the general safety of RDV has been studied, its
reproductive risk, including embryotoxicity, is largely unknown. Here,
to gain insights into its embryotoxic potential, we investigated the
effects of RDV on mouse preimplantation embryos cultured in vitro at the
concentrations comparable to the therapeutic plasma levels. Exposure to
RDV (2-8 M) did not affect the initiation of blastocyst formation,
although the maintenance of the cavity failed at 8 M due to increased
cell death. While exposure to 2-4 M permitted the cavity maintenance,
expressions of developmental regulator genes associated with the inner
cell mass (ICM) lineage were significantly diminished. Adverse effects
of RDV depended on the duration and timing of exposure, as treatment
between the 8-cell to early blastocyst stage most sensitively affected
cavity expansion, gene expressions, and cell proliferation, particularly
of the ICM than the trophectoderm lineage. GS-441524, a major metabolite
of RDV, did not impair blastocyst formation or cavity expansion,
although it altered gene expressions in a manner differently from RDV.
Additionally, RDV reduced the viability of human embryonic stem cells,
which were used as a model for the human ICM lineage, more potently than
GS-441524. These findings suggest that RDV is potentially embryotoxic to
impair the pluripotent lineage, and will be useful for designing and
interpreting further in vitro and in vivo studies on the reproductive
toxicity of RDV. Copyright  2022 Elsevier Inc.All rights
reserved.</td>
</tr>
<tr class="even">
<td align="left">COVID-19 vaccination and booster induced
authentic-virus neutralizing antibody response is superior to SARS-CoV-2
natural infection induced response.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Standing strong amid a pandemic: How a global online
team project stands up to the public health crisis.</td>
<td align="left">The annual instructional virtual team Project X brings
together professors and students from across the globe to engage in
client projects. The 2020 project was challenged by the global
disruption of the COVID-19 pandemic. This paper draws on a quantitative
dataset from a post-project survey among 500 participating students and
a qualitative narrative inquiry of personal experiences of the faculty
members. The findings reveal how innovative use of a variety of
collaboration and communication technologies helped students and their
professors in building emotional connection and compassion to support
each other in the midst of the crisis, and to accomplish the project
despite connectivity disruptions. The results suggest that the role of
an instructor changed to a coach and mentor, and technology was used to
create a greater sense of inclusion and co-presence in student-faculty
interactions. Ultimately, the paper highlights the role of technology to
help the participants navigate sudden crisis affecting a global online
instructional team project. The adaptive instructional teaching
strategies and technologies depicted in this study offer transformative
potential for future developments in higher education.  2022 British
Educational Research Association.</td>
</tr>
<tr class="even">
<td align="left">Prevalence of psychological distress on public health
officials amid COVID-19 pandemic.</td>
<td align="left"><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">While
the coronavirus disease 2019 (COVID-19) pandemic has led to increased
burnout among frontline healthcare workers (HCWs), little research has
been done regarding the potential psychological burden among public
health officials who have worked tirelessly to tackle the pandemic from
an administrative perspective. This study aimed to determine the
prevalence of burnout, depression, and job-related stress in Japanese
public health officers amid the COVID-19 pandemic.
<AbstractText Label="METHODS" NlmCategory="METHODS">We conducted an
anonymous, self-administered web-based cross-sectional survey including
basic demographics, work-related questions, the Maslach Burnout
Inventory, Patient Health Questionnaire-9, Utrecht Work Engagement
Scale-3, and Brief Job Stress Questionnaire. 100 public health officers
working in the public health centers (PHCs) in Okayama, Japan, answered
the survey in December 2021 when the 5th surge in the number of COVID-19
was over. <AbstractText Label="RESULTS" NlmCategory="RESULTS">The
prevalence of burnout, depression, and job-related stress was 27%, 43%,
and 62%, respectively. The multivariate logistic analysis demonstrated
that females, public health nurses, and those who suffered from a lack
of support from their workplaces were significantly associated with
psychological distress.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">While we
tend to focus on mitigation plans to help alleviate burnout of frontline
HCWs, more focus is needed to help public health officers, and public
health nurses, in particular, to alleviate their psychological distress
and job-related stress to prevent further staff shortages and secure
sustainable health systems. Copyright  2022 Elsevier B.V. All rights
reserved.</td>
</tr>
<tr class="odd">
<td align="left">COVID-19 heterogeneity in islands chain
environment.</td>
<td align="left"><AbstractText Label="BACKGROUND">It is critical to
capture data and modeling from the COVID-19 pandemic to understand as
much as possible and prepare for future epidemics and possible
pandemics. The Hawaiian Islands provide a unique opportunity to study
heterogeneity and demographics in a controlled environment due to the
geographically closed borders and mostly uniform pandemic-induced
governmental controls and restrictions.
<AbstractText Label="OBJECTIVE">The goal of the paper is to quantify the
differences and similarities in the spread of COVID-19 among different
Hawaiian islands as well as several other archipelago and islands, which
could potentially help us better understand the effect of differences in
social behavior and various mitigation measures. The approach should be
robust with respect to the unavoidable differences in time, as the
arrival of the virus and promptness of mitigation measures may vary
significantly among the chosen locations. At the same time, the
comparison should be able to capture differences in the overall pandemic
experience. <AbstractText Label="METHODS">We examine available data on
the daily cases, positivity rates, mobility, and employ a
compartmentalized model fitted to the daily cases to develop appropriate
comparison approaches. In particular, we focus on merge trees for the
daily cases, normalized positivity rates, and baseline transmission
rates of the models. <AbstractText Label="RESULTS">We observe noticeable
differences among different Hawaiian counties and interesting
similarities between some Hawaiian counties and other geographic
locations. The results suggest that mitigation measures should be more
localized, that is, targeting the county level rather than the state
level if the counties are reasonably insulated from one another. We also
notice that the spread of the disease is very sensitive to unexpected
events and certain changes in mitigation measures.
<AbstractText Label="CONCLUSIONS">Despite being a part of the same
archipelago and having similar protocols for mitigation measures,
different Hawaiian counties exhibit quantifiably different dynamics of
the spread of the disease. One potential explanation is that not
sufficiently targeted mitigation measures are incapable of handling
unexpected, localized outbreak events. At a larger-scale view of the
general spread of the disease on the Hawaiian island counties, we find
very interesting similarities between individual Hawaiian islands and
other archipelago and islands.</td>
</tr>
<tr class="even">
<td align="left">The Impacts of the COVID-19 Pandemic on
Service-Learning Experiences Among Undergraduate Public Health Students
in Hawaii.</td>
<td align="left">Service-learning is a high-impact educational practice
at the core of the undergraduate public health degree at the University
of Hawaii at Mnoa (UHM). This practice provides an invaluable learning
experience and professional opportunity for students to collaborate with
community partners and make significant contributions in the field. The
COVID-19 pandemic halted or disrupted service-learning experiences as
community partners adapted to shifting mandates and emergency orders.
Surveying the rapidly evolving landscape of partner organizations to
support service-learning is a challenge. Assessing changes to the
program mentorship or satisfaction is the first step to developing
protocols to ensure standardization of service-learning during times of
crisis. This study will address if and how the pandemic impacted
students satisfaction with required service-learning experiences.
Furthermore, authors hope to create a comprehensive list of practicum
partnering organizations, both focused on pandemic response and, more
generally, of the service-learning students at UHM, with the intent to
increase students and community partners in local service-learning.
Assessments were conducted to assess the impact of COVID-19 on
undergraduate students experiences with service-learning through use of
a program exit survey. The authors hypothesized pandemic-related
adjustments would not affect student satisfaction or skill development.
Despite challenges associated with the pandemic and emergency online
transitions, students persisted in personal and professional growth
associated with service-learning. This developed resilience supports
students as they graduate and enter a workforce adapting to remote work
demands and community needs. Copyright  2022 Kehl, Patil, Tagorda and
Nelson-Hurwitz.</td>
</tr>
<tr class="odd">
<td align="left">Impact of the COVID-19 Pandemic on the Hawaii Nursing
Workforce: A Cross-sectional Survey.</td>
<td align="left">The coronavirus disease (COVID-19) pandemic has placed
extraordinary strain on health care systems. This has led to increased
stress among health care workers, and nurses in particular, which has
had a negative impact on their physical and psychosocial wellbeing. This
is likely to negatively impact the nursing workforce at the state and
national levels as the pandemic continues. The purpose of this study was
to assess whether nurses licensed in Hawaii have considered leaving the
workforce. A cross-sectional online survey was conducted among Hawaii
nurses at all levels of licensure, with 421 responding. Of these nurses,
97 (23.0%) reported considering leaving the workforce, with safety
(39.2%) and family/caregiver strain (32.0%) being the most common
reasons. Reconsidering whether they should stay employed in their
current roles (Odds ratio [OR] 2.05; 95% CI 1.56 - 2.69) and fear to
continue providing direct patient care (OR 1.97; 95% CI 1.54 - 2.54)
were associated with increased odds of having considered leaving the
workforce. Based on these results, the State of Hawaii and local health
care organizations need to adjust their nursing workforce estimates and
address how to alleviate nurses stressors and safety concerns to
mitigate a potential workforce shortage. Research is needed to develop
interventions to support and empower nurses in their current roles but
also address future emergency preparedness. Copyright 2022 by
University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Tribulations and Triumphs of the COVID-19 Pandemic on
Cancer Care in Hawaii.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Characteristics of herpes zoster infection in patients
with COVID-19: a systematic scoping review.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although
there is literature reporting correlations between varicella zoster
virus (VZV) infections and COVID-19, insufficient evidence exists in
this regard. This scoping review aims to identify the existing evidence
regarding clinical characteristics of primary VZV infection or
reactivation in COVID-19.
<AbstractText Label="METHODS" NlmCategory="METHODS">Following the PRISMA
Extension for Scoping Reviews, MEDLINE and EMBASE were searched for all
peer-reviewed articles with relevant keywords including Zoster,
Herpes, and COVID-19 from their inception to November 20, 2021.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 19
articles with three observational studies and 16 case reports or series
were included. Primary VZV infections or reactivation were observed in
25 patients. Forty-eight percent of the patients had disseminated VZV
infection. The median time of VZV-related rash after the onset of
respiratory symptoms was 7.0 days (interquartile range: 0-18.8). Those
with COVID-19 and primary VZV infection or reactivation had low
lymphocyte counts with a median of 0.67  103 /l.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This scoping
review identified uncertainty and a lack of strong evidence to see the
association between primary VZV infection or reactivation and COVID-19.
However, those with COVID-19 may be more likely to have disseminated
VZV, which poses an additional challenge from an infection prevention
standpoint. Future studies are warranted to determine the association
between primary VZV infection or reactivation and long-term consequences
related to COVID-19.  2022 the International Society of
Dermatology.</td>
</tr>
<tr class="even">
<td align="left">Association of Septic Shock with Mortality in
Hospitalized COVID-19 Patients in Wuhan, China.</td>
<td align="left"><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Septic
shock is a severe complication of COVID-19 patients. We aim to identify
risk factors associated with septic shock and mortality among COVID-19
patients. <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total
of 212 COVID-19 confirmed patients in Wuhan were included in this
retrospective study. Clinical outcomes were designated as nonseptic
shock and septic shock. Log-rank test was conducted to determine any
association with clinical progression. A prediction model was
established using random forest.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The mortality of
septic shock and nonshock patients with COVID-19 was 96.7% (29/30) and
3.8% (7/182). Patients taking hypnotics had a much lower chance to
develop septic shock (HR = 0.096, p=0.0014). By univariate logistic
regression analysis, 40 risk factors were significantly associated with
septic shock. Based on multiple regression analysis, eight risk factors
were shown to be independent risk factors and these factors were then
selected to build a model to predict septic shock with AUC = 0.956.
These eight factors included disease severity (HR = 15, p &lt; 0.001),
age &gt; 65 years (HR = 2.6, p=0.012), temperature &gt; 39.1C (HR =
2.9, p=0.047), white blood cell count &gt; 10  10 (HR = 6.9, p &lt;
0.001), neutrophil count &gt; 75  10 (HR = 2.4, p=0.022), creatine
kinase &gt; 5 U/L (HR = 1.8, p=0.042), glucose &gt; 6.1 mmol/L (HR = 7,
p &lt; 0.001), and lactate &gt; 2 mmol/L (HR = 22, p &lt; 0.001).
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">We found 40
risk factors were significantly associated with septic shock. The model
contained eight independent factors that can accurately predict septic
shock. The administration of hypnotics could potentially reduce the
incidence of septic shock in COVID-19 patients. Copyright  2022 Shaoqiu
Chen et al.</td>
</tr>
<tr class="odd">
<td align="left">Hawaii Physician Workforce Assessment 2020.</td>
<td align="left">The Hawaii Physician Workforce project, launched in
2010, investigates state physician workforce trends. Over the past
decade, workforce demands have continued to climb as the state struggles
to maintain the physician supply. This article describes the current
state of the physician workforce, the physician age landscape, past
trends, as well as initial changes to the physician supply with the
COVID-19 pandemic. Data on practice location, full time equivalency of
time spent providing patient care in Hawaii, and specialty of
non-military physicians were clarified and informed via survey, internet
search, and direct calling methodologies. A proprietary microsimulation
modeling methodology was used to assess physician demand. The current
estimated physician shortage is between 710 and 1,008 full time
equivalents, the largest shortage in a decade. The unmet demand for
numbers of additional physicians is greatest on the largely urban island
of Oahu, however Oahus neighboring islands have the largest shortages
by percentage of demand. In fact, Hawaii island has over a 50% shortage
of physicians for the first time since the supply has been calculated
starting in 2010. Primary care has the greatest demand with a statewide
shortage of 412 full time equivalents. The average age of physicians in
Hawaii is 54 compared to the national average of 52. The authors
estimate that more than 52% of providers are utilizing telehealth and
that 10% of providers have retired or closed their practices since the
start of the COVID-19 pandemic. Hawaii is now in an urgent state of
need for recruitment and retention of physicians. Copyright 2022 by
University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Association between Mineralocorticoid Receptor
Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and
Meta-Analysis.</td>
<td align="left">Since the onset of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic, various potential targeted
therapies for SARS-CoV-2 infection have been proposed. The protective
effects of mineralocorticoid receptor antagonists (MRA) against tissue
fibrosis, pulmonary and systemic vasoconstriction, and inflammation have
been implicated in potentially attenuating the severity of SARS-CoV-2
infection by inhibiting the deleterious effects of aldosterone.
Furthermore, spironolactone, a type of MRA, has been suggested to have a
beneficial effect on SARS-CoV-2 outcomes through its dual action as an
MRA and antiandrogen, resulting in reduced transmembrane protease
receptor serine type 2 (TMPRSS2)-related viral entry to host cells. In
this study, we sought to investigate the association between MRA
antagonist therapy and mortality in SARS-CoV-2 patients via systematic
review and meta-analysis. The systematic review was performed according
to the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines. MEDLINE and EMBASE databases were
searched for studies that reported the incidence of mortality in
patients on MRA with SARS-CoV-2 infection. Pooled odds ratio (OR) and
95% confidence interval (CI) of the outcome were obtained using the
random-effects model. Five studies with a total of 1,388,178 subjects
(80,903 subjects receiving MRA therapy) met the inclusion criteria. We
included studies with all types of MRA therapy including spironolactone
and canrenone and found no association between MRA therapy and mortality
in SARS-CoV-2 infection (OR = 0.387, 95% CI: 0.134-1.117, p =
0.079).</td>
</tr>
<tr class="odd">
<td align="left">Identifying the Physical and Emotional Needs of Health
Care Workers in
Hawai<code>i During the COVID-19 Pandemic.                                                                                                                         |A mixed-methods study was performed to identify the physical and emotional needs of Hawai</code>i
health care workers during the COVID-19 pandemic, and the degree to
which these needs are being met by their clinic or hospital. Qualitative
interviews and demographic surveys were conducted with two cohorts of
health care workers. Cohort 1 (N=15) was interviewed between July 20 -
August 7, 2020, and Cohort 2 (N=16) between September 28 - October 9,
2020. A thematic analysis of the interview data was then performed.
Participants primary concern was contracting the illness at work and
transmitting it to their families. Solo practitioners working in
outpatient clinics reported more financial challenges and greater
difficulty obtaining PPE than those employed by hospitals or group
practices. While telehealth visits increased for both inpatient and
out-patient settings, the new visit type introduced new barriers to
entry for patients. The study findings may serve to better understand
the effect of COVID-19 on health care workers and support the
development of hospital and clinic procedures. Further research into the
impacts of COVID-19 on nurses in Hawai`i is recommended. Copyright 2022
by University Health Partners of Hawaii (UHP Hawaii).</td>
<td align="left"></td>
</tr>
<tr class="even">
<td align="left">Case Report: COVID Associated Pancytopenia Unmasking
Previously Undiagnosed Pernicious Anemia.</td>
<td align="left">Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)-associated pancytopenia is a known but rare complication of
COVID-19 syndrome that is not well described in literature. Severe acute
respiratory syndrome coronavirus 2 has shown the potential to affect any
organ including the bone marrow, which then results in a decrease in all
three blood cell lines. These cases usually resolve with the passage of
time and treatment of underlying risk factors. As COVID pneumonia rates
continue to increase worldwide, it is crucial to be able to recognize
this complication. Additionally, deeper investigation into patients
response to COVID infection can be complicated by unexpected underlying
disease. We report a case of a symptomatic 24-year-old active duty male
in Hawaii with post-COVID pancytopenia that was found to have previously
undiagnosed pernicious anemia and his response to standard
treatment.</td>
</tr>
<tr class="odd">
<td align="left">A framework for mapping and monitoring human-ocean
interactions in near real-time during COVID-19 and beyond.</td>
<td align="left">The human response to the COVID-19 pandemic set in
motion an unprecedented shift in human activity with unknown long-term
effects. The impacts in marine systems are expected to be highly dynamic
at local and global scales. However, in comparison to terrestrial
ecosystems, we are not well-prepared to document these changes in marine
and coastal environments. The problems are two-fold: 1) manual and
siloed data collection and processing, and 2) reliance on marine
professionals for observation and analysis. These problems are relevant
beyond the pandemic and are a barrier to understanding rapidly evolving
blue economies, the impacts of climate change, and the many other
changes our modern-day oceans are undergoing. The Our Ocean in
COVID-19 project, which aims to track human-ocean interactions
throughout the pandemic, uses the new eOceans platform (eOceans.app) to
overcome these barriers. Working at local scales, a global network of
ocean scientists and citizen scientists are collaborating to monitor the
ocean in near real-time. The purpose of this paper is to bring this
project to the attention of the marine conservation community,
researchers, and the public wanting to track changes in their area. As
our team continues to grow, this project will provide important
baselines and temporal patterns for ocean conservation, policy, and
innovation as society transitions towards a new normal. It may also
provide a proof-of-concept for real-time, collaborative ocean monitoring
that breaks down silos between academia, government, and at-sea
stakeholders to create a stronger and more democratic blue economy with
communities more resilient to ocean and global change.  2022 Elsevier
Ltd.All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">East Asian summer monsoon enhanced by COVID-19.</td>
<td align="left"><AbstractText Label="UNLABELLED">Anthropogenic
emissions decreased dramatically during the COVID-19 pandemic, but its
possible effect on monsoon is unclear. Based on coupled models
participating in the COVID Model Intercomparison Project (COVID-MIP), we
show modeling evidence that the East Asian summer monsoon (EASM) is
enhanced by 2.2% in terms of precipitation and by 5.4% in terms of the
southerly wind at lower troposphere, and the amplitude of the forced
response reaches about 1/3 of the standard deviation for interannual
variability. The enhanced EASM during COVID-19 pandemic is a fast
response to reduced aerosols, which is confirmed by the simulated
response to the removal of all anthropogenic aerosols. The observational
evidence, i.e., the anomalously strong EASM observed in 2020 and 2021,
also supports the simulated enhancement of EASM. The essential mechanism
for the enhanced EASM in response to COVID-19 is the enhanced zonal
thermal contrast between Asian continent and the western North Pacific
in the troposphere, due to the reduced aerosol concentration over Asian
continent and the associated latent heating feedback. As the enhancement
of EASM is a fast response to the reduction in aerosols, the effect of
COVID-19 on EASM dampens soon after the rebound of emissions based on
the models participating in COVID-MIP.
<AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="UNASSIGNED">The
online version contains supplementary material available at
10.1007/s00382-022-06247-8.  The Author(s), under exclusive licence to
Springer-Verlag GmbH Germany, part of Springer Nature 2022.</td>
</tr>
<tr class="odd">
<td align="left">Self-care and Wellness Checks in Emergency Field
Hospitals During COVID-19 Pandemic: A New Self-check Tool for Military
Personnel and Civilians.</td>
<td align="left">The authors explore the impact of cumulative stress on
United States (US) military service members (SM), including soldiers and
medical personnel, deployed to serve in New York City (NYC) communities.
Their mission was to assist in establishing emergency field hospitals
during the COVID-19 pandemic. Causative biopsychosocial factors are
presented, as well as the impact of wellness checks, which were utilized
to monitor the mood and morale of frontline healthcare providers,
military personnel, and infected patients in a 2,500-bed emergency field
hospital and a 1,000-bed Naval hospital ship operating in the
metropolitan NYC area. The authors introduce a self-care and wellness
tool, which assesses five core domains (physical, mental, emotional,
social, and spiritual) for the purpose of assessing and improving
individual overall well-being during periods of heightened stress. This
instrument could aid attending medical personnel in identifying patients
at risk of suicide. Likewise, the utility of this self-care tool is
applicable to both military SM and civilians, and includes soldiers and
medical personnel. Copyright  2022. Matrix Medical Communications. All
rights reserved.</td>
</tr>
<tr class="even">
<td align="left">A comparison of stress, symptoms, physical activity,
and adiposity among women at midlife before and during the
pandemic.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The
COVID-19 pandemic presented challenges that disproportionately impacted
women. Household roles typically performed by women (such as resource
acquisition and caretaking) became more difficult due to financial
strain, fear of infection, and limited childcare options among other
concerns. This research draws from an on-going study of hot flashes and
brown adipose tissue to examine the health-related effects of the
COVID-19 pandemic among 162 women aged 45-55 living in western
Massachusetts. <AbstractText Label="METHODS" NlmCategory="METHODS">We
compared women who participated in the study pre- and early pandemic
with women who participated mid-pandemic and later-pandemic (when
vaccines became widely available). We collected self-reported symptom
frequencies (e.g., aches/stiffness in joints, irritability), and
assessments of stress, depression, and physical activity through
questionnaires as well as measures of adiposity (BMI and percent body
fat). Additionally, we asked open-ended questions about how the pandemic
influenced womens health and experience of menopause. Comparisons
across pre-/early, mid-, and later pandemic categories were carried out
using ANOVA and Chi-square analyses as appropriate. The Levene test for
homogeneity of variances was examined prior to each ANOVA. Open-ended
questions were analyzed for yes/no responses and general themes.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Contrary to our
hypothesis that women would suffer negative health-related consequences
during the COVID-19 pandemic, we found no significant differences in
womens health-related measures or physical activity across the
pandemic. However, our analysis of open-ended responses revealed a
bi-modal distribution of answers that sheds light on our unexpected
findings. While some women reported higher levels of stress and anxiety
and lower levels of physical activity, other women reported benefitting
from the remote life that the pandemic imposed and described having more
time to spend on physical activity or in quality time with their
families. <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In
this cross-sectional comparison of women during the pre-/early, mid-,
and later-pandemic, we found no significant differences across means in
multiple health-related variables. However, open-ended questions
revealed that while some women suffered health-related effects during
the pandemic, others experienced conditions that improved their health
and well-being. The differential results of this study highlight a need
for more nuanced and intersectional research on risk, vulnerabilities,
and coping among mid-life women.  2022. The Author(s).</td>
</tr>
<tr class="odd">
<td align="left">Addressing Food Insecurity to Optimize Nutritional
Status.</td>
<td align="left">Chronic health conditions related to diet are linked
with increased risk for COVID-19 infection, complications, and
mortality. Adherence to a healthy diet pattern can be protective, but a
major barrier to healthy eating is the high cost of healthy foods.
Access to healthy foods is especially limited in households that
experience food insecurity, not having enough food or resources to get
food. Individuals who live in these households are also at increased
risk for a number of health conditions. Addressing food insecurity
within lifestyle medicine practice is needed to achieve optimal
nutrition status. Emerging food as medicine and other food access
programs are promising but coverage of such programs is lacking through
healthcare insurers. Medicaid waivers are a potential solution and have
been utilized in a handful of states. Copyright  2022 The
Author(s).</td>
</tr>
<tr class="even">
<td align="left">Experience of parents of preschool children in Hawaii
during the COVID-19 pandemic.</td>
<td align="left"><AbstractText Label="OBJECTIVE">The COVID-19 pandemic
has resulted in major disruption to economic, health, education, and
social systems. Families with preschool children experienced
extraordinary strain during this time. This paper describes a
qualitative study examining the experience of parents of preschool
children in Hawaii during the COVID-19 pandemic.
<AbstractText Label="SAMPLE">Thirteen (N = 13) parents of preschool
children living on the island of Oahu, Hawaii, participated in small
group discussions occurring in February and March 2021, approximately 1
year after the start of the pandemic in the state. Discussion
transcripts were coded and sorted into themes.
<AbstractText Label="RESULTS">Four themes emerged: stressors due to the
COVID-19 pandemic, family coping and resources, meaning of the COVID-19
crisis to the family, and family adaptation patterns. Themes mapped to
the Family Adjustment and Adaptation Response model.
<AbstractText Label="CONCLUSION">Families relied on various resources to
cope with stressors experienced due to the COVID-19 pandemic, and
adopted new patterns related to seeking healthcare and household
emergency preparedness. Findings may inform policies and interventions
to support families during the ongoing COVID-19 pandemic and future
public health emergencies.  2022 Wiley Periodicals LLC.</td>
</tr>
<tr class="odd">
<td align="left">Prioritizing Asian Americans, Native Hawaiians, and
Pacific Islanders in the U.S. Health Equity Agenda.</td>
<td align="left">Asian American, Native Hawaiian, and Pacific Islander
(AANHPI) populations are growing rapidly in the United States, yet
AANHPIs remain understudied, overlooked, and misunderstood. During the
COVID-19 pandemic, themes from the tragic history of anti-Asian bias and
marginalization have resurfaced in a surge of renewed bigotry and
xenophobic violence against AANHPIs. In this commentary, the authors
discuss the role of medical schools in combating anti-Asian sentiment as
an important step toward achieving health equity. Based on their
collective expertise in health disparities research, medical education,
and policy, they offer suggestions about how to disrupt the pattern of
invisibility and exclusion faced by AANHPI populations. They consider
ways that representative data, leadership in medical education, research
funding, national policies, and broad partnerships can help address
AANHPI health disparities. Copyright  2022 by the Association of
American Medical Colleges.</td>
</tr>
<tr class="even">
<td align="left">Outcomes and Safety of History-Based Screening for
Medication Abortion: A Retrospective Multicenter Cohort Study.</td>
<td align="left"><AbstractText Label="IMPORTANCE">Screening for
medication abortion eligibility typically includes ultrasonography or
pelvic examination. To reduce physical contact during the COVID-19
pandemic, many clinicians stopped requiring tests before medication
abortion and instead screened patients for pregnancy duration and
ectopic pregnancy risk by history alone. However, few US-based studies
have been conducted on the outcomes and safety of this novel model of
care. <AbstractText Label="OBJECTIVE">To evaluate the outcomes and
safety of a history-based screening, no-test approach to medication
abortion care.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This
retrospective cohort study included patients obtaining a medication
abortion without preabortion ultrasonography or pelvic examination
between February 1, 2020, and January 31, 2021, at 14 independent,
Planned Parenthood, academic-affiliated, and online-only clinics
throughout the US. <AbstractText Label="EXPOSURES">Medications for
abortion provided without preabortion ultrasonography or pelvic
examination and dispensed to patients in person or by mail.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">Effectiveness, defined
as complete abortion after 200 g of mifepristone and up to 1600 g of
misoprostol without additional intervention, and major abortion-related
adverse events, defined as hospital admission, major surgery, or blood
transfusion. <AbstractText Label="RESULTS">The study included data on
3779 patients with eligible abortions. The study participants were
racially and ethnically diverse and included 870 (23.0%) Black patients,
533 (14.1%) Latinx/Hispanic patients, 1623 (42.9%) White patients, and
327 (8.7%) who identified as multiracial or with other racial or ethnic
groups. For most (2626 [69.5%]), it was their first medication abortion.
Patients lived in 34 states, and 2785 (73.7%) lived in urban areas. In
2511 (66.4%) abortions, the medications were dispensed in person; in the
other 1268 (33.6%), they were mailed to the patient. Follow-up data were
obtained for 2825 abortions (74.8%), and multiple imputation was used to
account for missing data. Across the sample, 12 abortions (0.54%; 95%
CI, 0.18%-0.90%) were followed by major abortion-related adverse events,
and 4 patients (0.22%; 95% CI, 0.00%-0.45%) were treated for ectopic
pregnancies. Follow-up identified 9 (0.40%; 95% CI, 0.00%-0.84%)
patients who had pregnancy durations of greater than 70 days on the date
the mifepristone was dispensed that were not identified at screening.
The adjusted effectiveness rate was 94.8% (95% CI, 93.6%-95.9%).
Effectiveness was similar when medications were dispensed in person
(95.4%; 95% CI, 94.1%-96.7%) or mailed (93.3%; 95% CI, 90.7%-95.9%).
<AbstractText Label="CONCLUSIONS AND RELEVANCE">In this cohort study,
screening for medication abortion eligibility by history alone was
effective and safe with either in-person dispensing or mailing of
medications, resulting in outcomes similar to published rates of models
involving ultrasonography or pelvic examination. This approach may
facilitate more equitable access to this essential service by increasing
the types of clinicians and locations offering abortion care.</td>
</tr>
<tr class="odd">
<td align="left">Transmission of SARS-CoV-2 from mother to baby is
rare.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">The Lives of Native Hawaiian Elders and Their
Experiences With Healthcare: A Qualitative Analysis.</td>
<td align="left">Native Hawaiians are proud and resilient people who
have endured significant impacts from colonization. Despite being in a
time of vibrant cultural revitalization, Native Hawaiians have a shorter
life expectancy than other racial and ethnic groups in Hawaii. The
primary aim of this paper was to share data from the first year of a
5-year study with Native Hawaiian kpuna (elders) on their experiences
with healthcare, along with barriers to accessing healthcare. Ten kpuna
living in rural areas of Hawaii participated in three interviews each,
which were held in an informal, talk-story style. The first interview
focused on establishing rapport. The second interview focused on the
kpunas strengths, resiliencies, and what they would like to pass to
the next generation. The third interview focused on the elders
experiences with healthcare, which is the focus of this paper. All ten
kpuna reported growing up with limited access to Western healthcare;
rather, their families successfully treated many illnesses and injuries
with lau lapaau (Hawaiian herbal medicine) and other traditional
healing practices, as they had done for generations. As Western medicine
became more prevalent and accessible, they used both, but many preferred
holistic treatments such as prayer, a return to the traditional diet,
and lau lapaau. As a group, the kpuna rated their health as fair to
good; two had diabetes, two had cardiovascular disease, four had
neuropathies, and five were cancer survivors. The kpuna reported high
turnover among providers in rural communities. Limited access to
specialists often required them to travel to Honolulu for care, which
was costly and especially difficult during coronavirus disease 2019
(COVID-19). Regardless of provider ethnicity, the kpuna appreciated
those who took the time to get to know them as people and respected
Hawaiian cultural practices. They advised that Western providers speak
honestly and directly, have compassion, and build connections to
patients and their communities. Copyright  2022 Kawakami, Muneoka,
Burrage, Tanoue, Haitsuka and Braun.</td>
</tr>
<tr class="odd">
<td align="left">A Recombinant Subunit Vaccine Induces a Potent, Broadly
Neutralizing, and Durable Antibody Response in Macaques against the
SARS-CoV-2 P.1 (Gamma) Variant.</td>
<td align="left">FDA-approved and emergency use-authorized vaccines
using new mRNA and viral-vector technology are highly effective in
preventing moderate to severe disease; however, information on their
long-term efficacy and protective breadth against severe acute
respiratory syndrome coronavirus 2 variants of concern (VOCs) is
currently scarce. Here, we describe the durability and broad-spectrum
VOC immunity of a prefusion-stabilized spike (S) protein adjuvanted with
liquid or lyophilized CoVaccine HT in cynomolgus macaques. This
recombinant subunit vaccine is highly immunogenic and induces robust
spike-specific and broadly neutralizing antibody responses effective
against circulating VOCs (B.1.351 [Beta], P.1 [Gamma], and B.1.617
[Delta]) for at least three months after the final boost. Protective
efficacy and postexposure immunity were evaluated using a heterologous
P.1 challenge nearly three months after the last immunization. Our
results indicate that while immunization with both high and low S doses
shorten and reduce viral loads in the upper and lower respiratory tract,
a higher antigen dose is required to provide durable protection against
disease as vaccine immunity wanes. Histologically, P.1 infection causes
similar COVID-19-like lung pathology as seen with early pandemic
isolates. Postchallenge IgG concentrations were restored to peak
immunity levels, and vaccine-matched and cross-variant neutralizing
antibodies were significantly elevated in immunized macaques indicating
an efficient anamnestic response. Only low levels of P.1-specific
neutralizing antibodies with limited breadth were observed in control
(nonvaccinated but challenged) macaques, suggesting that natural
infection may not prevent reinfection by other VOCs. Overall, these
results demonstrate that a properly dosed and adjuvanted recombinant
subunit vaccine can provide protective immunity against circulating VOCs
for at least three months.</td>
</tr>
<tr class="even">
<td align="left">Lessons learned and lessons missed: impact of the
coronavirus disease 2019 (COVID-19) pandemic on all-cause mortality in
40 industrialised countries and US states prior to mass
vaccination.</td>
<td align="left">Background: Industrialised countries had varied
responses to the COVID-19 pandemic, which may lead to different death
tolls from COVID-19 and other diseases. Methods: We applied an ensemble
of 16 Bayesian probabilistic models to vital statistics data to estimate
the number of weekly deaths if the pandemic had not occurred for 40
industrialised countries and US states from mid-February 2020 through
mid-February 2021. We subtracted these estimates from the actual number
of deaths to calculate the impacts of the pandemic on all-cause
mortality. Results: Over this year, there were 1,410,300 (95% credible
interval 1,267,600-1,579,200) excess deaths in these countries,
equivalent to a 15% (14-17) increase, and 141 (127-158) additional
deaths per 100,000 people. In Iceland, Australia and New Zealand,
mortality was lower than would be expected in the absence of the
pandemic, while South Korea and Norway experienced no detectable change.
The USA, Czechia, Slovakia and Poland experienced &gt;20% higher
mortality. Within the USA, Hawaii experienced no detectable change in
mortality and Maine a 5% increase, contrasting with New Jersey, Arizona,
Mississippi, Texas, California, Louisiana and New York which experienced
&gt;25% higher mortality. Mid-February to the end of May 2020 accounted
for over half of excess deaths in Scotland, Spain, England and Wales,
Canada, Sweden, Belgium, the Netherlands and Cyprus, whereas
mid-September 2020 to mid-February 2021 accounted for &gt;90% of excess
deaths in Bulgaria, Croatia, Czechia, Hungary, Latvia, Montenegro,
Poland, Slovakia and Slovenia. In USA, excess deaths in the northeast
were driven mainly by the first wave, in southern and southwestern
states by the summer wave, and in the northern plains by the
post-September period. Conclusions: Prior to widespread vaccine-acquired
immunity, minimising the overall death toll of the pandemic requires
policies and non-pharmaceutical interventions that delay and reduce
infections, effective treatments for infected patients, and mechanisms
to continue routine health care. Copyright:  2022 Kontis V et al.</td>
</tr>
<tr class="odd">
<td align="left">Characteristics of bradyarrhythmia in patients with
COVID-19: Systematic scoping review.</td>
<td align="left">COVID-19 has recently been associated with the
development of bradyarrhythmias, although its mechanism is still
unclear. We aim to summarize the existing evidence regarding
bradyarrhythmia in COVID-19 and provide future directions for research.
Following the PRISMA Extension for Scoping Reviews, we searched MEDLINE
and EMBASE for all peer-reviewed articles using keywords
includingBradycardia, atrioventricular block, and COVID-19 from
their inception to October 13, 2021. Forty-three articles, including 11
observational studies and 59 cases from case reports and series, were
included in the systematic review. Although some observational studies
reported increased mortality in those with bradyarrhythmia and COVID-19,
the lack of comparative groups and small sample sizes hinder the ability
to draw definitive conclusions. Among 59 COVID-19 patients with
bradycardia from case reports and series, bradycardia most often
occurred in those with severe or critical COVID-19, and complete heart
block occurred in the majority of cases despite preserved LVEF (55.9%).
Pacemaker insertion was required in 76.3% of the patients, most of which
were permanent implants (45.8%). This systematic review summarizes the
current evidence and characteristics of bradyarrhythmia in patients with
COVID-19. Further studies are critical to assess the reversibility of
bradyarrhythmia in COVID-19 patients and to clarify potential
therapeutic targets including the need for permanent pacing.  2022
Wiley Periodicals LLC.</td>
</tr>
<tr class="even">
<td align="left">Health-care access and utilization among HIV-infected
men who have sex with men in two Chinese municipalities with or without
lockdown amidst early COVID-19 pandemic.</td>
<td align="left">City lockdown is critical to successfully contain the
COVID-19 pandemic. The impact of lockdown and COVID-19 pandemic on
healthcare among vulnerable population has yet to be explicated. A
cross-sectional survey was conducted among HIV-infected men who have sex
with men (MSM) in Wuhan with city lockdown and Shanghai without
lockdown, and healthcare interruptions were evaluated and compared. A
logistic regression analysis was employed to examine associates of
HIV-related healthcare interruptions and compromised mental health.
Compared to participants in Shanghai (N = 440), HIV-infected MSM in
Wuhan (N = 503) had significantly higher proportion of untimely
availability of antiretroviral drugs (ARVs) (20.6% vs.8.4%), obtaining
ARVs from outside institutions (29.1% vs.8.1%), postponed non-AIDS
treatment (6.4% vs.2.8%) and untimely follow-up appointments (33.4%
vs.14.5%). HIV-related healthcare interruptions were positively
associated with lockdown (OR = 4.89, 95% CI: 3.49-6.85) and non-local
residence (OR = 1.91, 95% CI: 1.37-2.64). Compromised mental health,
including insomnia and generalized anxiety disorders, was associated
with non-local residence (OR = 1.35, 95% CI: 1.01-1.81) and healthcare
interruptions (OR = 1.34, 95% CI: 1.01-1.79). HIV-infected MSM are
vulnerable to healthcare interruptions and mental health problems during
the COVID-19 pandemic, underscoring the need for tailored intervention
strategies to minimize deleterious health consequences.</td>
</tr>
<tr class="odd">
<td align="left">Cautious Optimism: Service Patterns in the Child and
Adolescent Mental Health Division During the COVID-19 Pandemic.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">In office management of optic capture of scleral
fixated posterior chamber intraocular lenses.</td>
<td align="left"><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Optic
capture of sutured scleral fixated posterior chamber intraocular lenses
(PC IOLs) is an occasional complication resulting in blurred vision and
discomfort. <AbstractText Label="METHODS" NlmCategory="METHODS">A
retrospective study of the management of 18 eyes (3.6%) with optic
capture out of 495 eyes with scleral fixated IOLs during the study
period. 54 procedures were performed in the management of optic capture
of sutured scleral fixated PC IOLs. An in-office technique was utilized
to relieve the optic capture by repositioning the optic posterior to the
iris. This technique was performed after topical anesthesia and topical
5% betadine with the patient stably positioned at the slit lamp. Using a
30-gauge needle, sometimes after a 15-degree paracentesis blade, the
needle was advanced in a parallel plane above the iris until the tip
reached the edge of the captured optic. The optic is engaged in the
inferior periphery away from the central visual axis, and pushed gently
posteriorly just enough to reposition the optic posterior to the iris.
In some cases, pilocarpine 2% drops were utilized after the procedure to
decrease the risk of recapture of the optic.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">All 54 procedures
were successfully performed in the office without significant pain or
discomfort. Vision before optic capture, during optic capture, and at
the first office visit after optic capture were comparable. There were
not any cases of endophthalmitis, hyphema, iris trauma, iris prolapse or
keratitis. While eight patients only had one episode of optic capture,
10 patients had multiple episodes of optic capture, all managed with
this in office procedure. Recurrent optic capture occurred more
frequently in eyes with fixation at less than 2 mm from the limbus than
eyes with scleral fixation at 2 mm from the limbus.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Reposition of
the optic after pupillary capture of a scleral fixated PC IOL can be
successfully performed in the office without discomfort or significant
complications and is an alternative management option to a return to the
operating room. This procedure may be especially important when there is
poor access to the operating room or restricted access to the operating
room as during the COVID19 pandemic.  2022 Published by Elsevier
Inc.</td>
</tr>
<tr class="odd">
<td align="left">Analysis of Vaccination Rates and New COVID-19
Infections by US County, July-August 2021.</td>
<td align="left">This cross-sectional study analyzes the association
between vaccination rates and COVID-19 incidence by county from July to
August 2021.</td>
</tr>
<tr class="even">
<td align="left">Anatomical Site, Viral Ribonucleic Acid Abundance, and
Time of Sampling Correlate With Molecular Detection of Severe Acute
Respiratory Syndrome Coronavirus 2 During Infection.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Nasopharyngeal
(NP) swabs are the standard for SARS-CoV-2 diagnosis. If less invasive
alternatives to NP swabs (eg, oropharyngeal [OP] or nasal swabs [NS])
are comparably sensitive, the use of these techniques may be preferable
in terms of comfort, convenience, and safety.
<AbstractText Label="METHODS" NlmCategory="METHODS">This study compared
the detection of SARS-CoV-2 in swab samples collected on the same day
among participants with at least one positive PCR test.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 755
participants had at least one set of paired swabs. Concordance between
NP and other swab types was 75% (NS), 72% (OP), 54% (rectal swabs [RS]),
and 78% (NS/OP combined). Kappa values were moderate for the NS, OP, and
NS/OP comparisons (0.50, 0.45, and 0.54, respectively). Highest
sensitivity relative to NP (0.87) was observed with a combination of
NS/OP tests (positive if either NS or OP was positive). Sensitivity of
the non-NP swab types was highest in the first week postsymptom onset
and decreased thereafter. Similarly, virus RNA quantity was highest in
the NP swabs as compared with NS, OP, and RS within two weeks
postsymptom onset. OP and NS performance decreased as virus RNA quantity
decreased. No differences were noted between NS specimens collected at
home or in clinic.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">NP swabs
detected more SARS-CoV-2 cases than non-NP swabs, and the sensitivity of
the non-NP swabs decreased with time postsymptom onset. While other
swabs may be simpler to collect, NP swabs present the best chance of
detecting SARS-CoV-2 RNA, which is essential for clinical care as well
as genomic surveillance. Published by Oxford University Press on behalf
of Infectious Diseases Society of America 2021.</td>
</tr>
<tr class="odd">
<td align="left">Prevalence and risk associated with asthma in children
hospitalized with SARS-CoV-2: a meta-analysis and systematic
review.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Persons tested for SAR-CoV-2 at a military treatment
facility in Hawaii.</td>
<td align="left">Health inequalities based on race are well-documented,
and the COVID-19 pandemic is no exception. Despite the advances in
modern medicine, access to health care remains a primary determinant of
health outcomes, especially for communities of color. African-Americans
and other minorities are disproportionately at risk for infection with
COVID-19, but this problem extends beyond access alone. This study
sought to identify trends in race-based disparities in COVID-19 in the
setting of universal access to care. Tripler Army Medical Center (TAMC)
is a Department of Defense Military Treatment Facility (DoD-MTF) that
provides full access to healthcare to active duty military members,
beneficiaries, and veterans. We evaluated the characteristics of
individuals diagnosed with SARS-CoV-2 infection at TAMC in a
retrospective, case-controlled (1:1) study. Most patients (69%) had
received a COVID-19 test within 3 days of symptom onset. Multivariable
logistic regression analyses were used to identify factors associated
with testing positive and to estimate adjusted odds ratios.
African-American patients and patients who identified as Other
ethnicities were two times more likely to test positive for SARS-CoV-2
relative to Caucasian patients. Other factors associated with testing
positive include: younger age, male gender, previous positive test,
presenting with &gt;3 symptoms, close contact with a COVID-19 positive
patient, and being a member of the US Navy. African-Americans and
patients who identify as Other ethnicities had disproportionately
higher rates of positivity of COVID-19. Although other factors
contribute to increased test positivity across all patient populations,
access to care does not appear to itself explain this discrepancy with
COVID-19.</td>
</tr>
<tr class="odd">
<td align="left">The COVID-19 pandemic: some thoughts on integrity in
research and communication.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Coronavirus Disease 2019 Temperature Trajectories
Correlate With Hyperinflammatory and Hypercoagulable Subphenotypes.</td>
<td align="left"><AbstractText Label="OBJECTIVES">Body temperature
trajectories of infected patients are associated with specific immune
profiles and survival. We determined the association between temperature
trajectories and distinct manifestations of coronavirus disease 2019.
<AbstractText Label="DESIGN">Retrospective observational study.
<AbstractText Label="SETTING">Four hospitals within an academic
healthcare system from March 2020 to February 2021.
<AbstractText Label="PATIENTS">All adult patients hospitalized with
coronavirus disease 2019. <AbstractText Label="INTERVENTIONS">Using a
validated group-based trajectory model, we classified patients into four
previously defined temperature trajectory subphenotypes using oral
temperature measurements from the first 72 hours of hospitalization.
Clinical characteristics, biomarkers, and outcomes were compared between
subphenotypes. <AbstractText Label="MEASUREMENTS AND MAIN RESULTS">The
5,903 hospitalized coronavirus disease 2019 patients were classified
into four subphenotypes: hyperthermic slow resolvers (n = 1,452, 25%),
hyperthermic fast resolvers (1,469, 25%), normothermics (2,126, 36%),
and hypothermics (856, 15%). Hypothermics had abnormal coagulation
markers, with the highest d-dimer and fibrin monomers (p &lt; 0.001) and
the highest prevalence of cerebrovascular accidents (10%, p = 0.001).
The prevalence of venous thromboembolism was significantly different
between subphenotypes (p = 0.005), with the highest rate in hypothermics
(8.5%) and lowest in hyperthermic slow resolvers (5.1%). Hyperthermic
slow resolvers had abnormal inflammatory markers, with the highest
C-reactive protein, ferritin, and interleukin-6 (p &lt; 0.001).
Hyperthermic slow resolvers had increased odds of mechanical
ventilation, vasopressors, and 30-day inpatient mortality (odds ratio,
1.58; 95% CI, 1.13-2.19) compared with hyperthermic fast resolvers. Over
the course of the pandemic, we observed a drastic decrease in the
prevalence of hyperthermic slow resolvers, from representing 53% of
admissions in March 2020 to less than 15% by 2021. We found that
dexamethasone use was associated with significant reduction in
probability of hyperthermic slow resolvers membership (27% reduction;
95% CI, 23-31%; p &lt; 0.001).
<AbstractText Label="CONCLUSIONS">Hypothermics had abnormal coagulation
markers, suggesting a hypercoagulable subphenotype. Hyperthermic slow
resolvers had elevated inflammatory markers and the highest odds of
mortality, suggesting a hyperinflammatory subphenotype. Future work
should investigate whether temperature subphenotypes benefit from
targeted antithrombotic and anti-inflammatory strategies. Copyright 
2022 by the Society of Critical Care Medicine and Wolters Kluwer Health,
Inc.All Rights Reserved.</td>
</tr>
<tr class="odd">
<td align="left">Understanding contributors to racial and ethnic
inequities in COVID-19 incidence and mortality rates.</td>
<td align="left"><AbstractText Label="BACKGROUND">Racial inequities in
Coronavirus 2019 (COVID-19) have been reported over the course of the
pandemic, with Black, Hispanic/Latinx, and Native American individuals
suffering higher case rates and more fatalities than their White
counterparts. <AbstractText Label="METHODS">We used a unique statewide
dataset of confirmed COVID-19 cases across Missouri, linked with
historical statewide hospital data. We examined differences by race and
ethnicity in raw population-based case and mortality rates. We used
patient-level regression analyses to calculate the odds of mortality
based on race and ethnicity, controlling for comorbidities and other
risk factors. <AbstractText Label="RESULTS">As of September 10, 2020
there were 73,635 confirmed COVID-19 cases in the State of Missouri.
Among the 64,526 case records (87.7% of all cases) that merged with
prior demographic and health care utilization data, 12,946 (20.1%) were
Non-Hispanic (NH) Black, 44,550 (69.0%) were NH White, 3,822 (5.9%) were
NH Other/Unknown race, and 3,208 (5.0%) were Hispanic. Raw cumulative
case rates for NH Black individuals were 1,713 per 100,000 population,
compared with 2,095 for NH Other/Unknown, 903 for NH White, and 1,218
for Hispanic. Cumulative COVID-19-related death rates for NH Black
individuals were 58.3 per 100,000 population, compared with 38.9 for NH
Other/Unknown, 19.4 for NH White, and 14.8 for Hispanic. In a model that
included insurance source, history of a social determinant billing code
in the patients claims, census block travel change, population density,
Area Deprivation Index, and clinical comorbidities, NH Black race (OR
1.75, 1.51-2.04, p&lt;0.001) and NH Other/Unknown race (OR 1.83,
1.36-2.46, p&lt;0.001) remained strongly associated with mortality.
<AbstractText Label="CONCLUSIONS">In Missouri, COVID-19 case rates and
mortality rates were markedly higher among NH Black and NH Other/Unknown
race than among NH White residents, even after accounting for social and
clinical risk, population density, and travel patterns during
COVID-19.</td>
</tr>
<tr class="even">
<td align="left">COVID-19 Is Changing Our Understanding of the
Neuroscience of Viral Infections: What We Can Do to Prepare for the
Future?</td>
<td align="left">In the approximately two years since the emergence of
COVID-19 (Coronavirus Disease 2019) myriad neurological symptoms have
been reported that are seemingly unrelated to each other [].</td>
</tr>
<tr class="odd">
<td align="left">Acute Epiploic Appendagitis in a COVID-19-Positive
Patient With Antiphospholipid Syndrome.</td>
<td align="left">As the coronavirus disease 2019 (COVID-19) pandemic is
still underway, a range of clinical presentations and pathologies
continue to present themselves in unexpected ways. One such pathology is
that of epiploic appendagitis, an uncommon and underdiagnosed cause of
acute abdominal pain. We present the case of a 50-something-year-old
male who presented with left lower quadrant abdominal pain in the
setting of acute COVID-19 infection, found to have acute epiploic
appendagitis. After persistent moderate to severe abdominal pain,
epiploic appendagitis was diagnosed by computed tomography (CT) imaging
findings. The patient was managed for his COVID-19 pneumonia over the
course of his hospitalization, as well as conservatively managed with
pain control measures for his epiploic appendagitis. This is the second
reported case in the literature to the best of our knowledge that shares
the case of acute epiploic appendagitis in a patient presenting with
acute abdominal pain, who is also found to be COVID-19-positive.
Procoagulant changes in coagulation pathways are found in patients with
severe COVID-19, and contribute to venous thromboembolism in this
patient population. Diagnosing and conservatively managing epiploic
appendagitis will lead to decreasing misdiagnosis, preventing invasive
or inappropriate treatments that may increase harm to patients, and more
adequately understanding the complications associated with COVID-19.
Copyright 2021, Kaakour et al.</td>
</tr>
<tr class="even">
<td align="left">Prognostic Factors for COVID-19 Hospitalized Patients
with Preexisting Type 2 Diabetes.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Type
2 diabetes (T2D) as a worldwide chronic disease combined with the
COVID-19 pandemic prompts the need for improving the management of
hospitalized COVID-19 patients with preexisting T2D to reduce
complications and the risk of death. This study aimed to identify
clinical factors associated with COVID-19 outcomes specifically targeted
at T2D patients and build an individualized risk prediction nomogram for
risk stratification and early clinical intervention to reduce mortality.
<AbstractText Label="METHODS" NlmCategory="METHODS">In this
retrospective study, the clinical characteristics of 382 confirmed
COVID-19 patients, consisting of 108 with and 274 without preexisting
T2D, from January 8 to March 7, 2020, in Tianyou Hospital in Wuhan,
China, were collected and analyzed. Univariate and multivariate Cox
regression models were performed to identify specific clinical factors
associated with mortality of COVID-19 patients with T2D. An
individualized risk prediction nomogram was developed and evaluated by
discrimination and calibration.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Nearly 15% (16/108)
of hospitalized COVID-19 patients with T2D died. Twelve risk factors
predictive of mortality were identified. Older age (HR = 1.076, 95% CI =
1.014-1.143, p=0.016), elevated glucose level (HR = 1.153, 95% CI =
1.038-1.28, p=0.0079), increased serum amyloid A (SAA) (HR = 1.007, 95%
CI = 1.001-1.014, p=0.022), diabetes treatment with only oral diabetes
medication (HR = 0.152, 95%CI = 0.032-0.73, p=0.0036), and oral
medication plus insulin (HR = 0.095, 95%CI = 0.019-0.462, p=0.019) were
independent prognostic factors. A nomogram based on these prognostic
factors was built for early prediction of 7-day, 14-day, and 21-day
survival of diabetes patients. High concordance index (C-index) was
achieved, and the calibration curves showed the model had good
prediction ability within three weeks of COVID-19 onset.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">By
incorporating specific prognostic factors, this study provided a
user-friendly graphical risk prediction tool for clinicians to quickly
identify high-risk T2D patients hospitalized for COVID-19. Copyright 
2022 Yuanyuan Fu et al.</td>
</tr>
<tr class="odd">
<td align="left">Early Impact of the COVID-19 Pandemic on Outpatient
Neurologic Care in Hawaii.</td>
<td align="left">In March 2020, Hawaii instituted public health
measures to prevent the spread of Coronavirus disease 2019 (COVID-19),
including stay-at-home orders, closure of non-essential businesses and
parks, use of facial coverings, social distancing, and a mandatory
14-day quarantine for travelers. In response to these measures, Hawaii
Pacific Neuroscience (HPN) modified practice processes to ensure
continuity of neurological treatment. A survey of patients was performed
to assess the impact of the COVID-19 pandemic and pandemic-related
practice processes for quality improvement. Overall, 367 patients seen
at HPN between April 22, 2020, and May 18, 2020, were surveyed via
telephone. Almost half (49.6%) participated in a telemedicine
appointment, with the majority finding it easy to use (87.4%) and as
valuable as face-to-face appointments (68.7%). Many (44.5%) patients
said they would have missed a health care appointment without the
availability of telemedicine, and 47.3% indicated they might prefer to
use telemedicine over in-person appointments in the future. Many
reported new or worsening mental health problems, including depression
(27.6%), anxiety (38.3%), or sleep disturbances (37.4%). A significant
number reported worsening of their condition, with 33.1% of patients who
experience migraines reporting increased symptom severity or frequency,
45.8% patients with Alzheimers disease reporting worsened symptoms,
38.5% of patients with Parkinsons disease who had a recent fall, and
50.0% of patients with multiple sclerosis experiencing new or worsened
symptoms. Insights from this survey applied to the practices
pandemic-related processes include emphasizing lifestyle modification,
screening for changes in mental health, optimizing treatment plans, and
continuing the option of telemedicine. Copyright 2022 by University
Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Real-time optical analysis of a colorimetric LAMP assay
for SARS-CoV-2 in saliva with a handheld instrument improves accuracy
compared with endpoint assessment.</td>
<td align="left">Controlling the course of the Coronavirus Disease 2019
(COVID-19) pandemic will require widespread deployment of consistent and
accurate diagnostic testing of the novel Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2). Ideally, tests should detect a
minimum viral load, be minimally invasive, and provide a rapid and
simple readout. Current Food and Drug Administration (FDA)-approved
RT-qPCR-based standard diagnostic approaches require invasive
nasopharyngeal swabs and involve laboratory-based analyses that can
delay results. Recently, a loop-mediated isothermal nucleic acid
amplification (LAMP) test that utilizes colorimetric readout received
FDA approval. This approach utilizes a pH indicator dye to detect drop
in pH from nucleotide hydrolysis during nucleic acid amplification. This
method has only been approved for use with RNA extracted from clinical
specimens collected via nasopharyngeal swabs. In this study, we
developed a quantitative LAMP-based strategy to detect SARS-CoV-2 RNA in
saliva. Our detection system distinguished positive from negative sample
types using a handheld instrument that monitors optical changes
throughout the LAMP reaction. We used this system in a streamlined LAMP
testing protocol that could be completed in less than 2 h to directly
detect inactivated SARS-CoV-2 in minimally processed saliva that
bypassed RNA extraction, with a limit of detection (LOD) of 50
genomes/reaction. The quantitative method correctly detected virus in
100% of contrived clinical samples spiked with inactivated SARS-CoV-2 at
either 1 (50 genomes/reaction) or 2 (100 genomes/reaction) of the LOD.
Importantly, the quantitative method was based on dynamic optical
changes during the reaction and was able to correctly classify samples
that were misclassified by endpoint observation of color.  2021
ABRF.</td>
</tr>
<tr class="odd">
<td align="left">Diabetes Self-Care Behaviors and Barriers to Clinical
Care During COVID-19 Pandemic for Marshallese Adults.</td>
<td align="left"><AbstractText Label="PURPOSE">The purpose of the study
was to explore experiences of Marshallese adults related to diabetes
self-care behaviors during the COVID-19 pandemic.
<AbstractText Label="METHODS">A qualitative descriptive design was
utilized to understand participants diabetes self-care behaviors during
the pandemic. Nine focus groups with 53 participants were held via
videoconference and conducted in English, Marshallese, or a mixture of
both languages. A priori codes based on diabetes self-care behaviors
provided a framework for analyzing and summarizing participant
experiences. <AbstractText Label="RESULTS">Both increases and decreases
in healthy eating and exercise were described, with improvements in
health behaviors attributed to health education messaging via social
media. Participants reported increased stress and difficulty monitoring
and managing glucose. Difficulty obtaining medication and difficulty
seeing their health care provider regularly was reported and attributed
to health care provider availability and lack of insurance due to job
loss. <AbstractText Label="CONCLUSIONS">The study provides significant
insight into the reach of health education campaigns via social media
and provides important information about the reasons for delays in care,
which extend beyond fear of contracting COVID-19 to structural
issues.</td>
</tr>
<tr class="even">
<td align="left">Hip Fracture Surgery Volumes Among Individuals 65 Years
and Older During the COVID-19 Pandemic.</td>
<td align="left">This study assesses hip fracture surgery volumes among
older individuals in California during the pandemic compared with
prepandemic rates.</td>
</tr>
<tr class="odd">
<td align="left">Inappropriate Telemetry Use Is Increased during the
COVID-19 Era.</td>
<td align="left">Due to the unprecedented COVID-19 pandemic, there may
be overuse of telemetry monitoring compared to the pre-pandemic period.
We compared the frequency of inappropriate telemetry use in the
pre-COVID-19 period (1 November 2019 to 28 February 2020) versus the
peri-COVID-19 period (1 March 2020 to 30 June 2020) at a major academic
hospital in Honolulu, Hawaii, by a retrospective chart review to assess
for the appropriateness of the telemetry orders during this period,
based on the 2017 American College of Cardiology/American Heart
Association guidelines. Compared to the pre-COVID-19 period, there was a
significant increase in inappropriate telemetry use during the
peri-COVID-19 period (X2 (1, N = 11,727) = 6.59, p = 0.0103). However,
there was no increase in the proportions of respiratory failure (4.0%)
or pneumonia (2.7%) during the peri-COVID-19 period. The increase in
inappropriate telemetry use may be related to the uncertainty in
clinical care and decision making amid the pandemic of the new virus.
Appropriate utilization of telemetry monitoring is increasingly
important during the pandemic due to the limited availability of
resources. Further investigation is needed to clarify the relationship
between the pandemic and trends in telemetry ordering.</td>
</tr>
<tr class="even">
<td align="left">Effect of Nudges on Downloads of COVID-19 Exposure
Notification Apps: A Randomized Clinical Trial.</td>
<td align="left">This randomized clinical trial examines the effect of
digital contact tracing using smartphone app nudges to increase
downloads of Pennsylvanias COVID Alert PA app.</td>
</tr>
<tr class="odd">
<td align="left">Undergraduate nursing students COVID-19 vaccine
intentions: A national survey.</td>
<td align="left"><AbstractText Label="INTRODUCTION">In December 2020,
the first two COVID-19 vaccines were approved in the United States
(U.S.) and recommended for distribution to front-line personnel,
including nurses. Nursing students are being prepared to fill critical
gaps in the health care workforce and have played important supportive
roles during the current pandemic. Research has focused on vaccine
intentions of current health care providers and less is known about
students intentions to vaccinate for COVID-19.
<AbstractText Label="METHODS">A national sample of undergraduate nursing
students were recruited across five nursing schools in five U.S. regions
in December 2020. The survey measured perceived risk/threat of COVID-19,
COVID-19 vaccine attitudes, perceived safety and efficacy of COVID-19
vaccines, sources for vaccine information and level of intention to
become vaccinated [primary, secondary (i.e., delayed), or no intention
to vaccinate]. <AbstractText Label="RESULTS">The final sample consisted
of 772 students. The majority (83.6%) had intentions to be vaccinated,
however of those 31.1% indicated secondary intention, a delay in
intention or increased hesitancy). The strongest predictors of primary
intention were positive attitudes (OR = 6.86; CI = 4.39-10.72), having
lower safety concerns (OR = 0.26; CI = 0.18-0.36), and consulting social
media as a source of information (OR = 1.56; CI = 1.23-1.97). Asian (OR
= 0.47; CI = 0.23-0.97) and Black (OR 0.26; CI = 0.08-0.80) students
were more likely to indicate secondary intention as compared to primary
intention. Students in the Midwest were most likely to indicate no
intention as compared to secondary intention (OR = 4.6; CI =
1.32-16.11). <AbstractText Label="CONCLUSIONS">As the first two COVID-19
vaccines were approved/recommended in the U.S. nursing students had
overall high intentions to vaccinate. Findings can guide development of
educational interventions that reduce concerns of vaccine safety that
are delivered in a way that is supportive and affirming to minoritized
populations while being respectful of geo-political differences.</td>
</tr>
<tr class="even">
<td align="left">COVID-19 Outcomes Among US Military Health System
Beneficiaries Include Complications Across Multiple Organ Systems and
Substantial Functional Impairment.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We
evaluated clinical outcomes, functional burden, and complications 1
month after coronavirus disease 2019 (COVID-19) infection in a
prospective US Military Health System (MHS) cohort of active duty,
retiree, and dependent populations using serial patient-reported outcome
surveys and electronic medical record (EMR) review.
<AbstractText Label="METHODS" NlmCategory="METHODS">MHS beneficiaries
presenting at 9 sites across the United States with a positive severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test, a
COVID-19-like illness, or a high-risk SARS-CoV-2 exposure were eligible
for enrollment. Medical history and clinical outcomes were collected
through structured interviews and International Classification of
Diseases-based EMR review. Risk factors associated with hospitalization
were determined by multivariate logistic regression.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1202
participants were enrolled. There were 1070 laboratory-confirmed
SARS-CoV-2 cases and 132 SARS-CoV-2-negative participants. In the first
month post-symptom onset among the SARS-CoV-2-positive cases, there were
212 hospitalizations, 80% requiring oxygen, 20 ICU admissions, and 10
deaths. Risk factors for COVID-19-associated hospitalization included
race (increased for Asian, Black, and Hispanic compared with
non-Hispanic White), age (age 45-64 and 65+ compared with &lt;45), and
obesity (BMI30 compared with BMI&lt;30). Over 2% of survey respondents
reported the need for supplemental oxygen, and 31% had not returned to
normal daily activities at 1 month post-symptom onset.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Older age,
reporting Asian, Black, or Hispanic race/ethnicity, and obesity are
associated with SARS-CoV-2 hospitalization. A proportion of acute
SARS-CoV-2 infections require long-term oxygen therapy; the impact of
SARS-CoV-2 infection on short-term functional status was substantial. A
significant number of MHS beneficiaries had not yet returned to normal
activities by 1 month.  The Author(s) 2021. Published by Oxford
University Press on behalf of Infectious Diseases Society of
America.</td>
</tr>
<tr class="odd">
<td align="left">Performance of the inFLUenza Patient-Reported Outcome
Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease
2019.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The
inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) is a
patient-reported outcome data collection instrument assessing symptoms
of viral respiratory tract infections across 8 body systems. This study
evaluated the measurement properties of FLU-PRO Plus in a study
enrolling individuals with coronavirus disease 2019 (COVID-19).
<AbstractText Label="METHODS" NlmCategory="METHODS">Data from a
prospective cohort study (EPICC) in US Military Health System
beneficiaries evaluated for COVID-19 was utilized. Adults with
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection with FLU-PRO Plus survey information within 1 week of symptom
onset were included. Reliability of FLU-PRO Plus was estimated using
intraclass correlation coefficient (ICC; 2 days reproducibility).
Known-groups validity was assessed using patient global assessment (PGA)
of disease severity. Patient report of return to usual health was used
to assess responsiveness (day 1-6/7).
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred
twenty-six SARS-CoV-2-positive participants were included in the
analysis. Reliability among those who reported no change in their
symptoms from one day to the next was high for most domains (ICC range,
0.68-0.94 for day 1 to day 2). Construct validity was demonstrated by
moderate to high correlation between the PGA rating of disease severity
and domain and total scores (eg, total scores correlation: 0.69
[influenza-like illness severity], 0.69 [interference in daily
activities], and -0.58 [physical health]). In addition, FLU-PRO Plus
demonstrated good known-groups validity, with increasing domain and
total scores observed with increasing severity ratings.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FLU-PRO Plus
performs well in measuring signs and symptoms in SARS-CoV-2 infection
with excellent construct validity, known-groups validity, and
responsiveness to change. Standardized data collection instruments
facilitate meta-analyses, vaccine effectiveness studies, and other
COVID-19 research activities. Published by Oxford University Press on
behalf of Infectious Diseases Society of America 2021.</td>
</tr>
<tr class="even">
<td align="left">Mental health at the COVID-19 frontline: An assessment
of distress, fear, and coping among staff and attendees at screening
clinics of rural/regional settings of Victoria, Australia.</td>
<td align="left"><AbstractText Label="PURPOSE">Research examining
psychological well-being associated with COVID-19 in rural/regional
Australia is limited. This study aimed to assess the extent of
psychological distress, fear of COVID-19, and coping strategies among
the attendees in COVID-19 screening clinics at 2 rural Victorian
settings. <AbstractText Label="METHODS">A cross-sectional study was
conducted during July 2020 to February 2021 inclusive. Participants were
invited to fill in an online questionnaire. Kessler Psychological
Distress Scale (K-10), Fear of COVID-19 Scale, and Brief Resilient
Coping Scale were used to assess psychological distress, fear of
COVID-19, and coping, respectively. <AbstractText Label="FINDINGS">Among
702 total participants, 69% were females and mean age (SD) was 49
(15.8) years. One in 5 participants (156, 22%) experienced high to very
high psychological distress, 1 in 10 (72, 10%) experienced high fear,
and more than half (397, 57%) had medium to high resilient coping.
Participants with mental health issues had higher distress (AOR 10.4,
95% CI: 6.25-17.2) and fear (2.56, 1.41-4.66). Higher distress was also
associated with having comorbidities, increased smoking (5.71,
1.04-31.4), and alcohol drinking (2.03, 1.21-3.40). Higher fear was
associated with negative financial impact, drinking alcohol (2.15,
1.06-4.37), and increased alcohol drinking. Medium to high resilient
coping was associated with being 60 years old (1.84, 1.04-3.24) and
completing Bachelor and above levels of education.
<AbstractText Label="CONCLUSION">People who had pre-existing mental
health issues, comorbidities, smoked, and consumed alcohol were
identified as high-risk groups for poorer psychological well-being in
rural/regional Victoria. Specific interventions to support the mental
well-being of these vulnerable populations, along with engaging health
care providers, should be considered.  2021 The Authors. The Journal of
Rural Health published by Wiley Periodicals LLC on behalf of National
Rural Health Association.</td>
</tr>
<tr class="odd">
<td align="left">Proof of concept for eliminating Aedes aegypti
production by means of integrated control including turtles, copepods,
tilapia, larvicides, and community participation in Monte Verde,
Honduras.</td>
<td align="left">Monte Verde, a periurban squatter community near San
Pedro Sula, virtually eliminated Aedes aegypti production in all known
larval habitats: wells; water storage containers including pilas (open
concrete water tanks used for laundry), 200-liter drums, 1000-liter
plastic cisterns, buckets; and objects collecting rainwater. The
project began in 2016 when Monte Verde was overrun with dengue, Zika,
and chikungunya. During more than a year of experimentation, Monte Verde
residents crafted an effective, sustainable, and environmentally
friendly toolkit that was inexpensive but required full community
participation. Biological control with copepods, turtles, and tilapia
was at the core of the toolkit, along with a mix of other methods such
as getting rid of unnecessary containers, scrubbing them to remove Ae.
aegypti eggs, and covering them to exclude mosquitoes or rainwater.
Environmentally friendly larvicides also had a limited but crucial role.
Key design features: (1) toolkit components known to be nearly 100%
effective at preventing Ae. aegypti production when fitted to
appropriate larval habitats; (2) using Ae. aegypti larval habitats as a
resource by transforming them into egg sinks to drive Ae. aegypti
population decline; (3) dedicated community volunteers who worked with
their neighbors, targeting 100% coverage of all known Ae. aegypti larval
habitats with an appropriate control method; (4) monthly monitoring in
which the volunteers visited every house to assess progress and improve
coverage as an ongoing learning experience for both volunteers and
residents. Taking pupae as an indicator of Ae. aegypti production, from
September 2018 to the end of the record in December 2021 (except for a
brief lapse during COVID lockdown in 2020), the monthly count of pupae
fluctuated between zero and 0.6% of the 22,984 pupae counted in the
baseline survey at the beginning of the project. Adult Ae. aegypti
declined to low numbers but did not disappear completely. There were no
recognizable cases of dengue, Zika, or chikungunya after June 2018,
though the study design based on a single site did not provide a basis
for rigorous confirmation that Monte Verdes Ae. aegypti control program
was responsible. Nonetheless, Monte Verdes success at eliminating Ae.
aegypti production can serve as a model for extending this approach to
other communities. Key ingredients for success were outside stimulation
and facilitation to foster shared community awareness and commitment
regarding the problem and its solution, enduring commitment of local
leadership, compatibility of the toolkit with the local community,
overcoming social obstacles, rapid results with success breeding
success, and building resilience. Copyright  2021. Published by
Elsevier B.V.</td>
</tr>
<tr class="even">
<td align="left">2020 Annual Report of the American Association of
Poison Control Centers National Poison Data System (NPDS): 38th Annual
Report.</td>
<td align="left"><AbstractText Label="INTRODUCTION">This is the 38th
Annual Report of the American Association of Poison Control Centers
(AAPCC) National Poison Data System (NPDS). As of 1 January, 2020, all
55 of the nations poison centers (PCs) uploaded case data automatically
to NPDS. The upload interval was 6.15 [4.60, 8.62] (median [25%, 75%])
minutes, effectuating a near real-time national exposure and information
database and surveillance system. <AbstractText Label="METHODS">We
analyzed the case data tabulating specific indices from NPDS. The
methodology was similar to that of previous years. Where changes were
introduced, the differences are identified. Cases with medical outcomes
of death were evaluated by a team of medical and clinical toxicologist
reviewers using an ordinal scale of 1-6 to assess the Relative
Contribution to Fatality (RCF) of the exposure.
<AbstractText Label="RESULTS">In 2020, 3,316,738 closed encounters were
logged by NPDS: 2,128,198 human exposures, 66,745 animal exposures,
1,116,568 information requests, and 5,160 human confirmed nonexposures.
Total encounters showed a 28.9% increase from 2019, while health care
facility (HCF) human exposure cases decreased by 10.6%. While all
information requests increased by 218.0%, medication identification
(Drug ID) requests decreased by 31.5%, and human exposure cases
decreased by 0.928%. Medical Information requests showed a 32.6-fold
increase, reflecting COVID-19 pandemic calls to PCs. Human exposures
with less serious outcomes have decreased 1.90% per year since 2008,
while those with more serious outcomes (moderate, major or death) have
increased 4.59% per year since 2000.Consistent with the previous year,
the top 5 substance classes most frequently involved in all human
exposures were analgesics (10.3%), household cleaning substances
(8.37%), cosmetics/personal care products (6.53%), antidepressants
(5.30%), and sedatives/hypnotics/antipsychotics (4.92%). As a class,
antidepressant exposures increased most rapidly, by 1,793 cases/year
(5.84%/year) over the past 10 years for cases with more serious
outcomes.The top 5 most common exposures in children age 5 years or less
were cosmetics/personal care products (11.8%), household cleaning
substances (11.3%), analgesics (7.57%), foreign
bodies/toys/miscellaneous (6.71%), and dietary
supplements/herbals/homeopathic (6.44%). Drug identification requests
comprised 2.89% of all information contacts. NPDS documented 4,488 human
exposures resulting in death; 3,869 (86.2%) of these were judged as
related (RCF of 1-Undoubtedly responsible, 2-Probably responsible, or
3-Contributory). <AbstractText Label="CONCLUSIONS">These data support
the continued value of PC expertise and need for specialized medical
toxicology information to manage more serious exposures. Unintentional
and intentional exposures continue to be a significant cause of
morbidity and mortality in the US. The near real-time status of NPDS
represents a national public health resource to collect and monitor US
exposure cases and information contacts. The continuing mission of NPDS
is to provide a nationwide infrastructure for surveillance for all types
of exposures (e.g., foreign body, infectious, venomous, chemical agent,
or commercial product), and the identification and tracking of
significant public health events. NPDS is a model system for the near
real-time surveillance of national and global public health.</td>
</tr>
<tr class="odd">
<td align="left">Predictive Value of an Age-Based Modification of the
National Early Warning System in Hospitalized Patients With
COVID-19.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early
recognition of high-risk patients with coronavirus disease 2019
(COVID-19) may improve outcomes. Although many predictive scoring
systems exist, their complexity may limit utility in COVID-19. We
assessed the prognostic performance of the National Early Warning Score
(NEWS) and an age-based modification (NEWS+age) among hospitalized
COVID-19 patients enrolled in a prospective, multicenter US Military
Health System (MHS) observational cohort study.
<AbstractText Label="METHODS" NlmCategory="METHODS">Hospitalized adults
with confirmed COVID-19 not requiring invasive mechanical ventilation at
admission and with a baseline NEWS were included. We analyzed each
scoring systems ability to predict key clinical outcomes, including
progression to invasive ventilation or death, stratified by baseline
severity (low [0-3], medium [4-6], and high [7]).
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 184 included
participants, those with low baseline NEWS had significantly shorter
hospitalizations (P &lt; .01) and lower maximum illness severity (P &lt;
.001). Most (80.2%) of low NEWS vs 15.8% of high NEWS participants
required no or at most low-flow oxygen supplementation. Low NEWS (3)
had a negative predictive value of 97.2% for progression to invasive
ventilation or death; a high NEWS (7) had high specificity (93.1%) but
low positive predictive value (42.1%) for such progression. NEWS+age
performed similarly to NEWS at predicting invasive ventilation or death
(NEWS+age: area under the receiver operating characteristics curve
[AUROC], 0.69; 95% CI, 0.65-0.73; NEWS: AUROC, 0.70; 95% CI, 0.66-0.75).
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">NEWS and
NEWS+age showed similar test characteristics in an MHS COVID-19 cohort.
Notably, low baseline scores had an excellent negative predictive value.
Given their easy applicability, these scoring systems may be useful in
resource-limited settings to identify COVID-19 patients who are unlikely
to progress to critical illness. Published by Oxford University Press on
behalf of Infectious Diseases Society of America 2021.</td>
</tr>
<tr class="even">
<td align="left">The Impact of COVID-19 on Pediatric Telepsychiatry
Training in Child and Adolescent Psychiatry Fellowships.</td>
<td align="left"><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This
report summarizes findings from a 2020 survey of US child and adolescent
psychiatry training programs that explored the impact of the COVID-19
pandemic on pediatric telepsychiatry training. The authors hypothesized
that telepsychiatry training significantly increased during the
pandemic, in part due to legal and regulatory waivers during the
COVID-19 public health emergency.
<AbstractText Label="METHODS" NlmCategory="METHODS">In August 2020, an
anonymous, 28-question online survey was emailed to all (138) accredited
child psychiatry fellowships on the Accreditation Council for Graduate
Medical Education website. Forty-nine programs responded (36%). This
analysis focuses on three of the 28 questions relevant to the
hypotheses: characteristics of the programs training in telepsychiatry;
perceived impediments to clinical training; and perceived impediments to
didactic training pre-COVID onset vs.post-COVID onset, respectively.
Total scores were created to investigate differences in training
programs and impediments to including telepsychiatry pre- and post-COVID
onset. Paired sample t-tests were used to compare means pre- and
post-COVID onset.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Results provided
support for significant differences between training components related
to telepsychiatry pre- and post-COVID onset, with participants reporting
more training components post-COVID onset (M = 5.69) than pre-COVID
onset (M = 1.80); t(48) = 9.33, p &lt; .001. Participants also reported
significantly fewer barriers to providing clinical experiences in
pediatric telepsychiatry post-COVID onset (M = 2.65) than pre-COVID
onset (M = 4.90); t(48) = - 4.20, p &lt; .001.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">During the
COVID-19 pandemic, pediatric telepsychiatry training in child psychiatry
fellowships increased significantly. Perceived barriers to providing
clinical, but not didactic, training decreased significantly.  2021.
Academic Psychiatry.</td>
</tr>
<tr class="odd">
<td align="left">COVID-19 Vaccine Willingness and Hesitancy Among
Marshallese Pacific Islanders.</td>
<td align="left">COVID-19 has disproportionally burdened racial and
ethnic minorities. Minority populations report greater COVID-19 vaccine
hesitancy; however, no studies document COVID-19 vaccine willingness
among Marshallese or any Pacific Islander group, who are often
underrepresented in research. This study documents United States (US)
Marshallese Pacific Islanders: willingness to get the COVID-19 vaccine,
willingness to participate in vaccine trials, and sociodemographic
factors associated with willingness. From July 27, 2020-November 22,
2020, a convenience sample of US Marshallese adults were recruited
through e-mail, phone calls, and a Marshallese community Facebook page
to participate in an online survey. Of those surveyed (n = 120), 32.5%
were extremely likely to get the COVID-19 vaccine; 20.8% were somewhat
likely; 14.2% were unlikely or very unlikely; and 26.7% stated they did
not know or were not sure. Only 16.7% stated they were willing to
participate in a COVID-19 vaccine trial. Vaccine willingness was
positively associated with older age, higher income, and longer US
residence. Health insurance status and having a primary care provider
were positively associated with vaccine willingness. Findings
demonstrate within-group variation in COVID-19 vaccine willingness. 
The Author(s) 2021.</td>
</tr>
<tr class="even">
<td align="left">Interprofessional Disaster Simulation During the
COVID-19 Pandemic: Adapting to Fully Online Learning.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This
paper describes the rapid conversion of a face-to-face interprofessional
(IP) disaster simulation to an online format in response to COVID-19
campus closures. <AbstractText Label="METHODS" NlmCategory="METHODS">The
online disaster simulation utilized internet-based tools allowing
real-time collaboration between IP students. Team exercises involved
disaster triage, disease outbreak investigation, and disaster response.
Surveys measuring self-assessment of various IP skills and simulation
learning outcomes (SLOs) were compared with responses from previous
face-to-face simulations.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Results indicated
mean scores for IP skills were higher for online students when compared
with in-person simulations, and all SLOs were met.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The online
disaster simulation provided an effective, innovative IP educational
opportunity.  2021 International Nursing Association for Clinical
Simulation and Learning. Published by Elsevier Inc.All rights
reserved.</td>
</tr>
<tr class="odd">
<td align="left">Impact of Coronavirus-2019 On Pediatric and Adult Heart
Transplantation Waitlist Activity and Mortality in The United States: A
Descriptive Approach.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Transplant
centers saw a substantial reduction in deceased donor solid organ
transplantation since the beginning of the coronavirus 2019 (COVID-19)
pandemic in the United States. There is limited data on the impact of
COVID-19 on adult and pediatric heart transplant volume and variation in
transplant practices. We hypothesized that heart transplant activity
decreased during COVID-19 with associated increased waitlist mortality.
<AbstractText Label="METHODS" NlmCategory="METHODS">The United Network
for Organ Sharing (UNOS) database was used to identify patients at the
time of listing for heart transplant from 2017-2020. Patients were
categorized as pediatric (&lt;18 years) or adult (18 years) and as
pre-COVID (2017-2019) or post-COVID (2020). Regional and statewide data
were taken from United States Census Bureau. CovidActNow project was
used to obtain COVID-19 mortality rates.
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Among pediatric
patients, average time on the waiting list decreased by 28 days. Even
though the average number of pediatric transplants (n=39 per month) did
not change significantly during 2020, there was a temporal decline in
the first quarter of 2020 followed by a sharp increase. Overall absolute
pediatric waitlist mortality decreased from 531 to 473, however female
mortality increased by 2%. Regional differences in pediatric mortality
were observed: Northeast, decreased by 75%; Midwest, decreased by 9%;
West, increased by 35%; and South, increased by 13%. North Dakota
(055), Oklahoma (021) and Hawaii (033) showed higher mortality than
other states per 100,000. In adults, average time on waiting list
increased by 40 days and there was an increase in the number of
transplants from 242 to 266. Adult waitlist mortality had a larger
decrease, 1844 to 1570, with an increase in female mortality of 7%.
Regional differences in adult mortality were also observed: Northeast,
decreased by 3%; Midwest, increased by 55%; West, increased by 45% and
South, decreased by 5%. Iowa (037), Wyoming (022), Arkansas (018) and
Vermont (019) had the highest mortality per 100,000 compared to the
other states.
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Pediatric
heart transplant volume declined in early 2020 followed by a later
increase, while adult transplant volume increased all year round.
Although, overall pediatric waitlist mortality decreased, female
waitlist mortality increased for both adults and pediatrics. Regional
differences in waitlist mortality were observed for both pediatrics and
adults. Future studies are needed to understand this initial correlation
and to determine the impact of COVID-19 on heart transplant recipients.
<AbstractText Label="FUNDING" NlmCategory="BACKGROUND">This research
received no specific grant from any funding agency in the public,
commercial or not-for-profit sectors.  2021 The Author(s).</td>
</tr>
<tr class="even">
<td align="left">Recombinant protein subunit SARS-CoV-2 vaccines
formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral
and cellular immune responses in mice.</td>
<td align="left">The speed at which several COVID-19 vaccines went from
conception to receiving FDA and EMA approval for emergency use is an
achievement unrivaled in the history of vaccine development. Mass
vaccination efforts using the highly effective vaccines are currently
underway to generate sufficient herd immunity and reduce transmission of
the SARS-CoV-2 virus. Despite the most advanced vaccine technology,
global recipient coverage, especially in resource-poor areas remains a
challenge as genetic drift in nave population pockets threatens overall
vaccine efficacy. In this study, we described the production of
insect-cell expressed SARS-CoV-2 spike protein ectodomain constructs and
examined their immunogenicity in mice. We demonstrated that, when
formulated with CoVaccine HTTM adjuvant, an oil-in-water nanoemulsion
compatible with lyophilization, our vaccine candidates elicit a
broad-spectrum IgG response, high neutralizing antibody (NtAb) titers
against SARS-CoV-2 prototype and variants of concern, specifically
B.1.351 (Beta) and P.1. (Gamma), and an antigen-specific IFN- secreting
response in outbred mice. Of note, different ectodomain constructs
yielded variations in NtAb titers against the prototype strain and some
VOC. Dose response experiments indicated that NtAb titers increased with
antigen dose, but not adjuvant dose, and may be higher with a lower
adjuvant dose. Our findings lay the immunological foundation for the
development of a dry-thermostabilized vaccine that is deployable without
refrigeration.  2021 Published by Elsevier Ltd.</td>
</tr>
<tr class="odd">
<td align="left">The Healthy Hawaii Strategic Plan 2030: A Roadmap for
Preventing and Managing Chronic Disease and Envisioning a Healthy and
Equitable Future.</td>
<td align="left">In June 2021, over 200 stakeholders, advocates, and
visionaries gathered to launch the Healthy Hawaii Strategic Plan 2030
(HHSP), a 10-year strategic plan for improving the health of Hawaii
residents by preventing and reducing chronic disease and advancing
health equity. The HHSP is a guide to enable coordination across common
risk factors, program areas, interventions, and strategies for chronic
disease prevention and control. Developed during the COVID-19 pandemic,
which revealed major areas of susceptibility in our health system
infrastructure and magnified existing disparities, the HHSP prioritizes
health equity and strives to create sustainable change to transform
communities, schools, health care and worksites to support the health of
the people of Hawaii. The HHSP is a living document and partners -
present and future - are invited to work together to achieve a healthier
future for the people of Hawaii. Copyright 2021 by University Health
Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Patients Compliance With Quarantine Requirements for
Exposure or Potential Symptoms of COVID-19.</td>
<td align="left">Reducing Coronavirus disease 2019 (COVID-19)
transmission relies on people quarantining after exposure to COVID-19 or
if they experience COVID-19 symptoms, and isolating from others if
COVID-19 positive. Quarantine and isolation last 10 to 14 days and can
be state-mandated; however, the level of compliance is unknown. The
University of Hawaii Department of Family Medicine clinic called
patients instructed by our physicians to quarantine for exposure risk or
symptoms of potential COVID-19 infection between March 15, 2020, and
April 15, 2020. None of the patients tested positive for COVID-19.
Sixty-nine of 90 (77%) patients completed follow-up calls and
self-reported whether they had stayed home. Of these 69 patients, 32
(46%) broke quarantine to buy groceries (36%), work (9%), visit others
(6%), or for other reasons (12%). For patients living alone, 8 of 11
(73%) left home to buy groceries. For employed patients, 6 of 39 (15%)
returned to work during their quarantine period. Nearly half of our
patients did not quarantine for the entire period. Many persons left
home to buy food or to work. Strong public health messaging is needed to
educate communities about the requirement to quarantine. Clinicians can
help by asking patients about social and financial ability to
quarantine, schedule follow-up appointments to remind patients to stay
home, and link patients to food programs, financial assistance, and
other community resources to successfully quarantine and prevent
COVID-19 transmission. Copyright 2021 by University Health Partners of
Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">Demographic and technological factors influencing
virtual seizure clinic visit satisfaction before and during the Covid-19
pandemic in rural Hawaii.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Telemedicine
clinic visits traditionally originated from spoke clinic sites, but
recent trends have favored home-based telemedicine, particularly in the
time of Covid-19. Our study focused on identification of barriers and
factors influencing perceptions of care with use of home-based
telemedicine in patients with seizures living in rural Hawaii. We
additionally compared characteristics of patients using telemedicine
versus in-person clinic visits prior to the Covid-19 pandemic.
<AbstractText Label="METHODS" NlmCategory="METHODS">For the
retrospective portion of our study, we queried charts of adult
outpatients treated by the two full-time epileptologists at a Level 4
epilepsy center accredited by the National Association of Epilepsy
Centers between November 2018 and December 2019. We included patients
who live on the neighbor islands of Hawaii but not on Oahu, i.e.,
patients who would require air travel to see an epileptologist. There
had been no set protocol at the epilepsy center for telemedicine
referral; our practice had been to offer telemedicine visits to all
neighbor island patients when felt to be appropriate. We collected
demographic and clinic visit data. For the prospective portion we
surveyed neighbor island patients or their caregivers, seen via
home-based telemedicine between March 2020 and December 2020. We
obtained verbal consent for study participation. Survey questions
addressed satisfaction with clinical care, visit preferences, and
potential barriers to care.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In a 14-month period
prior to the Covid-19 pandemic, 75 (61%) neighbor island patients were
seen exclusively in-person in seizure clinic while 47 (39%) had at least
one telemedicine visit. 39% of patients seen only in-person were female
whereas 38% of patients seen by telemedicine were female. Patients seen
in-person had an older median age (47.2 years) compared to those seen at
least once by telemedicine (42.4 years). The no-show rate was 13% for
in-person visits versus 4% for telemedicine visits. Among patients seen
in person, 17% were Asian, 32% Native Hawaiian, and 47% White, whereas
patients seen by telemedicine were 15% Asian, 23% Native Hawaiian, and
57% White. Patients who were seen in person lived in zip codes with
median household income of $68,516 and patients who were seen by
telemedicine lived in zip codes with median household income of $67,089.
Patients who were seen in person lived in zip codes in which 78% of the
population had access to broadband internet, whereas patients who were
seen by telemedicine lived in zip codes in which 79% of the population
had access to broadband internet. During the Covid-19 pandemic, we
surveyed 47 consecutive patients seen by telemedicine, 45% female with
median age of 33 years. Telemedicine connection was set up by the
patient in 74% of cases, or by the patients mother (15%), other family
member (9%), or other caregiver (2 %). Median patient satisfaction score
was 5 (highly satisfied) on a 5-point Likert scale with mean score of
4.6. Telemedicine visit was done using a smartphone by 62% of patients,
a computer by 36% of patients, and a tablet by 2% of patients. A home
WiFi connection was used in 83% of patients.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Home-based
telemedicine visits provide a high-satisfaction method for seizure care
delivery despite some obstacles. Demographic disparities may be an
obstacle to telemedicine care and seem to relate to race and possibly
age, rather than to sex/gender, household income, or access to broadband
internet. Additionally, despite high satisfaction overall, more patients
felt the physical exam was superior at in-person clinic visits and more
patients expressed a preference for in-person visits. During the
Covid-19 pandemic when there may be barriers to in-person clinic visits,
home-based telemedicine is a feasible alternative. Copyright  2021
Elsevier Inc.All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">An Examination of Coping Strategies and Intent to Leave
Child Welfare During the COVID 19 Pandemic.</td>
<td align="left">Child welfare work is inherently difficult, and child
welfare agencies are known to experience high rates of turnover. We
sought to expand the existing literature on intention to leave ones
child welfare agency and commitment to child welfare work through
examining the coping mechanisms of frontline workers. Having and
utilizing healthy coping mechanisms has proved beneficial to child
welfare workers in previous research. In this paper, we examine specific
coping mechanisms identified in the Comprehensive Organizational Health
Assessment and how they were associated with child welfare workers
intent to leave their agency and their commitment to remain in the field
of child welfare during the SARS CoV-2 (COVID-19) pandemic. We surveyed
over 250 child welfare caseworkers using the COHA instrument. Using both
bivariate analysis and linear regression, we identify specific coping
mechanisms, such as staying present with friends and family, as highly
influential and discuss ways to strengthen these areas.  The Author(s),
under exclusive licence to Springer Science+Business Media, LLC, part of
Springer Nature 2021.</td>
</tr>
<tr class="odd">
<td align="left">Sustaining effective COVID-19 control in Malaysia
through large-scale vaccination.</td>
<td align="left"><AbstractText Label="INTRODUCTION">As of 3rd June 2021,
Malaysia is experiencing a resurgence of COVID-19 cases. In response,
the federal government has implemented various non-pharmaceutical
interventions (NPIs) under a series of Movement Control Orders and, more
recently, a vaccination campaign to regain epidemic control. In this
study, we assessed the potential for the vaccination campaign to control
the epidemic in Malaysia and four high-burden regions of interest, under
various public health response scenarios.
<AbstractText Label="METHODS">A modified
susceptible-exposed-infectious-recovered compartmental model was
developed that included two sequential incubation and infectious
periods, with stratification by clinical state. The model was further
stratified by age and incorporated population mobility to capture NPIs
and micro-distancing (behaviour changes not captured through population
mobility). Emerging variants of concern (VoC) were included as an
additional strain competing with the existing wild-type strain. Several
scenarios that included different vaccination strategies (i.e.vaccines
that reduce disease severity and/or prevent infection, vaccination
coverage) and mobility restrictions were implemented.
<AbstractText Label="RESULTS">The national model and the regional models
all fit well to notification data but underestimated ICU occupancy and
deaths in recent weeks, which may be attributable to increased severity
of VoC or saturation of case detection. However, the true case detection
proportion showed wide credible intervals, highlighting incomplete
understanding of the true epidemic size. The scenario projections
suggested that under current vaccination rates complete relaxation of
all NPIs would trigger a major epidemic. The results emphasise the
importance of micro-distancing, maintaining mobility restrictions during
vaccination roll-out and accelerating the pace of vaccination for future
control. Malaysia is particularly susceptible to a major COVID-19
resurgence resulting from its limited population immunity due to the
countrys historical success in maintaining control throughout much of
2020. Copyright  2021 The Authors. Published by Elsevier B.V. All
rights reserved.</td>
</tr>
<tr class="even">
<td align="left">Experiences of Marshallese Food Processing Workers
during the COVID-19 Pandemic.</td>
<td align="left">The goal of this study was to conduct an exploratory
assessment of COVID-19 mitigation steps and compare workplace
experiences during the COVID-19 pandemic with Marshallese workers in
other occupations. Marshallese adults residing in the continental United
States (US) and Hawaii took part in an online survey. The sample was
divided into two categories: food processing workers and workers in all
other occupations. To examine differences between food processing
workers and workers from all other occupations, we used
Wilcoxon-Mann-Whitney U tests and Fishers Exact tests. Of those
employed at the time of the survey (n = 113), 31 were employed in food
processing plants, and 82 were employed in another occupation. Food
processing workers and workers in other occupations differed
significantly on level of education, length of residence in the US,
English-speaking ability, and health literacy. More food processing
workers reported that their employers installed barriers or provided
shields (45%), provided temperature screenings (71%), and tested for
COVID-19 (61%) compared with those in other occupations. A larger
proportion of food processing workers reported having no sick leave
compared with workers in other occupations, although they reported
COVID-19 testing and being insured at similar rates. This is the first
study to examine Marshallese food processing workers experiences during
the COVID-19 pandemic. Our findings show that while some food processing
employers implemented government-recommended guidelines to prevent the
spread of COVID-19, preventative and protective measures were not
comprehensively applied across the food processing industry, despite
efforts by public health agencies and community partners.</td>
</tr>
<tr class="odd">
<td align="left">Polymorphic landscape of SARS-CoV-2 genomes isolated
from Indian population in 2020 demonstrates rapid evolution in ORF3a,
ORF8, nucleocapsid phosphoprotein and spike glycoprotein.</td>
<td align="left">India, with around 15 million COVID-19 cases, recently
became the second worst-hit nation by the SARS-CoV-2 pandemic. In this
study, we analyzed the mutation and selection landscape of 516 unique
and complete genomes of SARS-CoV-2 isolates from India in a 12-month
span (from Jan to Dec 2020) to understand how the virus is evolving in
this geographical region. We identified 953 genome-wide loci displaying
single nucleotide polymorphism (SNP) and the Principal Component
Analysis and mutation plots of the datasets indicate an increase in
genetic variance with time. The 42% of the polymorphic sites display
substitutions in the third nucleotide position of codons indicating that
non-synonymous substitutions are more prevalent. These isolates
displayed strong evidence of purifying selection in ORF1ab, spike,
nucleocapsid, and membrane glycoprotein. We also find some evidence of
localized positive selections ORF1ab, spike glycoprotein, and
nucleocapsid. The CDSs for ORF3a, ORF8, nucleocapsid phosphoprotein, and
spike glycoprotein were found to evolve at rapid rate. This study will
be helpful in understanding the dynamics of rapidly evolving SARS-CoV-2.
Copyright  2021 Elsevier Ltd.All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">Design, Implementation, and Validation of an Automated,
Algorithmic COVID-19 Triage Tool.</td>
<td align="left"><AbstractText Label="OBJECTIVE">We describe the design,
implementation, and validation of an online, publicly available tool to
algorithmically triage patients experiencing severe acute respiratory
syndrome coronavirus (SARS-CoV-2)-like symptoms.
<AbstractText Label="METHODS">We conducted a chart review of patients
who completed the triage tool and subsequently contacted our
institutions phone triage hotline to assess tool- and
clinician-assigned triage codes, patient demographics, SARS-CoV-2
(COVID-19) test data, and health care utilization in the 30 days
post-encounter. We calculated the percentage of concordance between
tool- and clinician-assigned triage categories, down-triage (clinician
assigning a less severe category than the triage tool), and up-triage
(clinician assigning a more severe category than the triage tool)
instances. <AbstractText Label="RESULTS">From May 4, 2020 through
January 31, 2021, the triage tool was completed 30,321 times by 20,930
unique patients. Of those 30,321 triage tool completions, 51.7% were
assessed by the triage tool to be asymptomatic, 15.6% low severity,
21.7% moderate severity, and 11.0% high severity. The concordance rate,
where the triage tool and clinician assigned the same clinical severity,
was 29.2%. The down-triage rate was 70.1%. Only six patients were
up-triaged by the clinician. 72.1% received a COVID-19 test administered
by our health care system within 14 days of their encounter, with a
positivity rate of 14.7%. <AbstractText Label="CONCLUSION">The design,
pilot, and validation analysis in this study show that this COVID-19
triage tool can safely triage patients when compared with clinician
triage personnel. This work may signal opportunities for automated
triage of patients for conditions beyond COVID-19 to improve patient
experience by enabling self-service, on-demand, 24/7 triage access.
Thieme. All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Timeliness of provisional United States mortality data
releases during the COVID-19 pandemic: delays associated with electronic
death registration system and weekly mortality.</td>
<td align="left">All-cause mortality counts allow public health
authorities to identify populations experiencing excess deaths from
pandemics, natural disasters, and other emergencies. Delays in the
completeness of mortality counts may contribute to misinformation
because death counts take weeks to become accurate. We estimate the
timeliness of all-cause mortality releases during the COVID-19 pandemic
for the dates 3 April to 5 September 2020 by estimating the number of
weekly data releases of the NCHS Fluview Mortality Surveillance System
until mortality comes within 99% of the counts in the 19 March 19 2021
provisional mortality data release. States mortality counts take 5
weeks at median (interquartile range 4-7 weeks) to completion. The
fastest states were Maine, New Hampshire, Vermont, New York, Utah,
Idaho, and Hawaii. States that had not adopted the electronic death
registration system (EDRS) were 4.8 weeks slower to achieve complete
mortality counts, and each weekly death per 10^8 was associated with a
0.8 week delay. Emergency planning should improve the timeliness of
mortality data by improving state vital statistics digital
infrastructure.  2021. The Author(s), under exclusive licence to
Springer Nature Limited.</td>
</tr>
<tr class="even">
<td align="left">Sugar-Sweetened Beverage Fee: A Model to Address Health
Disparities in Hawaii.</td>
<td align="left">Sugar-sweetened beverage (SSB) consumption is
associated with increased risk of obesity, diabetes, and other chronic
diseases. SSB consumption is also a health equity issue, as rates of
consumption and related chronic diseases vary by race, ethnicity, and
income in Hawaii. The COVID-19 pandemic has highlighted the need for
greater investment in public health and the well-being of communities
experiencing health disparities because individuals with chronic
diseases are more likely to develop complications from the virus. It has
also created economic hardships for the people of Hawaii, especially
the states most vulnerable populations. Amid this health and economic
crisis, an opportunity exists to implement an SSB fee in Hawaii. An SSB
fee would impose a fee on SSB distributors that would be passed on to
consumers in the form of price increases that influence purchasing
behavior. Jurisdictions with SSB taxes or fees have seen reductions in
SSB purchases and consumption and have generated millions of dollars in
revenues to support health initiatives and reduce socioeconomic
disparities. Models predict that a $0.02 SSB fee in Hawaii could
generate $60.5 million and significantly reduce healthcare costs and
chronic diseases. This commentary will present an SSB fee policy as a
viable model for Hawaii to reduce SSB consumption, lower chronic
disease risks, and generate needed revenues to support health, reduce
inequities, and rebuild the states economy. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">Health Literate Hawaii: A Blueprint to Empower Health
and Wellbeing.</td>
<td align="left">Recent studies have identified high rates of chronic
disease in Hawaiis adults and youth. As the state responds to the
COVID-19 pandemic and looks beyond it, the prevention and management of
chronic diseases are critical for community health and wellbeing. Low
health literacy is more common in rural populations, Filipinos, and
Pacific Islanders in HawaiI, older adults, and many other groups with
high rates of chronic disease. Promoting health literacy can reduce
chronic disease burdens for individuals, families, and communities.
Using the framework of the social-ecological model, which is important
for visioning effective chronic disease management and prevention, this
article provides a blueprint of layers of influence for building a
health literate HawaiI generally and around chronic disease
specifically. The article will close with a call to action informed by
the National Action Plan to Improve Health Literacy for stakeholders and
providers to address health literacy in the state of HawaiI in
organizations, systems, and policy. These actions should address root
causes of disease and help build more equitable health outcomes across
the state now and in the future. Copyright 2021 by University Health
Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">He Aalii K Makani Mai Au: Developing a Cultural
Framework for Advancing COVID-19 Related, Community-informed Health
Policies.</td>
<td align="left">The Native Hawaiian and Pacific Islander community
found itself on the front pages of national news when the COVID-19
pandemic struck the United States. By April 2020, the small, frequently
overlooked community experienced the highest COVID-19 case rates in 5
states including Hawaii. In response, Native Hawaiian and Pacific
Islander networks across the US were mobilized to address the crisis. In
Hawaii, the Native Hawaiian Pacific Islander COVID-19 Response,
Recovery, and Resilience Team was created. Framed by Indigenous Pacific
based cultural values, protocols, and practices, the team consists of
multiple committees that examine policy; testing, contract tracing, and
isolation; communications; social supports and resources; and data and
research. Inherent in this work are the shared core values of pono
(righteousness, goodness), aloha (love, compassion), laulima
(cooperation), and imua (moving forward with strength) as well as an
ohana/aiga (family)-based, kuleana (responsibility)-centric approach
that acknowledges, honors, and values ike kpuna (ancestral knowledge).
With the burden of not only COVID-19 disparities, but also chronic
diseases and socioeconomic disparities that place Native Hawaiian and
Pacific Islander communities at increased risk for adverse impacts from
COVID-19, an effective response is critical. This article, authored by
members of the Teams Policy Committee, discusses the development of a
cultural framework that guides its advocacy efforts. The Policy
Committees work presents a cultural framework that grounds and guides
their efforts for effectively promoting a strong voice in governmental
and agency policies which would ultimately contribute to a healthy and
thriving Native Hawaiian and Pacific Islander community. Copyright 2021
by University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">The Critical Role Hawaiis Community Health Workers
Are Playing in COVID-19 Response Efforts.</td>
<td align="left">Community health workers play an instrumental role in
the health care system and are critical partners in pandemic response.
In Hawaii, community health workers are working to reduce the burden of
chronic disease among Pacific Islander, Filipino, and Native Hawaiian
populations in partnership with government agencies and health care
organizations. This commentary reviews the role community health workers
in Hawaii are playing in assisting with the COVID-19 response.
Utilizing their skills and the communitys trust, they are optimally
positioned to reach marginalized and vulnerable populations hit hardest
by COVID-19; community health workers educate, screen, and provide
social service referrals to community members. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Addressing Native Hawaiian and Pacific Islander Data
Deficiencies Through a Community-based Collaborative Response to the
COVID-19 Pandemic.</td>
<td align="left">Early evidence of disproportionate COVID-19 infection
and death rates in Native Hawaiian and Pacific Islander communities in
the continental US raised concerns for similar disparities in Hawaii,
where these communities make up 25% of the states population.
Representatives from more than 40 different government, academic,
institutional and community-based organizations partnered to form the
Hawaii Native Hawaiian and Pacific Islander COVID-19 Response,
Recovery, and Resilience Team. The team consists of 5 committees
including the Data &amp; Research Committee. This committee is tasked
with examining issues regarding the acquisition, quality, public
reporting, and utilization of race/ethnicity-related health data used to
inform priorities and guide resource allocation. Problems addressed by
this committee include: inconsistency across agencies in the use of race
identifiers, defaulting to the Office of Management and Budget standards
which aggregated Native Hawaiian and Pacific Islanders, and methods of
data collection and reporting by the Department of Health. Outcomes
include: 2 forms with race categories that reflect the population of
Hawaii; the reporting of disaggregated data by the Department of
Health; and conversations with testing sites, laboratories, and health
institutions urging a standardized form for race/ethnicity data
collection. The collection and reporting of disaggregated race/ethnicity
data is critical to guiding organizations in addressing underlying
inequities in chronic disease and social determinants of health that can
exacerbate the adverse effects of COVID-19. The Data and Research
Committees network offers a community-based model for collaborative
work that honors culture and ensures Native Hawaiian, Pacific Islander,
and other minority populations are recognized and counted. Copyright
2021 by University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">Micronesians Building Healthier Communities During the
COVID-19 Pandemic.</td>
<td align="left">Micronesian communities in Hawaii have a long history
of mobilizing to address challenges they encounter as the most recent
and fastest growing Pacific Islander immigrant population in the state.
In particular, community leaders navigate a slew of obstacles specific
to systemic racism and health care access. These hurdles have become
exacerbated by the COVID-19 pandemic, prompting a range of
Micronesian-led responses to the health crisis including strategic
adaptations to existing networks and roles to address essential public
health functions. These community responses have filled many critical
gaps left by the states delayed response to addressing the disparate
impact of COVID-19 on Micronesian communities. This article highlights
and encourages engagement with diverse models of collaboration and
elevation of Micronesian leadership that has resulted in more productive
cooperation with government leaders, agencies, and policymakers. This
work offers insight into pathways forward toward healthier Micronesian
families and communities. Copyright 2021 by University Health Partners
of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Exploring Challenges and Opportunities for
Breastfeeding in Hawaii During the COVID-19 Pandemic.</td>
<td align="left">Increasing exclusive breastfeeding rates is an
established public health strategy to reduce chronic disease and protect
infants from illness. The role of breastfeeding in addressing health
disparities takes on new significance as the COVID-19 pandemic has
disproportionately impacted some communities in Hawaii, and those with
chronic conditions face increased risk of hospitalization and death.
However, there are myriad policy, systemic, and environmental barriers
that make it difficult for parents to breastfeed, some of which have
been exacerbated by the COVID-19 pandemic. This editorial discusses the
importance of breastfeeding in reducing chronic disease, reviews the
status of breastfeeding in Hawaii, explores the challenges parents face
in breastfeeding their infants, especially in the time of COVID-19, and
presents opportunities for improved access to lactation care to reduce
health disparities. Copyright 2021 by University Health Partners of
Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">Much Needed Medicine: A Qualitative Study of Hawaii
Resident Views During COVID-19.</td>
<td align="left">The precarious financial status of the majority of
Hawaii residents coupled with the states heavy reliance on tourism
suggests that residents are particularly vulnerable to increased
economic hardship resulting from the COVID-19 pandemic, which
temporarily shut down the tourism industry and continues to erect
barriers for resuming operations. Understanding how Hawaii residents
prioritize access to health care, food economics, care of ina, and
culturally informed community in light of the current and future
economic situation can inform policy actions that will support public
health. To that end, this paper analyzes: (1) Hawaii residents views
on health, specifically food security and healthcare, and their
priorities for the future of these areas; (2) the differences between
Native Hawaiian and non-Native Hawaiian views and priorities; and (3)
the differences in views and priorities between families with higher and
lower levels of economic stability. The authors close with policy
recommendations that can be seen as medicine, or ways to heal Hawaii,
as the state shifts towards a more equitable and sustainable future.
Copyright 2021 by University Health Partners of Hawaii (UHP
Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Prevalence of Psychological Distress in Hawaii during
the COVID-19 Pandemic: Exploring Disparities Using 11 Waves of Data from
the Household Pulse Survey.</td>
<td align="left">Utilizing 11 waves of data from the Household Pulse
Survey collected between April and November 2020, this study examines
disparities in psychological distress (defined as having symptoms of
anxiety/depression) among adult residents of Hawaii during the COVID-19
pandemic. Results showed that 36.4% of the respondents reported symptoms
of distress. Younger age, female, and lower household income were
associated with higher levels of psychological distress than older age,
male, and higher household income. The prevalence ratios of distress for
those aged 18-24, 25-34, 35-44 and females were 43.1%, 47.3%, 44.1%, and
39.3% respectively. Asians experienced lower prevalence compared to
other racial/ethnic groups. Two practical implications are offered.
First, the economic sequelae of COVID-19 impact psychological distress
even when the community infection rate is stable. Second, disparities in
psychosocial distress demonstrate that social and economic resources are
needed by social groups such as young adults, females, and racial/ethnic
minorities that have experienced the highest impact. Strategies need to
be developed to mitigate the unavoidable local consequences of a
pandemic. Copyright 2021 by University Health Partners of Hawaii (UHP
Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">Advancing Health Equity in Hawaii: Critical
Reflections on COVID-19, Chronic Conditions, and Health
Disparities.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">The relevance of magnesium homeostasis in
COVID-19.</td>
<td align="left"><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">In
less than one and a half year, the COVID-19 pandemic has nearly brought
to a collapse our health care and economic systems. The scientific
research community has concentrated all possible efforts to understand
the pathogenesis of this complex disease, and several groups have
recently emphasized recommendations for nutritional support in COVID-19
patients. In this scoping review, we aim at encouraging a deeper
appreciation of magnesium in clinical nutrition, in view of the vital
role of magnesium and the numerous links between the pathophysiology of
SARS-CoV-2 infection and magnesium-dependent functions.
<AbstractText Label="METHODS" NlmCategory="METHODS">By searching PubMed
and Google Scholar from 1990 to date, we review existing evidence from
experimental and clinical studies on the role of magnesium in chronic
non-communicable diseases and infectious diseases, and we focus on
recent reports of alterations of magnesium homeostasis in COVID-19
patients and their association with disease outcomes. Importantly, we
conduct a census on ongoing clinical trials specifically dedicated to
disclosing the role of magnesium in COVID-19.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Despite many
methodological limitations, existing data seem to corroborate an
association between deranged magnesium homeostasis and COVID-19, and
call for further and better studies to explore the prophylactic or
therapeutic potential of magnesium supplementation.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We propose to
reconsider the relevance of magnesium, frequently overlooked in clinical
practice. Therefore, magnesemia should be monitored and, in case of
imbalanced magnesium homeostasis, an appropriate nutritional regimen or
supplementation might contribute to protect against SARS-CoV-2
infection, reduce severity of COVID-19 symptoms and facilitate the
recovery after the acute phase.  2021. The Author(s).</td>
</tr>
<tr class="odd">
<td align="left">Modeling the epidemiological impact of the UNAIDS 2025
targets to end AIDS as a public health threat by 2030.</td>
<td align="left"><AbstractText Label="BACKGROUND">UNAIDS has established
new program targets for 2025 to achieve the goal of eliminating AIDS as
a public health threat by 2030. This study reports on efforts to use
mathematical models to estimate the impact of achieving those targets.
<AbstractText Label="METHODS AND FINDINGS">We simulated the impact of
achieving the targets at country level using the Goals model, a
mathematical simulation model of HIV epidemic dynamics that includes the
impact of prevention and treatment interventions. For 77 high-burden
countries, we fit the model to surveillance and survey data for 1970 to
2020 and then projected the impact of achieving the targets for the
period 2019 to 2030. Results from these 77 countries were extrapolated
to produce estimates for 96 others. Goals model results were checked by
comparing against projections done with the Optima HIV model and the
AIDS Epidemic Model (AEM) for selected countries. We included estimates
of the impact of societal enablers (access to justice and law reform,
stigma and discrimination elimination, and gender equality) and the
impact of Coronavirus Disease 2019 (COVID-19). Results show that
achieving the 2025 targets would reduce new annual infections by 83%
(71% to 86% across regions) and AIDS-related deaths by 78% (67% to 81%
across regions) by 2025 compared to 2010. Lack of progress on societal
enablers could endanger these achievements and result in as many as 2.6
million (44%) cumulative additional new HIV infections and 440,000 (54%)
more AIDS-related deaths between 2020 and 2030 compared to full
achievement of all targets. COVID-19-related disruptions could increase
new HIV infections and AIDS-related deaths by 10% in the next 2 years,
but targets could still be achieved by 2025. Study limitations include
the reliance on self-reports for most data on behaviors, the use of
intervention effect sizes from published studies that may overstate
intervention impacts outside of controlled study settings, and the use
of proxy countries to estimate the impact in countries with fewer than
4,000 annual HIV infections. <AbstractText Label="CONCLUSIONS">The new
targets for 2025 build on the progress made since 2010 and represent
ambitious short-term goals. Achieving these targets would bring us close
to the goals of reducing new HIV infections and AIDS-related deaths by
90% between 2010 and 2030. By 2025, global new infections and AIDS
deaths would drop to 4.4 and 3.9 per 100,000 population, and the number
of people living with HIV (PLHIV) would be declining. There would be 32
million people on treatment, and they would need continuing support for
their lifetime. Incidence for the total global population would be below
0.15% everywhere. The number of PLHIV would start declining by
2023.</td>
</tr>
<tr class="even">
<td align="left">COVID-19 Containment Ship Model: A Case Study for
Pacific Island Response.</td>
<td align="left">The Republic of the Marshall Islands, American Samoa,
the Federated States of Micronesia, and the Republic of Palau have been
without any COVID-19 community transmission since the beginning of the
global pandemic. The Commonwealth of the Northern Mariana Islands has
experienced modest community transmission, and Guam has had significant
COVID-19 community transmission and morbidity. Although several of these
United States Affiliated Pacific Island jurisdictions made difficult
strategic choices to prevent the spread of COVID-19 which have been
largely successful, the built environment and the population density in
the urban areas of the Pacific remain inherently conducive to rapid
COVID-19 transmission. Rapid transmission could result in devastating
health and economic consequences in the absence of continued vigilance
and long-term strategic measures. The unique COVID-19 vulnerability of
islands in the Pacific can be modeled through examination of recent
outbreaks onboard several United States Naval ships and other marine
vessels. The environmental characteristics that pose challenges to
infection control on an isolated naval ship are analogous to the
environmental characteristics of these Pacific island communities.
Considering a collection of case studies of COVID-19 transmission on
ships and applying to Pacific Island environments, provides a heuristic,
easily accessible epidemiologic framework to identify methods for
interventions that are practical and reliable towards COVID-19
containment, prevention, and control. Using accessible evidence based
public health policies, infection risk can be decreased with the
objective of maintaining in-country health and social stability. These
case studies have also been examined for their relevance to current
discussions of health care infrastructure and policy in the Pacific
Islands, especially that of vaccination and repatriation of citizens
marooned in other countries. The need for aggressive preparation on the
parts of territories and nations not yet heavily exposed to the virus is
critical to avoid a rapid burn-through of disease across the islands,
which would likely result in catastrophic consequences. Copyright 2021
by University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">A Historical and Contemporary Review of the
Contextualization and Social Determinants of Health of Micronesian
Migrants in the United States.</td>
<td align="left">Hawaiis Pacific Islander (PI) population has suffered
a higher burden of coronavirus disease 2019 (COVID-19) infections,
hospitalizations, and deaths compared to other groups in the state. The
Hawaii Emergency Management Agency Community Care Outreach Unit
conducted an assessment across the state to gain an understanding of the
impact of the COVID-19 pandemic on the health and social welfare of
households. Survey data was collected from individuals across the state
during a period of 3 weeks (August 12-September 5, 2020). The following
are resulting recommendations from the Pacific Island community to
mitigate the impact and disparities of the pandemic as immediate and
medium-term structural requests: (1) ensure that Pacific Island
communities are proactively represented in state and county committees
that develop health interventions to ensure that relevant language and
culturally tailored communications and strategies are included, (2)
provide consistent funding and community centered support to ensure
consistent COVID-19 impact services for the Pacific Island families, (3)
enhance the capacity of PI health care navigators and interpreters
through increased funding and program support, and (4) engage state
policy makers immediately to understand and address the systemic
structural barriers to health care and social services for Pacific
Islanders in Hawaii. These recommendations were developed to address
the generational inequities and disparities that exist for Pacific
islanders in Hawaii which were exacerbated by the COVID-19 pandemic.
Copyright 2021 by University Health Partners of Hawaii (UHP
Hawaii).</td>
</tr>
<tr class="even">
<td align="left">A Report on the Impact of the COVID-19 Pandemic on the
Health and Social Welfare of the Pacific Islander Population in
Hawaii.</td>
<td align="left">Hawaiis Pacific Islander (PI) population has suffered
a higher burden of coronavirus disease 2019 (COVID-19) infections,
hospitalizations, and deaths compared to other groups in the state. The
Hawaii Emergency Management Agency Community Care Outreach Unit
conducted an assessment across the state to gain an understanding of the
impact of the COVID-19 pandemic on the health and social welfare of
households. Survey data was collected from individuals across the state
during a period of 3 weeks (August 12-September 5, 2020). The following
are resulting recommendations from the Pacific Island community to
mitigate the impact and disparities of the pandemic as immediate and
medium-term structural requests: (1) ensure that Pacific Island
communities are proactively represented in state and county committees
that develop health interventions to ensure that relevant language and
culturally tailored communications and strategies are included, (2)
provide consistent funding and community centered support to ensure
consistent COVID-19 impact services for the Pacific Island families, (3)
enhance the capacity of PI health care navigators and interpreters
through increased funding and program support, and (4) engage state
policy makers immediately to understand and address the systemic
structural barriers to health care and social services for Pacific
Islanders in Hawaii. These recommendations were developed to address
the generational inequities and disparities that exist for Pacific
islanders in Hawaii which were exacerbated by the COVID-19 pandemic.
Copyright 2021 by University Health Partners of Hawaii (UHP
Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">A Report on the Impact of the COVID-19 Pandemic on the
Health and Social Welfare of the Filipino Population in Hawaii.</td>
<td align="left">Hawaiis Filipino community has been deeply impacted
by coronavirus disease 2019 (COVID-19). This article reports the
findings for the Filipino population from the Hawaii Emergency
Management Agency (HI-EMA) Community Care Outreach Unit (CCO) Unit
evaluation assessment of the impact of COVID-19 on the health and social
welfare of individuals across the state. The survey was conducted from
August-September 2020. We propose recommendations to mitigate the impact
of the pandemic on this community, including the following actions: (1)
developing linguistically and culturally appropriate support for all
COVID-19 related services, especially for the high number of older
Filipinos with limited English proficiency, (2) providing support and
resource information in locations that are accessible to Filipino
communities, and (3) supporting those already doing work to address the
deep and diverse needs in the Filipino community with funding. Building
partnerships between existing Filipino organizations, health and social
service providers, and state agencies will contribute to sustainability
over time. Copyright 2021 by University Health Partners of Hawaii (UHP
Hawaii).</td>
</tr>
<tr class="even">
<td align="left">A Report on the Impact of the COVID-19 Pandemic on the
Health and Social Welfare of the Native Hawaiian Population in
Hawaii.</td>
<td align="left">Native Hawaiians (NHs) are among the most vulnerable
groups at greater risk for coronavirus disease 2019 (COVID-19). To
understand the impact of COVID-19 on the states population, a
35-question cross-sectional survey was administered across the state of
Hawaii. NH data from the larger report are provided here. The findings
indicate that the impact of COVID-19 is disproportionately affecting NH
households in areas of income and housing stability, chronic disease
prevalence, emotional wellness, and COVID-19 prevention. Short-,
medium-, and long-term recommendations are presented as next steps to
addressing the health inequities among NHs. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">A Report on the Impact of the COVID-19 Pandemic on the
Health and Social Welfare in the County of Maui, Hawaii.</td>
<td align="left">The Community Care Outreach Unit of the Hawaii
Emergency Management Agency (HI-EMA) Medical/Public Heath Branch
conducted a survey to gauge the impact, needs, and threats to the health
and social welfare of individuals and their families pertaining to
coronavirus disease 2019 (COVID-19). This article presents key findings
for the County of Maui (MC) in the state. A mixed-methods framework was
utilized for survey distribution and recruitment of participants from
across the state. Recruitment strategies included snowball sampling via
website and social media, and paper surveys. Descriptive analysis of the
data is presented to give a basic overview of the impact of COVID-19 in
MC. A total of 883 participants in MC responded to the survey.
Approximately one-third reported that they or family members experienced
reduced work hours or lost their job because of COVID-19. In all
questions related to paying for essential living needs, the percentage
of participants who expected to have future problems was higher than the
percentage who reported having current problems. Of those preparing for
the fall 2020 school semester, expected challenges included lack of
funds to purchase school supplies, lack of face coverings, and language
barriers. Most participants in MC perceived the severity of COVID-19 to
be moderate to very high, and there was a moderate level of knowledge
about which groups are more at risk for contracting severe COVID-19.
Less than half would know how to provide care for someone in their
family with COVID-19. Several resource barriers for caring for a family
member with COVID-19 were identified. The COVID-19 pandemic has had a
more severe impact on Native Hawaiian and Pacific Islander groups
compared to others in the county. The results may provide a baseline for
understanding the impact, needs, and threats to the health and social
welfare of individuals and their families in MC. Local stakeholders can
utilize this information to develop priorities, strategies, and programs
to address the COVID-19 pandemic response in MC. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">A Report on the Impact of the COVID-19 Pandemic on the
Health and Social Welfare in the County of Kauai, Hawaii.</td>
<td align="left">The Hawaii Emergency Management Agency Community Care
Outreach Unit (CCO) conducted a survey to gauge the impact of
coronavirus disease 2019 (COVID-19) on the health and social welfare of
individuals and their families across the state of Hawaii. A
mixed-methods framework was utilized for survey distribution. This
article presents a descriptive analysis of the data to provide a basic
overview of the impact of COVID-19 in Kauai County (KC), as assessed in
August/September 2020. A total of 420 participants in KC responded to
the statewide survey. Approximately one-third reported that they or
their family members experienced reduced work hours or lost their job
because of COVID-19. Many reported difficulties paying for many types of
living essentials and expected these difficulties to increase in the
near future. Prevalent challenges for the fall school semester included
access to funds for school supplies and face-coverings. About one-third
reported feeling nervous more than half the time or nearly every day in
the past 2 weeks, and one-fourth reported feeling worried more than half
the time or nearly every day in the past 2 weeks. The majority perceived
the severity of COVID-19 to be moderate/very high and most had at least
a moderate level of knowledge about risks for contracting severe
COVID-19. Less than half said they would know how to provide care for
someone in their family with COVID-19. Half of the respondents in KC
reported maintaining social distancing usually/all of the time, the
majority reported wearing a face-covering usually/always when needed.
The results provide a baseline for understanding the impact, needs, and
threats to the health and social welfare of households and their
families in KC as a result of COVID-19. Local stakeholders can utilize
this information for developing priorities, strategies, and programs to
address the pandemic where needed and also to assess progress in areas
of need. Copyright 2021 by University Health Partners of Hawaii (UHP
Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">A Report on the Impact of the COVID-19 Pandemic on the
Health and Social Welfare in the County of Hawaii, Hawaii.</td>
<td align="left">The Community Care Outreach Unit (CCO) of the Hawaii
Emergency Management Medical/Public Health Services Branch conducted a
survey to gauge the impact of coronavirus disease 2019 (COVID-19) on the
health and social welfare of individuals and families in the state of
Hawaii. A mixed-methods framework was utilized for survey distribution;
7927 respondents participated in the survey. This article presents key
findings for the states Hawaii County (HC). It presents a descriptive
analysis of the data to provide a basic overview of the impact of
COVID-19 in HC, as assessed in August-September 2020. A total of 936
participants from HC responded to the survey. Approximately one-third
reported that they or their family members experienced reduced work
hours, and one-fifth lost their jobs because of COVID-19. Many reported
difficulties paying for many types of living essentials and expected
these difficulties to increase in the near future. Challenges for the
fall school semester included lack of access to funds for school
supplies and face-coverings. The majority perceived the severity of
COVID-19 to be moderate/very high and most had at least a moderate level
of knowledge about risks for developing severe COVID-19. Approximately
half reported maintaining social distancing usually/all of the time, and
about two-thirds reported wearing a face-covering usually/always when
needed. Other barriers for COVID disease prevention and response
included a lack of space for quarantine/isolation of family members, not
having enough cleaning supplies, low knowledge of how to care for a
household member with COVID disease and not having someone available to
care for them if they contracted the virus. The results provide a
baseline for understanding the impact, needs, and threats to the health
and social welfare of individuals and their families as a result of
COVID-19 in HC. Local stakeholders can utilize this information when
developing priorities, strategies, and programs to address the pandemic
where needed. Copyright 2021 by University Health Partners of Hawaii
(UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">A Report on the Impact of the COVID-19 Pandemic on the
Health and Social Welfare in the City and County of Honolulu,
Hawaii.</td>
<td align="left">To address the impact of COVID-19 in the state of
Hawaii, the Hawaii Emergency Management Agency Medical Public Health
Branch activated its Community Care Outreach Unit (CCO Unit). A team
from this unit developed a survey to assess the impact, needs, and
threats to the health and social welfare of individuals and their
families as they pertain to COVID-19. This article presents key findings
for the City and County of Honolulu (CCH). A total of 5598 CCH residents
responded. Approximately half of these respondents reported they or
their household members experienced reduced work hours or lost their job
as a result of COVID-19. In all questions related to paying for
essential living costs, at the time of the survey, the percentage of
participants who expected to have future problems nearly doubled. Those
preparing for school in the fall school semester expected challenges
centered on insufficient funds to purchase school supplies, lack of
available face-coverings, and language barriers. Financial assistance,
rental assistance, and food assistance seemed to be more difficult to
apply for compared to health care services. The most common reasons for
difficulty with applications noted by residents included that they could
not figure out how to complete the form, did not have all the documents,
or could not get through on the telephone. About one-half of CCH
participants reported feeling nervous more than half of the days or
nearly every day in the past 2 weeks. Most perceived the severity of
COVID-19 to be moderate to very high. Less than half reported knowing
how to provide care for someone in their family with COVID-19. Half of
the CCH participants reported that they practice social distancing
usually or all of the time, and the majority reported wearing a
face-covering usually or always when outside of the home. A significant
portion of respondents reported barriers for providing care for a
household member exposed or infected with COVID-19. Such barriers
included a lack of space in their home for isolation; not having enough
cleaning supplies; no working thermometer in the home, or no family
member available to care for them. The results presented may provide a
baseline for understanding the impact, needs, and threats to the health
and social welfare of individuals and their families in CCH and across
the state of Hawaii. Local stakeholders can utilize this information in
developing priorities, strategies, and programs to address the pandemic
as it continues to unfold and learn lessons for future pandemics.
Copyright 2021 by University Health Partners of Hawaii (UHP
Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">A Report on the Impact of the COVID-19 Pandemic on the
Health and Social Welfare in the State of Hawaii.</td>
<td align="left">The coronavirus disease 2019 (COVID-19) pandemic has
had a profound impact on the world. To address the impact of COVID-19 in
the state of Hawaii, the Hawaii Emergency Management Agency (HI-EMA)
Community Care Outreach Unit conducted an assessment survey to determine
the impact of COVID-19 on the health and social welfare of individuals
and their families across the state. This article presents key statewide
findings from this assessment, including areas of need and
community-based recommendations to help mitigate the impact of the
pandemic, particularly for vulnerable groups. A total of 7927
participants responded to the assessment survey from across the states
counties. In all questions related to paying for essentials, the
percentage of participants that expect to have problems in the future,
as compared to now, almost doubled. Slightly higher than one-third
reported that they would know how to care for a family member in the
home with COVID-19, and half of the respondents reported a lack of space
for isolation in their home. About half reported that if they got
COVID-19, they would have someone available to care for them. Overall,
Native Hawaiian, Pacific Islander, and Filipino groups reported greater
burden in almost all areas surveyed. The results presented provide a
baseline in understanding the impact, needs, and threats to the health
and social welfare of individuals and their families across the state of
Hawaii. Local stakeholders can utilize this information when developing
priorities, strategies, and programs to address current and future
pandemics in the state. Copyright 2021 by University Health Partners of
Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">Impact of COVID-19 on Hawaii Community Agencies,
Service Organizations, and the Individuals They Serve: A Snapshot from a
Spring 2020 HI-EMA Survey.</td>
<td align="left">Health and social service organizations across Hawaii
were surveyed between April 29 and May 11, 2020 by the Community Care
Outreach Unit of the Hawaii Emergency Management Agency. This article
contextualizes and describes some of the major findings of that survey
that reveal the impact of coronavirus disease 2019 (COVID-19) on Hawaii
community agencies, service organizations, and the individuals they
serve. Major issues for individuals served by the responding
organizations included securing basic needs such as food and housing as
well as access to health services, mental health needs, and COVID-19
concerns (such as inadequate personal protective equipment, cleaning
supplies, quarantine, and testing issues). Respondents reported that job
loss and the resulting financial problems were a root cause of personal
strain among clients served. Community-level stress was related to the
distressed economy and store closures. Fulfilling immediate and future
needs of health and social service agencies and the individuals they
serve, as articulated in this report, could dampen the effect of
COVID-19, promote population wellbeing, and support community
resilience. Copyright 2021 by University Health Partners of Hawaii
(UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">Hawaii Journal of Health and Social Welfare Special
Issue on The Impact of COVID-19 on the Health and Social Welfare of the
People of Hawaii.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Social Work in Action: Anti-Asian Climate During
COVID-19: Through the Lens of an Asian Social Worker.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">GenoRisk: A polygenic risk score for Alzheimers
disease.</td>
<td align="left"><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Recent
clinical trials are considering inclusion of more than just
apolipoprotein E (APOE) 4 genotype as a way of reducing variability in
analysis of outcomes.
<AbstractText Label="METHODS" NlmCategory="METHODS">Case-control data
were used to compare the capacity of age, sex, and 58 Alzheimers
disease (AD)-associated single nucleotide polymorphisms (SNPs) to
predict AD status using several statistical models. Model performance
was assessed with Brier scores and tenfold cross-validation. Genotype
and sex  age estimates from the best performing model were combined
with age and intercept estimates from the general population to develop
a personalized genetic risk score, termed age, and sex-adjusted
GenoRisk. <AbstractText Label="RESULTS" NlmCategory="RESULTS">The
elastic net model that included age, age x sex interaction, allelic APOE
terms, and 29 additional SNPs performed the best. This model explained
an additional 19% of the heritable risk compared to APOE genotype alone
and achieved an area under the curve of 0.747.
<AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">GenoRisk
could improve the risk assessment of individuals identified for
prevention studies.  2021 The Authors. Alzheimers &amp; Dementia:
Diagnosis, Assessment &amp; Disease Monitoring published by Wiley
Periodicals, LLC on behalf of Alzheimers Association.</td>
</tr>
<tr class="even">
<td align="left">Variables Associated with Coronavirus Disease 2019
Vaccine Hesitancy Amongst Patients with Neurological Disorders.</td>
<td align="left"><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Given
that the success of vaccines against coronavirus disease 2019 (COVID-19)
relies on herd immunity, identifying patients at risk for vaccine
hesitancy is imperative-particularly for those at high risk for severe
COVID-19 (i.e., minorities and patients with neurological disorders).
<AbstractText Label="METHODS" NlmCategory="METHODS">Among patients from
a large neuroscience institute in Hawaii, vaccine hesitancy was
investigated in relation to over 30 sociodemographic variables and
medical comorbidities, via a telephone quality improvement survey
conducted between 23 January 2021 and 13 February 2021.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Vaccine willingness
(n = 363) was 81.3%. Univariate analysis identified that the odds of
vaccine acceptance reduced for patients who do not regard COVID-19 as a
severe illness, are of younger age, have a lower Charlson Comorbidity
Index, use illicit drugs, or carry Medicaid insurance. Multivariable
logistic regression identified the best predictors of vaccine hesitancy
to be: social media use to obtain COVID-19 information, concerns
regarding vaccine safety, self-perception of a preexisting medical
condition contraindicated with vaccination, not having received the
annual influenza vaccine, having some high school education only, being
a current smoker, and not having a prior cerebrovascular accident.
Unique amongst males, a conservative political view strongly predicted
vaccine hesitancy. Specifically for Asians, a higher body mass index,
while for Native Hawaiians and other Pacific Islanders (NHPI), a
positive depression screen, both reduced the odds of vaccine acceptance.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Upon
identifying the variables associated with vaccine hesitancy amongst
patients with neurological disorders, our clinic is now able to
efficiently provide ancillary COVID-19 education to sub-populations at
risk for vaccine hesitancy. While our results may be limited to the
sub-population of patients with neurological disorders, the findings
nonetheless provide valuable insight to understanding vaccine
hesitancy.</td>
</tr>
<tr class="odd">
<td align="left">Astronomical Use of Nitrous Oxide Associated With
Stress From the COVID-19 Pandemic and Lockdown.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Cancer statistics for the US Hispanic/Latino
population, 2021.</td>
<td align="left">The Hispanic/Latino population is the second largest
racial/ethnic group in the continental United States and Hawaii,
accounting for 18% (60.6 million) of the total population. An additional
3 million Hispanic Americans live in Puerto Rico. Every 3 years, the
American Cancer Society reports on cancer occurrence, risk factors, and
screening for Hispanic individuals in the United States using the most
recent population-based data. An estimated 176,600 new cancer cases and
46,500 cancer deaths will occur among Hispanic individuals in the
continental United States and Hawaii in 2021. Compared to non-Hispanic
Whites (NHWs), Hispanic men and women had 25%-30% lower incidence
(2014-2018) and mortality (2015-2019) rates for all cancers combined and
lower rates for the most common cancers, although this gap is
diminishing. For example, the colorectal cancer (CRC) incidence rate
ratio for Hispanic compared with NHW individuals narrowed from 0.75 (95%
CI, 0.73-0.78) in 1995 to 0.91 (95% CI, 0.89-0.93) in 2018, reflecting
delayed declines in CRC rates among Hispanic individuals in part because
of slower uptake of screening. In contrast, Hispanic individuals have
higher rates of infection-related cancers, including approximately
two-fold higher incidence of liver and stomach cancer. Cervical cancer
incidence is 32% higher among Hispanic women in the continental US and
Hawaii and 78% higher among women in Puerto Rico compared to NHW women,
yet is largely preventable through screening. Less access to care may be
similarly reflected in the low prevalence of localized-stage breast
cancer among Hispanic women, 59% versus 67% among NHW women.
Evidence-based strategies for decreasing the cancer burden among the
Hispanic population include the use of culturally appropriate lay health
advisors and patient navigators and targeted, community-based
intervention programs to facilitate access to screening and promote
healthy behaviors. In addition, the impact of the COVID-19 pandemic on
cancer trends and disparities in the Hispanic population should be
closely monitored.  2021 The Authors. CA: A Cancer Journal for
Clinicians published by Wiley Periodicals LLC on behalf of American
Cancer Society.</td>
</tr>
<tr class="odd">
<td align="left">Addendum needed on COVID-19 travel study.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Health Care Payers COVID-19 Impact Assessment: Lessons
Learned and Compelling Needs.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Disaggregating Data to Measure Racial Disparities in
COVID-19 Outcomes and Guide Community Response - Hawaii, March 1,
2020-February 28, 2021.</td>
<td align="left">Native Hawaiian and Pacific Islander populations have
been disproportionately affected by COVID-19 (1-3). Native Hawaiian,
Pacific Islander, and Asian populations vary in language; cultural
practices; and social, economic, and environmental experiences, which
can affect health outcomes (4). However, data from these populations
are often aggregated in analyses. Although data aggregation is often
used as an approach to increase sample size and statistical power when
analyzing data from smaller population groups, it can limit the
understanding of disparities among diverse Native Hawaiian, Pacific
Islander, and Asian subpopulations (4-7). To assess disparities in
COVID-19 outcomes among Native Hawaiian, Pacific Islander, and Asian
populations, a disaggregated, descriptive analysis, informed by
recommendations from these communities,** was performed using race data
from 21,005 COVID-19 cases and 449 COVID-19-associated deaths reported
to the Hawaii State Department of Health (HDOH) during March 1,
2020-February 28, 2021. In Hawaii, COVID-19 incidence and mortality
rates per 100,000 population were 1,477 and 32, respectively during this
period. In analyses with race categories that were not mutually
exclusive, including persons of one race alone or in combination with
one or more races, Pacific Islander persons, who account for 5% of
Hawaiis population, represented 22% of COVID-19 cases and deaths
(COVID-19 incidence of 7,070 and mortality rate of 150). Native Hawaiian
persons experienced an incidence of 1,181 and a mortality rate of 15.
Among subcategories of Asian populations, the highest incidences were
experienced by Filipino persons (1,247) and Vietnamese persons (1,200).
Disaggregating Native Hawaiian, Pacific Islander, and Asian race data
can aid in identifying racial disparities among specific subpopulations
and highlights the importance of partnering with communities to develop
culturally responsive outreach teams and tailored public health
interventions and vaccination campaigns to more effectively address
health disparities.</td>
</tr>
<tr class="even">
<td align="left">Using test positivity and reported case rates to
estimate state-level COVID-19 prevalence and seroprevalence in the
United States.</td>
<td align="left">Accurate estimates of infection prevalence and
seroprevalence are essential for evaluating and informing public health
responses and vaccination coverage needed to address the ongoing spread
of COVID-19 in each United States (U.S.) state. However, reliable,
timely data based on representative population sampling are unavailable,
and reported case and test positivity rates are highly biased. A simple
data-driven Bayesian semi-empirical modeling framework was developed and
used to evaluate state-level prevalence and seroprevalence of COVID-19
using daily reported cases and test positivity ratios. The model was
calibrated to and validated using published state-wide seroprevalence
data, and further compared against two independent data-driven
mathematical models. The prevalence of undiagnosed COVID-19 infections
is found to be well-approximated by a geometrically weighted average of
the positivity rate and the reported case rate. Our model accurately
fits state-level seroprevalence data from across the U.S. Prevalence
estimates of our semi-empirical model compare favorably to those from
two data-driven epidemiological models. As of December 31, 2020, we
estimate nation-wide a prevalence of 1.4% [Credible Interval (CrI):
1.0%-1.9%] and a seroprevalence of 13.2% [CrI: 12.3%-14.2%], with
state-level prevalence ranging from 0.2% [CrI: 0.1%-0.3%] in Hawaii to
2.8% [CrI: 1.8%-4.1%] in Tennessee, and seroprevalence from 1.5% [CrI:
1.2%-2.0%] in Vermont to 23% [CrI: 20%-28%] in New York. Cumulatively,
reported cases correspond to only one third of actual infections. The
use of this simple and easy-to-communicate approach to estimating
COVID-19 prevalence and seroprevalence will improve the ability to make
public health decisions that effectively respond to the ongoing COVID-19
pandemic.</td>
</tr>
<tr class="odd">
<td align="left">The challenge of COVID-19 for adult men and women in
the United States: disparities of psychological distress by gender and
age.</td>
<td align="left"><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">During
the COVID-19 pandemic, the prevalence of psychological distress rose
from 11% in 2019 to more than 40% in 2020. This study aims to examine
the disparities among US adult men and women.
<AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">We used 21
waves of cross-sectional data from the Household Pulse Survey that were
collected between April and December 2020 for the study. The Household
Pulse Survey was developed by the U.S. Census Bureau to document the
social and economic impact of COVID-19.
<AbstractText Label="METHODS" NlmCategory="METHODS">The study population
included four groups of adults: emerging adults (18-24 years); young
adults (25-44 years); middle-aged adults (45-64 years); and older adults
(65-88 years). Psychological distress was measured by their Generalized
Anxiety Disorder score and the Patient Health Questionnaire. The
prevalence of psychological stress was calculated using logistic models
adjusted for socio-demographic variables including race/ethnicity,
education, household income, and household structure. All descriptive
and regression analysis considered survey weights.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Younger age groups
experienced higher prevalence of psychological distress than older age
groups. Among emerging adults, the prevalence of anxiety (42.6%) and
depression (39.5%) was more than twice as high as older adults who
experienced prevalence of anxiety at 20% and depression at 16.6%. Gender
differences were also more apparent in emerging adults. Women between 18
and 24 years reported higher differential rates of anxiety and
depression than those with men (anxiety: 43.9% vs.28.3%; depression:
33.3% vs.24.9%).
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Understanding
the complex dynamics between COVID-19 and psychological distress has
emerged as a public health priority. Mitigating the negative mental
health consequences associated with the COVID-19 pandemic, for younger
generations and females in particular, will require local efforts to
rebuild capacity for social integration and social connection. Copyright
 2021 The Royal Society for Public Health. Published by Elsevier
Ltd.All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">Estimated US Infection- and Vaccine-Induced SARS-CoV-2
Seroprevalence Based on Blood Donations, July 2020-May 2021.</td>
<td align="left"><AbstractText Label="IMPORTANCE">People who have been
infected with or vaccinated against SARS-CoV-2 have reduced risk of
subsequent infection, but the proportion of people in the US with
SARS-CoV-2 antibodies from infection or vaccination is uncertain.
<AbstractText Label="OBJECTIVE">To estimate trends in SARS-CoV-2
seroprevalence related to infection and vaccination in the US
population. <AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">In a
repeated cross-sectional study conducted each month during July 2020
through May 2021, 17 blood collection organizations with blood donations
from all 50 US states; Washington, DC; and Puerto Rico were organized
into 66 study-specific regions, representing a catchment of 74% of the
US population. For each study region, specimens from a median of
approximately 2000 blood donors were selected and tested each month; a
total of 1 594 363 specimens were initially selected and tested. The
final date of blood donation collection was May 31, 2021.
<AbstractText Label="EXPOSURE">Calendar time.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">Proportion of persons
with detectable SARS-CoV-2 spike and nucleocapsid antibodies.
Seroprevalence was weighted for demographic differences between the
blood donor sample and general population. Infection-induced
seroprevalence was defined as the prevalence of the population with both
spike and nucleocapsid antibodies. Combined infection- and
vaccination-induced seroprevalence was defined as the prevalence of the
population with spike antibodies. The seroprevalence estimates were
compared with cumulative COVID-19 case report incidence rates.
<AbstractText Label="RESULTS">Among 1 443 519 specimens included, 733
052 (50.8%) were from women, 174 842 (12.1%) were from persons aged 16
to 29 years, 292 258 (20.2%) were from persons aged 65 years and older,
36 654 (2.5%) were from non-Hispanic Black persons, and 88 773 (6.1%)
were from Hispanic persons. The overall infection-induced SARS-CoV-2
seroprevalence estimate increased from 3.5% (95% CI, 3.2%-3.8%) in July
2020 to 20.2% (95% CI, 19.9%-20.6%) in May 2021; the combined infection-
and vaccination-induced seroprevalence estimate in May 2021 was 83.3%
(95% CI, 82.9%-83.7%). By May 2021, 2.1 SARS-CoV-2 infections (95% CI,
2.0-2.1) per reported COVID-19 case were estimated to have occurred.
<AbstractText Label="CONCLUSIONS AND RELEVANCE">Based on a sample of
blood donations in the US from July 2020 through May 2021, vaccine- and
infection-induced SARS-CoV-2 seroprevalence increased over time and
varied by age, race and ethnicity, and geographic region. Despite
weighting to adjust for demographic differences, these findings from a
national sample of blood donors may not be representative of the entire
US population.</td>
</tr>
<tr class="odd">
<td align="left">Making US poison centers a part of the solution to the
COVID-19 pandemic.</td>
<td align="left"><AbstractText Label="OBJECTIVES">Our six goals are: 1)
describe the relationship between the National Strategy for the COVID-19
Response and Pandemic Preparedness and the 55 US poison centers (PCs);
2) detail FDA emergency Use Authorization (EUA) COVID-19 vaccine-related
regulatory procedures and associated acronyms; 3) list availability of
specific vaccine clinical information to support PC staff COVID-19
vaccination and adverse event (AE) data collection; 4) describe required
health care practitioner COVID-19 vaccine AE reporting to the Vaccine AE
Reporting System (VAERS) and PC reporting options; 5) document public
and health care professionals use of PCs for COVID-19 vaccine
information; and 6) propose strategy to maximize PCs contribution to the
pandemic solution. <AbstractText Label="METHODS">We reviewed 13-Feb-2020
through 15-Apr-2021 National Poison Data System (NPDS) COVID-19 records
for changes over time. We examined NPDS cases and VAERS COVID-19 vaccine
reports 1-Nov-2020 through 2-Apr-2021 for vaccine manufacturer, patient
characteristics, state, and clinical effects.
<AbstractText Label="RESULTS">PCs reported 1,052,174 COVID-19 contacts;
maximum (peak) contacts/day (12,163) on 16-Mar-2020. As of 5-Apr-2021
the US reported &gt;167 million administrations of COVID-19 vaccines
(Pfizer-BioNTech, Moderna or Janssen). US PCs reported 162,052 COVID-19
vaccine contacts. Most (61.1%) were medical information calls, 34.9%
were drug information, and 2.58% were exposures. Over the same period
VAERS reported 49,078 COVID-19 vaccine cases reporting 226,205 symptoms
- headache most frequent, ranging from 20% to 40% across the 3 vaccines.
<AbstractText Label="CONCLUSIONS AND RECOMMENDATIONS">Although
differences exist between the intent and content of the 2 data sets,
NPDS volume is compelling. The PC nationwide 800 number facilitates data
collection and suggests comingling the 2 data streams has merit. PC
professionals received tens of thousands of calls and can: 1) support
fact-based vaccine information; 2) contribute vaccine AE follow-up
information: 3) advocate for best-case coding and reporting, especially
for vaccine adverse experiences.</td>
</tr>
<tr class="even">
<td align="left">Vaccines and variants: Modelling insights into emerging
issues in COVID-19 epidemiology.</td>
<td align="left">Mathematical modelling has played a pivotal role in
understanding the epidemiology of and guiding public health responses to
the ongoing coronavirus disease of 2019 (COVID-19) pandemic. Here, we
review the role of epidemiological models in understanding evolving
epidemic characteristics, including the effects of vaccination and
Variants of Concern (VoC). We highlight ways in which models continue to
provide important insights, including (1) calculating the herd immunity
threshold and evaluating its limitations; (2) verifying that nascent
vaccines can prevent severe disease, infection, and transmission but may
be less efficacious against VoC; (3) determining optimal vaccine
allocation strategies under efficacy and supply constraints; and (4)
determining that VoC are more transmissible and lethal than previously
circulating strains, and that immune escape may jeopardize
vaccine-induced herd immunity. Finally, we explore how models can help
us anticipate and prepare for future stages of COVID-19 epidemiology
(and that of other diseases) through forecasts and scenario projections,
given current uncertainties and data limitations. Copyright  2021.
Published by Elsevier Ltd.</td>
</tr>
<tr class="odd">
<td align="left">Vaccinations Against COVID-19 May Have Averted Up To
140,000 Deaths In The United States.</td>
<td align="left">COVID-19 vaccination campaigns continue in the United
States, with the expectation that vaccines will slow transmission of the
virus, save lives, and enable a return to normal life in due course.
However, the extent to which faster vaccine administration has affected
COVID-19-related deaths is unknown. We assessed the association between
US state-level vaccination rates and COVID-19 deaths during the first
five months of vaccine availability. We estimated that by May 9, 2021,
the US vaccination campaign was associated with a reduction of 139,393
COVID-19 deaths. The association varied in different states. In New
York, for example, vaccinations led to an estimated 11.7 fewer COVID-19
deaths per 10,000, whereas Hawaii observed the smallest reduction, with
an estimated 1.1 fewer deaths per 10,000. Overall, our analysis suggests
that the early COVID-19 vaccination campaign was associated with
reductions in COVID-19 deaths. As of May 9, 2021, reductions in COVID-19
deaths associated with vaccines had translated to value of statistical
life benefit ranging between $625 billion and $1.4 trillion.</td>
</tr>
<tr class="even">
<td align="left">Impact of the World Antimicrobial Awareness Week on
public interest between 2015 and 2020: A Google Trends analysis.</td>
<td align="left"><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To
evaluate the impact of the World Antimicrobial Awareness Week (WAAW) on
public awareness of antimicrobial resistance using Google Trends
analysis. <AbstractText Label="METHODS" NlmCategory="METHODS">The impact
of WAAW on public awareness of antimicrobial resistance (AMR),
antibacterial, and antibiotics in Japan, the UK, the United States,
and worldwide from 2015 to 2020 was analyzed, using the relative search
volume (RSV) of Google Trends as a surrogate. A joinpoint regression
analysis was performed to identify a statistically significant time
point of a change in trend.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">No joinpoints around
WAAW were identified in Japan, the United Kingdom, or the United States
from 2015 to 2020 with RSVs of AMR, whereas increasing RSVs were noted
worldwide in 2017 and 2020. Further, there were decreasing RSVs of
antibiotics in the first half of 2020, which could be due to the
COVID-19 pandemic. The study results suggest that WAAW did little to
improve public awareness of AMR in the selected countries despite its
contribution worldwide.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study
implies that we need to develop a more effective method to improve
public awareness to fight against AMR. Copyright  2021 The Author(s).
Published by Elsevier Ltd.. All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Predicting the Severity of Disease Progression in
COVID-19 at the Individual and Population Level: A Mathematical
Model.</td>
<td align="left">The impact of COVID-19 disease on health and economy
has been global, and the magnitude of devastation is unparalleled in
modern history. Any potential course of action to manage this complex
disease requires the systematic and efficient analysis of data that can
delineate the underlying pathogenesis. We have developed a mathematical
model of disease progression to predict the clinical outcome, utilizing
a set of causal factors known to contribute to COVID-19 pathology such
as age, comorbidities, and certain viral and immunological parameters.
Viral load and selected indicators of a dysfunctional immune response,
such as cytokines IL-6 and IFN which contribute to the cytokine storm
and fever, parameters of inflammation D-Dimer and Ferritin, aberrations
in lymphocyte number, lymphopenia, and neutralizing antibodies were
included for the analysis. The model provides a framework to unravel the
multi-factorial complexities of the immune response manifested in
SARS-CoV-2 infected individuals. Further, this model can be valuable to
predict clinical outcome at an individual level, and to develop
strategies for allocating appropriate resources to manage severe cases
at a population level.</td>
</tr>
<tr class="even">
<td align="left">Medical School Hotline: Immunoepigenetic-Microbiome
Axis: Implications for Health Disparities Research in Native Hawaiians
and Pacific Islanders.</td>
<td align="left">Native Hawaiian and Pacific Islander (NHPI) populations
suffer from disproportionately higher rates of chronic conditions, such
as type 2 diabetes, that arises from metabolic dysfunction and are often
associated with obesity and inflammation. In addition, the global
coronavirus disease 2019 pandemic has further compounded the effect of
health inequities observed in Indigenous populations, including NHPI
communities. Reversible lifestyle habits, such as diet, may either be
protective of or contribute to the increasing prevalence of health
inequities in these populations via the immunoepigenetic-microbiome
axis. This axis offers insight into the connection between diet,
epigenetics, the microbiome composition, immune function, and response
to viral infection. Epigenetic mechanisms that regulate inflammatory
states associated with metabolic diseases, including diabetes, are
impacted by diet. Furthermore, diet may modulate the gut microbiome by
influencing microbial diversity and richness; dysbiosis of the
microbiome is associated with chronic disease. A high fiber diet
facilitates a favorable microbiome composition and in turn increases
production of intermediate metabolites named short-chain fatty acids
(SCFAs) that act on metabolic and immune pathways. In contrast, low
fiber diets typically associated with a westernized lifestyle decreases
the abundance of microbial derived SCFAs. This decreased abundance is
characteristic of metabolic syndromes and activation of chronic
inflammatory states, having larger implications in disease pathogenesis
of both communicable and non-communicable diseases. Native Hawaiians and
Pacific Islanders that once thrived on healthy traditional diets may be
more sensitive than non-indigenous peoples to the metabolic perturbation
of westernized diets that impinge on the immunoepigenetic-gut microbiome
axis. Recent studies conducted in the Maunakea lab at the University of
Hawaii at Mnoa John A. Burns School of Medicine have helped elucidate
the connections between diet, microbiome composition, metabolic
syndrome, and epigenetic regulation of immune function to better
understand disease pathogenesis. Potentially, this research could point
to ways to prevent pre-disease conditions through novel biomarker
discovery using community-based approaches. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">Trends in psychological distress and COVID-19 incidence
across 15 U.S. metropolitan statistical areas in 2020.</td>
<td align="left">The United States experienced three surges of COVID-19
community infection since the World Health Organization declared the
pandemic on March 11, 2020. The prevalence of psychological distress
among U.S. adults increased from 11 % in 2019 to 35.9 % in April 2020
when New York City become the epicenter of the COVID-19 outbreak.
Analyzing 21 waves of the Household Pulse Survey data collected between
April 2020 and December 2020, this study aimed to examine the distress
level in the 15 most populated metropolitan areas in the U.S. Our study
found that, as the pandemic swept from East to South and soared in the
West, 39.9%-52.3 % U.S. adults living in these 15 metropolitan areas
reported symptoms of psychological distress. The highest distress levels
were found within the Western areas including Riverside-San
Bernardino-Ontario (52.3 % in July 2020, 95 % CI: 44.9%-59.6 %) and Los
Angeles-Long Beach-Anaheim (49.9 % in December 2020, 95 % CI: 44.5%-55.4
%). The lowest distress level was observed in
Washington-Arlington-Alexandria ranging from 29.1 % in May 2020 to 39.9
% in November 2020. COVID-19 and its complex ecology of social and
economic stressors have engaged high levels of sustained psychological
distress. Our findings will support the efforts of local, state and
national leadership to plan interventions by addressing not only the
medical, but also the economic and social conditions associated with the
pandemic. Copyright  2021 Elsevier Ltd.All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">The effect of a statewide COVID-19 shelter-in-place
order on shoulder arthroplasty for proximal humerus fracture volume and
length of stay.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although
the COVID-19 pandemic has disrupted elective shoulder arthroplasty
throughput, traumatic shoulder arthroplasty procedures are less apt to
be postponed. We sought to evaluate shoulder arthroplasty utilization
for fracture during the COVID-19 pandemic and Californias associated
shelter-in-place order compared to historical controls.
<AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a
cohort study with historical controls, identifying patients who
underwent shoulder arthroplasty for proximal humerus fracture in
California using our integrated electronic health record. The time
period of interest was following the implementation of the statewide
shelter-in-place order: March 19, 2020-May 31, 2020. This was compared
to three historical periods: January 1, 2020-March 18, 2020, March 18,
2019-May 31, 2019, and January 1, 2019-March 18, 2019. Procedure volume,
patient characteristics, in-hospital length of stay, and 30-day events
(emergency department visit, readmission, infection, pneumonia, and
death) were reported. Changes over time were analyzed using linear
regression adjusted for usual seasonal and yearly changes and age, sex,
comorbidities, and postadmission factors.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Surgical volume
dropped from an average of 4.4, 5.2, and 2.6 surgeries per week in the
historical time periods, respectively, to 2.4 surgeries per week after
shelter-in-place. While no more than 30% of all shoulder arthroplasty
procedures performed during any given week were for fracture during the
historical time periods, arthroplasties performed for fracture was the
overwhelming primary indication immediately after the shelter-in-place
order. More patients were discharged the day of surgery (+33.2%, P =
.019) after the shelter-in-place order, but we did not observe a change
in any of the corresponding 30-day events.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The volume
of shoulder arthroplasty for fracture dropped during the time of
COVID-19. The reduction in volume could be due to less shoulder trauma
due to shelter-in-place or a change in the indications for arthroplasty
given the perceived higher risks associated with intubation and surgical
care. We noted more patients undergoing shoulder arthroplasty for
fracture were safely discharged on the day of surgery, suggesting this
may be a safe practice that can be adopted moving forward.
<AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level III;
Retrospective Case-control Comparative Study.  2021 American Shoulder
and Elbow Surgeons. Published by Elsevier Inc.All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Clinical, Immunological, and Virological SARS-CoV-2
Phenotypes in Obese and Nonobese Military Health System
Beneficiaries.</td>
<td align="left"><AbstractText Label="BACKGROUND">The mechanisms
underlying the association between obesity and coronavirus disease 2019
(COVID-19) severity remain unclear. After verifying that obesity was a
correlate of severe COVID-19 in US Military Health System (MHS)
beneficiaries, we compared immunological and virological phenotypes of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
in both obese and nonobese participants.
<AbstractText Label="METHODS">COVID-19-infected MHS beneficiaries were
enrolled, and anthropometric, clinical, and demographic data were
collected. We compared the SARS-CoV-2 peak IgG humoral response and
reverse-transcription polymerase chain reaction viral load in obese and
nonobese patients, stratified by hospitalization, utilizing logistic
regression models. <AbstractText Label="RESULTS">Data from 511 COVID-19
patients were analyzed, among whom 24% were obese and 14% severely
obese. Obesity was independently associated with hospitalization
(adjusted odds ratio [aOR], 1.91; 95% confidence interval [CI],
1.15-3.18) and need for oxygen therapy (aOR, 3.39; 95% CI, 1.61-7.11).
In outpatients, severely obese had a log10 (1.89) higher nucleocapsid
(N1) genome equivalents (GE)/reaction and log10 (2.62) higher N2
GE/reaction than nonobese (P = 0.03 and P &lt; .001, respectively). We
noted a correlation between body mass index and peak anti-spike protein
IgG in inpatients and outpatients (coefficient = 5.48, P &lt; .001).
<AbstractText Label="CONCLUSIONS">Obesity is a strong correlate of
COVID-19 severity in MHS beneficiaries. These findings offer new
pathophysiological insights into the relationship between obesity and
COVID-19 severity.  The Author(s) 2021. Published by Oxford University
Press for the Infectious Diseases Society of America. All rights
reserved. For permissions, e-mail: <a href="mailto:journals.permissions@oup.com" class="email">journals.permissions@oup.com</a>.</td>
</tr>
<tr class="even">
<td align="left">Disparities in Native Hawaiian and Pacific Islander
COVID-19 Mortality: ACommunity-Driven Data Response.</td>
<td align="left">As of March 2021, Native Hawaiians and Pacific
Islanders (NHPIs) in the United States have lost more than 800 lives to
COVID-19-the highest per capita death rate in 18 of 20 US states
reporting NHPI deaths. However, NHPI risks are overlooked in policy
discussions. We discuss the NHPI COVID-19 Data Policy Lab and dashboard,
featuring the disproportionate COVID-19 mortality burden for NHPIs. The
Lab democratized NHPI data, developed community infrastructure and
resources, and informed testing site and outreach policies related to
health equity.</td>
</tr>
<tr class="odd">
<td align="left">Understanding COVID-19 dynamics and the effects of
interventions in the Philippines: A mathematical modelling study.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">COVID-19
initially caused less severe outbreaks in many low- and middle-income
countries (LMIC) compared with many high-income countries, possibly
because of differing demographics, socioeconomics, surveillance, and
policy responses. Here, we investigate the role of multiple factors on
COVID-19 dynamics in the Philippines, a LMIC that has had a relatively
severe COVID-19 outbreak.
<AbstractText Label="METHODS" NlmCategory="METHODS">We applied an
age-structured compartmental model that incorporated time-varying
mobility, testing, and personal protective behaviors (through a Minimum
Health Standards policy, MHS) to represent the first wave of the
Philippines COVID-19 epidemic nationally and for three highly affected
regions (Calabarzon, Central Visayas, and the National Capital Region).
We estimated effects of control measures, key epidemiological
parameters, and interventions.
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Population age
structure, contact rates, mobility, testing, and MHS were sufficient to
explain the Philippines epidemic based on the good fit between modelled
and reported cases, hospitalisations, and deaths. The model indicated
that MHS reduced the probability of transmission per contact by 13-27%.
The February 2021 case detection rate was estimated at ~8%, population
recovered at ~9%, and scenario projections indicated high sensitivity to
MHS adherence.
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">COVID-19
dynamics in the Philippines are driven by age, contact structure,
mobility, and MHS adherence. Continued compliance with low-cost MHS
should help the Philippines control the epidemic until vaccines are
widely distributed, but disease resurgence may be occurring due to a
combination of low population immunity and detection rates and new
variants of concern.  2021 Published by Elsevier Ltd.</td>
</tr>
<tr class="even">
<td align="left">Race, ethnicity, community-level socioeconomic factors,
and risk of COVID-19 in the United States and the United Kingdom.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There
is limited prior investigation of the combined influence of personal and
community-level socioeconomic factors on racial/ethnic disparities in
individual risk of coronavirus disease 2019 (COVID-19).
<AbstractText Label="METHODS" NlmCategory="METHODS">We performed a
cross-sectional analysis nested within a prospective cohort of 2,102,364
participants from March 29, 2020 in the United States (US) and March 24,
2020 in the United Kingdom (UK) through December 02, 2020 via the COVID
Symptom Study smartphone application. We examined the contribution of
community-level deprivation using the Neighborhood Deprivation Index
(NDI) and the Index of Multiple Deprivation (IMD) to observe
racial/ethnic disparities in COVID-19 incidence. ClinicalTrials.gov
registration: NCT04331509.
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Compared with
non-Hispanic White participants, the risk for a positive COVID-19 test
was increased in the US for non-Hispanic Black (multivariable-adjusted
odds ratio [OR], 1.32; 95% confidence interval [CI], 1.18-1.47) and
Hispanic participants (OR, 1.42; 95% CI, 1.33-1.52) and in the UK for
Black (OR, 1.17; 95% CI, 1.02-1.34), South Asian (OR, 1.39; 95% CI,
1.30-1.49), and Middle Eastern participants (OR, 1.38; 95% CI,
1.18-1.61). This elevated risk was associated with living in more
deprived communities according to the NDI/IMD. After accounting for
downstream mediators of COVID-19 risk, community-level deprivation still
mediated 16.6% and 7.7% of the excess risk in Black compared to White
participants in the US and the UK, respectively.
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Our
results illustrate the critical role of social determinants of health in
the disproportionate COVID-19 risk experienced by racial and ethnic
minorities.  2021 The Author(s).</td>
</tr>
<tr class="odd">
<td align="left">The Impact of COVID-19 on Psychotherapy Participation
Among Individuals With Posttraumatic Stress Disorder Enrolled in
Treatment Research.</td>
<td align="left">The onset of the COVID-19 pandemic disrupted many
aspects of daily life and required a rapid and unprecedented shift in
psychotherapy delivery from in-person to telemental health. In the
present study, we explored the impact of the pandemic on individuals
ability to participate in posttraumatic stress disorder (PTSD)
psychotherapy and the association between the impact of COVID-19 impact
on health and financial well-being and psychotherapy participation.
Participants (N = 161, 63.2% male, Mage = 42.7 years) were United States
military veterans (n = 108), active duty military personnel (n = 12),
and civilians (n = 6), who were participating in one of nine PTSD
treatment trials. The results indicate a predominately negative COVID-19
impact on therapy participation, although some participants (26.1%)
found attending therapy sessions through telehealth to be easier than
in-person therapy. Most participants (66.7%) reported that completing in
vivo exposure homework became harder during the pandemic. Moreover, the
impact of the pandemic on PTSD symptom severity and daily stress were
each associated with increased difficulty with aspects of therapy
participation. The findings highlight the unique challenges to engaging
in PTSD treatment during the pandemic as well as a negative impact on
daily stress and PTSD severity, both of which were related to treatment
engagement difficulties.  2021 International Society for Traumatic
Stress Studies.</td>
</tr>
<tr class="even">
<td align="left">Experience of isolation and quarantine hotels for
COVID-19 in Hawaii.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Renaissance in the Nursing Home During the COVID-19
Pandemic: Telemedicine Blooms in a Time of Crisis.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">A National Pediatric Telepsychiatry Curriculum for
Graduate Medical Education and Continuing Medical Education.</td>
<td align="left">Objectives: Our goal was to develop an open access
nationally disseminated online curriculum for use in graduate and
continuing medical education on the topic of pediatric telepsychiatry to
enhance the uptake of telepsychiatry among child psychiatry training
programs and improve access to mental health care for youth and
families. Methods: Following Kerns 6-stage model of curriculum
development, we identified a core problem, conducted a needs assessment,
developed broad goals and measurable objectives in a competency-based
model, and developed educational content and methods. The curriculum was
reviewed by experts and feedback incorporated. Given the urgent need for
such a curriculum due to the COVID-19 pandemic, the curriculum was
immediately posted on the American Academy of Child and Adolescent
Psychiatry and American Association of Directors of Psychiatric
Residency Training websites. Further evaluation will be conducted over
the next year. Results: The curriculum covers the six areas of core
competence adapted for pediatric telepsychiatry and includes teaching
content and resources, evaluation tools, and information about other
resources. Conclusion: This online curriculum is available online and
provides an important resource and set of standards for pediatric
telepsychiatry training. Its online format allows for ongoing revision
as the telepsychiatry landscape changes.</td>
</tr>
<tr class="odd">
<td align="left">Assessing licensed nurses COVID-19 vaccine attitudes
and intentions: a cross-sectional survey in the state of Hawaii.</td>
<td align="left">Nurses are the largest single occupation of health care
providers and at greatest risk for exposure to and acquisition of
Coronavirus Disease 2019 (COVID-19). In December 2020, nurses in Hawaii
were recruited for an online survey that measured perceived risk/threat
of COVID-19, vaccine attitudes, and perceived safety of COVID-19
vaccines, as well as level of intention: primary, secondary (i.e.,
delayed), or no intention to vaccinate. The final sample consisted of
423 nurses. Participants were primarily Asian (27.9%) and White (45.2%).
The majority were 18-50 years (65.5%) and female (87.0%), held an RN
license (91.7%), and identified as a staff nurse (57.7%) in the hospital
setting (56.7%). Among participants, 52.3% indicated primary intention,
27.9% secondary intention, and 19.9% no intention to vaccinate. The
strongest predictors of any level of intention were greater positive
attitudes toward COVID-19 vaccination and lower concerns related to
COVID-19 vaccine safety. Findings can guide interventions to support
vaccine acceptance for those who initially decline vaccination.</td>
</tr>
<tr class="even">
<td align="left">Association Between Administration of IL-6 Antagonists
and Mortality Among Patients Hospitalized for COVID-19: A
Meta-analysis.</td>
<td align="left"><AbstractText Label="IMPORTANCE">Clinical trials
assessing the efficacy of IL-6 antagonists in patients hospitalized for
COVID-19 have variously reported benefit, no effect, and harm.
<AbstractText Label="OBJECTIVE">To estimate the association between
administration of IL-6 antagonists compared with usual care or placebo
and 28-day all-cause mortality and other outcomes.
<AbstractText Label="DATA SOURCES">Trials were identified through
systematic searches of electronic databases between October 2020 and
January 2021. Searches were not restricted by trial status or language.
Additional trials were identified through contact with experts.
<AbstractText Label="STUDY SELECTION">Eligible trials randomly assigned
patients hospitalized for COVID-19 to a group in whom IL-6 antagonists
were administered and to a group in whom neither IL-6 antagonists nor
any other immunomodulators except corticosteroids were administered.
Among 72 potentially eligible trials, 27 (37.5%) met study selection
criteria. <AbstractText Label="DATA EXTRACTION AND SYNTHESIS">In this
prospective meta-analysis, risk of bias was assessed using the Cochrane
Risk of Bias Assessment Tool. Inconsistency among trial results was
assessed using the I2 statistic. The primary analysis was an inverse
variance-weighted fixed-effects meta-analysis of odds ratios (ORs) for
28-day all-cause mortality.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome
measure was all-cause mortality at 28 days after randomization. There
were 9 secondary outcomes including progression to invasive mechanical
ventilation or death and risk of secondary infection by 28 days.
<AbstractText Label="RESULTS">A total of 10 930 patients (median age, 61
years [range of medians, 52-68 years]; 3560 [33%] were women)
participating in 27 trials were included. By 28 days, there were 1407
deaths among 6449 patients randomized to IL-6 antagonists and 1158
deaths among 4481 patients randomized to usual care or placebo (summary
OR, 0.86 [95% CI, 0.79-0.95]; P = .003 based on a fixed-effects
meta-analysis). This corresponds to an absolute mortality risk of 22%
for IL-6 antagonists compared with an assumed mortality risk of 25% for
usual care or placebo. The corresponding summary ORs were 0.83 (95% CI,
0.74-0.92; P &lt; .001) for tocilizumab and 1.08 (95% CI, 0.86-1.36; P =
.52) for sarilumab. The summary ORs for the association with mortality
compared with usual care or placebo in those receiving corticosteroids
were 0.77 (95% CI, 0.68-0.87) for tocilizumab and 0.92 (95% CI,
0.61-1.38) for sarilumab. The ORs for the association with progression
to invasive mechanical ventilation or death, compared with usual care or
placebo, were 0.77 (95% CI, 0.70-0.85) for all IL-6 antagonists, 0.74
(95% CI, 0.66-0.82) for tocilizumab, and 1.00 (95% CI, 0.74-1.34) for
sarilumab. Secondary infections by 28 days occurred in 21.9% of patients
treated with IL-6 antagonists vs 17.6% of patients treated with usual
care or placebo (OR accounting for trial sample sizes, 0.99; 95% CI,
0.85-1.16). <AbstractText Label="CONCLUSIONS AND RELEVANCE">In this
prospective meta-analysis of clinical trials of patients hospitalized
for COVID-19, administration of IL-6 antagonists, compared with usual
care or placebo, was associated with lower 28-day all-cause mortality.
<AbstractText Label="TRIAL REGISTRATION">PROSPERO Identifier:
CRD42021230155.</td>
</tr>
<tr class="odd">
<td align="left">Analysis of COVID-19 and comorbidity co-infection model
with optimal control.</td>
<td align="left">In this work, we develop and analyze a mathematical
model for the dynamics of COVID-19 with re-infection in order to assess
the impact of prior comorbidity (specifically, diabetes mellitus) on
COVID-19 complications. The model is simulated using data relevant to
the dynamics of the diseases in Lagos, Nigeria, making predictions for
the attainment of peak periods in the presence or absence of
comorbidity. The model is shown to undergo the phenomenon of backward
bifurcation caused by the parameter accounting for increased
susceptibility to COVID-19 infection by comorbid susceptibles as well as
the rate of reinfection by those who have recovered from a previous
COVID-19 infection. Simulations of the cumulative number of active cases
(including those with comorbidity), at different reinfection rates, show
infection peaks reducing with decreasing reinfection of those who have
recovered from a previous COVID-19 infection. In addition, optimal
control and cost-effectiveness analysis of the model reveal that the
strategy that prevents COVID-19 infection by comorbid susceptibles is
the most cost-effective of all the control strategies for the prevention
of COVID-19.  2021 John Wiley &amp; Sons Ltd.</td>
</tr>
<tr class="even">
<td align="left">Estimation of delay-adjusted all-cause excess mortality
in the USA: March-December 2020.</td>
<td align="left">We estimate the delay-adjusted all-cause excess deaths
across 53 US jurisdictions. Using provisional data collected from
September through December 2020, we first identify a common mean
reporting delay of 2.8 weeks, whereas four jurisdictions have prolonged
reporting delays compared to the others: Connecticut (mean 5.8 weeks),
North Carolina (mean 10.4 weeks), Puerto Rico (mean 4.7 weeks) and West
Virginia (mean 5.5 weeks). After adjusting for reporting delays, we
estimate the percent change in all-cause excess mortality from March to
December 2020 with range from 0.2 to 3.6 in Hawaii to 58.4 to 62.4 in
New York City. Comparing the March-December with September-December 2020
periods, the highest increases in excess mortality are observed in South
Dakota (36.9-54.0), North Dakota (33.9-50.7) and Missouri (27.8-33.9).
Our findings indicate that analysis of provisional data requires caution
in interpreting the death counts in recent weeks, while one needs also
to account for heterogeneity in reporting delays of excess deaths among
US jurisdictions.</td>
</tr>
<tr class="odd">
<td align="left">Rapid Implementation of a Statewide Observational
Surveillance System to Monitor Wearing of Face Masks in Public
Spaces.</td>
<td align="left">This report describes the rapid implementation of a
statewide observational surveillance program to monitor the publics
wearing of face masks in public spaces during community spread of
Coronavirus disease 2019 (COVID-19). It describes how the Hawaii State
Department of Health partnered with University of Hawaii faculty to
develop and implement the surveillance program. The surveillance program
involved organizing volunteers to conduct weekly direct observations in
designated locations. A smartphone application (app) was created to
record real-time observational surveillance data. From September 5,
2020, to March 13, 2021, a total of 84 577 observations were conducted
across the state. Eighty-three percent of those observed were correctly
wearing a face mask, 7% were wearing a face mask incorrectly, and 10%
were not wearing a mask. Following the 2-week pilot phase of the
project, volunteers were surveyed regarding facilitators and barriers
for conducting observations and motivations for volunteering. Feedback
was used to refine project procedures. With few states having
implemented such a surveillance program, the information reported in
this article may inform communities interested in tracking mask-wearing
behaviors in the context of the COVID-19 pandemic. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">The information-seeking behavior and levels of
knowledge, precaution, and fear of college students in Iloilo,
Philippines amidst the COVID-19 pandemic.</td>
<td align="left">COVID-19 pandemic is devastating the health, social,
and economic well-being of citizens worldwide. The high rates of
morbidity and mortality and the absence of vaccines cause fear among the
people regardless of age, gender, or social status. Peoples fear is
heightened by misinformation spread across all media types, especially
on social media. Filipino college students are one of the top Internet
users worldwide and are very active in social media. Hence they are very
prone to misinformation. This paper aims to ascertain the levels of
knowledge, precaution, and fear of COVID-19 of the college students in
Iloilo, Philippines, and determine the effects of their
information-seeking behavior on the variables above. This paper is a
cross-sectional survey that used a qualitative-quantitative method and
snowball sampling technique. Data were gathered among 228 college
students using an online survey instrument a few months after the
pandemic began. College students were knowledgeable of the basic facts
about the highly infectious COVID-19. However, the majority were
inclined to believe the myths and misinformation regarding the pandemic.
Television was the primary, most believable, and preferred source when
seeking information. The Internet as a preferred source of information
was significantly associated with a high level of knowledge. In
contrast, the information sourced from interpersonal channels were found
to make college students very cautious. The local presence of COVID-19
cases had caused college students to fear, likely exacerbated by the
plethora of information about the pandemic, mostly from Facebook. This
is the first study conducted on the effects of the information-seeking
behavior on the levels of knowledge, precaution, and fear of COVID-19 of
the college students in Iloilo, Philippines.  2021 Elsevier Ltd.All
rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">An integrative multiomics analysis identifies putative
causal genes for COVID-19 severity.</td>
<td align="left"><AbstractText Label="PURPOSE">It is critical to
identify putative causal targets for SARS coronavirus 2, which may guide
drug repurposing options to reduce the public health burden of COVID-19.
<AbstractText Label="METHODS">We applied complementary methods and
multiphased design to pinpoint the most likely causal genes for COVID-19
severity. First, we applied cross-methylome omnibus (CMO) test and
leveraged data from the COVID-19 Host Genetics Initiative (HGI)
comparing 9,986 hospitalized COVID-19 patients and 1,877,672 population
controls. Second, we evaluated associations using the complementary
S-PrediXcan method and leveraging blood and lung tissue gene expression
prediction models. Third, we assessed associations of the identified
genes with another COVID-19 phenotype, comparing very severe respiratory
confirmed COVID versus population controls. Finally, we applied a
fine-mapping method, fine-mapping of gene sets (FOGS), to prioritize
putative causal genes. <AbstractText Label="RESULTS">Through analyses of
the COVID-19 HGI using complementary CMO and S-PrediXcan methods along
with fine-mapping, XCR1, CCR2, SACM1L, OAS3, NSF, WNT3, NAPSA, and
IFNAR2 are identified as putative causal genes for COVID-19 severity.
<AbstractText Label="CONCLUSION">We identified eight genes at five
genomic loci as putative causal genes for COVID-19 severity.  2021. The
Author(s), under exclusive licence to the American College of Medical
Genetics and Genomics.</td>
</tr>
<tr class="even">
<td align="left">Epidemics and the future of coffee production.</td>
<td align="left">In this perspective, we draw on recent scientific
research on the coffee leaf rust (CLR) epidemic that severely impacted
several countries across Latin America and the Caribbean over the last
decade, to explore how the socioeconomic impacts from COVID-19 could
lead to the reemergence of another rust epidemic. We describe how past
CLR outbreaks have been linked to reduced crop care and investment in
coffee farms, as evidenced in the years following the 2008 global
financial crisis. We discuss relationships between CLR incidence,
farmer-scale agricultural practices, and economic signals transferred
through global and local effects. We contextualize how current COVID-19
impacts on labor, unemployment, stay-at-home orders, and international
border policies could affect farmer investments in coffee plants and in
turn create conditions favorable for future shocks. We conclude by
arguing that COVID-19s socioeconomic disruptions are likely to drive
the coffee industry into another severe production crisis. While this
argument illustrates the vulnerabilities that come from a globalized
coffee system, it also highlights the necessity of ensuring the
well-being of all. By increasing investments in coffee institutions and
paying smallholders more, we can create a fairer and healthier system
that is more resilient to future social-ecological shocks.</td>
</tr>
<tr class="odd">
<td align="left">Undergraduate nursing students perceptions on nursing
education during the 2020 COVID-19 pandemic: A national sample.</td>
<td align="left"><AbstractText Label="BACKGROUND">In 2020, nursing
educational programs were abruptly interrupted and largely moved online
due to the COVID-19 pandemic. <AbstractText Label="PURPOSE">To explore
nursing students perspectives about the effects of the pandemic on
their education and intention to join the nursing workforce.
<AbstractText Label="METHODS">Undergraduate nursing students from 5
universities across 5 United States regions were invited to participate
in an online survey to elicit both quantitative and qualitative data.
<AbstractText Label="FINDINGS">The final sample included quantitative
data on 772 students and qualitative data on 540 students. Largely
(65.1%), students reported that the pandemic strengthened their desire
to become a nurse; only 11% had considered withdrawing from school.
Qualitatively, students described the effect of the pandemic on their
psychosocial wellbeing, adjustment to online learning, and challenges to
clinical experiences. <AbstractText Label="CONCLUSION">Findings
highlighted the need to develop emergency education preparedness plans
that address student wellbeing and novel collaborative partnerships
between schools and clinical partners. Copyright  2021 Elsevier
Inc.All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">Self-limited myocarditis presenting with chest pain and
ST segment elevation in adolescents after vaccination with the BNT162b2
mRNA vaccine.</td>
<td align="left">Two adolescent males presented within 3 days after the
first and second dose of the BNT162b2 vaccine with chest pain. Elevated
troponin levels, ST segment elevation, and enhancement of the myocardium
in cardiac MRI suggested myocarditis. Left ventricular function remained
normal, symptoms resolved, and patients were discharged in 4 days.
BNT162b2 vaccine may be associated with self-limited myocarditis in
youth.</td>
</tr>
<tr class="odd">
<td align="left">Structural inequities in seasonal influenza vaccination
rates.</td>
<td align="left"><AbstractText Label="BACKGROUND">Influenza immunization
is a highly effective method of reducing illness, hospitalization and
mortality from this disease. However, influenza vaccination rates in the
U.S. remain below public health targets and persistent structural
inequities reduce the likelihood that Black, American Indian and Alaska
Native, Latina/o, Asian groups, and populations of low socioeconomic
status will receive the influenza vaccine.
<AbstractText Label="METHODS">We analyzed correlates of influenza
vaccination rates using the 2019 Behavioral Risk Factor Surveillance
System (BRFSS) in the year 2020. Our analysis compared influenza
vaccination as the outcome of interest with the variables age, sex,
race, education, income, geographic location, health insurance status,
access to primary care, history of delaying care due to cost, and
comorbidities such as: asthma, cardiovascular disease, hypertension,
body mass index, cancer and diabetes.
<AbstractText Label="RESULTS">Non-Hispanic White (46.5%) and Asian
(44.1%) participants are more likely to receive the influenza vaccine
compared to Non-Hispanic Black (36.7%), Hispanic (33.9%), American
Indian/Alaskan Native (36.6%), and Native Hawaiian/Other Pacific
Islander (37.9%) participants. We found persistent structural inequities
that predict influenza vaccination, within and across racial and ethnic
groups, including not having health insurance [OR: 0.51 (0.47-0.55)],
not having regular access to primary care [OR: 0.50 (0.48-0.52)], and
the need to delay medical care due to cost [OR: 0.75 (0.71-0.79)].
<AbstractText Label="CONCLUSION">As COVID-19 vaccination efforts evolve,
it is important for physicians and policymakers to identify the
structural impediments to equitable U.S. influenza vaccination so that
future vaccination campaigns are not impeded by these barriers to
immunization.</td>
</tr>
<tr class="even">
<td align="left">Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the
United States of America with spike protein D178H and membrane protein
V70L mutations.</td>
<td align="left">The SARS-CoV-2 B.1.1.7 lineage is highly infectious and
as of April 2021 accounted for 92% of COVID-19 cases in Europe and 59%
of COVID-19 cases in the U.S. It is defined by the N501Y mutation in the
receptor-binding domain (RBD) of the Spike (S) protein, and a few other
mutations. These include two mutations in the N terminal domain (NTD) of
the S protein, HV69-70del and Y144del (also known as Y145del due to the
presence of tyrosine at both positions). We recently identified several
emerging SARS-CoV-2 variants of concerns, characterized by Membrane (M)
protein mutations, including I82T and V70L. We now identify a
sub-lineage of B.1.1.7 that emerged through sequential acquisitions of
M:V70L in November 2020 followed by a novel S:D178H mutation first
observed in early February 2021. The percentage of B.1.1.7 isolates in
the US that belong to this sub-lineage increased from 0.15% in February
2021 to 1.8% in April 2021. To date, this sub-lineage appears to be
U.S.-specific with reported cases in 31 states, including Hawaii. As of
April 2021, it constituted 36.8% of all B.1.1.7 isolates in Washington.
Phylogenetic analysis and transmission inference with Nextstrain suggest
this sub-lineage likely originated in either California or Washington.
Structural analysis revealed that the S:D178H mutation is in the NTD of
the S protein and close to two other signature mutations of B.1.1.7,
HV69-70del and Y144del. It is surface exposed and may alter NTD tertiary
configuration or accessibility, and thus has the potential to affect
neutralization by NTD directed antibodies.</td>
</tr>
<tr class="odd">
<td align="left">The Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes
Significant Symptoms, Live Virus Shedding, and Viral Genetic
Diversity.</td>
<td align="left">Little is known about severe acute respiratory syndrome
coronavirus 2 vaccine-breakthrough infections (VBIs). Here we
characterize 24 VBIs in predominantly young healthy persons. While none
required hospitalization, a proportion endorsed severe symptoms and shed
live virus as high as 4.13  103 plaque-forming units/mL. Infecting
genotypes included both variant-of-concern (VOC) and non-VOC strains. 
The Author(s) 2021. Published by Oxford University Press for the
Infectious Diseases Society of America.</td>
</tr>
<tr class="even">
<td align="left">Problematic Use of Internet-Related Activities and
Perceived Weight Stigma in Schoolchildren: A Longitudinal Study Across
Different Epidemic Periods of COVID-19 in China.</td>
<td align="left">Background: Social distancing and school suspension due
to the coronavirus pandemic (COVID-19) may have a negative impact on
childrens behavior and well-being. Problematic smartphone use (PSU),
problematic social media use (PSMU) and perceived weight stigma (PWS)
are particularly important issues for children, yet we have a poor
understanding of how these may have been affected by lockdowns and
physical isolation resulting from COVID-19. This research aimed to
understand how these psychosocial and behavioral variables may be
associated with psychological distress, and how these associations may
have changed during the COVID-19 pandemic. Methods: A total of 489
children completed a three-wave longitudinal study from January 2020 to
June 2020. The first wave was conducted before the COVID-19 outbreak.
The second wave was conducted during the outbreak. The third wave was
conducted during post-COVID-19 lockdown. Questionnaires measured
psychological distress, PSU, PSMU, and PWS. Results: PSU, PSMU, PWS and
psychological distress were all significantly associated with each
other. PSU was significantly higher during outbreak. PWS was
significantly higher before outbreak. We found an increased association
between PSMU and PWS across three waves in all three models. The
association between PSU and depression/anxiety decreased across three
waves; however, association between PSMU and depression/anxiety
increased across three waves. Conclusions: COVID-19 initiated school
suspension and associated lockdowns appear to have exacerbated PSU and
depression among children. However, PWS was reduced during this period.
Children should use smartphones and social media safely and cautiously,
and be aware of the potential exposure to weight stigmatization.
Copyright  2021 Fung, Siu, Potenza, OBrien, Latner, Chen, Chen and
Lin.</td>
</tr>
<tr class="odd">
<td align="left">Telehealth amid the COVID-19 pandemic: perception among
Asian, Native Hawaiian and Pacific Islander cancer patients.</td>
<td align="left">Aim: To assess the perception of telehealth visits
among a multiracial cancer population during the coronavirus disease
2019 pandemic. Methods: This cross-sectional study was conducted at
outpatient cancer clinics in Hawaii between March and August 2020.
Patients were invited to participate in the survey either by phone or
email. Results: Of the 212 survey respondents, 61.3% were Asian, 23.6%
were White and 15.1% were Native Hawaiians or Pacific Islanders. Asians,
Native Hawaiians and Pacific Islanders were less likely to desire future
telehealth visits compared with Whites. Predictors with regard to
preferring future telehealth visits included lower income and
hematopoietic cancers. Conclusion: The authors found racial differences
in preference for telehealth. Future studies aimed at overcoming these
racial disparities are needed to provide equitable oncology care.</td>
</tr>
<tr class="even">
<td align="left">Investigating the Impact of Job Loss and Decreased Work
Hours on Physical and Mental Health Outcomes Among US Adults During the
COVID-19 Pandemic.</td>
<td align="left"><AbstractText Label="OBJECTIVE">To investigate
associations between adverse changes in employment status and physical
and mental health among US adults (aged 18 years or older) during the
COVID-19 pandemic. <AbstractText Label="METHODS">Data from participants
(N = 2565) of a national Internet panel (June 2020) were assessed using
path analyses to test associations between changes in self-reported
employment status and hours worked and physical and mental health
outcomes. <AbstractText Label="RESULTS">Respondents who lost a job after
March 1, 2020 (vs those who did not) reported more than twice the number
of mentally unhealthy days. Females and those lacking social support had
significantly worse physical and mental health outcomes. Participants in
the lowest, pre-pandemic household income groups reported experiencing
worse mental health. <AbstractText Label="CONCLUSIONS">Results
demonstrate the importance of providing economic and social support
services to US adults experiencing poor mental and physical health
during the COVID-19 pandemic. Copyright  2021 American College of
Occupational and Environmental Medicine.</td>
</tr>
<tr class="odd">
<td align="left">Time Trends in Racial/Ethnic Differences in COVID-19
Infection and Mortality.</td>
<td align="left">Studies documenting coronavirus disease 2019 (COVID-19)
racial/ethnic disparities in the United States were limited to data from
the initial few months of the pandemic, did not account for changes over
time, and focused primarily on Black and Hispanic minority groups. To
fill these gaps, we examined time trends in racial/ethnic disparities in
COVID-19 infection and mortality. We used the Veteran Health
Administrations (VHA) national database of veteran COVID-19 infections
over three time periods: 3/1/2020-5/31/2020 (spring); 6/1/2020-8/31/2020
(summer); and 9/1/2020-11/25/2020 (fall). We calculated COVID-19
infection and mortality predicted probabilities from logistic regression
models that included time period-by-race/ethnicity interaction terms,
and controlled for age, gender, and prior diagnosis of CDC risk factors.
Racial/ethnic groups at higher risk for COVID-19 infection and mortality
changed over time. American Indian/Alaskan Natives (AI/AN), Blacks,
Hispanics, and Native Hawaiians/Other Pacific Islanders experienced
higher COVID-19 infections compared to Whites during the summertime.
There were mortality disparities for Blacks in springtime, and AI/ANs,
Asians, and Hispanics in summertime. Policy makers should consider the
dynamic nature of racial/ethnic disparities as the pandemic evolves, and
potential effects of risk mitigation and other (e.g., economic) policies
on these disparities. Researchers should consider how trends in
disparities change over time in other samples.</td>
</tr>
<tr class="even">
<td align="left">Author Correction: Mortality outcomes with
hydroxychloroquine and chloroquine in COVID-19 from an international
collaborative meta-analysis of randomized trials.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Insights in Public Health: Methamphetamine Use during
COVID-19 in Hawaii.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Delayed, transient and self-resolving neutropenia
following COVID-19 pneumonia.</td>
<td align="left">A novel coronaravirus, identified as SARS-CoV-2, spread
throughout the world in 2020. The COVID-19 pandemic has led to many
discoveries and clinical manifestations. A young patient is presented
with new, self-resolving neutropenia presenting weeks after a prolonged
hospital stay for COVID-19 pneumonia. Workup included analysis for
underlying infection, nutritional abnormalities, malignancy, medication
and toxin exposure, all of which were negative. From 2020 to the
present, few reports have described neutropenia associated with a recent
COVID-19 infection. In particular, no reports have described a delayed
presentation of neutropenia. The authors would like to propose that the
significant inflammatory response associated with COVID-19 is likely
what led to this patients postviral neutropenia. Furthermore, in young
healthy patients, bone marrow biopsy may be deferred and a
watchful-waiting approach may be taken to assess for neutropenia
resolution.  BMJ Publishing Group Limited 2021. No commercial re-use.
See rights and permissions. Published by BMJ.</td>
</tr>
<tr class="odd">
<td align="left">Five Years and Moving Forward: A Successful Joint
Academic-Practice Public Partnership to Improve the Health of Hawaiis
Schoolchildren.</td>
<td align="left"><AbstractText Label="BACKGROUND">In 2014, the Hawaii
Department of Education (DOE), the only statewide school system in the
United States, predominately enrolled children (keiki) from underserved
communities and lacked school nurses or a school health program. Chronic
absenteeism due to health concerns was identified as a barrier to
academic success. <AbstractText Label="METHODS">The DOE and a public
university created Hawaii Keiki: Healthy and Ready to Learn (HK), a
program to provide school-based services for 170 Title 1 schools in
urban and rural settings and build momentum for statewide collective
action. HK has maintained support from public and private entities to
address student health. <AbstractText Label="RESULTS">This paper
describes 5 years of program development, implementation, and continuing
challenges. Most recently in 2020-2021, HK pivoted in the face of school
campus closings due to COVID-19 with strategic plans, including
telehealth, to move forward in this changed school environment.
<AbstractText Label="CONCLUSIONS">The HK program has increased awareness
of students needs and is addressing the imperative to build health
services within public schools. The multipronged approach of building
awareness of need, providing direct services, educating future care
providers, and supporting sound policy development, has an impact that
goes beyond any one individual area.  2021 American School Health
Association.</td>
</tr>
<tr class="even">
<td align="left">Face masks against COVID-19: Standards, efficacy,
testing and decontamination methods.</td>
<td align="left">Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the virus responsible for the novel coronavirus disease
2019 (COVID-19), has caused a global pandemic on a scale not seen for
over a century. Increasing evidence suggests that respiratory droplets
and aerosols are likely the most common route of transmission for
SARS-CoV-2. Since the virus can be spread by presymptomatic and
asymptomatic individuals, universal face masking has been recommended as
a straightforward and low-cost strategy to mitigate virus transmission.
Numerous governments and public health agencies around the world have
advocated for or mandated the wearing of masks in public settings,
especially in situations where social distancing is not possible.
However, the efficacy of wearing a mask remains controversial. This
interdisciplinary review summarizes the current, state-of-the-art
understanding of mask usage against COVID-19. It covers three main
aspects of mask usage amid the pandemic: quality standards for various
face masks and their fundamental filtration mechanisms, empirical
methods for quantitatively determining mask integrity and particle
filtration efficiency, and decontamination methods that allow for the
reuse of traditionally disposable N95 and surgical masks. The focus is
given to the fundamental physicochemical and engineering sciences behind
each aspect covered in this review, providing novel insights into the
current understanding of mask usage to curb COVID-19 spread. Copyright 
2021 Elsevier B.V. All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Adapting to the COVID-19 Pandemic.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Structural Racism and Micronesians in Hawaii: The
COVID-19 Syndemic.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">A real-time and high-throughput neutralization test
based on SARS-CoV-2 pseudovirus containing monomeric infrared
fluorescent protein as reporter.</td>
<td align="left">Neutralizing antibodies to SARS-CoV-2 have been shown
to correlate with protection in animals and humans, disease severity,
survival, and vaccine efficacy. With the ongoing large-scale vaccination
in different countries and continuous surge of new variants of global
concerns, a convenient, cost-effective and high-throughput
neutralization test is urgently needed. Conventional SARS-CoV-2
neutralization test is tedious, time-consuming and requires a biosafety
level 3 laboratory. Despite recent reports of neutralizations using
different pseudoviruses with a luciferase or green fluorescent protein
reporter, the laborious steps, inter-assay variability or high
background limit their high-throughput potential. In this study we
generated lentivirus-based pseudoviruses containing a monomeric infrared
fluorescent protein reporter to develop neutralization assays. Similar
tropism, infection kinetics and mechanism of entry through
receptor-mediated endocytosis were found in the three pseudoviruses
generated. Compared with pseudovirus D614, pseudovirus with D614G
mutation had decreased shedding and higher density of S1 protein present
on particles. The 50% neutralization titers to pseudoviruses D614 or
D614G correlated with the plaque reduction neutralization titers to live
SARS-CoV-2. The turn-around time of 48-72 h, minimal autofluorescence,
one-step image quantification, expandable to 384-well, sequential
readouts and dual quantifications by flow cytometry support its
high-throughput and versatile applications at a non-reference and
biosafety level 2 laboratory, in particular for assessing the
neutralization sensitivity of new variants by sera from natural
infection or different vaccinations during our fight against the
pandemic.</td>
</tr>
<tr class="even">
<td align="left">Ethical considerations and patient safety concerns for
cancelling non-urgent surgeries during the COVID-19 pandemic: a
review.</td>
<td align="left">At the time of writing of this article, there have been
over 110 million cases and 2.4 million deaths worldwide since the start
of the Coronavirus Disease 2019 (COVID-19) pandemic, postponing millions
of non-urgent surgeries. Existing literature explores the complexities
of rationing medical care. However, implications of non-urgent surgery
postponement during the COVID-19 pandemic have not yet been analyzed
within the context of the four pillars of medical ethics. The objective
of this review is to discuss the ethics of elective surgery cancellation
during the COVID-19 pandemic in relation to beneficence,
non-maleficence, justice, and autonomy. This review hypothesizes that a
more equitable decision-making algorithm can be formulated by analyzing
the ethical dilemmas of elective surgical care during the pandemic
through the lens of these four pillars. This papers analysis shows that
non-urgent surgeries treat conditions that can become urgent if left
untreated. Postponement of these surgeries can cause cumulative harm
downstream. An improved algorithm can address these issues of
beneficence by weighing local pandemic stressors within predictive
algorithms to appropriately increase surgeries. Additionally, the
potential harms of performing non-urgent surgeries extend beyond the
patient. Non-maleficence is maintained through using enhanced screening
protocols and modifying surgical techniques to reduce risks to patients
and clinicians. This model proposes a system to transfer patients from
areas of high to low burden, addressing the challenge of justice by
considering facility burden rather than value judgments concerning the
nature of a particular surgery, such as cosmetic surgeries. Autonomy can
be respected by giving patients the option to cancel or postpone
non-urgent surgeries. However, in the context of limited resources in a
global pandemic, autonomy is not absolute. Non-urgent surgeries can
ethically be postponed in opposition to the patients preference. The
proposed algorithm attempts to uphold the four principles of medical
ethics in rationing non-urgent surgical care by building upon existing
decision models, using additional measures of resource burden and
surgical safety to increase health care access and decrease long-term
harm as much as possible. The next global health crisis will undoubtedly
present its own unique challenges. This model may serve as a
comprehensive starting point in determining future guidelines for
non-urgent surgical care.</td>
</tr>
<tr class="odd">
<td align="left">Racial and Ethnic Disparities in Incidence of
SARS-CoV-2 Infection, 22 US States and DC, January 1-October 1,
2020.</td>
<td align="left">We examined disparities in cumulative incidence of
severe acute respiratory syndrome coronavirus 2 by race/ethnicity, age,
and sex in the United States during January 1-October 1, 2020.
Hispanic/Latino and non-Hispanic Black, American Indian/Alaskan Native,
and Native Hawaiian/other Pacific Islander persons had a substantially
higher incidence of infection than non-Hispanic White persons.</td>
</tr>
<tr class="even">
<td align="left">The sustainability-peace nexus in crisis contexts: how
the Rohingya escaped the ethnic violence in Myanmar, but are trapped
into environmental challenges in Bangladesh.</td>
<td align="left">Because of ethnic and cultural violence in Myanmar,
approximately a million Rohingya fled to neighboring Bangladesh starting
from August 2017, in what the UN has called a textbook example of
ethnic cleansing. Those arriving in Bangladesh were able to escape
decade-long ethnic violence in Myanmar, but the Rohingyas immediate
destination, Coxs Bazar district is one of the most climate-vulnerable
and disaster-prone areas in Bangladesh. Currently, they have been
subjected to extreme rainfalls, landslides, and flashfloods. With the
COVID-19 pandemic, they continue to face fear and further
marginalization in resource-constrained Bangladesh, as well as increased
vulnerability due to tropical cyclones, flashfloods, and landslides. The
Rohingya in southeast Bangladesh are now at the epicenter of a
humanitarian and sustainability crisis. However, their situation is not
entirely unique. Millions of displaced, stateless or refugees around the
world are facing multi-dimensional crises in various complex
geopolitical, and climatic situations. Using the theoretical lens of
political ecology and critical development studies, this paper analyzes
the sustainability-peace nexus for millions of Rohingya in Myanmar and
in Bangladesh. This paper is based on information from various sources,
including three ethnographic field visits in recent years, which helped
to get local insights into the current sustainability challenges in this
humanitarian context. The core arguments of this paper suggest that
sustainability-peace nexus will especially be compromised in
climate-vulnerable resource-constrained conditions. To overcome this
challenge, decolonizing Rohingya solutions would be critical, by
engaging the Rohingya in the process of development and meaningful
change, which can affect their lives, livelihoods, and wellbeing. Even
though this paper has a specific geographical focus, the insights are
relevant in parts of the world facing similar social, economic,
political, and environmental challenges.  The Author(s), under
exclusive licence to Springer Japan KK, part of Springer Nature
2021.</td>
</tr>
<tr class="odd">
<td align="left">Dynamics of the COVID-19 epidemic in urban and rural
areas in the United States.</td>
<td align="left"><AbstractText Label="PURPOSE">There is a growing
concern about the COVID-19 epidemic intensifying in rural areas in the
United States (U.S.). In this study, we described the dynamics of
COVID-19 cases and deaths in rural and urban counties in the U.S.
<AbstractText Label="METHODS">Using data from April 1 to November 12,
2020, from Johns Hopkins University, we estimated COVID-19 incidence and
mortality rates and conducted comparisons between urban and rural areas
in three time periods at the national level, and in states with higher
and lower COVID-19 incidence rates.
<AbstractText Label="RESULTS">Results at the national level showed
greater COVID-19 incidence rates in urban compared to rural counties in
the Northeast and Mid-Atlantic regions of the U.S. at the beginning of
the epidemic. However, the intensity of the epidemic has shifted to a
rapid surge in rural areas. In particular, high incidence states located
in the Mid-west of the country had more than 3,400 COVID-19 cases per
100,000 people compared to 1,284 cases per 100,000 people in urban
counties nationwide during the third period (August 30 to November 12).
<AbstractText Label="CONCLUSIONS">Overall, the current epicenter of the
epidemic is located in states with higher infection rates and mortality
in rural areas. Infection prevention and control efforts including
healthcare capacity should be scaled up in these vulnerable rural areas.
Copyright  2021. Published by Elsevier Inc.</td>
</tr>
<tr class="even">
<td align="left">Spotlight on Nursing: Hawaii Nurses Play Major Role in
COVID-19 Pandemic Response.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Insights in Public Health: Pre-Surgical Screening and
Incidence of COVID-19 Infection at the Shriners Hospitals for Children -
Honolulu.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Mortality outcomes with hydroxychloroquine and
chloroquine in COVID-19 from an international collaborative
meta-analysis of randomized trials.</td>
<td align="left">Substantial COVID-19 research investment has been
allocated to randomized clinical trials (RCTs) on
hydroxychloroquine/chloroquine, which currently face recruitment
challenges or early discontinuation. We aim to estimate the effects of
hydroxychloroquine and chloroquine on survival in COVID-19 from all
currently available RCT evidence, published and unpublished. We present
a rapid meta-analysis of ongoing, completed, or discontinued RCTs on
hydroxychloroquine or chloroquine treatment for any COVID-19 patients
(protocol: <a href="https://osf.io/QESV4/" class="uri">https://osf.io/QESV4/</a> ). We systematically identified
unpublished RCTs (ClinicalTrials.gov, WHO International Clinical Trials
Registry Platform, Cochrane COVID-registry up to June 11, 2020), and
published RCTs (PubMed, medRxiv and bioRxiv up to October 16, 2020).
All-cause mortality has been extracted (publications/preprints) or
requested from investigators and combined in random-effects
meta-analyses, calculating odds ratios (ORs) with 95% confidence
intervals (CIs), separately for hydroxychloroquine and chloroquine.
Prespecified subgroup analyses include patient setting, diagnostic
confirmation, control type, and publication status. Sixty-three trials
were potentially eligible. We included 14 unpublished trials (1308
patients) and 14 publications/preprints (9011 patients). Results for
hydroxychloroquine are dominated by RECOVERY and WHO SOLIDARITY, two
highly pragmatic trials, which employed relatively high doses and
included 4716 and 1853 patients, respectively (67% of the total sample
size). The combined OR on all-cause mortality for hydroxychloroquine is
1.11 (95% CI: 1.02, 1.20; I = 0%; 26 trials; 10,012 patients) and for
chloroquine 1.77 (95%CI: 0.15, 21.13, I = 0%; 4 trials; 307 patients).
We identified no subgroup effects. We found that treatment with
hydroxychloroquine is associated with increased mortality in COVID-19
patients, and there is no benefit of chloroquine. Findings have unclear
generalizability to outpatients, children, pregnant women, and people
with comorbidities.</td>
</tr>
<tr class="odd">
<td align="left">The COVID-19 Pandemic: Effects on Civil Registration of
Births and Deaths and on Availability and Utility of Vital Events
Data.</td>
<td align="left">The complex and evolving picture of COVID-19-related
mortality highlights the need for data to guide the response. Yet many
countries are struggling to maintain their data systems, including the
civil registration system, which is the foundation for detailed and
continuously available mortality statistics. We conducted a search of
country and development agency Web sites and partner and media reports
describing disruptions to the civil registration of births and deaths
associated with COVID-19 related restrictions.We found considerable
intercountry variation and grouped countries according to the level of
disruption to birth and particularly death registration. Only a minority
of the 66 countries were able to maintain service continuity during the
COVID-19 restrictions. In the majority, a combination of legal and
operational challenges resulted in declines in birth and death
registration. Few countries established business continuity plans or
developed strategies to deal with the backlog when restrictions are
lifted.Civil registration systems and the vital statistics they generate
must be strengthened as essential services during health emergencies and
as core components of the response to COVID-19.</td>
</tr>
<tr class="even">
<td align="left">Predicting the severity of disease progression in
COVID-19 at the individual and population level: A mathematical
model.</td>
<td align="left">The impact of COVID-19 disease on health and economy
has been global, and the magnitude of devastation is unparalleled in
modern history. Any potential course of action to manage this complex
disease requires the systematic and efficient analysis of data that can
delineate the underlying pathogenesis. We have developed a mathematical
model of disease progression to predict the clinical outcome, utilizing
a set of causal factors known to contribute to COVID-19 pathology such
as age, comorbidities, and certain viral and immunological parameters.
Viral load and selected indicators of a dysfunctional immune response,
such as cytokines IL-6 and IFN, which contribute to the cytokine storm
and fever, parameters of inflammation d-dimer and ferritin, aberrations
in lymphocyte number, lymphopenia, and neutralizing antibodies were
included for the analysis. The model provides a framework to unravel the
multi-factorial complexities of the immune response manifested in
SARS-CoV-2 infected individuals. Further, this model can be valuable to
predict clinical outcome at an individual level, and to develop
strategies for allocating appropriate resources to mitigate severe cases
at a population level.</td>
</tr>
<tr class="odd">
<td align="left">Fine-Scale Temporal Dynamics of SARS-CoV-2 RNA
Abundance in Wastewater during A COVID-19 Lockdown.</td>
<td align="left">Wastewater is a pooled sampling instrument that may
provide rapid and even early disease signals in the surveillance of
COVID-19 disease at the community level, yet the fine-scale temporal
dynamics of SARS-CoV-2 RNA in wastewater remains poorly understood. This
study tracked the daily dynamics of SARS-CoV-2 RNA in the wastewater
from two wastewater treatment plants (WWTPs) in Honolulu during a
rapidly expanding COVID-19 outbreak and a responding four-week lockdown
that resulted in a rapid decrease of daily clinical COVID-19 new cases.
The wastewater SARS-CoV-2 RNA concentration from both WWTPs, as measured
by three quantification assays (N1, N2, and E), exhibited both
significant inter-day fluctuations (101.2-105.1 gene copies or GC/L in
wastewater liquid fractions, or 101.4-106.2 GC/g in solid fractions) and
an overall downward trend over the lockdown period. Strong and
significant correlation was observed in measured SARS-CoV-2 RNA
concentrations between the solid and liquid wastewater fractions, with
the solid fraction containing majority (82.5%-92.5%) of the SARS-CoV-2
RNA mass and the solid-liquid SARS-CoV-2 RNA concentration ratios
ranging from 103.6 to 104.3 mL/g. The measured wastewater SARS-CoV-2 RNA
concentration was normalized by three endogenous fecal RNA viruses (F+
RNA coliphages Group II and III, and pepper mild mottle virus) to
account for variations that may occur during the multi-step wastewater
processing and molecular quantification, and the normalized abundance
also exhibited similar daily fluctuations and overall downward trend
over the sampling period. Copyright  2021 Elsevier Ltd.All rights
reserved.</td>
</tr>
<tr class="even">
<td align="left">Genomic Analysis of SARS-CoV-2 Variants of Concern
Circulating in Hawaii to Facilitate Public-Health Policies.</td>
<td align="left">Using genomics, bioinformatics and statistics, herein
we demonstrate the effect of statewide and nationwide quarantine on the
introduction of SARS-CoV-2 variants of concern (VOC) in Hawaii. To
define the origins of introduced VOC, we analyzed 260 VOC sequences from
Hawaii, and 301,646 VOC sequences worldwide, deposited in the GenBank
and global initiative on sharing all influenza data (GISAID), and
constructed phylogenetic trees. The trees define the most recent common
ancestor as the origin. Further, the multiple sequence alignment used to
generate the phylogenetic trees identified the consensus single
nucleotide polymorphisms in the VOC genomes. These consensus sequences
allow for VOC comparison and identification of mutations of interest in
relation to viral immune evasion and host immune activation. Of note is
the P71L substitution within the E protein, the protein sensed by TLR2
to produce cytokines, found in the B.1.351 VOC may diminish the efficacy
of some vaccines. Based on the phylogenetic trees, the B.1.1.7, B.1.351,
B.1.427, and B.1.429 VOC have been introduced in Hawaii multiple times
since December 2020 from several definable geographic regions. From the
first worldwide report of VOC in GenBank and GISAID, to the first
arrival of VOC in Hawaii, averages 320 days with quarantine, and 132
days without quarantine. As such, the effect of quarantine is shown to
significantly affect the time to arrival of VOC in Hawaii, both during
and following quarantine. Further, the collective 2020 quarantine of
43-states in the United States demonstrates a profound impact in
delaying the arrival of VOC in states that did not practice quarantine,
such as Utah. Our data demonstrates that at least 76% of all definable
SARS-CoV-2 VOC have entered Hawaii from California, with the B.1.351
variant in Hawaii originating exclusively from the United Kingdom.
These data provide a foundation for policy-makers and public-health
officials to apply precision public health genomics to real-world
policies such as mandatory screening and quarantine.</td>
</tr>
<tr class="odd">
<td align="left">Provision of medication abortion in Hawaii during
COVID-19: Practical experience with multiple care delivery models.</td>
<td align="left"><AbstractText Label="OBJECTIVE">To demonstrate the
effectiveness of medication abortion with the implementation of
telemedicine and a no-test protocol in response to the COVID-19
pandemic. <AbstractText Label="STUDY DESIGN">This is a retrospective
cohort study of patients who had a medication abortion up to 77 days
gestation at the University of Hawaii between April and November 2020.
Patients had the option of traditional in clinic care or telemedicine
with either in clinic pickup or mailing of medications. During this
time, a no-test protocol for medication abortion without prior labs or
ultrasound was in place for eligible patients. The primary outcome was
the rate of successful medication abortion without surgical
intervention. Secondary outcomes included abortion-related
complications. <AbstractText Label="RESULTS">A total of 334 patients
were dispensed mifepristone and misoprostol, 149 (44.6%) with
telemedicine with in-person pickup of medications, 75 (22.5%) via
telemedicine with medications mailed, and 110 (32.9%) via traditional in
person visits. The overall rate of complete medication abortion without
surgical intervention was 95.8%, with success rates of 96.8, 97.1, and
93.6% for the clinic pickup, mail, and clinic visit groups,
respectively. Success for those without an ultrasound performed prior to
the procedure was 96.6%, compared to 95.5% for those with ultrasound. We
obtained follow-up data for 87.8% of participants.
<AbstractText Label="CONCLUSIONS">Medication abortion was safe and
effective while offering multiple modes of care delivery including
telemedicine visits without an ultrasound performed prior to dispensing
medications. <AbstractText Label="IMPLICATIONS">Incorporating
telemedicine and a no-test protocol for medication abortion is safe and
has the potential to expand access to abortion care. All care models had
low rates of adverse events, which contradicts the idea that the Risk
Evaluation and Mitigation Strategyincreases the safety of medication
abortion. Copyright  2021 Elsevier Inc.All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">Expansion of a direct-to-patient telemedicine abortion
service in the United States and experience during the COVID-19
pandemic.</td>
<td align="left"><AbstractText Label="OBJECTIVE">To present updated
evidence on the safety, efficacy and acceptability of a
direct-to-patient telemedicine abortion service and describe how the
service functioned during the COVID-19 pandemic.
<AbstractText Label="STUDY DESIGN">We offered the study at 10 sites that
provided the service in 13 states and Washington DC. Interested
individuals obtained any needed preabortion tests locally and had a
videoconference with a study clinician. Sites sent study packages
containing mifepristone and misoprostol by mail and had remote follow-up
consultations within one month by telephone (or by online survey, if the
participant could not be reached) to evaluate abortion completeness. The
analysis was descriptive. <AbstractText Label="RESULTS">We mailed 1390
packages between May 2016 and September 2020. Of the 83% (1157/1390) of
abortions for which we obtained outcome information, 95% (1103/1157)
were completed without a procedure. Participants made 70 unplanned
visits to emergency rooms or urgent care centers for reasons related to
the abortion (6%), and 10 serious adverse events occurred, including 5
transfusions (0.4%). Enrollment increased substantially with the onset
of COVID-19. Although a screening ultrasound was required, sites
determined in 52% (346/669) of abortions that occurred during COVID that
those participants should not get the test to protect their health. Use
of urine pregnancy test to confirm abortion completion increased from
67% (144/214) in the 6 months prior to COVID to 90% (602/669) in the 6
months during COVID. Nearly all satisfaction questionnaires (99%,
1013/1022) recorded that participants were satisfied with the service.
<AbstractText Label="CONCLUSIONS">This direct-to-patient telemedicine
service was safe, effective, and acceptable, and supports the claim that
there is no medical reason for mifepristone to be dispensed in clinics
as required by the Food and Drug Administration. In some cases,
participants did not need to visit any facilities to obtain the service,
which was critical to protecting patient safety during the COVID-19
pandemic. <AbstractText Label="IMPLICATIONS">Medical abortion using
telemedicine and mail is effective and can be safely provided without a
pretreatment ultrasound. This method of service delivery has the
potential to greatly improve access to abortion care in the United
States. Copyright  2021 Elsevier Inc.All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Re: Colorectal screening: We have not caught up. A
surge of colorectal cancer after the coronavirus disease 2019 (COVID-19)
pandemic?.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Health promotion preparedness for health crises - a
must or nice to have? Case studies and global lessons learned from
the COVID-19 pandemic.</td>
<td align="left">The current COVID-19 pandemic has exposed missing links
between health promotion and national/global health emergency policies.
In response, health promotion initiatives were urgently developed and
applied around the world. A selection of case studies from five
countries, based on the Socio-Ecological Model of Health Promotion,
exemplify real-world action and challenges for health promotion
intervention, research, and policy during the COVID-19 pandemic.
Interventions range from a focus on individuals/families, organizations,
communities and in healthcare, public health, education and media
systems, health-promoting settings, and policy. Lessons learned
highlight the need for emphasizing equity, trust, systems approach, and
sustained action in future health promotion preparedness strategies.
Challenges and opportunities are highlighted regarding the need for
rapid response, clear communication based on health literacy, and
collaboration across countries, disciplines, and health and education
systems for meaningful solutions to global health crises.</td>
</tr>
<tr class="odd">
<td align="left">Association of COVID-19 Outbreak with Changes in
Physical Activity Among Adults with Elevated Risk for Major Adverse
Cardiovascular Events.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">The Relationship Between Childrens Problematic
Internet-related Behaviors and Psychological Distress During the Onset
of the COVID-19 Pandemic: A Longitudinal Study.</td>
<td align="left"><AbstractText Label="BACKGROUND">The outbreak of the
coronavirus disease 2019 (COVID-19) pandemic has generated negative
effects on psychological well-being worldwide, including in
schoolchildren. Government requirements to stay at home and avoid social
and school settings may impact psychological well-being by modifying
various behaviors such as problematic phone and Internet use, yet there
is a paucity of research on this issue. This study examined whether the
COVID-19 outbreak may have impacted problematic smartphone use (PSU),
problematic gaming (PG), and psychological distress, specifically the
pattern of relationships between PSU, PG, and psychological distress in
schoolchildren. <AbstractText Label="METHODS">Longitudinal data on
psychological distress, PSU, and PG were collected from 575 children in
primary schools in 3 waves: Waves 1 and 2 were conducted before the
COVID-19 outbreak and Wave 3 during the outbreak. Cross-lagged panel
models were used to examine relationships between factors across the 3
waves. <AbstractText Label="RESULTS">Cross-lagged models found that
higher levels of PSU were not significantly related prospectively to
greater psychological distress before the COVID-19 outbreak, but this
prospective relationship became significant during the COVID-19
outbreak. Whereas PG was associated prospectively with psychological
distress before the COVID-19 outbreak (ie, between Waves 1 and 2), this
association became nonsignificant during the COVID-19 lockdown (ie,
between Waves 2 and 3). <AbstractText Label="CONCLUSIONS">The COVID-19
outbreak has seemed to change prospective relationships between PSU and
psychological distress and PG and psychological distress in
schoolchildren. Future research should examine whether restrictions on
or information provided to schoolchildren may exacerbate PSUs effects on
psychological distress. Copyright  2021 American Society of Addiction
Medicine.</td>
</tr>
<tr class="odd">
<td align="left">Factors associated with the intention to obtain a
COVID-19 vaccine among a racially/ethnically diverse sample of women in
the USA.</td>
<td align="left">Widespread uptake of the COVID-19 vaccine is critical
to halt the pandemic. At present, little is known about factors that
will affect vaccine uptake, especially among diverse racial/ethnic
communities that have experienced the highest burden of COVID. We
administered an online survey to a Qualtrics respondent panel of women
ages 27-45 years (N = 396) to assess vaccine intentions and attitudes,
and trusted vaccine information sources. 56.8% intended to be vaccinated
and 25.5% were unsure. In bivariate analyses, a greater percentage of
non-Latina White (NLW) and Chinese women reported that they would be
vaccinated, compared with Latina and non-Latina Black (NLB) women (p
&lt; 0.001). Those who were uninsured, unemployed and those with lower
incomes were less likely to say that they would be vaccinated. In
analyses stratified by race/ethnicity, NLB women remained significantly
less likely to report that they would be vaccinated compared with NLW
women (adjusted odds ratio: 0.47; 95% confidence interval: 0.23, 0.94),
controlling for age, marital status, income, education, employment, and
insurance status. When analyses were additionally controlled for beliefs
in vaccine safety and efficacy, racial/ethnic differences were no longer
significant (adjusted odds ratio: 0.64; 95% confidence interval: 0.31,
1.34). Given that NLB women were less likely to report the intention to
be vaccinated, targeted efforts will be needed to promote vaccine
uptake. It will be critical to emphasize that the vaccine is safe and
effective; this message may be best delivered by trusted community
members. Published by Oxford University Press on behalf of the Society
of Behavioral Medicine 2021.</td>
</tr>
<tr class="even">
<td align="left">Association of clinical factors and recent anticancer
therapy with COVID-19 severity among patients with cancer: a report from
the COVID-19 and Cancer Consortium.</td>
<td align="left"><AbstractText Label="BACKGROUND">Patients with cancer
may be at high risk of adverse outcomes from severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of
patients with cancer and coronavirus 2019 (COVID-19) reported to the
COVID-19 and Cancer Consortium (CCC19) to identify prognostic clinical
factors, including laboratory measurements and anticancer therapies.
<AbstractText Label="PATIENTS AND METHODS">Patients with active or
historical cancer and a laboratory-confirmed SARS-CoV-2 diagnosis
recorded between 17 March and 18 November 2020 were included. The
primary outcome was COVID-19 severity measured on an ordinal scale
(uncomplicated, hospitalized, admitted to intensive care unit,
mechanically ventilated, died within 30 days). Multivariable regression
models included demographics, cancer status, anticancer therapy and
timing, COVID-19-directed therapies, and laboratory measurements (among
hospitalized patients). <AbstractText Label="RESULTS">A total of 4966
patients were included (median age 66 years, 51% female, 50%
non-Hispanic white); 2872 (58%) were hospitalized and 695 (14%) died;
61% had cancer that was present, diagnosed, or treated within the year
prior to COVID-19 diagnosis. Older age, male sex, obesity,
cardiovascular and pulmonary comorbidities, renal disease, diabetes
mellitus, non-Hispanic black race, Hispanic ethnicity, worse Eastern
Cooperative Oncology Group performance status, recent cytotoxic
chemotherapy, and hematologic malignancy were associated with higher
COVID-19 severity. Among hospitalized patients, low or high absolute
lymphocyte count; high absolute neutrophil count; low platelet count;
abnormal creatinine; troponin; lactate dehydrogenase; and C-reactive
protein were associated with higher COVID-19 severity. Patients
diagnosed early in the COVID-19 pandemic (January-April 2020) had worse
outcomes than those diagnosed later. Specific anticancer therapies
(e.g.R-CHOP, platinum combined with etoposide, and DNA
methyltransferase inhibitors) were associated with high 30-day all-cause
mortality. <AbstractText Label="CONCLUSIONS">Clinical factors
(e.g.older age, hematological malignancy, recent chemotherapy) and
laboratory measurements were associated with poor outcomes among
patients with cancer and COVID-19. Although further studies are needed,
caution may be required in utilizing particular anticancer therapies.
<AbstractText Label="CLINICAL TRIAL IDENTIFIER">NCT04354701. Copyright 
2021 The Author(s). Published by Elsevier Ltd.. All rights
reserved.</td>
</tr>
<tr class="odd">
<td align="left">Nutrition care practice patterns for patients with
COVID-19-A preliminary report.</td>
<td align="left"><AbstractText Label="BACKGROUND">Severe acute
respiratory syndrome coronavirus 2 is a respiratory virus that poses
risks to the nutrition status and survival of infected patients, yet
there is paucity of data to inform evidence-based quality care.
<AbstractText Label="METHODS">We collected data on the nutrition care
provided to patients with coronavirus disease 2019 (COVID-19) by
registered dietitian nutritionists (RDNs).
<AbstractText Label="RESULTS">Hospitalized COVID-19 patients (N = 101)
in this cohort were older adults and had elevated body mass index. The
most frequent nutrition problems were inadequate oral intake (46.7%),
inadequate energy intake (18.9%), and malnutrition (18.4%). These
problems were managed predominantly with enteral nutrition, food
supplements, and multivitamin-multimineral supplement therapy. Over 90%
of documented problems required a follow-up.
<AbstractText Label="CONCLUSION">This data set is the first of its kind
to report on the types of nutrition diagnoses and interventions for
COVID-19 cases used by RDNs and highlights the need for increased and
continued nutrition care.  2021 American Society for Parenteral and
Enteral Nutrition.</td>
</tr>
<tr class="even">
<td align="left">Genetic Characteristics and Phylogeny of 969-bp S Gene
Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H
Mutation.</td>
<td align="left">The COVID-19 pandemic has ravaged the world, caused
over 1.8 million deaths in its first year, and severely affected the
global economy. Hawaii has not been spared from the transmission of
SARS-CoV-2 in the local population, including high infection rates in
racial and ethnic minorities. Early in the pandemic, we described in
this journal various technologies used for the detection of SARS-CoV-2.
Herein we characterize a 969-bp SARS-CoV-2 segment of the S gene
downstream of the receptor-binding domain. At the John A. Burns School
of Medicine Biocontainment Facility, RNA was extracted from an
oropharyngeal swab and a nasal swab from 2 patients from Hawaii who
were infected with SARS-CoV-2 in August 2020. Following PCR, the 2 viral
strains were sequenced using Sanger sequencing, and phylogenetic trees
were generated using MEGAX. Phylogenetic tree results indicate that the
virus has been introduced to Hawaii from multiple sources. Further, we
decoded 13 single nucleotide polymorphisms across 13 unique SARS-CoV-2
genomes within this region of the S gene, with 1 non-synonymous mutation
(P681H) found in the 2 Hawaii strains. The P681H mutation has unique
and emerging characteristics with a significant exponential increase in
worldwide frequency when compared to the plateauing of the now universal
D614G mutation. The P681H mutation is also characteristic of the new
SARS-CoV-2 variants from the United Kingdom and Nigeria. Additionally,
several mutations resulting in cysteine residues were detected,
potentially resulting in disruption of the disulfide bridges in and
around the receptor-binding domain. Targeted sequence characterization
is warranted to determine the origin of multiple introductions of
SARS-CoV-2 circulating in Hawaii. Copyright 2021 by University Health
Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">Authors reply: Independent investigation may be more
reliable in the event with political nature.</td>
<td align="left">We welcome their additional suggestion that the
government should publish potential causes for and implications of the
additional outbreak beyond the quarantine to the international
scientific community so that similar outbreaks may be swiftly prevented.
However, given the absence of government-driven publications, we
published this report based on our independent investigation, which may
be more reliable considering the inherently sensitive and political
nature of the events.  2020 The Authors. Journal of General and Family
Medicine published by John Wiley &amp; Sons Australia, Ltd on behalf of
Japan Primary Care Association.</td>
</tr>
<tr class="even">
<td align="left">Exploring the impacts of travel-implied policy factors
on COVID-19 spread within communities based on multi-source data
interpretations.</td>
<td align="left">The global Coronavirus Disease 2019 (COVID-19) pandemic
has led to the implementation of social distancing measures such as
work-from-home orders that have drastically changed peoples
travel-related behavior. As countries are easing up these measures and
people are resuming their pre-pandemic activities, the second wave of
COVID-19 is observed in many countries. This study proposes a Community
Activity Score (CAS) based on inter-community traffic characteristics
(in and out of community traffic volume and travel distance) to capture
the current travel-related activity level compared to the pre-pandemic
baseline and study its relationship with confirmed COVID-19 cases.
Fourteen other travel-related factors belonging to five categories
(Social Distancing Index, residents staying at home, travel frequency
and distance, mobility trend, and out-of-county visitors) and three
social distancing measures (stay-at-home order, face-covering order, and
self-quarantine for out-of-county travels) are also considered to
reflect the likelihood of exposure to the COVID-19. Considering that it
usually takes days from exposure to confirming the infection, the
exposure-to-confirm temporal delay between the time-varying
travel-related factors and their impacts on the number of confirmed
COVID-19 cases is considered in this study. Honolulu County in the State
of Hawaii is used as a case study to evaluate the proposed CAS and other
factors on confirmed COVID-19 cases with various temporal delays at a
county-level. Negative Binomial models were chosen to study the impacts
of travel-related factors and social distancing measures on COVID-19
cases. The case study results show that CAS and other factors are
correlated with COVID-19 spread, and models that factor in the
exposure-to-confirm temporal delay perform better in forecasting
COVID-19 cases later. Policymakers can use the studys various findings
and insights to evaluate the impacts of social distancing policies on
travel and effectively allocate resources for the possible increase in
confirmed COVID-19 cases. Copyright  2021 Elsevier Ltd.All rights
reserved.</td>
</tr>
<tr class="odd">
<td align="left">Community Transmission of SARS-CoV-2 at Three Fitness
Facilities - Hawaii, June-July 2020.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">An Emergent Network for the Diffusion of Innovations
Among Local Health Departments at the Onset of the COVID-19
Pandemic.</td>
<td align="left"><AbstractText Label="INTRODUCTION">Communication
networks among professionals can be pathways for accelerating the
diffusion of innovations if some local health departments (LHDs) drive
the spread of knowledge. Such a network could prove valuable during
public health emergencies such as the novel coronavirus disease 2019
(COVID-19) pandemic. Our objective was to determine whether LHDs in the
United States were tied together in an informal network to share
information and advice about innovative community health practices,
programs, and policies. <AbstractText Label="METHODS">In January and
February 2020, we conducted an online survey of 2,303 senior LHD leaders
to ask several questions about their sources of advice. We asked
respondents to rank up to 3 other LHDs whose practices informed their
work on new public health programs, evidence-based practices, and
policies intended to improve community health. We used a social network
analysis program to assess answers. <AbstractText Label="RESULTS">A
total of 329 LHDs responded. An emergent network appeared to operate
nationally among 740 LHDs. Eleven LHDs were repeatedly nominated by
peers as sources of advice or examples (ie, opinion leaders), and 24
acted as relational bridges to hold these emergent networks together
(ie, boundary spanners). Although 2 LHDs played both roles, most LHDs we
surveyed performed neither of these roles.
<AbstractText Label="CONCLUSION">Opinion leading and boundary spanning
health departments can be accessed to increase the likelihood of
affecting the rate of interest in and adoption of innovations. Decision
makers involved in disseminating new public health practices, programs,
or policies may find our results useful both for emergencies and for
practice-as-usual.</td>
</tr>
<tr class="odd">
<td align="left">Development of a multiplex Loop-Mediated Isothermal
Amplification (LAMP) assay for on-site diagnosis of SARS CoV-2.</td>
<td align="left">A newly identified coronavirus, designated as severe
acute respiratory syndrome coronavirus 2 (SARS CoV-2), has spread
rapidly from its epicenter in China to more than 150 countries across
six continents. In this study, we have designed three
reverse-transcription loop-mediated isothermal amplification (RT-LAMP)
primer sets to detect the RNA-dependent RNA polymerase (RdRP), Envelope
(E) and Nucleocapsid protein (N) genes of SARS CoV-2. For one tube
reaction, the detection limits for five combination SARS CoV-2 LAMP
primer sets (RdRP/E, RdRP/N, E/N, RdRP/E/N and RdRP/N/Internal control
(actin beta)) were evaluated with a clinical nasopharyngeal swab sample.
Among the five combination, the RdRP/E and RdRP/N/IC multiplex LAMP
assays showed low detection limits. The sensitivity and specificity of
the RT-LAMP assay were evaluated and compared to that of the widely used
Allplex 2019-nCoV Assay (Seegene, Inc., Seoul, South Korea) and
PowerChek 2019-nCoV Real-time PCR kit (Kogenebiotech, Seoul, South
Korea) for 130 clinical samples from 91 SARS CoV-2 patients and 162 NP
specimens from individuals with (72) and without (90) viral respiratory
infections. The multiplex RdRP (FAM)/N (CY5)/IC (Hex) RT-LAMP assay
showed comparable sensitivities (RdRP: 93.85%, N: 94.62% and RdRP/N:
96.92%) to that of the Allplex 2019-nCoV Assay (100%) and superior to
those of PowerChek 2019-nCoV Real-time PCR kit (RdRP: 92.31%, E: 93.85%
and RdRP/E: 95.38%).</td>
</tr>
<tr class="even">
<td align="left">COVID-19 drug practices risk antimicrobial resistance
evolution.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Validation of the GeneXpert Xpress SARS-CoV-2 PCR assay
using saliva as biological specimen.</td>
<td align="left">In the pandemic, rapid and accurate detection of
SARS-CoV-2 is crucial in controlling the outbreak. Recent studies have
shown a high detection rate using saliva/oral fluids as specimens for
laboratory detection of the virus. We intended to evaluate the test
performance of the Xpert Xpress SARS-CoV-2 cartridge assay in comparison
to a conventional qRT-PCR testing, using saliva as biological specimen.
Forty saliva samples from symptomatic participants were collected.
Conventional qRT-PCR was performed for amplification of E and RdRp genes
and the Xpert Xpress SARS-CoV-2 assay amplified E and N2 genes. In the
conventional assay, the median cycle threshold value of the E gene was
34.9, and of the RdRp gene was 38.3. In the Xpert Xpress assay, the
median cycle threshold value of the E gene was 29.7, and of the N2 gene
was 31.6. These results can allow a broaden use of molecular tests for
management of COVID-19 pandemic, especially in resources-limited
settings. Copyright  2021 Sociedade Brasileira de Infectologia.
Published by Elsevier Espaa, S.L.U. All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">A Bayesian Mixture Model for Predicting the COVID-19
Related Mortality in the United States.</td>
<td align="left">An outbreak of SARS-CoV-2 has led to a global pandemic
affecting virtually every country. As of August 31, 2020, globally,
there have been approximately 25,500,000 confirmed cases and 850,000
deaths; in the United States (50 states plus District of Columbia),
there have been more than 6,000,000 confirmed cases and 183,000 deaths.
We propose a Bayesian mixture model to predict and monitor COVID-19
mortality across the United States. The model captures skewed unimodal
(prolonged recovery) or multimodal (multiple surges) curves. The results
show that across all states, the first peak dates of mortality varied
between April 4, 2020 for Alaska and June 18, 2020 for Arkansas. As of
August 31, 2020, 31 states had a clear bimodal curve showing a strong
second surge. The peak date for a second surge ranged from July 1, 2020
for Virginia to September 12, 2020 for Hawaii. The first peak for the
United States occurred about April 16, 2020-dominated by New York and
New Jersey-and a second peak on August 6, 2020-dominated by California,
Texas, and Florida. Reliable models for predicting the COVID-19 pandemic
are essential to informing resource allocation and intervention
strategies. A Bayesian mixture model was able to more accurately predict
the shape of the mortality curves across the United States than other
models, including the timing of multiple peaks. However, given the
dynamic nature of the pandemic, it is important that the results be
updated regularly to identify and better monitor future waves, and
characterize the epidemiology of the pandemic.</td>
</tr>
<tr class="odd">
<td align="left">Exploring Usage of COVID Coach, a Public Mental Health
App Designed for the COVID-19 Pandemic: Evaluation of Analytics
Data.</td>
<td align="left"><AbstractText Label="BACKGROUND">The COVID-19 pandemic
has significantly impacted mental health and well-being. Mobile mental
health apps can be scalable and useful tools in large-scale disaster
responses and are particularly promising for reaching vulnerable
populations. COVID Coach is a free, evidence-informed mobile app
designed specifically to provide tools and resources for addressing
COVID-19-related stress. <AbstractText Label="OBJECTIVE">The purpose of
this study was to characterize the overall usage of COVID Coach, explore
retention and return usage, and assess whether the app was reaching
individuals who may benefit from mental health resources.
<AbstractText Label="METHODS">Anonymous usage data collected from COVID
Coach between May 1, 2020, through October 31, 2020, were extracted and
analyzed for this study. The sample included 49,287 unique user codes
and 3,368,931 in-app events. <AbstractText Label="RESULTS">Usage of
interactive tools for coping and stress management comprised the
majority of key app events (n=325,691, 70.4%), and the majority of app
users tried a tool for managing stress (n=28,009, 58.8%). COVID Coach
was utilized for 3 days by 80.9% (n=34,611) of the sample whose first
day of app use occurred within the 6-month observation window. Usage of
the key content in COVID Coach predicted returning to the app for a
second day. Among those who tried at least one coping tool on their
first day of app use, 57.2% (n=11,444) returned for a second visit;
whereas only 46.3% (n=10,546) of those who did not try a tool returned
(P&lt;.001). Symptoms of anxiety, depression, and posttraumatic stress
disorder (PTSD) were prevalent among app users. For example, among app
users who completed an anxiety assessment on their first day of app use
(n=4870, 11.4% of users), 55.1% (n=2680) reported levels of anxiety that
were moderate to severe, and 29.9% (n=1455) of scores fell into the
severe symptom range. On average, those with moderate levels of
depression on their first day of app use returned to the app for a
greater number of days (mean 3.72 days) than those with minimal symptoms
(mean 3.08 days; t1=3.01, P=.003). Individuals with significant PTSD
symptoms on their first day of app use utilized the app for a
significantly greater number of days (mean 3.79 days) than those with
fewer symptoms (mean 3.13 days; t1=2.29, P=.02).
<AbstractText Label="CONCLUSIONS">As the mental health impacts of the
pandemic continue to be widespread and increasing, digital health
resources, such as apps like COVID Coach, are a scalable way to provide
evidence-informed tools and resources. Future research is needed to
better understand for whom and under what conditions the app is most
helpful and how to increase and sustain engagement. Beth K Jaworski,
Katherine Taylor, Kelly M Ramsey, Adrienne Heinz, Sarah Steinmetz, Ian
Pagano, Giovanni Moraja, Jason E Owen. Originally published in the
Journal of Medical Internet Research (<a href="http://www.jmir.org" class="uri">http://www.jmir.org</a>), 01.03.2021.</td>
</tr>
<tr class="even">
<td align="left">Prevalence of Asymptomatic SARS-CoV-2 Infection.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Psychological distress and internet-related behaviors
between schoolchildren with and without overweight during the COVID-19
outbreak.</td>
<td align="left"><AbstractText Label="OBJECTIVE">The novel coronavirus
disease 2019 (COVID-19) pandemic, and its resulting social policy
changes may result in psychological distress among schoolchildren with
overweight. This study thus aimed to (1) compare psychological distress
(including fear of COVID-19 infection, stress, anxiety, and depression),
perceived weight stigma, and problematic internet-related behaviors
between schoolchildren with and without overweight; (2) assess whether
perceived weight stigma and problematic internet-related behaviors
explained psychological distress.
<AbstractText Label="METHODS">Schoolchildren (n = 1357; mean age = 10.7
years) with overweight (n = 236) and without overweight (n = 1121)
completed an online survey assessing their fear of COVID-19 infection,
stress, anxiety, depression, perceived weight stigma, problematic
smartphone application use, problematic social media use, and
problematic gaming. <AbstractText Label="RESULTS">Schoolchildren with
overweight had significantly higher levels of COVID-19 infection fear,
stress, depression, perceived weight stigma, and problematic social
media use than those without overweight. Regression models showed that
perceived weight stigma and problematic internet-related behaviors were
significant predictors of psychological distress among schoolchildren
with overweight. <AbstractText Label="CONCLUSION">Strategies to manage
perceived weight stigma and problematic internet-related behaviors may
have a positive influence on mental health among schoolchildren with
overweight under health-threatening circumstances, such as the current
COVID-19 pandemic.</td>
</tr>
<tr class="even">
<td align="left">Reinventing health promotion for healthy default
beverage laws in the face of COVID-19.</td>
<td align="left">Shortly after a healthy default beverage (HDB) law took
effect in Hawaii, requiring restaurants that serve childrens meals to
offer healthy beverages with the meals, the COVID-19 pandemic struck.
Efforts to contain the virus resulted in changes to restaurants
operations and disrupted HDB implementation efforts. Economic
repercussions from containment efforts have exacerbated food insecurity,
limited access to healthy foods, and created obstacles to chronic
disease management. Promoting healthy default options is critical at a
time when engaging in healthy behaviors is difficult, but important, to
both prevent and manage chronic disease and decrease COVID-19 risk. This
commentary discusses COVID-19s impact on restaurant operations and
healthy eating, and the resulting challenges and opportunities for this
promising health promotion intervention.</td>
</tr>
<tr class="odd">
<td align="left">Distance Management of Spinal Disorders During the
COVID-19 Pandemic and Beyond: Evidence-Based Patient and Clinician
Guides From the Global Spine Care Initiative.</td>
<td align="left"><AbstractText Label="BACKGROUND">The COVID-19 pandemic
has greatly limited patients access to care for spine-related symptoms
and disorders. However, physical distancing between clinicians and
patients with spine-related symptoms is not solely limited to
restrictions imposed by pandemic-related lockdowns. In most low- and
middle-income countries, as well as many underserved marginalized
communities in high-income countries, there is little to no access to
clinicians trained in evidence-based care for people experiencing spinal
pain. <AbstractText Label="OBJECTIVE">The aim of this study is to
describe the development and present the components of evidence-based
patient and clinician guides for the management of spinal disorders
where in-person care is not available.
<AbstractText Label="METHODS">Ultimately, two sets of guides were
developed (one for patients and one for clinicians) by extracting
information from the published Global Spine Care Initiative (GSCI)
papers. An international, interprofessional team of 29 participants from
10 countries on 4 continents participated. The team included
practitioners in family medicine, neurology, physiatry, rheumatology,
psychology, chiropractic, physical therapy, and yoga, as well as
epidemiologists, research methodologists, and laypeople. The
participants were invited to review, edit, and comment on the guides in
an open iterative consensus process. <AbstractText Label="RESULTS">The
Patient Guide is a simple 2-step process. The first step describes the
nature of the symptoms or concerns. The second step provides information
that a patient can use when considering self-care, determining whether
to contact a clinician, or considering seeking emergency care. The
Clinician Guide is a 5-step process: (1) Obtain and document patient
demographics, location of primary clinical symptoms, and psychosocial
information. (2) Review the symptoms noted in the patient guide. (3)
Determine the GSCI classification of the patients spine-related
complaints. (4) Ask additional questions to determine the GSCI
subclassification of the symptom pattern. (5) Consider appropriate
treatment interventions. <AbstractText Label="CONCLUSIONS">The Patient
and Clinician Guides are designed to be sufficiently clear to be useful
to all patients and clinicians, irrespective of their location,
education, professional qualifications, and experience. However, they
are comprehensive enough to provide guidance on the management of all
spine-related symptoms or disorders, including triage for serious and
specific diseases. They are consistent with widely accepted
evidence-based clinical practice guidelines. They also allow for
adequate documentation and medical record keeping. These guides should
be of value during periods of government-mandated physical or social
distancing due to infectious diseases, such as during the COVID-19
pandemic. They should also be of value in underserved communities in
high-, middle-, and low-income countries where there is a dearth of
accessible trained spine care clinicians. These guides have the
potential to reduce the overutilization of unnecessary and expensive
interventions while empowering patients to self-manage uncomplicated
spinal pain with the assistance of their clinician, either through
direct in-person consultation or via telehealth communication. Scott
Haldeman, Margareta Nordin, Patricia Tavares, Rajani Mullerpatan,
Deborah Kopansky-Giles, Vincent Setlhare, Roger Chou, Eric Hurwitz,
Caroline Treanor, Jan Hartvigsen, Michael Schneider, Ralph Gay, Jean
Moss, Joan Haldeman, David Gryfe, Adam Wilkey, Richard Brown, Geoff
Outerbridge, Stefan Eberspaecher, Linda Carroll, Reginald Engelbrecht,
Kait Graham, Nathan Cashion, Stefanie Ince, Erin Moon. Originally
published in JMIR Public Health and Surveillance (<a href="http://publichealth.jmir.org" class="uri">http://publichealth.jmir.org</a>), 17.02.2021.</td>
</tr>
<tr class="even">
<td align="left">Genome-wide DNA methylation profiling of peripheral
blood reveals an epigenetic signature associated with severe
COVID-19.</td>
<td align="left">The global pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly pathogenic
RNA virus causing coronavirus disease 2019 (COVID-19) in humans.
Although most patients with COVID-19 have mild illness and may be
asymptomatic, some will develop severe pneumonia, acute respiratory
distress syndrome, multi-organ failure, and death. RNA viruses such as
SARS-CoV-2 are capable of hijacking the epigenetic landscape of host
immune cells to evade antiviral defense. Yet, there remain considerable
gaps in our understanding of immune cell epigenetic changes associated
with severe SARS-CoV-2 infection pathology. Here, we examined
genome-wide DNA methylation (DNAm) profiles of peripheral blood
mononuclear cells from 9 terminally-ill, critical COVID-19 patients with
confirmed SARS-CoV-2 plasma viremia compared with uninfected,
hospitalized influenza, untreated primary HIV infection, and
mild/moderate COVID-19 HIV coinfected individuals. Cell-type
deconvolution analyses confirmed lymphopenia in severe COVID-19 and
revealed a high percentage of estimated neutrophils suggesting
perturbations to DNAm associated with granulopoiesis. We observed a
distinct DNAm signature of severe COVID-19 characterized by
hypermethylation of IFN-related genes and hypomethylation of
inflammatory genes, reinforcing observations in infection models and
single-cell transcriptional studies of severe COVID-19. Epigenetic clock
analyses revealed severe COVID-19 was associated with an increased DNAm
age and elevated mortality risk according to GrimAge, further validating
the epigenetic clock as a predictor of disease and mortality risk. Our
epigenetic results reveal a discovery DNAm signature of severe COVID-19
in blood potentially useful for corroborating clinical assessments,
informing pathogenic mechanisms, and revealing new therapeutic targets
against SARS-CoV-2. 2021 Society for Leukocyte Biology.</td>
</tr>
<tr class="odd">
<td align="left">Genetic Characteristics and Phylogeny of 969-bp S Gene
Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H
Mutation.</td>
<td align="left">COVID-19 pandemic has ravaged the world, caused over
1.8 million deaths in the first year, and severely affected the global
economy. Hawaii is not spared from the transmission of SARS-CoV-2 in the
local population, including high infection rates in racial and ethnic
minorities. Early in the pandemic, we described in this journal various
technologies used for the detection of SARS-CoV-2. Herein we
characterize a 969-bp SARS-CoV-2 segment of the S gene downstream of the
receptor-binding domain. At the John A. Burns School of Medicine
Biocontainment Facility, RNA was extracted from an oropharyngeal swab
and a nasal swab from two patients from Hawaii who were infected with
the SARS-CoV-2 in August 2020. Following PCR, the two viral strains were
sequenced using Sanger sequencing, and phylogenetic trees were generated
using MEGAX. Phylogenetic tree results indicate that the virus has been
introduced to Hawaii from multiple sources. Further, we decoded 13
single nucleotide polymorphisms across 13 unique SARS-CoV-2 genomes
within this region of the S gene, with one non-synonymous mutation
(P681H) found in the two Hawaii strains. The P681H mutation has unique
and emerging characteristics with a significant exponential increase in
worldwide frequency when compared to the plateauing of the now universal
D614G mutation. The P681H mutation is also characteristic of the new
SARS-CoV-2 variants from the United Kingdom and Nigeria. Additionally,
several mutations resulting in cysteine residues were detected,
potentially resulting in disruption of the disulfide bridges in and
around the receptor-binding domain. Targeted sequence characterization
is warranted to determine the origin of multiple introductions of
SARS-CoV-2 circulating in Hawaii.</td>
</tr>
<tr class="even">
<td align="left">Coronavirus 2019 Infectious Disease Epidemic: Where We
Are, What Can Be Done and Hope For.</td>
<td align="left">Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) spreads mainly by means of aerosols (microdroplets) in
enclosed environments, especially those in which temperature and
humidity are regulated by means of air-conditioning. About 30% of
individuals infected with SARS-CoV-2 develop coronavirus disease 2019
(COVID-19) disease. Among them, approximately 25% require
hospitalization. In medicine, cases are identified as those who become
ill.During this pandemic, cases have been identified as those with a
positive SARS-CoV-2 polymerase chain reaction test, including
approximately 70% who were asymptomatic-this has caused unnecessary
anxiety. Individuals more than 65 years old, those affected by obesity,
diabetes, asthma, or are immune-depressed owing to cancer and other
conditions, are at a higher risk of hospitalization and of dying of
COVID-19. Healthy individuals younger than 40 years very rarely die of
COVID-19. Estimates of the COVID-19 mortality rate vary because the
definition of COVID-19-related deaths varies. Belgium has the highest
death rate at 154.9 per 100,000 persons, because it includes anyone who
died with symptoms compatible with COVID-19, even those never tested for
SARS-CoV-2. The United States includes all patients who died with a
positive test, whether they died because of, or with, SARS-CoV-2.
Countries that include only patients in which COVID-19 was the main
cause of death, rather than a cofactor, have lower death rates. Numerous
therapies are being developed, and rapid improvements are anticipated.
Because of disinformation, only approximately 50% of the U.S. population
plans to receive a COVID-19 vaccine. By sharing accurate information,
physicians, health professionals, and scientists play a key role in
addressing myths and anxiety, help public health officials enact
measures to decrease infections, and provide the best care for those who
become sick. In this article, we discuss these issues. Copyright  2021
International Association for the Study of Lung Cancer. Published by
Elsevier Inc.All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">National Psoriasis Foundation COVID-19 Task Force
guidance for management of psoriatic disease during the pandemic:
Version 2-Advances in psoriatic disease management, COVID-19 vaccines,
and COVID-19 treatments.</td>
<td align="left"><AbstractText Label="OBJECTIVE">To update guidance
regarding the management of psoriatic disease during the COVID-19
pandemic. <AbstractText Label="STUDY DESIGN">The task force (TF)
includes 18 physician voting members with expertise in dermatology,
rheumatology, epidemiology, infectious diseases, and critical care. The
TF was supplemented by nonvoting members, which included fellows and
National Psoriasis Foundation staff. Clinical questions relevant to the
psoriatic disease community were informed by inquiries received by the
National Psoriasis Foundation. A Delphi process was conducted.
<AbstractText Label="RESULTS">The TF updated evidence for the original
22 statements and added 5 new recommendations. The average of the votes
was within the category of agreement for all statements, 13 with high
consensus and 14 with moderate consensus.
<AbstractText Label="LIMITATIONS">The evidence behind many guidance
statements is variable in quality and/or quantity.
<AbstractText Label="CONCLUSIONS">These statements provide guidance for
the treatment of patients with psoriatic disease on topics including how
the disease and its treatments affect COVID-19 risk, how medical care
can be optimized during the pandemic, what patients should do to lower
their risk of getting infected with severe acute respiratory syndrome
coronavirus 2 (including novel vaccination), and what they should do if
they develop COVID-19. The guidance is a living document that is
continuously updated by the TF as data emerge. Copyright  2021 American
Academy of Dermatology, Inc.Published by Elsevier Inc.All rights
reserved.</td>
</tr>
<tr class="even">
<td align="left">Impact of the Coronavirus Disease 2019 Pandemic on
Utilization of Mechanical Circulatory Support As Bridge to Heart
Transplantation.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Junctional tachycardia due to multisystem inflammatory
syndrome in children with SARS-CoV-2 infection in a 12-year-old
female.</td>
<td align="left">A 12-year-old girl presented with fever and signs of
systemic inflammation, and was found to have junctional tachycardia. She
was subsequently diagnosed with Multisystem Inflammatory Syndrome in
Children and treated with intravenous immunoglobulin and steroids, which
led to resolution of the arrhythmia.</td>
</tr>
<tr class="even">
<td align="left">Nonprofit capacities and emergency management during
the COVID-19 pandemic: Insights from a Taiwan-based international
nonprofit organization.</td>
<td align="left">During the COVID-19 pandemic, some nonprofit
organizations (NPOs) have been struggling to maintain their operations,
while others are able to coordinate with partners to provide programs
and services locally and globally. This study explores how NPOs are able
to survive and actively engage in local and global COVID-19 responses by
investigating the organizational capacities of the Tzu Chi Foundation, a
Taiwan-based international NPO. This study employs interview data and
secondary data from a variety of sources to answer the research
questions. Through this case study, we find that Tzu Chi Foundations
capacity to coordinate local and global COVID-19 issues quickly,
broadly, and effectively can be attributed to three main factors: (1)
clear mission and charismatic leadership, (2) rich experience of
disaster relief and recovery strategies, and (3) committed and active
volunteers. Moreover, we find that financial management capacity and
adaptive capacity are two crucial kinds of capacity for enabling the Tzu
Chi Foundation to survive and continuously engage in emergency responses
during the pandemic. We conclude with implications for future nonprofit
capacity and emergency management research.</td>
</tr>
<tr class="odd">
<td align="left">The COVID-19 pandemic: a target for surfactant
therapy?</td>
<td align="left"><AbstractText Label="INTRODUCTION">The dramatic impact
of COVID-19 on humans worldwide has initiated an extraordinary search
for effective treatment approaches. One of these is the administration
of exogenous surfactant, which is being tested in ongoing clinical
trials. <AbstractText Label="AREAS COVERED">Exogenous surfactant is a
life-saving treatment for premature infants with neonatal respiratory
distress syndrome. This treatment has also been tested for acute
respiratory distress syndrome (ARDS) with limited success possibly due
to the complexity of that syndrome. The 60-year history of successes and
failures associated with surfactant therapy distinguishes it from many
other treatments currently being tested for COVID-19 and provides the
opportunity to discuss the factors that may influence the success of
this therapy. <AbstractText Label="EXPERT OPINION">Clinical data provide
a strong rationale for using exogenous surfactant in COVID-19 patients.
Success of this therapy may be influenced by the mechanical ventilation
strategy, the timing of treatment, the doses delivered, the method of
delivery and the preparations utilized. In addition, future development
of enhanced preparations may improve this treatment approach. Overall,
results from ongoing trials may not only provide data to indicate if
this therapy is effective for COVID-19 patients, but also lead to
further scientific understanding and improved treatment strategies.</td>
</tr>
<tr class="even">
<td align="left">Early impact of the COVID-19 pandemic on outpatient
migraine care in Hawaii: Results of a quality improvement survey.</td>
<td align="left"><AbstractText Label="OBJECTIVE">A survey was
implemented for early assessment of pandemic-related practice processes
and quality improvement (QI). <AbstractText Label="BACKGROUND">In
response to the public health measures in Hawaii to curtail the
coronavirus 2019 pandemic, Hawaii Pacific Neuroscience (HPN) adapted
their patient care to ensure continuity of neurological treatment.
<AbstractText Label="METHODS">The telephone survey was conducted on
patients seen at HPN during the period of April 22, 2020-May 18, 2020 to
address four areas related to patients outpatient experience: delivery
of care, general well-being, experience with telemedicine, and
disease-specific questions. <AbstractText Label="RESULTS">A total of 928
patients were contacted of which 429 (46.2%) patients responded and 367
(85.5%) agreed to participate. A total of 133 patients with migraine and
234 patients with other neurological conditions provided responses. Our
migraine patients survey responses suggest that their well-being was
disproportionately negatively affected by the pandemic. Survey
respondents with migraine were significantly more likely than their
non-migraine peers to report worsening anxiety and sleep problems
[62/132 (47.0%) vs.78/234 (33.3%), 2 = 6.64, p = 0.010, and 64/132
(48.5%) vs.73/234 (31.2%), 2 = 10.77, p = 0.001]; migraine patients
also reported worsening of depression as a result of the pandemic more
than patients with other diagnoses, though this was not statistically
significant [44/132 (33.3%) vs.57/234 (24.4%), 2 = 3.40, p = 0.065].
In regard to access to healthcare, significantly more migraine patients
reported running out of medications than those with other diagnoses
[20/133 (15.0%) vs.18/234 (7.7%), 2 = 4.93, p = 0.026]. More avoided
seeking medical help for new health problems because of the pandemic
[30/133 (22.6%) vs.30/234 (12.8%), 2 = 5.88, p = 0.015]. Migraine
patients were also significantly impacted economically by the pandemic;
43/132 (32.4%) of migraine patients reported losing their jobs as the
result of the pandemic versus 34/234 (14.5%) of their peers (2 = 11.20,
p &lt; 0.001). An increase in headache severity or frequency was
reported in 39/118 (33.1%) of respondents and 19/118 (16.1%) reported to
using more abortive therapy than usual. Telemedicine was well received
by almost all patients who took advantage of the option. Most of those
patients found telemedicine to be easy to use and as valuable as an
in-person visit. Migraine patients indicated with more frequency that
without the telemedicine option, they would have missed their medical
appointments [37/68 (54.4%) vs.56/144 (38.6%), 2 = 4.31, p = 0.038]; a
majority would prefer or consider telemedicine for future appointments
over in-person visits. <AbstractText Label="CONCLUSIONS">Insights gained
from this QI survey to the practices new pandemic-related processes
include stressing lifestyle modification, optimizing treatment plans,
and continuing the option of telemedicine.  2020 American Headache
Society.</td>
</tr>
<tr class="odd">
<td align="left">Pregnant people deserve the protection offered by
SARS-CoV-2 vaccines.</td>
<td align="left"> It is imperative that vaccine development and
deployment include pregnant individuals because:  They are at equal, if
not greater, risk of severe COVID-19 illness than nonpregnant patients.
 Vertical transmission of SARS-CoV-2 to the fetus has been documented.
 Placental injury from SARS-CoV-2 may lead to stillbirth and poor
neonatal outcome.</td>
</tr>
<tr class="even">
<td align="left">Theory-based Behavioral Predictors of Self-reported Use
of Face Coverings in Public Settings during the COVID-19 Pandemic in the
United States.</td>
<td align="left"><AbstractText Label="BACKGROUND">Investigating
antecedents of behaviors, such as wearing face coverings, is critical
for developing strategies to prevent SARS-CoV-2 transmission.
<AbstractText Label="PURPOSE">The purpose of this study was to determine
associations between theory-based behavioral predictors of intention to
wear a face covering and actual wearing of a face covering in public.
<AbstractText Label="METHODS">Data from a cross-sectional panel survey
of U.S. adults conducted in May and June 2020 (N = 1,004) were used to
test a theory-based behavioral path model. We (a) examined predictors of
intention to wear a face covering, (b) reported use of cloth face
coverings, and (c) reported use of other face masks (e.g., a surgical
mask or N95 respirator) in public. <AbstractText Label="RESULTS">We
found that being female, perceived importance of others wanting the
respondent to wear a face covering, confidence to wear a face covering,
and perceived importance of personal face covering use was positively
associated with intention to wear a face covering in public. Intention
to wear a face covering was positively associated with self-reported
wearing of a cloth face covering if other people were observed wearing
cloth face coverings in public at least rarely (aOR = 1.43), with
stronger associations if they reported sometimes (aOR = 1.83), often
(aOR = 2.32), or always (aOR = 2.96). For other types of face masks, a
positive association between intention and behavior was only present
when observing others wearing face masks often (aOR = 1.25) or
always (aOR = 1.48). <AbstractText Label="CONCLUSIONS">Intention to
wear face coverings and observing other people wearing them are
important behavioral predictors of adherence to the CDC recommendation
to wear face coverings in public. Published by Oxford University Press
on behalf of the Society of Behavioral Medicine 2020.</td>
</tr>
<tr class="odd">
<td align="left">Unique pattern of COVID-19 infection in the State of
Hawaii.</td>
<td align="left">This is a brief report on an unusual observation
regarding COVID-19 cases. The State of Hawaii is one of the most remote
of the Pacific islands and the population is approximately 1.4 million.
The racial and ethnic diversity is very high. For example, white
Caucasians comprise 25%, Asians including Japanese, Chinese, and other
Asians account for 30%, Hawaiians for 20%, and Pacific Islanders mostly
from Micronesia and Samoa comprise 4%. We discovered that the COVID-19
rate in the latter group was up to 10 times that in all of the other
groups combined and they accounted for almost 30% of cases. Moreover, we
are unaware of COVID-19 transmission from Pacific Islanders to islanders
with other ethnicities. Thus, there is an epidemic within the epidemic
in Hawaii. Copyright  2020 The Author(s). Published by Elsevier Ltd..
All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">The lower COVID-19 related mortality and incidence
rates in Eastern European countries are associated with delayed start of
community circulation.</td>
<td align="left"><AbstractText Label="BACKGROUND">The purpose of this
analysis was to assess the variations in COVID-19 related mortality in
relation to the time differences in the commencement of virus
circulation and containment measures in the European Region.
<AbstractText Label="METHODS">The data for the current analysis (N = 50
countries) were retrieved from the John Hopkins University dataset on
the 7th of May 2020, with countries as study units. A piecewise
regression analysis was conducted with mortality and cumulative
incidence rates introduced as dependent variables and time interval
(days from the 22nd of January to the date when 100 first cases were
reported) as the main predictor. The country average life expectancy at
birth and outpatient contacts per person per year were statistically
adjusted for in the regression model.
<AbstractText Label="RESULTS">Mortality and incidence were strongly and
inversely intercorrelated with days from January 22, respectively -0.83
(p&lt;0.001) and -0.73 (p&lt;0.001). Adjusting for average life
expectancy and outpatients contacts per person per year, between days 33
to 50 from the 22nd of the January, the average mortality rate decreased
by 30.1/million per day (95% CI: 22.7, 37.6, p&lt;0.001). During
interval 51 to 73 days, the change in mortality was no longer
statistically significant but still showed a decreasing trend. A similar
relationship with time interval was found for incidence. Life expectancy
and outpatients contacts per person per year were not associated with
mortality rate. <AbstractText Label="CONCLUSION">Countries in Europe
that had the earliest COVID-19 circulation suffered the worst
consequences in terms of health outcomes, specifically mortality. The
drastic social isolation measures, quickly undertaken in response to
those initial outbreaks appear effective, especially in Eastern European
countries, where community circulation started after March 11th. The
study demonstrates that efforts to delay the early spread of the virus
may have saved an average 30 deaths daily per one million
inhabitants.</td>
</tr>
<tr class="odd">
<td align="left">Heterogeneity in SIR epidemics modeling: superspreaders
and herd immunity.</td>
<td align="left">Deterministic epidemic models, such as the
Susceptible-Infected-Recovered (SIR) model, are immensely useful even if
they lack the nuance and complexity of social contacts at the heart of
network science modeling. Here we present a simple modification of the
SIR equations to include the heterogeneity of social connection
networks. A typical power-law model of social interactions from network
science reproduces the observation that individuals with a high number
of contacts, hubs or superspreaders, can become the primary conduits
for transmission. Conversely, once the tail of the distribution is
saturated, herd immunity sets in at a smaller overall recovered fraction
than in the analogous SIR model. The new dynamical equations suggest
that cutting off the tail of the social connection distribution, i.e.,
stopping superspreaders, is an efficient non-pharmaceutical intervention
to slow the spread of a pandemic, such as the Coronavirus Disease 2019
(COVID-19).  The Author(s) 2020.</td>
</tr>
<tr class="even">
<td align="left">Quantifying human mobility behaviour changes during the
COVID-19 outbreak in the United States.</td>
<td align="left">Since the first case of the novel coronavirus disease
(COVID-19) was confirmed in Wuhan, China, social distancing has been
promoted worldwide, including in the United States, as a major community
mitigation strategy. However, our understanding remains limited in how
people would react to such control measures, as well as how people would
resume their normal behaviours when those orders were relaxed. We
utilize an integrated dataset of real-time mobile device location data
involving 100 million devices in the contiguous United States (plus
Alaska and Hawaii) from February 2, 2020 to May 30, 2020. Built upon the
common human mobility metrics, we construct a Social Distancing Index
(SDI) to evaluate peoples mobility pattern changes along with the
spread of COVID-19 at different geographic levels. We find that both
government orders and local outbreak severity significantly contribute
to the strength of social distancing. As people tend to practice less
social distancing immediately after they observe a sign of local
mitigation, we identify several states and counties with higher risks of
continuous community transmission and a second outbreak. Our proposed
index could help policymakers and researchers monitor peoples real-time
mobility behaviours, understand the influence of government orders, and
evaluate the risk of local outbreaks.</td>
</tr>
<tr class="odd">
<td align="left">Airborne Transmission of COVID-19: Aerosol Dispersion,
Lung Deposition, and Virus-Receptor Interactions.</td>
<td align="left">Coronavirus disease 2019 (COVID-19), due to infection
by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
now causing a global pandemic. Aerosol transmission of COVID-19,
although plausible, has not been confirmed by the World Health
Organization (WHO) as a general transmission route. Considering the
rapid spread of SARS-CoV-2, especially nosocomial outbreaks and other
superspreading events, there is an urgent need to study the possibility
of airborne transmission and its impact on the lung, the primary body
organ attacked by the virus. Here, we review the complete pathway of
airborne transmission of SARS-CoV-2 from aerosol dispersion in air to
subsequent biological uptake after inhalation. In particular, we first
review the aerodynamic and colloidal mechanisms by which aerosols
disperse and transmit in air and deposit onto surfaces. We then review
the fundamental mechanisms that govern regional deposition of micro- and
nanoparticles in the lung. Focus is given to biophysical interactions
between particles and the pulmonary surfactant film, the initial
alveolar-capillary barrier and first-line host defense system against
inhaled particles and pathogens. Finally, we summarize the current
understanding about the structural dynamics of the SARS-CoV-2 spike
protein and its interactions with receptors at the atomistic and
molecular scales, primarily as revealed by molecular dynamics
simulations. This review provides urgent and multidisciplinary knowledge
toward understanding the airborne transmission of SARS-CoV-2 and its
health impact on the respiratory system.</td>
</tr>
<tr class="even">
<td align="left">Organizational Health Literacy: Opportunities for
Patient-Centered Care in the Wake of COVID-19.</td>
<td align="left"><AbstractText Label="BACKGROUND AND OBJECTIVES">The
coronavirus disease-2019 (COVID-19) pandemic is transforming the health
care sector. As health care organizations move from crisis mobilization
to a new landscape of health and social needs, organizational health
literacy offers practical building blocks to provide high-quality,
efficient, and meaningful care to patients and their families.
Organizational health literacy is defined by the Institute of Medicine
as the degree to which an organization implements policies, practices,
and systems that make it easier for people to navigate, understand, and
use information and services to take care of their health.
<AbstractText Label="METHODS">This article synthesizes insights from
organizational health literacy in the context of current major health
care challenges and toward the goal of innovation in patient-centered
care. We first provide a brief overview of the origins and outlines of
organizational health literacy research and practice. Second, using an
established patient-centered innovation framework, we show how the
existing work on organizational health literacy can offer a menu of
effective, patient-centered innovative options for care delivery systems
to improve systems and outcomes. Finally, we consider the high value of
management focusing on organizational health literacy efforts,
specifically for patients in health care transitions and in the rapid
transformation of care into myriad distance modalities.
<AbstractText Label="RESULTS">This article provides practical guidance
for systems and informs decisions around resource allocation and
organizational priorities to best meet the needs of patient populations
even in the face of financial and workforce disruption.
<AbstractText Label="CONCLUSIONS">Organizational health literacy
principles and guidelines provide a road map for promoting
patient-centered care even in this time of crisis, change, and
transformation. Health system leaders seeking innovative approaches can
have access to well-established tool kits, guiding models, and materials
toward many organizational health literacy goals across treatment,
diagnosis, prevention, education, research, and outreach. Copyright 
2020 Wolters Kluwer Health, Inc.All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Dynamic Public Health Surveillance to Track and
Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis
Study.</td>
<td align="left"><AbstractText Label="BACKGROUND">The emergence of
SARS-CoV-2, the virus that causes COVID-19, has led to a global
pandemic. The United States has been severely affected, accounting for
the most COVID-19 cases and deaths worldwide. Without a coordinated
national public health plan informed by surveillance with actionable
metrics, the United States has been ineffective at preventing and
mitigating the escalating COVID-19 pandemic. Existing surveillance has
incomplete ascertainment and is limited by the use of standard
surveillance metrics. Although many COVID-19 data sources track
infection rates, informing prevention requires capturing the relevant
dynamics of the pandemic. <AbstractText Label="OBJECTIVE">The aim of
this study is to develop dynamic metrics for public health surveillance
that can inform worldwide COVID-19 prevention efforts. Advanced
surveillance techniques are essential to inform public health decision
making and to identify where and when corrective action is required to
prevent outbreaks. <AbstractText Label="METHODS">Using a longitudinal
trend analysis study design, we extracted COVID-19 data from global
public health registries. We used an empirical difference equation to
measure daily case numbers for our use case in 50 US states and the
District of Colombia as a function of the prior number of cases, the
level of testing, and weekly shift variables based on a dynamic panel
model that was estimated using the generalized method of moments
approach by implementing the Arellano-Bond estimator in R.
<AbstractText Label="RESULTS">Examination of the United States and state
data demonstrated that most US states are experiencing outbreaks as
measured by these new metrics of speed, acceleration, jerk, and
persistence. Larger US states have high COVID-19 caseloads as a function
of population size, density, and deficits in adherence to public health
guidelines early in the epidemic, and other states have alarming rates
of speed, acceleration, jerk, and 7-day persistence in novel infections.
North and South Dakota have had the highest rates of COVID-19
transmission combined with positive acceleration, jerk, and 7-day
persistence. Wisconsin and Illinois also have alarming indicators and
already lead the nation in daily new COVID-19 infections. As the United
States enters its third wave of COVID-19, all 50 states and the District
of Colombia have positive rates of speed between 7.58 (Hawaii) and
175.01 (North Dakota), and persistence, ranging from 4.44 (Vermont) to
195.35 (North Dakota) new infections per 100,000 people.
<AbstractText Label="CONCLUSIONS">Standard surveillance techniques such
as daily and cumulative infections and deaths are helpful but only
provide a static view of what has already occurred in the pandemic and
are less helpful in prevention. Public health policy that is informed by
dynamic surveillance can shift the country from reacting to COVID-19
transmissions to being proactive and taking corrective action when
indicators of speed, acceleration, jerk, and persistence remain positive
week over week. Implicit within our dynamic surveillance is an early
warning system that indicates when there is problematic growth in
COVID-19 transmissions as well as signals when growth will become
explosive without action. A public health approach that focuses on
prevention can prevent major outbreaks in addition to endorsing
effective public health policies. Moreover, subnational analyses on the
dynamics of the pandemic allow us to zero in on where transmissions are
increasing, meaning corrective action can be applied with precision in
problematic areas. Dynamic public health surveillance can inform
specific geographies where quarantines are necessary while preserving
the economy in other US areas. Lori Ann Post, Tariq Ziad Issa, Michael
J Boctor, Charles B Moss, Robert L Murphy, Michael G Ison, Chad J
Achenbach, Danielle Resnick, Lauren Nadya Singh, Janine White, Joshua
Marco Mitchell Faber, Kasen Culler, Cynthia A Brandt, James Francis
Oehmke. Originally published in the Journal of Medical Internet Research
(<a href="http://www.jmir.org" class="uri">http://www.jmir.org</a>),
03.12.2020.</td>
</tr>
<tr class="even">
<td align="left">CoVaccine HT Adjuvant Potentiates Robust Immune
Responses to Recombinant SARS-CoV-2 Spike S1 Immunization.</td>
<td align="left">The current COVID-19 pandemic has claimed hundreds of
thousands of lives and its causative agent, SARS-CoV-2, has infected
millions, globally. The highly contagious nature of this respiratory
virus has spurred massive global efforts to develop vaccines at record
speeds. In addition to enhanced immunogen delivery, adjuvants may
greatly impact protective efficacy of a SARS-CoV-2 vaccine. To
investigate adjuvant suitability, we formulated protein subunit vaccines
consisting of the recombinant S1 domain of SARS-CoV-2 Spike protein
alone or in combination with either CoVaccine HT or Alhydrogel.
CoVaccine HT induced high titres of antigen-binding IgG after a single
dose, facilitated affinity maturation and class switching to a greater
extent than Alhydrogel and elicited potent cell-mediated immunity as
well as virus neutralizing antibody titres. Data presented here suggests
that adjuvantation with CoVaccine HT can rapidly induce a comprehensive
and protective immune response to SARS-CoV-2. Copyright  2020 Haun,
Lai, Williams, Wong, Lieberman, Pessaint, Andersen and Lehrer.</td>
</tr>
<tr class="odd">
<td align="left">CCR5 inhibition in critical COVID-19 patients decreases
inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2
RNA in plasma by day 14.</td>
<td align="left"><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now
a global pandemic. Emerging results indicate a dysregulated immune
response. Given the role of CCR5 in immune cell migration and
inflammation, we investigated the impact of CCR5 blockade via the
CCR5-specific antibody leronlimab on clinical, immunological, and
virological parameters in severe COVID-19 patients.
<AbstractText Label="METHODS" NlmCategory="METHODS">In March 2020, 10
terminally ill, critical COVID-19 patients received two doses of
leronlimab via individual emergency use indication. We analyzed changes
in clinical presentation, immune cell populations, inflammation, as well
as SARS-CoV-2 plasma viremia before and 14 days after treatment.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Over the 14-day
study period, six patients survived, two were extubated, and one
discharged. We observed complete CCR5 receptor occupancy in all donors
by day 7. Compared with the baseline, we observed a concomitant
statistically significant reduction in plasma IL-6, restoration of the
CD4/CD8 ratio, and resolution of SARS-CoV2 plasma viremia (pVL).
Furthermore, the increase in the CD8 percentage was inversely correlated
with the reduction in pVL (r = -0.77, p = 0.0013).
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study
design precludes clinical efficacy inferences but the results implicate
CCR5 as a therapeutic target for COVID-19 and they form the basis for
ongoing randomized clinical trials. Copyright  2020 The Authors.
Published by Elsevier Ltd.. All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">An Outbreak of Covid-19 on an Aircraft Carrier.</td>
<td align="left"><AbstractText Label="BACKGROUND">An outbreak of
coronavirus disease 2019 (Covid-19) occurred on the U.S.S. Theodore
Roosevelt, a nuclear-powered aircraft carrier with a crew of 4779
personnel. <AbstractText Label="METHODS">We obtained clinical and
demographic data for all crew members, including results of testing by
real-time reverse-transcriptase polymerase chain reaction (rRT-PCR). All
crew members were followed up for a minimum of 10 weeks, regardless of
test results or the absence of symptoms.
<AbstractText Label="RESULTS">The crew was predominantly young (mean
age, 27 years) and was in general good health, meeting U.S. Navy
standards for sea duty. Over the course of the outbreak, 1271 crew
members (26.6% of the crew) tested positive for severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection by rRT-PCR testing, and
more than 1000 infections were identified within 5 weeks after the first
laboratory-confirmed infection. An additional 60 crew members had
suspected Covid-19 (i.e., illness that met Council of State and
Territorial Epidemiologists clinical criteria for Covid-19 without a
positive test result). Among the crew members with laboratory-confirmed
infection, 76.9% (978 of 1271) had no symptoms at the time that they
tested positive and 55.0% had symptoms develop at any time during the
clinical course. Among the 1331 crew members with suspected or confirmed
Covid-19, 23 (1.7%) were hospitalized, 4 (0.3%) received intensive care,
and 1 died. Crew members who worked in confined spaces appeared more
likely to become infected. <AbstractText Label="CONCLUSIONS">SARS-CoV-2
spread quickly among the crew of the U.S.S. Theodore Roosevelt.
Transmission was facilitated by close-quarters conditions and by
asymptomatic and presymptomatic infected crew members. Nearly half of
those who tested positive for the virus never had symptoms. Copyright 
2020 Massachusetts Medical Society.</td>
</tr>
<tr class="odd">
<td align="left">The impact of COVID-19 on manuscript submissions to
Pediatric Research.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Medicine in motion: Opportunities, challenges and data
analytics-based solutions for traditional medicine integration into
western medical practice.</td>
<td align="left"><AbstractText Label="ETHNOPHARMACOLOGICAL RELEVANCE" NlmCategory="BACKGROUND">Traditional
pharmacopeias have been developed by multiple cultures and evaluated for
efficacy and safety through both historical/empirical iteration and more
recently through controlled studies using Western scientific paradigms
and an increasing emphasis on data science methodologies for network
pharmacology. Traditional medicines represent likely sources of
relatively inexpensive drugs for symptomatic management as well as
potential libraries of new therapeutic approaches. Leveraging this
potential requires hard evidence for efficacy that separates science
from pseudoscience.
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We
performed a review of non-Western medical systems and developed case
studies that illustrate the epistemological and practical translative
barriers that hamper their transition to integration with Western
approaches. We developed a new data analytics approach, in silico
convergence analysis, to deconvolve modes of action, and potentially
predict desirable components of TM-derived formulations based on
computational consensus analysis across cultures and medical systems.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Abstraction,
simplification and altered dose and delivery modalities were identified
as factors that influence actual and perceived efficacy once a medicine
is moved from a non-Western to Western setting. Case studies on these
factors highlighted issues with translation between non-Western and
Western epistemologies, including those where epistemological and
medicinal systems drive markets that can be epicenters for zoonoses such
as the novel Coronavirus. The proposed novel data science approach
demonstrated the ability to identify and predict desirable medicinal
components for a test indication, pain.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Relegation
of traditional therapies to the relatively unregulated nutraceutical
industry may lead healthcare providers and patients to underestimate the
therapeutic potential of these medicines. We suggest three areas of
emphasis for this field: First, vertical integration and embedding of
traditional medicines into healthcare systems would subject them to
appropriate regulation and evidence-based practice, as viable
integrative implementation mode. Second, we offer a new
Bradford-Hill-like framework for setting research priorities and
evaluating efficacy, with the goal of rescuing potentially valuable
therapies from the nutraceutical market and discrediting those that are
pseudoscience. Third, data analytics pipelines offer new capacity to
generate new types of TMS-inspired medicines that are
rationally-designed based on integrated knowledge across cultures, and
also provide an evaluative framework against which to test claims of
fidelity and efficacy to TMS made for nutraceuticals. Copyright  2020
The Author(s). Published by Elsevier B.V. All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Cancer Screening During the Coronavirus Disease-2019
Pandemic: A Perspective From the National Cancer Institutes PROSPR
Consortium.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Global Public Health Database Support to
Population-Based Management of Pandemics and Global Public Health
Crises, Part II: The Database.</td>
<td align="left">This two-part article examines the global public health
(GPH) information system deficits emerging in the coronavirus disease
2019 (COVID-19) pandemic. It surveys past, missed opportunities for
public health (PH) information system and operational improvements,
examines current megatrend changes to information management, and
describes a new multi-disciplinary model for population-based management
(PBM) supported by a GPH Database applicable to pandemics and GPH
crises.</td>
</tr>
<tr class="odd">
<td align="left">Associations Between Genetically Predicted Protein
Levels and COVID-19 Severity.</td>
<td align="left">It is critical to identify potential causal targets for
SARS-CoV-2, which may guide drug repurposing options. We assessed the
associations between genetically predicted protein levels and COVID-19
severity. Leveraging data from the COVID-19 Host Genetics Initiative
comparing 6492 hospitalized COVID-19 patients and 1 012 809 controls, we
identified 18 proteins with genetically predicted levels to be
associated with COVID-19 severity at a false discovery rate of &lt;0.05,
including 12 that showed an association even after Bonferroni
correction. Of the 18 proteins, 6 showed positive associations and 12
showed inverse associations. In conclusion, we identified 18 candidate
proteins for COVID-19 severity.  The Author(s) 2020. Published by
Oxford University Press for the Infectious Diseases Society of America.
All rights reserved. For permissions, e-mail: <a href="mailto:journals.permissions@oup.com" class="email">journals.permissions@oup.com</a>.</td>
</tr>
<tr class="even">
<td align="left">Epilepsy in the time of COVID-19.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Commentaries on Viewpoint: The interaction between
SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral
susceptibility and myopathies.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Perspective: Cancer Patient Management Challenges
During the COVID-19 Pandemic.</td>
<td align="left">On March 11, 2020, the WHO has declared the coronavirus
disease 2019 (COVID-19) a global pandemic. As the last few months have
profoundly changed the delivery of health care in the world, we should
recognize the effort of numerous comprehensive cancer centers to share
experiences and knowledge to develop best practices to care for
oncological patients during the COVID-19 pandemic. Patients as well as
physicians must be aware of all these constraints and profound social,
personal, and medical challenges posed by the tackling of this deadly
disease in everyday life in order to adjust to such a completely novel
scenario. This review will discuss facing the challenges and the current
approaches that cancer centers in Italy and United States are adopting
in order to cope with clinical and research activities. Copyright  2020
Terracciano, Buonerba, Scafuri, De Berardinis, Calin, Ferrajoli, Fabbri
and Cimmino.</td>
</tr>
<tr class="odd">
<td align="left">Workflow Solutions for Primary Care Clinic Recovery
During the COVID-19 Pandemic: A Primer.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Will COVID-19 be one shock too many for smallholder
coffee livelihoods?</td>
<td align="left">Coffee supports the livelihoods of millions of
smallholder farmers in more than 52 countries, and generates billions of
dollars in revenue. The threats that COVID-19 pose to the global coffee
sector is daunting with profound implications for coffee production. The
financial impacts will be long-lived and uneven, and smallholders will
be among the hardest hit. We argue that the impacts are rooted in the
systemic vulnerability of the coffee production system and the unequal
ways the sector is organized: Large revenues from the sale of coffee in
the Global North are made possible by mostly impoverished smallholders
in the Global South. COVID-19 will accentuate the existing
vulnerabilities and create new ones, forcing many smallholders into
alternative livelihoods. This outcome, however, is not inevitable.
COVID-19 presents an opportunity to rebalance the system that currently
creates large profits on one end of the supply chain and great
vulnerability on the other.  2020 Elsevier Ltd.All rights
reserved.</td>
</tr>
<tr class="odd">
<td align="left">Spotlight on Nursing: Navigating Uncharted Waters:
Preparing COVID-19 Capable Nurses to Work in a Transformed
Workplace.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Public Compliance with Face Mask Use in Honolulu and
Regional Variation.</td>
<td align="left">Infections with the SARS-CoV-2 virus are increasing in
Hawaii at alarming rates. In the absence of a SARS-CoV-2 virus vaccine,
the options for control include social distancing, improved hygiene, and
face mask use. There is evidence that mask use may decrease the rates of
viral transmission. The rate of effective face mask use has not yet been
established in Hawaii. The authors performed an observational study at
2 locations in Honolulu and evaluated outdoor face mask use compliance
in 200 people. Simultaneous observations were performed in a downtown
Honolulu business area and in Waikiki, an area focusing on tourism.
Overall, 77% of all subjects used face masks in an appropriate fashion,
covering their nose and mouth, while 23% were either incorrectly masked
or not masked. The rate of compliance with correct public mask use in
downtown Honolulu (88%) was significantly higher than in Waikiki (66%)
(P=.0003, Odds Ratio [95% Confidence Interval]=3.78 [1.82, 7.85]) These
findings suggest that there are opportunities for improvement in rates
of public face mask use and a potential decrease in the spread of
COVID-19 in our population. Four proposed actions are suggested,
including a reassessment of the face mask exemption requirements,
enhanced mask compliance education, non-threatening communication for
non-compliance, and centralization of information of the public
compliance with face mask use. Copyright 2020 by University Health
Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">Ensuring mental health access for vulnerable
populations in COVID era.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Evidence based care for pregnant women with
covid-19.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Prediction and Severity Ratings of COVID-19 in the
United States.</td>
<td align="left"><AbstractText Label="OBJECTIVES">The objectives of this
study is to predict the possible trajectory of coronavirus disease 2019
(COVID-19) spread in the United States. Prediction and severity ratings
of COVID-19 are essential for pandemic control and economic reopening in
the United States. <AbstractText Label="METHOD">In this study, we apply
the logistic and Gompertz model to evaluate possible turning points of
the COVID-19 pandemic in different regions. By combining uncertainty and
severity factors, this study constructed an indicator to assess the
severity of the coronavirus outbreak in various states.
<AbstractText Label="RESULTS">Based on the index of severity ratings,
different regions of the United States are classified into 4 categories.
The result shows that it is possible to identify the first turning point
in Montana and Hawaii. It is unclear when the rest of the states will
reach the first peak. However, it can be inferred that 75% of regions
will not reach the first peak of coronavirus before August 2, 2020.
<AbstractText Label="CONCLUSION">It is still essential for the majority
of states to take proactive steps to fight against COVID-19 before
August 2, 2020.</td>
</tr>
<tr class="even">
<td align="left">National Psoriasis Foundation COVID-19 Task Force
Guidance for Management of Psoriatic Disease During the Pandemic:
Version 1.</td>
<td align="left"><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To
provide guidance about management of psoriatic disease during the
coronavirus disease 2019 (COVID-19) pandemic.
<AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">A task force
(TF) of 18 physician voting members with expertise in dermatology,
rheumatology, epidemiology, infectious diseases, and critical care was
convened. The TF was supplemented by nonvoting members, which included
fellows and National Psoriasis Foundation (NPF) staff. Clinical
questions relevant to the psoriatic disease community were informed by
questions received by the NPF. A Delphi process was conducted.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The TF approved 22
guidance statements. The average of the votes was within the category of
agreement for all statements. All guidance statements proposed were
recommended, 9 with high consensus and 13 with moderate consensus.
<AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The evidence
behind many guidance statements is limited in quality.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These
statements provide guidance for the management of patients with
psoriatic disease on topics ranging from how the disease and its
treatments impact COVID-19 risk and outcome, how medical care can be
optimized during the pandemic, what patients should do to lower their
risk of getting infected with severe acute respiratory syndrome
coronavirus 2 and what they should do if they develop COVID-19. The
guidance is intended to be a living document that will be updated by the
TF as data emerge. Copyright  2020 American Academy of Dermatology,
Inc.Published by Elsevier Inc.All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Saliva is a reliable, non-invasive specimen for
SARS-CoV-2 detection.</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the cause of
Coronavirus Disease 2019 (COVID-19). Although Real Time Reverse
Transcription Polymerase Chain Reaction (qRT-PCR) of respiratory
specimens is the gold standard test for detection of SARS-CoV-2
infection, collecting nasopharyngeal swabs causes discomfort to patients
and may represent considerable risk for healthcare workers. The use of
saliva as a diagnostic sample has several advantages.
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this
study was to validate the use of saliva as a biological sample for
diagnosis of COVID-19.
<AbstractText Label="METHODS" NlmCategory="METHODS">This study was
conducted at Infectious Diseases Research Laboratory (LAPI), in
Salvador, Brazil. Participants presenting with signs/symptoms suggesting
SARS-CoV-2 infection underwent a nasopharyngeal swab (NPS) and/or
oropharyngeal swab (OPS), and saliva collection. Saliva samples were
diluted in PBS, followed by RNA isolation and RT-Real Time PCR for
SARS-CoV-2. Results of conventional vs saliva samples testing were
compared. Statistical analyses were performed using Statistical Package
for the Social Sciences software (SPSS) version 18.0.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred
fifty-five participants were recruited and samples pairs of NPS/OPS and
saliva were collected. The sensitivity and specificity of RT-PCR using
saliva samples were 94.4% (95% CI 86.4-97.8) and 97.62% (95% CI
91.7-99.3), respectively. There was an overall high agreement (96.1%)
between the two tests.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Use of
self-collected saliva samples is an easy, convenient, and low-cost
alternative to conventional NP swab-based molecular tests. These results
may allow a broader use of molecular tests for management of COVID19
pandemic, especially in resources-limited settings. Copyright  2020
Sociedade Brasileira de Infectologia. Published by Elsevier Espaa,
S.L.U. All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">Delivering Prolonged Exposure Therapy via
Videoconferencing During the COVID-19 Pandemic: An Overview of the
Research and Special Considerations for Providers.</td>
<td align="left">Leveraging technology to provide evidence-based therapy
for posttraumatic stress disorder (PTSD), such as prolonged exposure
(PE), during the COVID-19 pandemic helps ensure continued access to
first-line PTSD treatment. Clinical video teleconferencing (CVT)
technology can be used to effectively deliver PE while reducing the risk
of COVID-19 exposure during the pandemic for both providers and
patients. However, provider knowledge, experience, and comfort level
with delivering mental health care services, such as PE, via CVT is
critical to ensure a smooth, safe, and effective transition to virtual
care. Further, some of the limitations associated with the pandemic,
including stay-at-home orders and physical distancing, require that
providers become adept at applying principles of exposure therapy with
more flexibility and creativity, such as when assigning in vivo
exposures. The present paper provides the rationale and guidelines for
implementing PE via CVT during COVID-19 and includes practical
suggestions and clinical recommendations. Published 2020. This article
is a U.S. Government work and is in the public domain in the USA.</td>
</tr>
<tr class="odd">
<td align="left">Comparison of Telehealth-Related Ethics and Guidelines
and a Checklist for Ethical Decision Making in the Midst of the COVID-19
Pandemic.</td>
<td align="left">Applied behavior analysis (ABA) services have been
provided primarily in the fields of health care and education across
various settings using an in-person service delivery model. Due to the
COVID-19 pandemic, the necessity of and demand for ABA services using
telehealth have increased. The purpose of the present article was to
cross-examine the ethical codes and guidelines of different, but related
fields of practice and to discuss potential implications for
telehealth-based ABA service delivery. We reviewed the
telehealth-specific ethical codes and guidelines of the American
Psychological Association, the American Academy of Pediatrics, and the
National Association of Social Workers, along with the related ABA
literature. These organizations addressed several useful and unique
ethical concerns that have not been addressed in ABA literature. We also
developed a brief checklist for ABA practitioners to evaluate their
telehealth readiness by meeting the legal, professional, and ethical
requirements of ABA services.  Association for Behavior Analysis
International 2020.</td>
</tr>
<tr class="even">
<td align="left">What is the best mouthrinse against coronaviruses?</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Reactive arthritis after COVID-19 infection.</td>
<td align="left">Reactive arthritis (ReA) is typically preceded by
sexually transmitted disease or gastrointestinal infection. An
association has also been reported with bacterial and viral respiratory
infections. Herein, we report the first case of ReA after the he severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This
male patient is in his 50s who was admitted with COVID-19 pneumonia. On
the second day of admission, SARS-CoV-2 PCR was positive from
nasopharyngeal swab specimen. Despite starting standard dose of
favipiravir, his respiratory condition deteriorated during
hospitalisation. On the fourth hospital day, he developed acute
respiratory distress syndrome and was intubated. On day 11, he was
successfully extubated, subsequently completing a 14-day course of
favipiravir. On day 21, 1 day after starting physical therapy, he
developed acute bilateral arthritis in his ankles, with mild enthesitis
in his right Achilles tendon, without rash, conjunctivitis, or preceding
diarrhoea or urethritis. Arthrocentesis of his left ankle revealed mild
inflammatory fluid without monosodium urate or calcium pyrophosphate
crystals. Culture of synovial fluid was negative. Plain X-rays of his
ankles and feet showed no erosive changes or enthesophytes. Tests for
syphilis, HIV, anti-streptolysin O (ASO), Mycoplasma, Chlamydia
pneumoniae, antinuclear antibody, rheumatoid factor, anticyclic
citrullinated peptide antibody and Human Leukocyte Antigen-B27 (HLA-B27)
were negative. Gonococcal and Chlamydia trachomatis urine PCR were also
negative. He was diagnosed with ReA. Nonsteroidal Anti-Inflammatory Drug
(NSAID)s and intra-articular corticosteroid injection resulted in
moderate improvement.  Author(s) (or their employer(s)) 2020. Re-use
permitted under CC BY-NC. No commercial re-use. See rights and
permissions. Published by BMJ.</td>
</tr>
<tr class="even">
<td align="left">3D printing of face shields to meet the immediate need
for PPE in an anesthesiology department during the COVID-19
pandemic.</td>
<td align="left"><AbstractText Label="BACKGROUND">Anesthesia providers
are at risk for contracting COVID-19 due to close patient contact,
especially during shortages of personal protective equipment. We present
an easy to follow and detailed protocol for producing 3D printed face
shields and an effective decontamination protocol, allowing their reuse.
<AbstractText Label="METHODS">The University of Nebraska Medical Center
(UNMC) produced face shields using a combination of 3D printing and
assembly with commonly available products, and produced a simple
decontamination protocol to allow their reuse. To evaluate the
effectiveness of the decontamination protocol, we inoculated bacterial
suspensions of E. coli and S. aureus on to the face shield components,
performed the decontamination procedure, and finally swabbed and
enumerated organisms onto plates that were incubated for 12-24 hours.
Decontamination effectiveness was evaluated using the average log10
reduction in colony counts. <AbstractText Label="RESULTS">Approximately
112 face shields were constructed and made available for use in 72
hours. These methods were successfully implemented for in-house
production at UNMC and at Tripler Army Medical Center (Honolulu,
Hawaii). Overall, the decontamination protocol was highly effective
against both E. coli and S. aureus, achieving a 4 log10 (99.99%)
reduction in colony counts for every replicate from each component of
the face shield unit. <AbstractText Label="DISCUSSION">Face shields not
only act as a barrier against the soiling of N95 face masks, they also
serve as more effective eye protection from respiratory droplets over
standard eye shields. Implementation of decontamination protocols
successfully allowed face shield and N95 mask reuse, offering a higher
level of protection for anesthesiology providers at the onset of the
COVID-19 pandemic. <AbstractText Label="CONCLUSIONS">In a time of urgent
need, our protocol enabled the rapid production of face shields by
individuals with little to no 3D printing experience, and provided a
simple and effective decontamination protocol allowing reuse of the face
shields. Copyright  2020 Association for Professionals in Infection
Control and Epidemiology, Inc.All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">Obstetric hospital preparedness for a pandemic: an
obstetric critical care perspective in response to COVID-19.</td>
<td align="left">The Coronavirus disease 2019 (COVID-19) caused by
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic
has had a rapid and deadly onset, spreading quickly throughout the
world. Pregnant patients have had high mortality rates, perinatal
losses, and Intensive Care Unit (ICU) admissions from acute respiratory
syndrome Coronavirus (SARS-CoV) and Middle East respiratory syndrome
Coronavirus (MERS-CoV) in the past. Potentially, a surge of patients may
require hospitalization and ICU care beyond the capacity of the health
care system. This article is to provide institutional guidance on how to
prepare an obstetric hospital service for a pandemic, mass casualty, or
natural disaster by identifying a care model and resources for a large
surge of critically ill pregnant patients over a short time. We
recommend a series of protocols, education, and simulation training,
with a structured and tiered approach to match the needs for the
patients, for hospitals specialized in obstetrics.</td>
</tr>
<tr class="even">
<td align="left">COVID-19 outbreak on the Diamond Princess Cruise Ship
in February 2020.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Academic clinical learning environment in obstetrics
and gynecology during the COVID-19 pandemic: responses and lessons
learned.</td>
<td align="left">COVID-19 pandemic is changing profoundly the obstetrics
and gynecology (OB/GYN) academic clinical learning environment in many
different ways. Rapid developments affecting our learners, patients,
faculty and staff require unprecedented collaboration and quick, deeply
consequential readjustments, almost on a daily basis. We summarized here
our experiences, opportunities, challenges and lessons learned and
outline how to move forward. The COVID-19 pandemic taught us there is a
clear need for collaboration in implementing the most current
evidence-based medicine, rapidly assess and improve the everchanging
healthcare environment by problem solving and how to instead of
should we approach. In addition, as a community with very limited
resources we have to rely heavily on internal expertise, ingenuity and
innovation. The key points to succeed are efficient and timely
communication, transparency in decision making and reengagement. As time
continues to pass, it is certain that more lessons will emerge.</td>
</tr>
<tr class="even">
<td align="left">Role of modelling in COVID-19 policy development.</td>
<td align="left">Models have played an important role in policy
development to address the COVID-19 outbreak from its emergence in China
to the current global pandemic. Early projections of international
spread influenced travel restrictions and border closures. Model
projections based on the viruss infectiousness demonstrated its
pandemic potential, which guided the global response to and prepared
countries for increases in hospitalisations and deaths. Tracking the
impact of distancing and movement policies and behaviour changes has
been critical in evaluating these decisions. Models have provided
insights into the epidemiological differences between higher and lower
income countries, as well as vulnerable population groups within
countries to help design fit-for-purpose policies. Economic evaluation
and policies have combined epidemic models and traditional economic
models to address the economic consequences of COVID-19, which have
informed policy calls for easing restrictions. Social contact and
mobility models have allowed evaluation of the pathways to safely relax
mobility restrictions and distancing measures. Finally, models can
consider future end-game scenarios, including how suppression can be
achieved and the impact of different vaccination strategies. Copyright 
2020. Published by Elsevier Ltd.</td>
</tr>
<tr class="odd">
<td align="left">Modelling insights into the COVID-19 pandemic.</td>
<td align="left">Coronavirus disease 2019 (COVID-19) is a newly emerged
infectious disease caused by the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) that was declared a pandemic by the World
Health Organization on 11th March, 2020. Response to this ongoing
pandemic requires extensive collaboration across the scientific
community in an attempt to contain its impact and limit further
transmission. Mathematical modelling has been at the forefront of these
response efforts by: (1) providing initial estimates of the SARS-CoV-2
reproduction rate, R0 (of approximately 2-3); (2) updating these
estimates following the implementation of various interventions (with
significantly reduced, often sub-critical, transmission rates); (3)
assessing the potential for global spread before significant case
numbers had been reported internationally; and (4) quantifying the
expected disease severity and burden of COVID-19, indicating that the
likely true infection rate is often orders of magnitude greater than
estimates based on confirmed case counts alone. In this review, we
highlight the critical role played by mathematical modelling to
understand COVID-19 thus far, the challenges posed by data availability
and uncertainty, and the continuing utility of modelling-based
approaches to guide decision making and inform the public health
response. Unless otherwise stated, all bracketed error margins
correspond to the 95% credible interval (CrI) for reported estimates.
Copyright  2020. Published by Elsevier Ltd.</td>
</tr>
<tr class="even">
<td align="left">The Daniel K. Inouye College of Pharmacy Scripts: Panic
or Panacea, Changing the Pharmacists Role in Pandemic COVID-19.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Combating COVID-19 and Building Immune Resilience: A
Potential Role for Magnesium Nutrition?</td>
<td align="left">Background: In December 2019, the viral pandemic of
respiratory illness caused by COVID-19 began sweeping its way across the
globe. Several aspects of this infectious disease mimic metabolic events
shown to occur during latent subclinical magnesium deficiency.
Hypomagnesemia is a relatively common clinical occurrence that often
goes unrecognized since magnesium levels are rarely monitored in the
clinical setting. Magnesium is the second most abundant intracellular
cation after potassium. It is involved in &gt;600 enzymatic reactions in
the body, including those contributing to the exaggerated immune and
inflammatory responses exhibited by COVID-19 patients.Methods: A summary
of experimental findings and knowledge of the biochemical role magnesium
may play in the pathogenesis of COVID-19 is presented in this
perspective. The National Academy of Medicines Standards for Systematic
Reviews were independently employed to identify clinical and prospective
cohort studies assessing the relationship of magnesium with
interleukin-6, a prominent drug target for treating COVID-19.Results:
Clinical recommendations are given for prevention and treatment of
COVID-19. Constant monitoring of ionized magnesium status with
subsequent repletion, when appropriate, may be an effective strategy to
influence disease contraction and progression. The peer-reviewed
literature supports that several aspects of magnesium nutrition warrant
clinical consideration. Mechanisms include its calcium-channel
blocking effects that lead to downstream suppression of nuclear
factor-K, interleukin-6, c-reactive protein, and other related
endocrine disrupters; its role in regulating renal potassium loss; and
its ability to activate and enhance the functionality of vitamin D,
among others.Conclusion: As the world awaits an effective vaccine,
nutrition plays an important and safe role in helping mitigate patient
morbidity and mortality. Our group is working with the Academy of
Nutrition and Dietetics to collect patient-level data from intensive
care units across the United States to better understand nutrition care
practices that lead to better outcomes.</td>
</tr>
<tr class="even">
<td align="left">Viewpoint: Pacific Voyages - Ships - Pacific
Communities: A Framework for COVID-19 Prevention and Control.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">A role for selenium-dependent GPX1 in SARS-CoV-2
virulence.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Communicating Effectively With Hospitalized Patients
and Families During the COVID-19 Pandemic.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">The Impact of the COVID-19 Pandemic on Vulnerable Older
Adults in the United States.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">Covid-19 and Diabetes in Hawaii.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Treatments Administered to the First 9152 Reported
Cases of COVID-19: A Systematic Review.</td>
<td align="left">The emergence of SARS-CoV-2/2019 novel coronavirus
(COVID-19) has created a global pandemic with no approved treatments or
vaccines. Many treatments have already been administered to COVID-19
patients but have not been systematically evaluated. We performed a
systematic literature review to identify all treatments reported to be
administered to COVID-19 patients and to assess time to clinically
meaningful response for treatments with sufficient data. We searched
PubMed, BioRxiv, MedRxiv, and ChinaXiv for articles reporting treatments
for COVID-19 patients published between 1 December 2019 and 27 March
2020. Data were analyzed descriptively. Of the 2706 articles identified,
155 studies met the inclusion criteria, comprising 9152 patients. The
cohort was 45.4% female and 98.3% hospitalized, and mean (SD) age was
44.4 years (SD 21.0). The most frequently administered drug classes were
antivirals, antibiotics, and corticosteroids, and of the 115 reported
drugs, the most frequently administered was combination
lopinavir/ritonavir, which was associated with a time to clinically
meaningful response (complete symptom resolution or hospital discharge)
of 11.7 (1.09) days. There were insufficient data to compare across
treatments. Many treatments have been administered to the first 9152
reported cases of COVID-19. These data serve as the basis for an
open-source registry of all reported treatments given to COVID-19
patients at www.CDCN.org/CORONA . Further work is needed to prioritize
drugs for investigation in well-controlled clinical trials and treatment
protocols.</td>
</tr>
<tr class="even">
<td align="left">Insights in Public Health: COVID-19 Special Column: The
Crisis of Non-Communicable Diseases in the Pacific and the Coronavirus
Disease 2019 Pandemic.</td>
<td align="left">Globally, coronavirus disease 2019 (COVID-19) is
threatening human health and changing the way people live. With the
increasing evidence showing comorbidities of COVID-19 and
non-communicable diseases (NCDs), the Pacific region, where
approximately 75% of deaths are due to NCDs, is significantly vulnerable
during this crisis unless urgent action is taken. Whilst enforcing the
critical mitigation measures of the COVID-19 pandemic in the Pacific, it
is also paramount to incorporate and strengthen NCD prevention and
control measures to safeguard people with NCDs and the general
population; keep people healthy and minimise the impact of COVID-19. To
sustain wellbeing of health, social relationships, and the economy in
the Pacific, it is a critical time for all governments, development
partners and civil societies to show regional solidarity in the fight
against emerging COVID-19 health crisis and existing Pacific NCDs crisis
through a whole of government and whole of society approach. Copyright
2020 by University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">COVID-19 Special Column: COVID-19 Hits Native Hawaiian
and Pacific Islander Communities the Hardest.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">COVID-19 Special Column: Principles Behind the
Technology for Detecting SARS-CoV-2, the Cause of COVID-19.</td>
<td align="left">Nationwide shortages of tests that detect severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and diagnose coronavirus
disease 2019 (COVID-19) have led the US Food and Drug Administration
(FDA) to significantly relax regulations regarding COVID-19 diagnostic
testing. To date the FDA has given emergency use authorization (EUA) to
48 COVID-19 in vitro diagnostic tests and 21 high complexity
molecular-based laboratory developed tests, as well as implemented
policies that give broad authority to clinical laboratories and
commercial manufacturers in the development, distribution, and use of
COVID-19 diagnostic tests. Currently, there are 2 types of diagnostic
tests available for the detection of SARS-CoV-2: (1) molecular and (2)
serological tests. Molecular detection of nucleic acid (RNA or DNA)
sequences relating to the suspected pathogen is indicative of an active
infection with the suspected pathogen. Serological tests detect
antibodies against the suspected pathogen, which are produced by an
individuals immune system. A positive serological test result indicates
recent exposure to the suspected pathogen but cannot be used to
determine if the individual is actively infected with the pathogen or
immune to reinfection. In this article, the SARS-CoV-2 diagnostic tests
currently approved by the FDA under EUA are reviewed, and other
diagnostic tests that researchers are developing to detect SARS-CoV-2
infection are discussed. Copyright 2020 by University Health Partners
of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="odd">
<td align="left">ACE2 receptor expression in testes: implications in
coronavirus disease 2019 pathogenesis.</td>
<td align="left">Expression of angiotensin-converting enzyme 2, receptor
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is high
in the testes, therefore SARS-CoV-2 infection and its association with
male reproductive health should be investigated in male coronavirus
disease 2019 patients.</td>
</tr>
<tr class="even">
<td align="left">Caring for Critically Ill Adults With Coronavirus
Disease 2019 in a PICU: Recommendations by Dual Trained
Intensivists.</td>
<td align="left"><AbstractText Label="OBJECTIVE">In the midst of the
severe acute respiratory syndrome coronavirus 2 pandemic, which causes
coronavirus disease 2019, there is a recognized need to expand critical
care services and beds beyond the traditional boundaries. There is
considerable concern that widespread infection will result in a surge of
critically ill patients that will overwhelm our present adult ICU
capacity. In this setting, one proposal to add surge capacity has been
the use of PICU beds and physicians to care for these critically ill
adults. <AbstractText Label="DESIGN">Narrative review/perspective.
<AbstractText Label="SETTING">Not applicable.
<AbstractText Label="PATIENTS">Not applicable.
<AbstractText Label="INTERVENTIONS">None.
<AbstractText Label="MEASUREMENTS AND MAIN RESULTS">The viruss high
infectivity and prolonged asymptomatic shedding have resulted in an
exponential growth in the number of cases in the United States within
the past weeks with many (up to 6%) developing acute respiratory
distress syndrome mandating critical care services. Coronavirus disease
2019 critical illness appears to be primarily occurring in adults.
Although pediatric intensivists are well versed in the care of acute
respiratory distress syndrome from viral pneumonia, the care of
differing aged adult populations presents some unique challenges. In
this statement, a team of adult and pediatric-trained critical care
physicians provides guidance on common adult issues that may be
encountered in the care of these patients and how they can best be
managed in a PICU. <AbstractText Label="CONCLUSIONS">This concise
scientific statement includes references to the most recent and relevant
guidelines and clinical trials that shape management decisions. The
intention is to assist PICUs and intensivists in rapidly preparing for
care of adult coronavirus disease 2019 patients should the need
arise.</td>
</tr>
<tr class="odd">
<td align="left">Geospatial analysis of COVID-19 and otolaryngologists
above age 60.</td>
<td align="left"><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The
2019 novel coronavirus (COVID-19) is disproportionately impacting older
individuals and healthcare workers. Otolaryngologists are especially
susceptible with the elevated risk of aerosolization and corresponding
high viral loads. This study utilizes a geospatial analysis to
illustrate the comparative risks of older otolaryngologists across the
United States during the COVID-19 pandemic.
<AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">Demographic
and state population data were extracted from the State Physician
Workforce Reports published by the AAMC for the year 2018. A geospatial
heat map of the United States was then constructed to illustrate the
location of COVID-19 confirmed case counts and the distributions of ENTs
over 60 years for each state.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2018, out of a
total of 9578 practicing U.S. ENT surgeons, 3081 were older than 60
years (32.2%). The states with the highest proportion of ENTs over 60
were Maine, Delaware, Hawaii, and Louisiana. The states with the highest
ratios of confirmed COVID-19 cases to the number of total ENTs over 60
were New York, New Jersey, Massachusetts, and Michigan.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on our
models, New York, New Jersey, Massachusetts, and Michigan represent
states where older ENTs may be the most susceptible to developing severe
complications from nosocomial transmission of COVID-19 due to a
combination of high COVID-19 case volumes and a high proportion of ENTs
over 60 years. Copyright  2020 Elsevier Inc.All rights reserved.</td>
</tr>
<tr class="even">
<td align="left">The War on COVID-19 Pandemic: Role of Rehabilitation
Professionals and Hospitals.</td>
<td align="left">The global outbreak of coronavirus disease 2019 has
created an unprecedented challenge to the society. Currently, the United
States stands as the most affected country, and the entire healthcare
system is affected, from emergency department, intensive care unit,
postacute care, outpatient, to home care. Considering the debility,
neurological, pulmonary, neuromuscular, and cognitive complications,
rehabilitation professionals can play an important role in the recovery
process for individuals with coronavirus disease 2019. Clinicians across
the nations rehabilitation system have already begun working to
initiate intensive care unit-based rehabilitation care and develop
programs, settings, and specialized care to meet the short- and
long-term needs of these individuals. We describe the anticipated
rehabilitation demands and the strategies to meet the needs of this
population. The complications from coronavirus disease 2019 can be
reduced by (1) delivering interdisciplinary rehabilitation that is
initiated early and continued throughout the acute hospital stay, (2)
providing patient/family education for self-care after discharge from
inpatient rehabilitation at either acute or subacute settings, and (3)
continuing rehabilitation care in the outpatient setting and at home
through ongoing therapy either in-person or via telehealth.</td>
</tr>
<tr class="odd">
<td align="left">The COronavirus Pandemic Epidemiology (COPE)
Consortium: A Call to Action.</td>
<td align="left">The rapid pace of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2; COVID-19) pandemic presents challenges to the
real-time collection of population-scale data to inform near-term public
health needs as well as future investigations. We established the
COronavirus Pandemic Epidemiology (COPE) consortium to address this
unprecedented crisis on behalf of the epidemiology research community.
As a central component of this initiative, we have developed a COVID
Symptom Study (previously known as the COVID Symptom Tracker) mobile
application as a common data collection tool for epidemiologic cohort
studies with active study participants. This mobile application collects
information on risk factors, daily symptoms, and outcomes through a
user-friendly interface that minimizes participant burden. Combined with
our efforts within the general population, data collected from nearly 3
million participants in the United States and United Kingdom are being
used to address critical needs in the emergency response, including
identifying potential hot spots of disease and clinically actionable
risk factors. The linkage of symptom data collected in the app with
information and biospecimens already collected in epidemiology cohorts
will position us to address key questions related to diet, lifestyle,
environmental, and socioeconomic factors on susceptibility to COVID-19,
clinical outcomes related to infection, and long-term physical, mental
health, and financial sequalae. We call upon additional epidemiology
cohorts to join this collective effort to strengthen our impact on the
current health crisis and generate a new model for a collaborative and
nimble research infrastructure that will lead to more rapid translation
of our work for the betterment of public health. 2020 American
Association for Cancer Research.</td>
</tr>
<tr class="even">
<td align="left">Risk Factors Associated With Clinical Outcomes in 323
Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan,
China.</td>
<td align="left"><AbstractText Label="BACKGROUND">With evidence of
sustained transmission in more than 190 countries, coronavirus disease
2019 (COVID-19) has been declared a global pandemic. Data are urgently
needed about risk factors associated with clinical outcomes.
<AbstractText Label="METHODS">A retrospective review of 323 hospitalized
patients with COVID-19 in Wuhan was conducted. Patients were classified
into 3 disease severity groups (nonsevere, severe, and critical), based
on initial clinical presentation. Clinical outcomes were designated as
favorable and unfavorable, based on disease progression and response to
treatments. Logistic regression models were performed to identify risk
factors associated with clinical outcomes, and log-rank test was
conducted for the association with clinical progression.
<AbstractText Label="RESULTS">Current standard treatments did not show
significant improvement in patient outcomes. By univariate logistic
regression analysis, 27 risk factors were significantly associated with
clinical outcomes. Multivariate regression indicated age &gt;65 years (P
&lt; .001), smoking (P = .001), critical disease status (P = .002),
diabetes (P = .025), high hypersensitive troponin I (&gt;0.04 pg/mL, P =
.02), leukocytosis (&gt;10  109/L, P &lt; .001), and neutrophilia
(&gt;75  109/L, P &lt; .001) predicted unfavorable clinical outcomes.
In contrast, the administration of hypnotics was significantly
associated with favorable outcomes (P &lt; .001), which was confirmed by
survival analysis. <AbstractText Label="CONCLUSIONS">Hypnotics may be an
effective ancillary treatment for COVID-19. We also found novel risk
factors, such as higher hypersensitive troponin I, predicted poor
clinical outcomes. Overall, our study provides useful data to guide
early clinical decision making to reduce mortality and improve clinical
outcomes of COVID-19.  The Author(s) 2020. Published by Oxford
University Press for the Infectious Diseases Society of America. All
rights reserved. For permissions, e-mail: <a href="mailto:journals.permissions@oup.com" class="email">journals.permissions@oup.com</a>.</td>
</tr>
<tr class="odd">
<td align="left">High-flow nasal cannula may be no safer than
non-invasive positive pressure ventilation for COVID-19 patients.</td>
<td align="left">NA</td>
</tr>
<tr class="even">
<td align="left">SAGES and EAES recommendations for minimally invasive
surgery during COVID-19 pandemic.</td>
<td align="left">The unprecedented pandemic of COVID-19 has impacted
many lives and affects the whole healthcare systems globally. In
addition to the considerable workload challenges, surgeons are faced
with a number of uncertainties regarding their own safety, practice, and
overall patient care. This guide has been drafted at short notice to
advise on specific issues related to surgical service provision and the
safety of minimally invasive surgery during the COVID-19 pandemic.
Although laparoscopy can theoretically lead to aerosolization of blood
borne viruses, there is no evidence available to confirm this is the
case with COVID-19. The ultimate decision on the approach should be made
after considering the proven benefits of laparoscopic techniques versus
the potential theoretical risks of aerosolization. Nevertheless, erring
on the side of safety would warrant treating the coronavirus as
exhibiting similar aerosolization properties and all members of the OR
staff should use personal protective equipment (PPE) in all surgical
procedures during the pandemic regardless of known or suspected COVID
status. Pneumoperitoneum should be safely evacuated via a filtration
system before closure, trocar removal, specimen extraction, or
conversion to open. All emergent endoscopic procedures performed during
the pandemic should be considered as high risk and PPE must be used by
all endoscopy staff.</td>
</tr>
<tr class="odd">
<td align="left">COVID-19 Community Stabilization and Sustainability
Framework: An Integration of the Maslow Hierarchy of Needs and Social
Determinants of Health.</td>
<td align="left">All levels of government are authorized to apply
coronavirus disease 2019 (COVID-19) protection measures; however, they
must consider how and when to ease lockdown restrictions to limit
long-term societal harm and societal instability. Leaders that use a
well-considered framework with an incremental approach will be able to
gradually restart society while simultaneously maintaining the public
health benefits achieved through lockdown measures. Economically
vulnerable populations cannot endure long-term lockdown, and most
countries lack the ability to maintain a full nationwide relief
operation. Decision-makers need to understand this risk and how the
Maslow hierarchy of needs and the social determinants of health can
guide whole of society policies. Aligning decisions with societal needs
will help ensure all segments of society are catered to and met while
managing the crisis. This must inform the process of incremental easing
of lockdowns to facilitate the resumption of community foundations, such
as commerce, education, and employment in a manner that protects those
most vulnerable to COVID-19. This study proposes a framework for
identifying a path forward. It reflects on baseline requirements,
regulations and recommendations, triggers, and implementation. Those
desiring a successful recovery from the COVID-19 pandemic need to adopt
an evidence-based framework now to ensure community stabilization and
sustainability.</td>
</tr>
<tr class="even">
<td align="left">Insights from immuno-oncology: the Society for
Immunotherapy of Cancer Statement on access to IL-6-targeting therapies
for COVID-19.</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">Pain Management Best Practices from Multispecialty
Organizations During the COVID-19 Pandemic and Public Health
Crises.</td>
<td align="left"><AbstractText Label="BACKGROUND">It is nearly
impossible to overestimate the burden of chronic pain, which is
associated with enormous personal and socioeconomic costs. Chronic pain
is the leading cause of disability in the world, is associated with
multiple psychiatric comorbidities, and has been causally linked to the
opioid crisis. Access to pain treatment has been called a fundamental
human right by numerous organizations. The current COVID-19 pandemic has
strained medical resources, creating a dilemma for physicians charged
with the responsibility to limit spread of the contagion and to treat
the patients they are entrusted to care for.
<AbstractText Label="METHODS">To address these issues, an expert panel
was convened that included pain management experts from the military,
Veterans Health Administration, and academia. Endorsement from
stakeholder societies was sought upon completion of the document within
a one-week period. <AbstractText Label="RESULTS">In these guidelines, we
provide a framework for pain practitioners and institutions to balance
the often-conflicting goals of risk mitigation for health care
providers, risk mitigation for patients, conservation of resources, and
access to pain management services. Specific issues discussed include
general and intervention-specific risk mitigation, patient flow issues
and staffing plans, telemedicine options, triaging recommendations,
strategies to reduce psychological sequelae in health care providers,
and resource utilization. <AbstractText Label="CONCLUSIONS">The COVID-19
public health crisis has strained health care systems, creating a
conundrum for patients, pain medicine practitioners, hospital leaders,
and regulatory officials. Although this document provides a framework
for pain management services, systems-wide and individual decisions must
take into account clinical considerations, regional health conditions,
government and hospital directives, resource availability, and the
welfare of health care providers. The Author(s) 2020. Published by
Oxford University Press on behalf of the American Academy of Pain
Medicine. This work is written by a US Government employee and is in the
public domain in the US.</td>
</tr>
<tr class="even">
<td align="left">Coronaviruses: Facts, Myths, and Hypotheses.</td>
<td align="left">NA</td>
</tr>
</tbody>
</table>
<p>Done! Knit the document, commit, and push.</p>
</div>
<div id="final-pro-tip-optional" class="section level2">
<h2>Final Pro Tip (optional)</h2>
<p>You can still share the HTML document on github. You can include a
link in your <code>README.md</code> file as the following:</p>
<pre class="md"><code>View [here](https://cdn.jsdelivr.net/gh/:user/:repo@:tag/:file) </code></pre>
<p>For example, if we wanted to add a direct link the HTML page of
lecture 6, we could do something like the following:</p>
<pre class="md"><code>View Week 6 Lecture [here]()</code></pre>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
